[
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Path No.: Date Obtained: (Age: ). Date Received: F. See Addendum/Procedure. SPECIMEN: A:Lymph node, right axilla sentinel node, biopsy. B:Breast, right, lumpectomy. C:Lymph nodes, right axilla, dissection. DIAGNOSIS(ES): A. Lymph node, right axilla sentinel node, biopsy: - Carcinoma in 1 sentinel node following carcinoma of right breast. B. Breast, right, lumpectomy: - Carcinoma, invasive ductal type, moderately-differentiated, with focal micropapillary features,. Nottingham's score 5 (2+2+1). - Carcinoma, intraductal, comedo type with microcalcifications. - Lobular neoplasia, focal, classical type. - Fibrocystic disease, proliferative, with apocrine metaplasia, sclerosing adenosis and. microcalcifications. - Cicatricial fibrosis and organizing granulation tissue with fat necrosis, consistent with previous. biopsy site. - Fibroadenoma, microscopic. C. Lymph nodes, right axilla, dissection: - No evidence of carcinoma in 14 lymph nodes. Date Dictated: CLINICAL INFORMATION: Breast cancer. GROSS DESCRIPTION: The specimen is received in three parts. Part A is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and \"R sentinel lymph node\". It consists of one firm tan to red lymph node measuring 2.0 x 1.8 X 1,0 cm, The. specimen is serially sectioned. Submitted in toto in three cassettes labeled AFS, A1 and A2. AFS = frozen section, A1. - A2 = remaining tissue,. Part B is received unfixed in a container labeled with the patient's name and \"R breast lumpectomy\". It consists of a. piece of yellow-white fibrofatty tissue measuring 10.5 X 9.0 x 6,0 cm. An ellipse of skin is not present. An X-ray is. received. A localization needle is not noted. A short suture is noted indicating the superior margin and a row of long. sutures are noted indicating the lateral margin. A mass is palpated in the center. The superficial surface is inked yellow. and the deep surface is inked black. The specimen is serially sectioned. On cut section, the mass is tan, firm, poorly. circumscribed and measures 3.2 x 3.0 x 3.0 cm. The mass comes to 0.3 cm of the superficial, 0.5 cm of the deep and. 2.5 cm of the lateral margins. The tissue is composed of 60% fat and 40% intermixed firm tan-white parenchyma. Representative sections are submitted in 29 cassettes labeled B1 - B29. Legend: B1 = mass and closest deep surface,. B2 = mass and closest superficial surface(B1 and B2 = full thickness of mass),. B3 - B8 = mass with adjacent deep margin. B9 - B17 = superficial margin over mass. B18 - B19 = mass. B20 - B21 = superior. B22 - B23 = deep margin in lateral part(closest to mass). B24 - B25 If lateral. B26 - B27 = inferior. B28 - B29 = medial. Part C is received unfixed in a container labeled with the patient's name and \"R axillary lymph node dissection\". It. consists of two pieces of yellow-red fatty tissue measuring 4.0 x 2.7 x 1.0 cm and 10.0 x 7.0 X 1.0 cm. A suture is noted. attached to one end of the larger piece of fatty tissue. Fourteen lymph moves measuring from 0.6 X 0.5 x 0.5 cm. to. 3.5. x 1.5 x 1.0 cm are identified. The lymph nodes are submitted in toto 10 cassettes labeled C1 - C10. Legend: C1 = five intact nodes, C2 - C5 = one bisected node in each cassettes, C6 = one intact node, C7 - C8 = one. large quadrisected node, C9 - C10 = nodes closest to suture(larger node is bisected). INTRAOPERATIVE CONSULTATION: AFS: Metastatic carcinoma in lymph node. Performed by: Resident: interpreted by: Attending: MICROSCOPIC DESCRIPTION: I. TYPE OF SPECIMEN: Right breast, excisional biopsy/lumpectomy. Right axillary node dissection. II. LOCATION OF THE TUMOR: Upper outer quadrant. III. TYPE OF NEOPLASM: Carcinoma, invasive - ductal type NOS with micropapillary features. Histological Grading: Moderately differentiated. (Nuclear grade 2 and Tubular & Glandular differentiation grade 2). Ductal carcinoma in situ, nuclear grade 3, multifocal 10%. intraductal comedo subtype. Necrosis is present within the intraductal subtype. Lobular neoplasia, type A (monomorphic), Focal in 2 of 29 slides. IV. GROSS/MICRO FINAL INVASIVE TUMOR SIZE INTERPRETATION: 3.2 x 3.0 x 3.0 cm. V. BORDERS OF INVASIVE NEOPLASM: III-defined. VI. VASCULAR SPACE INVASION: Present in lymphatics. VII. CALCIFICATION: Present in both malignant and benign areas. VIII. NIPPLE: N/A. IX. SKIN: N/A. X. ADJACENT BREAST TISSUE: Fibroadenoma (size 0,2 cm.). Cystic disease, proliferative. XI. SURGICAL MARGIN: No carcinoma is identified on surgical margins. Tumor distance from closest deep (slide \"B1\") margin: 0.6 cm. XII. AXILLARY LYMPH NODES: TOTAL: 15. HIGH POINT: 2. SENTINEL NODE: 1. XIII. POSITIVE LYMPH NODES: TOTAL: 1. HIGH POINT: 0. SENTINEL NODE: 1. DEGREE OF INVOLVEMENT: Extensive replacement. EXTRANODAL EXTENSION: Present. XIV. PECTORAL MUSCLE: No pectoral muscle identified. This report has been reviewed electronically and signed on. Interpreted by: Attending: The diagnosis was rendered by the attending pathologist. Addendum. ADDENDUM. Slides were reviewed by. The diagnosis rendered is in. agreement with the original diagnosis. This procedure/addenda has been electronically reviewed and signed on. Interpreted by: Attending: Note: Immunochemistry testing performed at. was developed and Its performance characteristics determined by the. These tests were interpreted in conjunction with external positive and internal negative controla, unless otherwise noted It has not been cleared or approved by the US. FDA. This test is used for clinical purposes only, It should not be regarded as Investigational or for research.\n        ",
    "Answer": 1,
    "Filename": "TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the pathology report, the gross/micro final invasive tumor size interpretation is 3.2 x 3.0 x 3.0 cm. This size falls into the category of T2, as the tumor is greater than 2 cm but less than or equal to 5 cm. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract information from the pathology report, specifically the tumor size.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.2 x 3.0 x 3.0 cm, which corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Path No.: Date Obtained: (Age: ). Date Received: F. SPECIMEN: Breast, right, skin sparing modified radical mastectomy. DIAGNOSIS(ES): Breast, right, skin sparing modified radical mastectomy: Invasive ductal carcinoma, poorly differentiated (Modified Scarff Bloom Richardson Score 3+3+2=8/9),. multifocal, with lymphatic invasion. Metastatic carcinoma in 1/23 axillary lymph nodes (See microscopic description). pT2N1. CLINICAL INFORMATION: Right breast cancer. GROSS DESCRIPTION: The specimen is received unfixed in a container labeled with the patient's name and \"Right breast mastectomy\". It. consists. of. a right modified mastectomy specimen measuring 24,0 X 20,0 x 5.2 cm. A suture is noted indicating the. axillary tail. The overlying skin measures 14.5 X 8.0 cm. The nipple is mobile and everted. An underlying mass is. palpable in the 6 o'clock position. The deep (fascial) margin- is inked black and the remaining margins are inked yellow. The. axillary tissue measures 11.0 X 6,5 x 2.0 cm. Multiple lymph nodes are palpable within it measuring from 0.5 cm to. 1.7 cm in greatest dimension. The lymph nodes are dissected, proceeding from the breast toward the axilla. The. specimen is serially sectioned at closely spaced intervals revealing a firm, poorly circumscribed, white and focally. hemorrhagic. mass measuring 3.5 x 3.0 x 2.0 cm located in the inferior aspect of the specimen (6 o'clock position). The. mass comes to within 0.8 cm of the skin and 3.0 cm of the deep margin. A second firm, well circumscribed mass. measuring 0.7 x 0.5 x 0.5 is also identified located located 0.8 cm from the skin, 2.4 cm from the deep margin and 2,0. cm from the previously described mass, superiorly. The parenchyma superior and lateral to both masses is firm,. lobulated and gritty over an area measuring 4.0 x 3.5 x 2.0 cm. The remaining tissue is composed of a moderate. amount of breast tissue and a moderate amount of yellow fatty tissue. Representative sections are submitted in 37. cassettes labeled A1-A37. Please note: The specimen was placed in formalin at. LEGEND: A1-A3 = Nipple. A4 = Deep margin closest to main mass. A5 = Main mass with closest skin. A6-A8 = Main mass. A9-A10 = Smaller mass. A11 = Smaller mass with closest skin. A12 = Deep margin closest to smaller mass. A13-A18 = Gritty area surrounding masses. A19-A20 = Upper inner quadrant. A21-A22 = Lower inner quadrant. A23-A24 = Lower outer quadrant. A25-A26 = Upper outer quadrant. A27 = Bisected lymph node closest to breast. A28 =3 intact nodes. A29 = 3 intact nodes. A30 = 1 bisected node. A31. = 1 bisected node. A32 = 1 bisected node. A33 = 2 intact nodes. A34 = 4 intact nodes. A35 = 3 intact nodes. A36 = 2 intact nodes. A37 = 1 bisected node at high point. MICROSCOPIC DESCRIPTION: I. TYPE OF SPECIMEN: Right modified radical mastectomy. II. LOCATION OF THE TUMOR: Central (6 o'clock), extending into lower inner and outer quadrants. III. TYPE OF NEOPLASM: Carcinoma, invasive, ductal, with central scar and micropapillary features. Poorly Differentiated, Total score 8. (Tubule Score 3, Nuclear Grade Score 3, Mitotic Score 2). Ductal carcinoma in situ, nuclear grade 3, multifocal 30%. Intraductal papillary subtype. Intraductal micropapillary subtype. Intraductal solid subtype. Intraductal comedo subtype. Necrosis is present within the intraductal carcinoma. Lobular neoplasia is not present. IV. GROSS/MICRO FINAL INVASIVE TUMOR SIZE INTERPRETATION: 3.5 x 3.0 x 2,0 cm. (In addition, separate. foci of invasive carcinoma are seen superior to and lateral to the main mass these have a similar histology; the largest. such focus measures 1.5cm on the slide. VI. VASCULAR SPACE INVASION: Present in lymphatics. VII. CALCIFICATION: Present in malignant areas. VIII,. NIPPLE: Present, uninvolved by cancer. IX. SKIN: Present, uninvolved by cancer. X. ADJACENT BREAST TISSUE: Cystic disease, proliferative with atypia. XI. MARGINS: Negative. XII. AXILLARY LYMPH NODES: XII. AXILLARY LYMPH NODES: TOTAL: 23. HIGH POINT: 1. XIII. POSITIVE LYMPH NODES: XIII. POSITIVE LYMPH NODES: TOTAL: 1. LEVEL I;. 1 (adjacent to breast). EXTRANODAL EXTENSION: Present. XIV. PECTORAL MUSCLE: No pectoral muscle identified. XV. PATHOLOGIC STAGING (pTNM) AJCC 7th Edition: Reflects staging only of the current specimen. Ultimate. staging responsibility rests with the primary physician. pT2: Tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension. pN1a: Metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm). This report has been reviewed electronically and signed on. Interpreted by: Attending: The diagnosis was rendered by the attending pathologist. Note; Immunochemistry testing performed at. was developed and its performance characteristice determined by the. These tests were interpreted in conjunction with external positive and internal regative controls, unless otherwise noted. It has not been cleared of approved by the US. FDA. This test Is used for clinical purposes only. it should not be regarded as investigational or for research.\n        ",
    "Answer": 1,
    "Filename": "TCGA-3C-AALJ.265E5A9A-64FD-4B86-89BC-5E89F253C118",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the provided pathology report. The key information for determining the T stage is the size of the tumor and its extension to nearby tissues. The report mentions that the tumor measures 3.5 x 3.0 x 2.0 cm, which directly informs the T stage classification. According to the AJCC 7th edition, T1 is defined as a tumor not more than 2.0 cm in greatest dimension, T2 is defined as a tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension, T3 is defined as a tumor more than 5.0 cm in greatest dimension, and T4 is defined by the tumor's extension to the chest wall or skin, regardless of size. Given that the tumor in question is 3.5 cm in its greatest dimension, it falls into the T2 category because it is more than 2.0 cm but not more than 5.0 cm. Additionally, the report explicitly states 'pT2' under the pathologic staging section, which aligns with this interpretation.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report, such as tumor size and invasion. Then, I'll apply the AJCC Cancer Staging Manual (7th edition) rules to determine the T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Path No.: Date Obtained: (Age: ). Date Received: F. See Addendum/Procedure. SPECIMEN: A:Subnipple tissue, right breast, excision. B:Lymph node, right axilla sentinel node, biopsy. C:Lymph node, right axilla sentinel node #2, biopsy. D:Breast, right, total mastectomy. E:Skin, right breast, excision. DIAGNOSIS(ES): A. Subnipple tissue, right breast, excision: Nipple ducts with atypical micropapillary hyperplasia. No carcinoma seen. B. Lymph node, right axilla sentinel node, biopsy: Lymph node, bisected and serially sectioned, negative for carcinoma. IHC for cytokeratin is negative. C. Lymph node, right axilla sentinel node #2, biopsy: Lymph node, quadrasected and serially sectioned, single focus of carcinoma seen by light microscopy. and IHC for cytokeratin (focus of < 10 cells, ITC). D. Breast, right, total mastectomy: Infiltrating ductal carcinoma, well differentiated (1+2+1=4/9), spanning 2,0 cm, arising in a background. of ductal carcinoma in situ, intermediate to high grade. Infiltrating ductal carcinoma, separate focus, moderately differentiated (3+3+1=719), spanning 0.6 cm. Extensive ductal carcinoma in situ, solid, cribriform and micropapillary type, with necrosis and. microcalcification, seen on 15 of 26 slides and extending to within 0.1 cm of deep margin. The. micropapillary DCIS is seen in the nipple duct sections. Lobular carcinoma in situ, monomorphic type. Intraductal papillomas and sclerosing adenosis with microcalcification. Fibroadenoma. E. Skin, right breast, excision: Fragments of skin. CLINICAL INFORMATION: Right breast cancer,. GROSS DESCRIPTION;. The specimen is received in five parts. Part A is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and \"Rt subnipple tissue R/O cancer\". It consists of one piece of red soft tissue measuring 1.1 x 0,9 X 0.3 cm. The specimen is entirely submitted in one cassette labeled AFS. Part B is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and \"Right axillary sentinel lymph node #1\". It consists of one piece of fatty tissue measuring 3.2 x 1.4 x 0.8 cm. One lymph node is palpated measuring 1.8 cm in greatest dimension. The lymph node is bisected. The specimen is. entirely submitted in four cassettes labeled BFS1-BFS2, B1 and B2. Please note: Three levels and cytokeratin stains. are ordered for the lymph node only. Legend: BFS1-BFS2 = frozen section-lymph node, B1-B2 = remaining tissue. Part C is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and \"Right axillary sentinel lymph node #2\". It consists of one piece of fatty tissue measuring 2.8 x 1.9 x 1.1 cm. One. lymph node is palpated measuring 2.7 cm in greatest dimension. The lymph node is quadrisected. The specimen. is entirely submitted in five cassettes labeled CFS1-CFS4 and C1. Please note: Three levels and cytokeratin stains are. ordered for the lymph node only. Legend: CFS1-CFS4 = frozen section-lymph node, C1 = remaining tissue. Part D is received unfixed in a container labeled with the patient's name and \"Right breast mastectomy, stitch short. anterior subnipple tissue, stitch long = lateral\". It consists of a right total skin sparing mastectomy specimen measuring. 22.0. x. 14.0. X. 3.5 cm. A short suture is noted indicating the subareolar and a long suture is noted indicating the superior. (as per Dr. the long suture was mistakenly labeled \"lateral\"). An underlying mass is palpable located 1.0 cm. from. the. subareolar. The subareolar is inked blue, the superficial margin is inked yellow and the deep margin is inked. black. The axillary tissue measures 2.5 x 1.5 x 0.5 cm. No lymph nodes are palpable within it. The. specimen is serially sectioned at closely spaced intervals, revealing an area of white, cystic parenchyma measuring. 6.0 x 4.0 x 2.5 cm located in the center, 0.5 cm from the deep margin and 0.2 cm from the superficial margin. Within. the cystic parenchyma is a firm, poorly circumscribed, white-tan mass measuring 2.0 x 2.0 x 1.5 cm which comes to. within 0.6 cm from the deep margin and 1.3 cm from the superficial margin. At least four scattered yellow-white nodules. measuring from 0.5 cm to 0.8 cm in diameter are also seen within the cystic parenchyma located 0.3 cm from the. deep. margin and 1.5 cm from the superficial margin and at least 1.0 cm from the mass. The remainder of the specimen is. composed of a moderate amount of breast tissue (60%) and a moderate amount of yellow fatty tissue (40%). Also. received in the container is one irregular piece of soft, fibrofatty, yellow-red tissue measuring 4.0 x 3.0 x 1.0 cm. On cut. surface, no discrete lesions or lymph nodes are identified. Representative sections are submitted in 26 cassettes. labeled D1-D26. Please note: The specimen was placed in formalin at. LEGEND: D1-D2 = Submucosal area. D3-D4 = Mass with adjacent deep margin. D5-D7 = Remaining portion of mass. D8 = Superficial margin closest to mass. D9-D10 = Nodule closest to mass with adjacent surrounding tissue and deep margin. D11 = Remaining portion of nodule with adjacent surrounding tissue. D12-D15 = Surrounding nodules in cystic parenchyma. D16-D17 = Cystic parenchyma. D18-D19 = Upper inner quadrant. D20-D21 = Lower inner quadrant. D22-D23 = Lower outer quadrant. D24-D25 = Upper outer quadrant. D26 = Fibrofatty tissue also received in the container. Part E Is received unfixed in a container labeled with the patient's name and \"Skin from mastectomy R breast\". It. consists of a strip of rubbery, tan-brown skin measuring 11.6 x 0.7 x 0.2 cm. Representative sections are submitted in. one cassette labeled E1. Please note: The specimen was placed in formalin at. INTRAOPERATIVE CONSULTATION: AFS: Benign breast tissue and large ducts. No carcinoma seen. BFS1, BFS2: No carcinoma seen. CFS1, CFS2: No carcinoma seen. CFS3, CFS4: No carcinoma seen. Performed by: Resident: Interpreted by: Attending: MICROSCOPIC DESCRIPTION: TYPE OF SPECIMEN: Right total mastectomy with sentinel node dissection. II. LOCATION OF THE TUMOR: Central. III. TYPE OF NEOPLASM: Carcinoma, Invasive, Ductal - NOS (Nodule 1). Well Differentiated, Total score 4. (Tubule Score 1, Nuclear Grade Score 2, Mitotic Score 1). TUMOR SIZE: The tumor's greatest dimension 2.0 cm. Carcinoma, Invasive, Ductal - NOS (Nodule 2). Moderately Differentiated, Total score 7. (Tubule Score 3, Nuclear Grade Score 3, Mitotic Score 1). TUMOR SIZE: The tumor's greatest dimension 0.6 cm. Ductal carcinoma in situ, nuclear grade 3, widespread 30%. QUANTITATION: Ductal carcinoma in situ is present in 15 of 26 slides of breast. Intraductal solid subtype, cribriform, comedo, micropapillary/. VI. VASCULAR SPACE INVASION: Present in lymphatics. VII. CALCIFICATION: Present in both malignant and benign areas. VIII. NIPPLE: Ducts involved by DCIS. IX. SKIN: Present, uninvolved by cancer. X. ADJACENT BREAST TISSUE: Cystic disease, proliferative with atypia. MARGINS: Tumor distance from closest margin DCIS- <0.1 cm fromm deep margin. XII. AXILLARY LYMPH NODES: Sentinel - 2. XIII. POSITIVE LYMPH NODES: Sentinel - ITC only. XV. PATHOLOGIC STAGING (pTNM) AJCC 7th Edition: Reflects staging only. of the current specimen. Ultimate. staging responsibility rests with the primary physician. pT1c: Tumor more than 1.0 cm but not more than 2.0 cm in greatest dimension. pNO(ITC,i+): No regional lymph node metastasis on H & E histologically, (ie. Individual tumor cells seen,. none greater than 0.2 mm, positive IHC. COMMENT(S): Case shown at. This report has been reviewed electronically and signed on. Interpreted by: Attending: The diagnosis was rendered by the attending pathologist. Receptor Expression Analysis. INTERPRETATION. Test Performed on formalin fixed paraffin embedded section of: mastectomy. The results are for invasive carcínoma #1. Specimen part: D. Slide#. D3. Fixation: adequate. This tumor is considered positive for estrogen receptor expression (21 % of the cells are positive). The. specimen was adequate for evaluation for ER as per ASCO/CAP guidelines 2010. Approximately 75 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-estrogen receptor antibody. ) with an average intermediate intensity. This tumor is considered positive for progesterone receptor expression (> 1 % of the cells are positive). The. specimen was adequate for evaluation for PR as per ASCO/CAP guidelines 2010, Approximately 80 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-progesterone receptor antibody. ) with an average strong intensity. Equivocal/indeterminate for HER2 expression. Her-2/neu over-expression has been evaluated, on a formalin fixed. paraffin embedded section, using the. (proprietary kit). Using the ASCO/CAP scoring criteria, the. score is: 2. Invasive carcinoma #2: This tumor is considered positive for estrogen receptor expression (>1 % of the cells are positive). The. specimen was adequate for evaluation for ER as per ASCO/CAP guidelines 2010, Approximately 100 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-estrogen receptor antibody. SP1) with an average strong intensity. This tumor is considered positive for progesterone receptor expression @ 1 % of the cells are positive). The. specimen was adequate for evaluation for PR as per ASCO/CAP guidelines 2010. Approximately 100 % of the. carcinoma cell nuclei stain with an immunohistochemical stain utilizing an anti-progesterone receptor antibody. 1E2) with an average strong intensity. Positive for HER2 overexpression. Her-2/neu over-expression has been evaluated, on formalin fixed paraffin. embedded sections, using the. (proprietary kit). Using the ASCO/CAP scoring criteria, the. score: 3. This procedure/addenda has been electronically reviewed and signed on. Interpreted by: Attending: Note: Immunochemistry testing performed at. was developed and ils performance characteristics determined by the. These tests were interpreted in conjunction with externel positive and internal negative controis, unless otherwise noted, It has not been cleared or approved by the US. FDA. This test is used for clinical purposes only. It should not be regarded as investigational or for research. END OF REPORTI.\n        ",
    "Answer": 0,
    "Filename": "TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the tumor size and extent as described in the pathology report.\">\">\">\">\">Step 1: Identify the tumor size. The report mentions two invasive ductal carcinomas: one is well-differentiated with a size of 2.0 cm, and the other is moderately differentiated with a size of 0.6 cm.\">\">\">\">\">Step 2: Consider the definition of each T stage according to the AJCC 7th edition:\">\">\">\">\">- T1: Tumor more than 0.1 cm but not more than 2.0 cm in greatest dimension.\">\">\">\">\">- T2: Tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension.\">\">\">\">\">- T3: Tumor more than 5.0 cm in greatest dimension.\">\">\">\">\">- T4: Tumor of any size with direct extension to the chest wall or skin.\">\">\">\">\">Step 3: Apply the definitions to the tumor sizes found in the report. The largest tumor is 2.0 cm, which falls within the criteria for T1. Although there are multiple foci of cancer, including a separate 0.6 cm tumor and extensive ductal carcinoma in situ, the size of the largest invasive tumor is what primarily determines the T stage in this context.\">\">\">\">\">Step 4: Consider if there's any evidence of direct extension to the chest wall or skin, which would classify the tumor as T4. The report does not indicate such extension; in fact, it states that the skin is uninvolved by cancer.\">\">\">\">\">Conclusion: Based on the information provided in the pathology report, the pathologic T stage for this breast cancer is T1 because the largest invasive tumor is more than 1.0 cm but not more than 2.0 cm in greatest dimension, and there is no evidence of direct extension to the chest wall or skin.",
    "BaselineChoice": "T1",
    "Monologue": "The user has provided a pathology report for a breast cancer patient. The task is to determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). To accomplish this, I will first extract relevant information from the pathology report using the extract_information tool. Then, I will apply the T-staging rules based on the extracted information to determine the correct T stage. Finally, I will use the produce_final_staging_response tool to format my response into a JSON schema with 'reasoning' and 'stage' as keys.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm, as stated in the pathology report, which aligns with the T2 stage criteria in the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Procedure: Left radical mastectomy. Preoperative diagnosis: CARCINOMA OF THE LEFT BREAST. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LEFT BREAST 2. LEFT AXILLARY CONTENTS. Diagnosis: 1. LEFT BREAST: Infiltrating lobular carcinoma grade 2. Tumor is 2.8 x 3.5 x 3.0 cm in dimensions. Vascular invasion is not present. 2. LEFT AXILLARY LYMPH NODES: Four (out of fourteen) axillary lymph nodes are positive for metastatic carcinoma. Gross description: 1. LEFT BREAST: Received fresh, is a left breast measured 30.0 x 27.0 x 9.0 cm in dimensions with an axillary fat,. en bloc. The firm white-gray tumor 2.8 x 3.5 x 3.0 cm in dimensions is present in the outer. quadrants. 2. LEFT AXILLARY CONTENTS: Within the axillary fat there are fourteen lymph nodes ranging from 0.2 to 2.0 cm in greatest. dimension.\n        ",
    "Answer": 1,
    "Filename": "TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor. The T stage is classified as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor is any size with direct extension to the chest wall or skin. The pathology report states that the tumor is 2.8 x 3.5 x 3.0 cm in dimensions. The greatest dimension of the tumor is 3.5 cm, which is more than 2 cm but not more than 5 cm. Therefore, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract the tumor size from the pathology report and apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition).",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 2.8 x 3.5 x 3.0 cm, which corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Gender: Female. Color: White. Origin: Nature of material: Breast. Biopsy number: Gross description: Received one piece of fibrofatty tissue measuring 2.2 x1.2 X 0.4 cm marked with shorts suture. On slicing in the central part is a white and firm area measuring 0.4 cm in the largest. diameter. Microscopy. Dispensable description. Conclusions: Right breast wide excision: Invasive lobular carcinoma, grade 1;. Immunohistochemistry: e-cadherin: negative;. ER: positive in 70%;. PgR: positive in 20%;. HER2: negative (score 1+). PARTICIPANTS OF APPRAISAL REPORT. Issuer. - Reviewer. - Reviewer.\n        ",
    "Answer": 1,
    "Filename": "TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to identify the size of the invasive tumor. The provided pathology report describes a white and firm area, which corresponds to the tumor, measuring 0.4 cm in the largest diameter. According to the AJCC Cancer Staging Manual (7th edition), the pathologic T stage is defined as follows: T1 - Tumor >0.1 cm but =2 cm in greatest dimension, T2 - Tumor >2 cm but =5 cm in greatest dimension, T3 - Tumor >5 cm in greatest dimension, and T4 - Tumor of any size with direct extension to the chest wall or skin. Since the tumor size is 0.4 cm, which falls within the range of >0.1 cm but =2 cm, the pathologic T stage for this breast cancer patient would be T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and depth of invasion, and then apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition). I will use the extract_information tool to gather the necessary data and the get_t_stage_rule tool to determine the appropriate T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is 2 centimeters (cm) or less in greatest dimension.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Gender: Female. Color: White. Origin: Nature of material: Breast. Biopsy number: Gross description: Specimens are received in three containers. Container 01: Right breast (mastectomy) weighing 863 g. It measures 22.5 x 17.5 x 4.0 cm. Superficially, a skin ellipse is seen, and measures 18.0 X 7.0 cm. There is no superficial lesion. On. slicing in the breast parenchyma is a white spiculated nodule with central necrosis measuring 3.5. x 2.5 x 0.8 cm. Macroscopically, all the margins are clear. Container 02: Axillary lymph node: One white, soft and nodular tissue measuring 1.1 x 0.8 x 0.3. cm containing no gross lesion. Container 03: 10 Axillary lymph nodes. A gross nodular fibrofatty tissue measuring 3.0 x 2.2 x. 0.6 cm in aggregate. Contained within the tissue are 4 soft nodular structures with diameters. ranging from 0.2 to 0.4 cm in the largest diameters. Microscopy. Dispensable description. Conclusions: Right breast: Invasive lobular carcinoma, grade 1, measuring 1.1 cm in the largest diameter;. Clear surgical margins. Lymph nodes: There is no lymph nodes metastasis. PARTICIPANTS OF APPRAISAL REPORT. - Issuer. - Reviewer.\n        ",
    "Answer": 1,
    "Filename": "TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size of the invasive carcinoma. The T stage is primarily based on the size of the tumor. Here's the breakdown relevant to the provided options:\\admin T1: Tumor is 2 cm or less in greatest dimension.\\admin T2: Tumor is more than 2 cm but not more than 5 cm in greatest dimension.\\admin T3: Tumor is more than 5 cm in greatest dimension.\\admin T4: Tumor of any size with direct extension to the chest wall or skin, not including the pectoralis muscle adherence.\\admin Given the pathology report, the invasive lobular carcinoma measures 1.1 cm in the largest diameter. Based on this information, the tumor size falls into the category of T1, as it is 2 cm or less in greatest dimension.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage, I need to extract information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 1.1 cm corresponds to a T1 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Procedure Date: Accession Date: CLINICAL DATA: breast mass. IOC/FROZEN: A1FS: Infiltrating carcinoma. reported at. GROSS EXAMINATION: A. \"Left Breast Mass, One Stitch Lateral, Two Stitches Anterior (Frozen Section)\". The. specimen is received fresh. for frozen section designated \"Left Breast Mass, One Stitch Lateral, Two Stitches. Anterior\". and consists of a 9.5 X 6.3 X 4.0 cm portion of tan-yellow fibroadipose tissue. The. posterior margin is inked black. and the anterior margin is inked blue. Sectioning shows a 3.4 x 2.8 x 2.5 cm solid ill-. defined tan-white infiltrating. mass which extends very close to the anterior and posterior inked margins. Representative sections are submitted. in twelve cassettes. A1FS- frozen section remnant; A2-A4- mass and posterior margin;. A5, A6- mass and anterior. margin; A7- inferior margin; A8- superior margin; A9, A10- medial margin; A11, A12-. lateral margin. Placed in formalin: Removed from formalin: Fixation time: 56 hours and 5 minutes. B. \"Left Breast Mass (B), One Stitch Lateral, Two Stitch Anterior\". The specimen is. received in formalin designated \"Left Breast Mass (B), One Stitch Lateral, Two Stitch. Anterior\" and consists of a 6.8 x. 4.2 X 2.7 cm portion of tan-yellow fibroadipose tissue with sutures as described. The. lateral margin is inked black,. the medial margin is inked blue, the superior margin is inked yellow, and the inferior. margin is inked orange and. the posterior margin is inked green. Sectioning shows an ill-defined area of grey-white. induration measuring. approximately 2.0 X 1.5 X 1.5 cm located in the posterior portion of the specimen, and. extending close to the. inferior, lateral and medial margins. The remaining specimen is composed primarily of. pale yellow lobular adipose. tissue. Representative sections are submitted in fourteen cassettes. B1-B6- ill-defined. area of induration with. lateral, medial and inferior margins; B7, B8- posterior margin; B9- B11 - superior margin;. B12- anterior margin;. B13, B14- additional sections of breast tissue with lateral and medial margins. Placed in formalin: Removed from formalin: Fixation time: 7 hours and 20minutes. C. \"Skin Tags\". The specimen is received in formalin designated \"Skin Tags\" and. consists of. multiple grey-brown skin fragments measuring up to 0.5 cm. Submitted in toto in one. cassette. Placed in formalin: Removed from formalin: Fixation time: 7 hours and 20 minutes. DIAGNOSIS: A. Left breast mass, excision: Infiltrating ductal carcinoma of the breast; see synoptic report. B. Left breast mass: Few microscopic foci of atypical ductal hyperplasia, with marked fibrocystic changes. Residual carcinoma is not identified. C. Skin tags: Skin tags, benign. SYNOPTIC REPORT: INFILTRATING BREAST CANCER. Procedure: Excision without wire-guided localization. Lymph Node Sampling: Not performed. Specimen Laterality: Left. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma with areas of. mucinous differentiation. Tumor Size: 3.4 cm in greatest diameter. Histologic Grade: Glandular/Tubular Differentiation: 3. Mitotic Rate: 3. Nuclear Pleomorphism: 3. Overall Grade: 3 of 3. Tumor Focality: Single focus of invasive carcinoma. Ductal Carcinoma In Situ. Few foci of ductal carcinoma in situ present; extensive intraductal component not. identified. Margins: Deep surgical margin: Positive for invasive carcinoma (one low power field). Anterior surgical margin: Negative for infiltrating carcinoma (infiltrating carcinoma. reaches within 0.5 mm of. the anterior surgical margin, in two low power fields). Lymph Nodes: Not submitted. Lymph-Vascular Space Invasion: Present. Pathologic Staging: Primary Tumor: pT2. Regional Lymph Nodes: pNX. Distant Metastasis: Not Applicable. COMMENT: Prognostic markers are pending; a supplemental report will follow. CPT Code: 88307 X 2, 88305, 88331.\n        ",
    "Answer": 1,
    "Filename": "TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extension to nearby tissues. The T stages are defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the tumor size is 3.4 cm in greatest diameter. This information directly corresponds to the criteria for T2, as the tumor is greater than 2 cm but less than or equal to 5 cm. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report, such as tumor size and whether the tumor has invaded the chest wall or skin. Then, I can use this information to apply the T-staging rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Sentinel lymph node #1, biopsy: No carcinoma in one lymph node (0/1); see. comment. B. Sentinel lymph node #2, biopsy: No carcinoma in one lymph node (0/1); see. comment. C. Breast, left, wire-guided partial mastectomy: 1. Adenoid cystic carcinoma, SBR Grade 1, 1.2 cm; see comment. 2. Microcalcifications involving benign ducts. 3. Atypical ductal hyperplasia. 4. Apocrine metaplasia. 5. Blopsy site changes. 6. Fibroadenoma. D. Breast, right, mammoplasty: 1. Intraductal papilloma. 2. Sclerosing adenosis. 3. Apocrine metaplasia. 4. Microcalcifications involving benign glands. 5. Microcysts. Page of 6. Working Draft. 6. Skin with no significant pathologic abnormality. 7. No carcinoma identified. E. Breast, left, mammoplasty: 1. Usual ductal hyperplasia. 2. Apocrine metaplasia. 3. Fibroadenoma. 4. Skin with no significant pathologic abnormality. 5. No carcinoma identified. Note: This is an unusual tumor. H&E sections show a relatively circumscribed tumor with large nests. of epithelial cells in a cribriform growth pattern. The stroma is sclerotic. The differential diagnosis. includes adenoid cystic carcinoma or a cribriform variant of invasive ductal carcinoma. A prior core. needle biopsy of the left breast at 6 o'clock (. ) was reviewed. Immunohistochemical studies were necessary to evaluate this case and establish the correct. diagnosis. The following immunohistochemical stains were performed and evaluated: ER: Positive, 2+ staining in 75% of cells. PR: Negative, no staining in any tumor cells. (internal positive control present). CD117: Positive. SMA: Focally positive, relatively high background. SMM: No myoepithelial cells present around most nests of tumor cells. p63: Positive in basaloid cells in most areas. The above Immunohistochemical stains support a diagnosis if adenoid cystic carcinoma. Although ER. expression is often negative in adenoid cystic carcinoma, the presence of basal cell Immunophenotype. (positive p63) and the positive CD117 support this diagnosis. Insofar as adenoid cystic carcinoma. represents a dual population of basaloid and epithelial cells, it may be that this example is somewhat. rich in the epithelial component thus explaining the ER positivity. The above interpretation may also. explain the rather diffuse CD117 staining. The absence of a define myoepithelial layer by the SMM. further supports the diagnosis. We recognize that this tumor was also sent for gene expression. profiling so correlation with those findings for a basaloid expression profile is also suggested. Drs. and. have reviewed selected stides form this case and. concur with the diagnosis of adenoid cystic carcinoma. Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Adenoid cystic carcinoma. - Invasive tumor size: 1.2 cm. - Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 2. Mitotic count: 1 mitotic figures/10 HPF. Tubule/papilla formation: 1. Total points and overall grade = 4 points = grade 1. - Lymphatic-vascular Invasion: None. - Skin/nipple: No specific pathologic abnormalities. - Margins for invasive tumor: Negative. - Anterior (skin): N/A. - Posterior: Negative (tumor is > 1 cm away). - Inferior lateral margin (black ink): Negative; (tumor is >1 cm away, on stide C4). - Inferior medial margin (green Ink): Negative; (tumor is > 1 cm away, on slide C5). - Superior margin (blue Ink): Negative; (tumor is >1 cm away, on slide C3). - Microcalcifications: Present, involving benign ducts. Working Draft. - Lobular carcinoma in situ: None. - Lymph node status: Negative. - Total number sampled: 2. - AJCC/UICC stage: pT1cNOMX. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein. over-expression. An immunohistochemical assay was performed by manual morphometry on block C3 using the CB11 monocional antibody to. HER2/neu oncoprotein. The staining Intensity of this carcinoma was 0 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are Issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. In addition to the above findings, several lymph nodes are enlarged with a fairly monotonous. population of small lymphocytes, concerning for lymphoma. Immunohistochemical stains were. performed to characterize the small lymphocyte population as follows: CD20: Highlights widely scattered aggregates of small lymphoid cells, consistent with primary. follicies. - CD3: Highlights small lymphocytes predominantly in interfollicular areas. - CD21: Highlights aggregates of dendritic cells underlying B cell aggregates, confirming their Identity. as B cell follicles. - CD23: Highlights aggregates of dendritic cells underlying B cell aggregates, confirming their identity. as B cell follicies. Together, these findings are consistent with a diagnosis of benign quiescent nodes, and argue against. a diagnosis of lymphoma. Dr. of. Hematopathology has reviewed parts A and B and agrees with the above. interpretation. A preliminary diagnosis was given to. in Dr. clinic on. Additional. preliminary diagnosis given to. in Dr. clinic on. Intraoperative Consult Diagnosis. FS1 (A1) Sentinel lymph node #1 (half of the specimen), biopsy: Rare scattered atypical cells. Cannot completely rule out carcinoma. Defer to permanent. Dr. concurs. (Dr. FS2 (A2) Sentinel lymph node #1 (other half of the specimen), biopsy: Rare scattered atypical cells. Cannot completelv rule out carcinoma. Defer to permanent. Dr. concurs. (Dr. FS3 (B) Sentinel lymph node #2, blopsy: Rare scattered atypical cells. Cannot completely rule out. carcinoma. Defer to permanent. Dr. concurs. (Dr. Clinical History. The patient is a :year-old female with adenoid cystic carcinoma of the left breast vs. ductal. carcinoma. She has an additional lesion, seen on MRI, suspicious for carcinoma. The patient now. undergoes left wire-guided partial mastectomy and sentinel lymph node dissection with bilateral. mammoplasty for symmetry. Gross Description. Working Draft. The specimen is received in five parts, each labeled with the patient's name and unit number. Parts. A-C are received fresh. Parts D-E are received in formalin. Part A, additionally labeled \"1 - sentinel lymph node # 1 count = 5900,\" consists of one soft, ovoid,. red-yellow, irregular, unoriented fibroadipose tissue fragment that is 3.2 x 2 x 1 cm. It is oriented by. a stitch placed by the surgeon marking the hottest spot. The stitch area is inked blue. Adipose tissue. is removed. Lymph node candidate is bisected. 50% of the lymph node candidate is submitted for. frozen section diagnosis 1, with the frozen section remnant submitted in cassette A1. The remaining. 50% of the lymph node candidate is submitted for frozen section diagnosis 2, with the frozen section. remnant submitted in cassette A2. The remaining adipose tissue is submitted in cassette A3. Part B, additionally labeled \"2 - sentinel lymph node #2 count = 12700,\" consists of one soft,. red-yellow, irregular, unoriented, ovoid, oriented fibroadipose tissue fragment that is 2 x 1.7 x 0.8 cm. A stitch Is placed by the surgeon marking the hottest spot; this area is inked blue. Adipose tissue is. removed. The lymph node candidate is bisected and submitted for frozen section diagnosis 3, with the. frozen section remnant submitted in cassette B1. The remaining adipose tissue is submitted in. cassette B2. Part C is labeled \"left breast needle localization biopsy.\". SPECIMEN TYPE: Wire-guided partial mastectomy. - SKIN ELLIPSE: Present. - NIPPLE: Not present. - ORIENTATION: - Double long suture: Lateral, on side with Telfa. - Short double suture: Superior. - Short single suture: Inferior, opposite of needle wire. - INKING (for microscopic evaluation): - Black: Lateral (Telfa side). Green: Medial (side opposite wire needle). - Blue: Superior (side with wire). - SIZE OF SPECIMEN: - Medial-lateral dimension: 6 cm. - Superior-inferior dimension: 6 cm. - Anterior-posterior dimension: 11.2 cm. - TOTAL NUMBER OF SLICES: 19. - First slice (slice 1): Anterior margin (skin). - Last slice (slice 19): Posterior margin. - GROSS PATHOLOGY: On serial sectioning, multiple nodules are Identified throughout the breast. parenchyma. A dominant, rubbery/hard, tan-pink mass is identified in slices 3-4 and measures 1 x 1. x. 0.8 cm. This mass is located centrally within the slices and is located 1.1 cm from the blue ink, 1. cm. from the green ink, and 1.5 cm from the black Ink. Two tan-white rubbery nodules are seen in. slice 5; one nodule measures 0.7 x 0.4 x 0.3 cm and is 0.7 cm from the blue ink. The other nodule. measures 0.3 x 0.3 x 0.3 cm and is 0.2 cm from the blue ink. A tan-yellow rubbery nodule is. identified In slice 7-8, measuring 0.4 x 0.3 x 0.3 cm. In addition, a white-tan rubbery nodular area. is. seen in slice 8, abutting the black ink and measuring 0.6 x 0.3 x 0.2 cm. A white-tan rubbery nodule. is also seen in slice 9, abutting the blue ink, and measuring 0.3 x 0.2 x 0.2 cm. An additional hard,. tan-pink nodule is seen in slice 9, measuring 0.3 x 0.3 x 0.3 cm. A tan-white rubbery nodule is seen. in slices 15-16, measuring 0.5 x 0.5 x 0.5 cm. This nodule is suspicious for a lymph node. The needle. tip is present in slice 15. Representative sections are submitted as follows: Cassette C1: Skin (slice 1). Cassettes C2-CS: Dominant mass in slices 3-4, entirely submitted. Cassette C6: Larger nodule, slice 5. Cassette C7: Smaller nodule, slice 5. Cassette C8: Nodule, slices 7-8. Cassette C9: Nodular area in slice 8, abutting black Ink. Cassette C10: Both nodules in slice 9. Cassette C11: Nodule, slice 11. Cassettes C12-C13: Nodule, slices 15-16, entirely submitted. Working Draft. Cassettes C14-C15: Posterior margin, perpendicularly sectioned. Part D, labeled \"right breast tissue and skin,\" consists of one fragment of fibrofatty tissue with. attached skin and multiple other fragments of skin and fibrofatty tissue measuring, in aggregate, 13 x. 10 x 3.5 cm and weighing 170 gm in total. The fragments of skin are grossly unremarkable, with no. suspicious lesions or areas. A single tan-yellow nodule measuring 0.1 x 0.1 x 0.1 cm is noted in one. of the fibrofatty tissue fragments, which also contains an area that is mostly fibrous. The largest. fibrofatty tissue fragment with attached skin, measuring 11.5 x 9.2 x 3.5 cm and the skin ellipse. measuring 8 x 7 cm, contains a single white-tan, rubbery, nodular area measuring 0.3 x 0.2 x 0.2 cm. The rest of the specimen is grossly unremarkable, with no other suspicious lesions seen. Representative sections are submitted as follows: Cassette D1: 0.1 x 0.1 x 0.1 cm nodule from fibrofatty tissue fragment. Cassette D2: Fibrous area from fibrofatty tissue fragment. Cassette D3: Nodular area from largest specimen. Cassette D4: Representative section skin and fibrofatty tissue from largest specimen. Part E, labeled \"left breast tissue and skin,\" consists of multiple fragments of fibrofatty tissue, as well. as multiple fragments of skin, in aggregate measuring 6.5 x 6.5 x 2.2 cm and weighing 154 gm in. total. The skin fragments are grossly unremarkable, with no suspicious areas or lesions seen. One. fibrofatty tissue fragment contains a tan-white, lobulated, rubbery, nodular area measuring 1.2 x 1.1 x. 1 cm. The rest of the fibrofatty tissue fragments are grossly unremarkable, with no suspicious lesions. or areas seen. Representative sections are submitted as follows: Cassette E1: Representative section of skin. Cassettes E2-E3: Nodule in fibrofatty tissue fragment, entirely submitted. Cassette E4: Representative section of fibrofatty tissue. /Pathology Resident. Fee Codes: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Consult, Surgical w/ blocks or tissue. Final Diagnosis. Review of. from. Left breast, 6 o'clock, core needle biopsy: Malignant neoplasm with cribriform growth. pattern; see comment. MD. MD. _Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Fibroadipose tissue, see comment. Working Draft. Spccimen Class: Accessioned: Specimen(s) Received: Left breast, needle core biopsy 5:00, Scm from nipple. Final Diagnosis. Left breast, 5:00, 5 cm from nipple, needle core biopsy : 1. Fibroadenoma with microcalcifications see comment. 2. Fat necrosis.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A1-A0SB.BEC7EEA9-6DEA-4402-A3A1-07EF33D58174",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, and T4 - Tumor is any size with direct extension to the chest wall or skin. According to the provided pathology report, the invasive tumor size is 1.2 cm. This measurement directly corresponds to the T1 classification, as the tumor is 2 cm or less in its greatest dimension. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage of the breast cancer patient, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size and extent of invasion were evaluated, and based on the provided information, the cancer was determined to be at an early stage with minimal invasion.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Sentinel lymph node, left axilla, biopsy: No tumor (0/1). B. Sentinal lymph node, left axilla, biopsy: No tumor (0/1). C. Left breast, needle localized partial mastectomy: 1. Invasive ductal carcinoma, 4 cm, grade 2, present at anterior margin; see comment. 2. Ductal carcinoma in situ, low and intermediate nuclear grade with necrosis, negative. margins; see comment. 3. Calcifications associated with DCIS and benign epithelium. 4. Proliferative fibrocystic changes (usual ductal hyperplasia, apocrine metaplasia, cyst. formation). 5. Prior biopsy site changes. D. Left axilla, excision: No tumor. E. Lymph node, left axilla, biopsy: No tumor (0/1). Note: Breast Tumor Synoptic Comment. - Laterality: Left breast. - Invasive tumor type: Ductal. - Invasive tumor size: 4 cm maximum diameter (eight consecutive specimen slices involved, each 0.5 cm. thick). - Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 3, 3 points. Mitotic count: 6 mitotic figures/10 HPF, 1 point. Working Draft. Tubule/papilla formation: 10-75%, 2 points. Total points and SBR grade = 6 points, grade 2. - Lymphatic-vascular invasion: Not identified. - Perineural invasion: Not identified. - Resection margins for invasive tumor: - Deep margin: Negative; closest distance of tumor 0.2cm (slide C6). - Medial margin: Negative; closest distance of tumor 1.1 cm (gross). - Lateral margin: Negative; closest distance of tumor 1.3 cm (gross). - Anterior/superior margin: Positive (slides C13 and C17). - Anterior/inferior margin: Negative; closest distance of tumor 0.4 cm (slides C3 and C14). - Ductal carcinoma in situ (DCIS) type: Cribriform. - Ductal carcinoma in situ size: Foci span throughout the invasive component. - Ductal carcinoma in situ nuclear grade: Low-to-intermediate. - Necrosis in ductal carcinoma in situ: Present. Microcalcifications: Present in association with DCIS and benign ducts. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative; closest distance of tumor 0.2 cm (slide C2). - Medial margin: Negative; closest distance of tumor, <0,2 cm; (slide C1). - Lateral margin: Negative; closest distance of tumor greater than 1 cm (gross). - Anterior/superior margin: Negative; closest distance of tumor 0.5 cm (slide C2). - Anterior/inferior margin: Negative; closest distance of tumor greater than 1 cm (gross). - Lymph node status: Negative. - Number of positive lymph nodes: 0. - Total number sampled: 3. - AJCC/UICC stage: pT2NOMX. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node cluster, left axilla, biopsy: No tumor seen. (Dr. FS2 (B) Left axilla, sentinel lymph node #2, biopsy: No tumor seen. (Dr. Clinical History. The patient is a. year-old woman with a history of biopsy-proven low-grade invasive and in situ ductal. carcinoma (. i who undergoes left breast needle-localized lumpectomy and sentinel lymph node. sampling. Gross Description. The specimen is received fresh in five parts each labeled with the patient's name and unit number. Part A is additionally labeled. It consists of one soft, pink-yellow, irregular,. glistening, unoriented, fibroadipose tissue fragment that is 2.8 x 1.8 x 0.9 cm. The specimen is entirely. submitted for frozen section. The frozen remnant is entirely submitted in cassette A1. Part B is additionally labeled. It consists of one soft, pink-yellow,. irregular, glistening, unoriented, fibroadipose tissue fragment that is 3 x 2.5 x 0.7 cm.A single large lymph. node candidate is identified, bisected, and entirely submitted for intraoperative consultation with the. remnant submitted in cassette B1. The remaining adipose tissue is submitted in cassette B2. Part C is additionally labeled. a It consists of a lumpectomy specimen measuring 5.4. cm from superior to inferior, 6.4 cm from medial to lateral and 2.6 cm from anterior to posterior. The. specimen has been oriented with a long black surgical indicating the lateral position and a short black. surgical suture indicating the superior position. The specimen is coronally sectioned from medial to. lateral into 13 slices to reveal diffusely white-yellow breast parenchyma with an apparent biopsy site. cavity extending from slices 7 through 10 and measuring 2.6 cm from superior to inferior, 4.4 cm from. medial to lateral and 2.4 cm from anterior to posterior. The specimen is inked as follows for microscopic. evaluation of surgical margins: Anterior-superior black-yellow, anterior-inferior green and posterior. black. Representative sections are submitted as follows: Cassette C1: Slice 1 (medial margin), perpendicular. Cassette C2: Slice 3. Cassette C3: Slice 4, inferior. Working Draft. Cassette C4: Slice 5, inferior. Cassette C5: Slice 6, superior. Cassette C6: Slice 6, mid. Cassette C7: Slice 6, inferior. Cassette C8: Slice 7, superior. Cassette C9: Slice 7, inferior. Cassette C10: Slice 8, superior. Cassette C11: Slice 8, mid. Cassette C12: Slice 8, inferior. Cassette C13: Slice 9, superior. Cassette C14: Slice 9, mid. Cassette C15: Slice 9, inferior. Cassette C16: Slice 10, superior. Cassette C17: Slice 10, mid. Cassette C18: Slice 10, inferior. Cassette C19: Slice 11. Cassette C20: Slice 13 (lateral margin), perpendicular. Slices 1, 6, 7, 8, 9, 10 and 13 are entirely submitted. Part D is additionally labeled. It consists of two unoriented fragments of. yellow-tan, fibroadipose tissue measuring 3.0 x 2.5 x 0.5 cm. The specimen is entirely submitted in. cassette D1. Part E is additionally labeled \". It consists of a single unoriented. fragment of tan-yellow, soft tissue measuring 0.6 x 0.5 x 0.3 cm. A single candidate lymph node is. identified, measuring 0.6 cm in greatest dimension. The specimen is entirely submitted in cassette E1. /Pathology Resident. MD/Pathologist. Fee Codes: Other Specimens. Specimen Class: Accessioned. Specimen(s) Received: Lip, upper left. Final Diagnosis. Lip, upper left: Mucous retention cyst. Specimen Class: Accessioned: Specimen(s) Received: Left breast re-excision (fresh). Final Diagnosis. Left breast, excisional biopsy : 1. No residual tumor. 2. Prior surgical site changes. 3. Microcalcifications in benign ducts and lobules. MD. MD. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Jaginal/Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Other Interpretations/Results: SHIFT IN FLORA SUGGESTIVE OF BACTERIAL VAGINOSIS. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. _Specimen Class: Accessioned: Specimen(s) Received: Left breast core biopsy at. , ,N + 4. Final Diagnosis. Left breast,. core biopsy: 1. Invasive ductal carcinoma, SBR grade 1; see comment. 2. Ductal carcinoma in situ, intermediate grade with comedonecrosis. 3. Calcifications within ductal carcinoma in situ. Procedure/Addenda for. ADDENDUM. Date of Addendum.: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors as well as for HER2 was performed. on block A1. The test for estrogen receptors is positive. There is strong nuclear staining in >90% of tumor cells. The test for progesterone receptors is positive. There is strong nuclear staining in >90% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed using the CB11 monoclonal antibody to HER2/neu. oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered borderline. We and others have observed that many carcinomas with staining. intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore submitted for. FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Working Draft. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as investigational or for rescarch. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (\"CLIA\"). as qualified to perform high-complexity clinical testing. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical, Direct. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Inactive endometrium; no evidence of hyperplasia or carcinoma. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Weakly proliferative pattern with gland and stromal breakdown. Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical, Direct. BENIGN CELLULAR CHANGES. Predominance of Coccobacilli consistent with shift in vaginal flora. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Working Draft. Specimen Class: Accessioned. Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Proliferative endometrium with irregular maturation, no evidence. of hyperplasia or carcinoma. Specimen Class: : Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical, Direct. BENIGN CELLULAR CHANGES. Predominance of Coccobacilli consistent with shift in vaginal flora. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: 1. Benign cyst. See comment. 2. Fibrocystic change. Specimen Class: Accessioned. Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Simple hyperplasia without atypia; see comment. Specimen Class: Accessioned: Specimen(s) Received: Endocervical, Direct. Final Diagnosis. Endocervical, Direct. BENIGN CELLULAR CHANGES. Cytologically benign endometrial cells present in a postmenopausal woman. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Paoe 6 of R. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: A: Probable polyps, B: Endometrium, curretage. Final Diagnosis. A. Endometrium, probable polyp, biopsy: Proliferative endometrium with focal simple. hyperplasia, in part polypoid. B. Endometrium, curettage: 1. Proliferative endometrium with irregular maturation. 2. Focal simple hyperplasia. 3. Focal tubal metaplasia. Specimen Class: Accessioned. Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Disordered proliferative endometrium with cystic and oncocytic. changes and stromal breakdown; see note. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Disordered proliferative endometrium with focal stromal. breakdown. QA Review(s). Consultation Obtained. roblem?. Reviewers: Result(s): Agree. .elated specimen(s): Specimen Class: Accessioned: Specimen(s) Received: ENDOCERVICAL. Final Diagnosis. CELLULAR CHANGES WITHIN NORMAL LIMITS. BENIGN. Conversion. Signed Out by Cytotechnologist. Specimen Class: Accessioned. Specimen(s) Received: A) ENDOMETRIAL BX. Working Draft. Fical Diagnosis. UTERUS, ENDOMETRIUM, BIOPSY: SECRETORY ENDOMETRIUM. SEE NOTE. Conversion. MD.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is categorized as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. The provided pathology report mentions an invasive ductal carcinoma with a size of 4 cm. Since the tumor size is greater than 2 cm but less than or equal to 5 cm, it falls into the T2 category. Additionally, there's no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report regarding tumor size and other factors that could influence T staging, such as the presence of tumor at margins or the involvement of skin or chest wall.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The invasive tumor size is 4 cm, which falls within the criteria for a T2 classification according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Right breast, biopsy: No evidence of tumor in one lymph node (0/1). B. Left axilla, sentinel lymph node #1, dissection: No evidence of tumor in three lymph. nodes (0/3). C. Right breast, mastectomy: 1. Skin with no significant pathologic abnormality. 2. Proliferative fibrocystic changes. 3. Microcalcifications in association with benign glands. D. Left breast, mastectomy: 1. Invasive carcinoma, 2.0 cm, SBR grade 2, see comment. 2. Ductal carcinoma in situ, low grade, see comment. 3. Skin with no significant pathologic abnormality. 4. Fibroadenoma. 5. Microcalcifications associated with invasive carcinoma and benign glands. 6. Proliferative fibrocystic changes. Working Draft. 7. Papillomatosis. 8. Pseudoangiomatous stromal hyperplasia. E. Nonsentinel lymph node, left axilla, dissection: No evidence of tumor in four lymph. nodes (0/4). F. Right breast, re-excision of superior portion: Benign breast parenchyma. Note: In Part D (left breast), the area indicated by the surgeon with a green stitch shows proliferative. fibrocystic changes, sclerosing adenosis, and pseudoangiomatous stromal hyperplasia. There is no. evidence of carcinoma in the area around the green suture. Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Mixed ductal and lobular type (tumor is present in Slides D1, D2, D5, and D18). - Invasive tumor size: 2.0 cm maximum diameter (Slide D5). - Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 2 points. Mitotic count: 16 mitotic figures/10 HPF, 2 points. Tubule/papilla formation: Definite tubule formation <10%, 3 points. Total points and SBR grade = 7 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Resection margins for invasive tumor: - Deep margin: Positive (Slide D2, 5). - Medial margin: Widely clear; >1 cm. - Lateral margin: Widely clear; >1 cm. - Anterior/superior margin: Widely clear; >1 cm. - Anterior/inferior margin: Widely clear; >1 cm. - Ductal carcinoma in situ (DCIS) type: Solid. - Ductal carcinoma in situ size: DCIS present as scattered microscopic foci associated with the invasive. component on Slides D1 and D2. - Ductal carcinoma in situ nuclear grade: Low grade. - Necrosis in ductal carcinoma in situ: None. - Microcalcifications: Present involving invasive carcinoma. - Resection margins for ductal carcinoma in situ: - Deep margin: Close; within less than 0.3 cm (Slide D1). - Medial margin: Widely clear; >1 cm. - Lateral margin: Widely clear; >1 cm. - Anterior/superior margin: Widely clear; >1 cm. - Anterior/inferior margin: Widely clear; >1 cm. - Lobular carcinoma in situ (LCIS): Not identified. - Lymph node status: No evidence of tumor in eight lymph nodes (0/8). - AJCC/UICC stage: pT1cNOMX. - Nontumorous breast tissue: Proliferative fibrocystic changes, Fibroadenoma, pseudoangiomatous. hyperplasia. - Nipple: Unremarkable. - Skin/dermis: Unremarkable. Immunohistochemical tests for estrogen, progesterone and Her2 Neu are pending and will follow in an. addendum. Intraoperative Consult Diagnosis. FS1 (A) Right breast nodule, biopsy: Lymph node with no tumor seen. (Dr. FS2 (B) Sentinel lymph node, left axilla, biopsy: Three lymph nodes, no tumor seen. (Dr. Working Draft. Clinical History. The patient is a. woman with breast cancer. A. tracking sheet. accompanies the specimen and indicates a high family risk for cancer and preoperative diagnosis of. known left breast cancer in the upper outer quadrant. No specimen radiograph is requested. Multifocality is suspected on the left side. Special stains for ER, PR, and HER2/neu are requested as a. repeat. The diagram indicates that the known tumor is in the upper outer quadrant of the left breast, and. a suspicious area is present in the upper inner quadrant at approximately the 11 o'clock position above. the nipple. Recent MRI indicates the presence of a known 2-cm tumor with clip present in the lateral. breast of the left breast in addition to an adjacent 5-mm lesion that is immediately posteromedial to the. primary lesion. A 5-mm suspicious area is also identified in the slightly upper inner quadrant. Gross Description. The specimen is received in six parts, each labeled with the patient's name and medical record number. Parts A through D and F are received fresh, and Part E is received in formalin. Part A is additionally labeled \"right breast nodule.\" It consists of a single unoriented, irregular piece of. soft, pink tissue, measuring 0.7 x 0.5 x 0.3 cm. The specimen is entirely submitted for frozen section. diagnosis as FS1, with the frozen section remnant submitted in cassette A1. Part B is additionally labeled \"sentinel lymph node left axilla, count - 1800, frozen section.\" It consists. of. a single irregular piece of soft, yellow-pink, fatty tissue, measuring 3.0 x 2.0 x 0.6 cm. The specimen is. entirely submitted for frozen section diagnosis as FS2, with the frozen section remnant submitted in. cassette B1. Part C is additionally labeled \"right breast.\" It consists of a mastectomy specimen, oriented with a short. suture considered superior and long suture considered lateral; oriented as such, the specimen measures. 3.2 cm from anterior to posterior, 14.7 cm from medial to lateral, and 13,7 cm from superior to inferior. The mastectomy specimen weighs 212.5 gm. The specimen includes an area of skin, measuring 14.5 x. 6.7 cm, with nipple, measuring 1.7 x 1.7 x 1.5 cm, and areola, measuring 3 x 3.8 cm. The specimen has. been previously inked and serially sectioned by the. serial. slices. Inking follows standard inking, with posterior black, anterior superior blue, and anterior inferior. green. The accompanying research paperwork indicates that a fragment of tissue has been taken for. tissue banking. Cut sections reveal that the breast is composed almost entirely of homogeneous, firm,. white, fibrous tissue that abuts the deep margin. Thin layers of adipose tissue are present in the anterior. surface as well as the medial aspect of the specimen. No grossly evident lesions are identified. The nipple. and skin similarly appear unremarkable. Slice 1 is considered medial, and slice 10 is considered lateral. The nipple, thereby, is in slice 5. Representative sections are submitted as follows: Cassettes C1-C2: Nipple, entirely submitted. Cassette C3: Upper outer quadrant from slice 8. Cassette C4: Upper outer quadrant from slice 7. Cassette C5: Lower outer quadrant from slice 8. Cassette C6: Lower outer quadrant from slice 7. Cassette C7: Upper inner quadrant from slice 4. Cassette C8: Upper inner quadrant from slice 3. Cassette C9: Lower inner quadrant from slice 3. Cassette C10: Lower inner quadrant from slice 2 and section of skin from slice 4. Part D is additionally labeled \"left breast,\" with further specification in the requisition form indicating that. a green stitch - questionable secondary cancer, correlate with MRI, and black short superior, long =. lateral. A firm, pale-tan, circumscribed lesion, measuring 1.6 x 1.2 x 1.4 cm, is present at the 3 o'clock position, 3. cm from the nipple; this contains a surgical clip. The lesion is 0.1 cm from the deep margin, 0.9 cm from. the skin, 2.2 cm from anterior superior, 1.9 cm from anterior inferior, 3.5 cm from the lateral margin, and. < 10 cm from the medial margin. Immediately inferior and medial to main lesion, a 0.4-cm area contains. multiple punctate, firm, yellow spots. This lesion is 0.5 cm from the large lesion and is 0.5 from the deep. margin. The remainder of the specimen is composed mostly of firm, fibrous tissue, showing multiple. small cystic areas, with a maximum diameter of 0.4 cm, throughout. The area adjacent to the green. suture on slice 6 similarly consists of dense, fibrous tissue, and no definitive lesions are identified in this. area. The skin, nipple, and areola appear unremarkable. Working Draft. Accompanying paperwork from the. ndicates that a portion of the. specimen has been taken for tissue banking. The specimen contains a short stitch and long black stitch,. taken to be superior and lateral, respectively, and has been previously inked and sectioned by the. research technician into ten slices, from medial to lateral. Inking is as per standard, with posterior in. black, anterior superior in blue, and anterior inferior in green. The blue ink appears faint. The. most-medial slice is taken as slice 1 and the most-lateral slice as slice 10. The specimen, thereby,. measures 2.5 cm from anterior to posterior, 15.6 cm from medial to lateral, and 16.6 cm from superior to. inferior and weighs 192.5 gm. A skin ellipse is present, measuring 6.6 x 13.1 cm, with the long axis in the. mediolateral extent. The areola measures 3.4 x 3 cm, and the nipple measures 1.8 x 1.6 x 1.6 cm. The. nipple lies in slices 5 and 6. The green nylon suture is in the posterior aspect of slice 6 at the 12 o'clock. position, 3.5 cm superior to the nipple. Representative sections are submitted as follows: Cassette D1: 1.6-cm lateral lesion in relation to deep margin from slice 8. Cassette D2: Punctate, yellow lesion from slice 8. Cassette D3: Nearest anterior-superior margin in slice 8. Cassette D4: Nearest anterior-inferior margin from slice 8. Cassette D5: Additional 1.6-cm lesion in relation to skin. Cassettes D6-D7: Nipple, entirely submitted. Cassette D8: Area marked by green suture, including skin and anterior-superior and deep. margins. Cassettes D9-D11: Additional sections of area marked by the green suture en bloc from slice 6. Cassette D12: Area adjacent to green suture from slice 5. Cassette D13: Area adjacent to green suture from slice 7. Cassette D14: Inferior margin of slice 8. Cassette D15: Superior margin of slice 8. Cassette D16: Lateral margin from slice 10. Cassette D17: Medial margin from slice 1. Cassette D18: Intervening area between primary lesion and lateral margin from slice 9. Cassette D19: Upper inner quadrant, rectangular from slice 4 and triangular from slice. 3. Cassette D20: Lower inner quadrant, rectangular from slice 5, triangular from slice 4. Cassette D21: Upper outer quadrant, rectangular from slice 8, triangular from slice 9. Cassette D22: Lower outer quadrant, triangular from slice 7, rectangular from slice 9. Part E is additionally labeled \"nonsentinel lymph node left axilla.\" It consists of a single unoriented. fragment of largely adipose tissue, measuring 2.4 x 1.4 x 0.5 cm. A single 1.4-cm lymph node is. identified. The candidate lymph node is bisected and entirely submitted in cassette E1. The remainder of. the soft tissue is entirely submitted in cassette E2. Part F is additionally labeled \"re-excision superior portion right breast\" and has an additional note in the. requisition form indicating that the stitch = new margin. It consists of a single fragment of adipose. tissue, measuring 3 x 2.2 x 0.9 cm, marked by a single black suture. The surface containing the black. suture is inked in black and the opposite surface in blue. The specimen is serially sectioned to reveal. mostly adipose tissue, with a single 0.7-cm area of white, fibrous tissue. The specimen is entirely. submitted in cassettes F1 through F3. /Pathology Resident. Fee Codes: Addenda. Addendum. Date Complete: Paoe 4 of R. Working Draft. Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors as well as for HER2 was performed. on block D5. The test for estrogen receptors is positive. There is strong (3+) nuclear staining in 85% of tumor cells. Internal positive control is positive. The test for progesterone receptors is. There is strong (3+) nuclear staining in~100% - of tumor cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed using the CB11 monoclonal antibody to HER2/neu. oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3 (HER2 test interpreted by. Dr. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered borderline. We and others have observed that many carcinomas with staining. intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore submitted for. FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration. Tne FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (\"CLIA\"). as qualified to perform high-complexity clinical testing. /Pathologist. Addendum. Date Complete: Addendum Comment. An immunohistochemical test for progesterone receptors was performed on block D5. The test for progesterone receptors is positive. There is strong nuclear staining in - -100% of tumor cells. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration. The FDA nas. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (\"CLIA\"). as qualified to perform high-complexity clinical testing. (Pathologist. Working Draft. Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Rectal, polyp. Final Diagnosis. Rectum, polypectomy: Hyperplastic polyp. Specimen Class: Accessioned: Specimen(s) Received: Pelvic Washing. Final Diagnosis. Pelvic Washing. BENIGN. Reactive mesothelial cells. Specimen Class: Accessioned: Specimen(s) Received: A: Risk reducing salpingo-oophorectormy- right ovary- FS, B: Risk reducing salpingo-oophorectormy-. left ovary- FS, C: Endometrium, curettage- perm, D: Endocervix, curettage- perm. Final Diagnosis. A. Right ovary, salpingo-oophorectomy: No significant pathologic abnormality; see. comment. B. Left ovary, salpingo-oophorectomy: No significant pathologic abnormality; see. comment. C. Endometrium, curettage: Tissue insufficient for accurate evaluation; see. comment. D. Endocervix, curettage: Scant fragments of squamous and glandular epithelium. with no significant pathologic abnormality. Specimen Class: Accessioned: Specimen(s) Received: Cervical, Thin Prep Imaged. Final Diagnosis. Cervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic pattern. Inflammation. Working Draft. SPECIMEN ADEQUACY: Satisfactory for evaluation; atrophic pattern with no identifiable. endocervical/transformation zone component. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation; atrophic pattern with no identifiable. endocervical/transformation zone component. Specimen Class: Accessioned. Specimen(s) Received: Left breast core needle biopsy at 2:30, N + 3-4. Final Diagnosis. Left breast, needle core biopsy: Invasive carcinoma; see comment. MD. Procedure/Addenda for. ADDENDUM. Date of Addendum.: Addendum Comment. Immunohistochemical stain for E-Cadherin was performed and evaluated on A1. The invasive carcinoma. shows area with moderate membrane staining and others that are negative or demonstrate granular. staining. Thus, this invasive carcinoma displays features of both ductal and lobular carcinoma. Dr. has reviewed the immunohistochemical stained slide and concurs. The immunoperoxidase stain(s) reported above were developed and their performance characteristics. determined by the. They have not been cleared or. approved by the U. S. Food and Drug Administration. The FDA has determined that such clearance or. approval is not necessary. These tests are used for clinical purposes. They should not be regarded as. investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (\"CLIA\") as qualified to perform high-complexity clinical testing. Specimen Class: Accessioned: Specimen(s) Received: Left Axilla Lymph Node, Fine Needle Aspiration. Working Draft. Final Diagnosis. Left Axilla Lymph Node, Fine Needle Aspiration: Benign reactive lymph node, see note. This lymph node shows a spectrum of small to large sized lymphocytes with scattered. tingible body macrophages. No evidence of neoplasia is seen. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Adenocarcinoma, see comment. Procedure/Addenda for. ADDENDUM. Date of Addendum.: Acdendum Comment. An immunohistochemical test for estrogen and progesterone receptors as well as for HEr-2-neu was. performed on the material submitted for cell block. The test for estrogen receptors is positive There is strong nuclear staining in 90% of tumor cells. The test for progesterone receptors is positive. There is strong nuclear staining in 80% of tumor cells. Result of HER2/neu test: This carcinoma is borderline for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on cell block using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 2 on a scale of 0-3. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of. HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered borderline. We and others have observed that. many carcinomas with staining intensity scores of 2 do not show gene amplification. All carcínomas with. staining intensity scores of 2 are therefore submitted for FISH testing. The results of the FISH test are. issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu. oncoprotein. Tumors in this category show an excellent correlation between the results of. immunohistochemical and FISH testing, and almost always show gene amplification. Dr. has reviewed the HER2/neu stain and concurs.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A1-A0SE.CFF567FC-8867-4CA4-85AE-81A7D30095E7",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The provided pathology report mentions an invasive carcinoma with a maximum diameter of 2.0 cm. There is no mention of the tumor breaking through the skin or chest wall, or of any other characteristics that would automatically classify it as T3 or T4. Given that the tumor size is 2.0 cm, which falls into the T1 category since T1 tumors are defined as those with a maximum diameter of 2 cm or less, we can determine the pathologic T stage based on this size criterion.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the provided pathology report. The report mentions an invasive carcinoma with a maximum diameter of 2.0 cm. We should extract relevant information from the report and apply the T-staging rules to determine the correct stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The invasive tumor size is 2.0 cm maximum diameter, with no evidence of tumor in eight lymph nodes, and the tumor is more than 1 cm but not more than 2 cm in greatest dimension.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Working Draft. CELLULAR CHANGES WITHIN NORMAL LIMITS. Inflammation. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Benign dyssynchronous secretory endometrium; no hyperplasia or carcinoma. identified. Specimen Class: Accessioned: Signed Out: (. Specimen(s) Received: Cervical. Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Inflammation. Endocervical cells present. SPECIMEN ADEQUACY: Satisfactory for evaluation but limited by obscuring white blood cells. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: Bladder Washing. Final Diagnosis. Bladder Washing. BENIGN. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Urine, catheterized. Final Diagnosis. BENIGN. See Below. Specimen Class: Accessioned. {HighRisk Specimen}. Specimen(s) Received: Vaginal/Cervical/Endocervical. Final Diagnosis. CELLULAR CHANGES WITHIN NORMAL LIMITS. Squamous metaplasia. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: BLADDER WASH. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Specimen(s) Received: BLADDER WASH. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Specimen(s) Received: BLADDER WASH. Fina) Diagnosis. BENIGN. Conversion. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: VAGINALCERVICAU/ENDOCERVICAI. Final Diagnosis. BETHESDA: CELLULAR CHANGES WITHIN NORMAL LIMITS. BENIGN. Inflammation. Conversion. Specimen Class: Accessioned: Specimen(s) Received: URINE, CATHETERIZED. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Signed Out: &. Specimen(s) Received: VAGINAL/CERVICAL/ENDOCERVICAL. Final Diagnosis. DESCRIPTIVE DIAGNOSIS. Diagnosis Deferred. Conversion. Specimen Class: Accessioned: Specimen(s) Received: SITE NOT SPECIFIED. Final Diagnosis. DESCRIPTIVE DIAGNOSIS. Diagnosis Deferred. Inflammation. Conversion. Specimen Class: Accessioned. Specimen(s) Received: VAGINAL/CERVICAL/ENDOCERVICAL. Final Diagnosis. BENIGN. Conversion. FND OF REPORT. Final Pathologic Diagnosis: A. Sentinel lymph node #1, left axilla, biopsy: No carcinoma identified in one lymph. node (0/1). B. Sentinel lymph node #2, left axilla, biopsy: No carcinoma identified in one lymph. node (0/1). Working Draft. C. Left breast, mastectomy;. 1. Infiltrating ductal carcinoma, SBR grade 2, 2.4 cm; see comment. 2. Intermediate to high grade ductal carcinoma in-situ, cribriform and comedo types. 3. Non-proliferative fibrocystic changes. 4. Duct ectasia. D. Right breast, mastectomy: 1. Atypical lobular hyperplasia. 2. Non-proliferative fibrocystic changes. 3. Duct ectasia. 4. Microcalcifications associated with benign ducts and stroma. 5. No carcinoma identified. E. Soft tissue, right breast, excision: Fibroadipose tissue with skeletal muscle; no breast. parenchyma or carcinoma identified. F. Left ovary and fallopian tube, salpingooophorectomy: - Ovary: No significant pathologic abnormality. - Fallopian tube: Benign paratubal cyst. G. Right ovary and fallopian tube, salpingooophorectomy: - Ovary: No significant pathologic abnormality. - Fallopian tube: Benign paratubal cyst. H. Omentum, biopsy: Benign fibrous nodule. I. Soft tissue, left upper peritoneum, biopsy: Benign fibroadipose tissue. J. Omentum, omentectomy: No significant pathologic abnormality. Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Infiltrating ductal. - Invasive tumor size: 2.4 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 3, 3 points. Mitotic count: 7 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: > 10% but <75%, 2 points. Total points and SBR grade - 6 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Invasive tumor necrosis: None identified. - Mononuclear cell reaction: None/minimal. - Resection margins for invasive tumor: Widely clear. - Deep margin: Widely clear; closest distance of tumor 2 cm. - Medial margin: Widely clear; closest distance of tumor > 6 cm. - Lateral margin: Widely clear; closest distance of tumor 2.8 cm. Anterior/superior margin: Widely clear; closest distance of tumor 5.5 cm. Anterior/inferior margin: Widely clear; closest distance of tumor >6 cm. - Ductal carcinoma in situ (DCIS) type: Cribriform and comedo. - Ductal carcinoma in situ size: ~2.0 cm in maximum diameter. Ductal carcinoma in situ nuclear grade: Intermediate to high grade. - Necrosis in ductal carcinoma in situ: Present. - Microcalcifications: Not identified. Working Draft. - Resection margins for ductal carcinoma in situ: Widely clear (see above for invasive tumor. - Lobular carcinoma in situ (LCIS): Not identified. - Number of lobules involved: N/A. - Nuclear type/size: N/A. - Resection margins for pleomorphic lobular carcinoma in situ: N/A. - Lymph node status: Negative. - Number of positive lymph nodes: 0. - Total number sampled: 2. - AJCC/UICC stage: pT2NOMx. - Nontumorous breast tissue: Non-proliferative fibrocystic change; duct ectasia. - Nipple: Unremarkable. - Skin/dermis: Unremarkable. Pagetoid spread of carcinoma is seen in benign ducts adjacent to the tumor. No such spread is seen away. from the tumor. Atypical lobular hyperplasia is present in the contralateral (right) breast. An immunohistochemical test for estrogen and progesterone receptors as well as for HER2 was performed. on block C3. The test for estrogen receptors is positve. There is moderate nuclear staining in >95% of tumor cells. Internal positive control is positive. The test for progesterone receptors is positive. There is moderate to strong nuclear staining in 90% of. tumor cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed using the CB11 monoclonal antibody to HER2/neu. oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3 (HER2 test interpreted by. Dr. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered borderline. We and others have observed that many carcinomas with staining. intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore submitted for. FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node # 1, left axilla, biopsy: No carcinoma. FS2 (B) Sentinel lymph node #2, left axilla, biopsy: No carcinoma. FS3 (G) Right adnexa, salpingo-oophorectomy: Paratubal cyst with hemorrhage. FS4 (H) Omentum, biopsy: Dense fibrous connective tissue, no carcinoma. FS5 (I) Left upper quadrant, peritoneum, biopsy: No carcinoma. F. Left adnexa, salpingo-oophorectomy: Paratubal cyst (gross diagnosis only). Clinical History. Working Draft. The patient is a .year-old woman with left breast cancer. She undergoes bilateral mastectomies. Gross Description. The specimen is received in ten parts, each labeled with the patient's name and unit number. Parts A. through I are received fresh, and Part J is received in formalin. Part A, additionally labeled \"1. consists of one pink, unoriented,. fibroadipose tissue fragment measuring 1.5 x 0.8 x 0.8 cm. The entire specimen is frozen for frozen. section diagnosis 1, and subsequently submitted in cassette A1. Part B, additionally labeled. consists of one pink-red, unoriented,. fibroadipose tissue fragment measuring 1.3 x 0.8 x 0.7 cm. The entire specimen is frozen for frozen. section diagnosis 2, and subsequently submitted in cassette B1. Part C is additionally labeled. It consists of a mastectomy specimen, measuring. 15.8 cm from superior to inferior, 15.6 cm from medial to lateral, and 8.2 cm from anterior to posterior. The specimen weighs 442.5 gm. In the lateral aspect of the specimen is a spiculated, firm, tan mass,. measuring 2.4 x 1.2 x 1.2 cm. This mass is 2.0 cm from the deep margin, 5.5 cm from the superior. margin, >6 cm from the inferior margin, 2.8 cm from the lateral margin, and >6 cm from the medial. margin. In the anterior-inferior portion of the breast, there are dilated ducts, filled with cheesy material. This area is 0.2 cm from the deep margin. The remainder of the breast parenchyma is unremarkable. Two. pieces of tumor are banked, one for tissue banking and one for the epithelial cell study. Representative. sections are submitted as follows: Cassette C1: Nipple. Cassettes C2-C3: Spiculated mass. Cassette C4: Deep margin beneath tumor. Cassette C5: Lateral margin. Cassette C6: Lower outer quadrant. Cassette C7: Lower inner quadrant. Cassette C8: Medial margin. Cassette C9: Upper inner quadrant. Cassette C10: Anterior-inferior area with duct ectasia. Part D is additionally labeled. It consists of a mastectomy specimen, measuring. 18.2 cm from superior to inferior, 16.2 cm from medial to lateral, and 4.8 cm from anterior to posterior. The specimen weighs 688 gm. A short stitch is designated by the surgeon as superior, and a long stitch is. designated by the surgeon as lateral. In the inferior-medial portion of the specimen is a fragment of skin,. measuring 7.5 x 4.9 cm. It is white and unremarkable. There is a nipple, measuring 1.3 x 1.5 x 1.6 cm. The specimen is notable for dilated ducts with a viscous, yellow-tan material within them. This material. extends into one of the nipple ducts. No masses are noted, nor are any areas suspicious for DCIS. appreciated. The anterior-superior portion of the specimen is inked blue, the anterior-inferior portion of. the specimen is inked green, and the posterior aspect of the specimen is inked black. Multiple sections of. unremarkable breast parenchyma are taken for two studies, including a high-risk study and an epithelial. cell study. Representative sections are submitted as follows: Cassettes D1-D2: Nipple and surrounding skin. Cassette D3: Representative section of anterior-inferior breast with dilated duct. Cassette D4: Representative section of lower inner breast with dilated ducts. Cassette D5: Representative section of upper inner breast. Cassette D6: Representative section of medial breast. Cassette D7: Representative section of upper outer breast. Cassette D8: Representative section of upper inner breast. Cassette D9: Representative section of lateral breast. Part E is additionally labeled. It consists of a single irregular fragment of soft, yellow tissue, measuring 5.4 x 3.8 x 1.5 cm. A suture. has been placed on one aspect of the specimen and is designated the new margin. That aspect of the. specimen is inked black, and the specimen is serially sectioned and entirely submitted in cassettes E1. through E5. Part F is received fresh labeled,. It consists of an. Working Draft. ovary, measuring 4.3 x 2 x 0.8 cm, with attached fallopian tube, measuring 0.8 x 0.5 x 6 cm. There is a. simple paratubal cyst, measuring 1.5 x 1.5 x 0.5 cm. This is received undisrupted, with a thin 0.1 cm. translucent wall, and contains 20 CC of clear fluid. In addition, there is a second small paratubal cyst,. measuring 0.5 x 0.5 x 0.5 cm. The ovary is serially sectioned, and no abnormalities are detected, other. than a 0.5 x 0.5 x 0.5 cm small white firm area. The fallopian tube is serially sectioned, and no. abnormalities are detected. Cassettes are submitted as follows: Cassettes F1-F9: Ovary, entirely submitted (firm, white area in cassette F7). Cassettes F10-F12: Fallopian tube, entirely submitted. Cassette F13: Representative section of the paratubal cyst and smaller, 0.5-cm paratubal cyst. Cassette F14: Representative section of broad ligament. Part G is additionally labeled. It consists of an ovary with attached fallopian tube,. weighing 15.9 gm. There is a disrupted hemorrhagic, cystic mass in the broad ligament, measuring 2.3 x. 1.6 x 1.5 cm, no capsule is visualized. A representative section of the cystic mass is submitted for frozen. section diagnosis as FS3. The ovary and tube do not appear involved by the lesion. The ovary is inked. black, it contains a simple corpus luteal cyst measuring 1.5 x 1.6 x 0.8 cm. The ovary measures 3.5 x 3. x. 1 cm, and the tube measures 6.5 x 0.8 cm. The ovary and fallopian tube are serially sectioned, and no. abnormalities are detected. Cassettes are submitted as follows: Cassettes G1-G6: Ovary, entirely submitted. Cassettes G7-G10: Fallopian tube, entirely submitted. Cassettes G11-G12: Lesion in broad ligament, entirely submitted. Cassette G13: Frozen section remnant. Part H is additionally labeled. It consists of an unoriented piece of yellow,. adipose tissue, measuring 5 x 1.3 x 0.4 cm, with a white-tan, soft nodule, measuring 0.3 x 0.3 x 0.3 cm,. attached to one end. This is entirely submitted for frozen section diagnosis as FS4, with the frozen. section remnant submitted in cassette H1. The remaining omentum is entirely submitted in cassette H2. Part I is additionally labeled. It consists of multiple unoriented. fragments of tissue, measuring 1 x 0.3 x 0.1 cm in aggregate. The specimen is entirely submitted for. frozen section diagnosis as FS5, with the frozen section remnant submitted in cassette 11. Part J is additionally labeled. It consists of an aggregate of fatty tissue, measuring 4 x 2 x 0.5. cm. No abnormalities are detected. Tne specimen is entirely submitted in cassettes J1 through J3. /Pathology Resident. Fee Codes: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Benign scar tissue, see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Vaginal/Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Reactive cellular changes. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Right Breast, implant capsule. Final Diagnosis. Right breast, implant capsule, capsulectomy: Peri-prosthetic capsule. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. No transformation zone components are identified. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Fragments of benign endocervical tissue and no definitive. endometrium, see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: A: Left breast capsule, B: Right breast capsule. Final Diagnosis. A. Breast capsule, left, excision: Dense fibrous tissue with chronic inflammation. B. Breast capsule, right, excision: Dense fibrous tissue with chronic inflammation. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: A: Skin, biopsy, shave, right scalp, B: Skin, biopsy, shave, left scalp, C: Skin, biopsy, punch, left upper. arm. Final Diagnosis. (Final Report Not Signed Out}. {Not Entered}. Specimen Class: Accessioned. Specimen(s) Received: A: Pelvic Washing, B: Diaphragm Washing. Working Draft. Final Diagnosis. A: Pelvic Washing. BENIGN. Reactive mesothelial cells. B: Diaphragm Washing. BENIGN. Reactive mesothelial cells. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Adenocarcinoma, morphologically consistent. with a primary breast carcinoma. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Reactive cellular changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: Right foot foreign body. Final Diagnosis. Foot, right, excision: Fragment of hyperkeratotic squamous epithelium. Specimen Class: Accessioned. Specimen(s) Received: Cytology, GYN, Site Not Specified, Thin Prep. Final Diagnosis. Cytology, GYN, Site Not Specified, Thin Prep. Working Draft. NEGATIVE FOR INTRAEPITHELIAL. LESION OR MALIGNANCY. Reactive cellular changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep. Fina) Diagnosis. Cervical/Endocervical, Thin Prep. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical,Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Endocervical cells present. SPECIMEN ADEQUACY: Satisfactory for evaluation but limited by obscuring white blood cells. Gpecimen Class: Accessioned: Specimen(s) Received: Skin, biopsy, left chin. Final Diagnosis. {Final Report Not Signed Out}. (Not Entered}. Specimen Class: Accessioned. Specimen(s) Received: Cervical, Direct. Final Diagnosis. Cervical, Direct.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size and extent of the tumor. The pathologic T stage is based on the largest dimension of the invasive tumor. According to the provided pathology report, the invasive tumor size is 2.4 cm. ",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage of the breast cancer patient, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.4 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition)",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Right axillary sentinel lymph node #1, count = 3500, dissection: Metastatic. adenocarcinoma in one of two lymph nodes (1/2). B. Right axillary sentinel lymph node #2, count = 500, dissection: No tumor in two. lymph nodes (0/2). C. Right breast, partial mastectomy: 1. Invasive micropapillary carcinoma, 2.1 cm, associated with microcalcifications; see. comment. 2. Atypical lobular hyperplasia. 3. Fibroadenoma. 4. Microcalcifications in benign ducts. D. Sentinel lymph node #3, count = 350, dissection: No tumor in two lymph nodes. (0/2). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive micropapillary carcinoma. - Invasive tumor size: 2.1 cm maximum diameter. The tumor is present in slices 4, 5, 9, and 10; however. the tumor has been banked from slices 6, 7, and 8. Therefore, the tumor extends through seven. consecutive slices, each with a width of approximately 0.3 cm, for a total maximum diameter of 2.1 cm. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: < 10 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in <10%, 3 points. Working Draft. Total points and SBR grade - 7 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Resection margins for invasive tumor: - Deep margin: Negative (1 cm). - Medial margin: Negative (0.9 cm). - Lateral margin: Negative (0.6 cm). - Anterior/superio: margin: Negative (0.5 cm). - Anterior/inferior margin: Negative (greater than 1 cm). - Ductal carcínoma in situ (DCIS) type: None identified. Microcalcifications: Present involving both benign ducts and invasive carcinoma. - Lobular carcinoma in situ (LCIS): None identified. - Lymph node status: - Number of positive lymph nodes: 1. - Total number sampled: 6. - Diameter of largest metastasis: 2.1 mm. - Extranodal extension: Absent. - AJCC/UICC stage: pT2N1aMX. - Nontumorous breast tissue: Atypical lobular hyperplasia, fibroadenoma, and sclerosing adenosis. - Additional comments: We reviewed the original frozen section slides and concur with the frozen section. diagnosis rendered. The metastatic tumor in Part A was only present in the additionally submitted. sections of the lymph node (slide A2). Level sections on A2-A4 confirms the diagnosis. Select slides from. part C were shown at the. the faculty in attendance concurred. with the above diagnosis of micropapillary type of invasive carcinoma. Dr. has reviewed A2. and concurs with the diagnosis. An immunohistochemical test for estrogen and progesterone receptors was performed on block C9. The test for estrogen receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. The test for progesterone receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block C9 using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Slide A2 was shown at the departmental Consensus Conference, and the faculty in attendance concurred. with the above diagnosis. Intraoperative Consult Diagnosis. FS1 (A) Right axillary SLN #1, biopsy: Negative for carcinoma. (Dr. Clinical History. The patient is a. year-old woman with right breast carcinoma. Working Draft. Gross Description. The specimen is received in four parts, each labeled with the patient's name and medical record number. Part A is received fresh and labeled. It consists of one pink-yellow,. soft, fatty tissue that measures 3.1 x 2.5 x 0.8 cm. The specimen is strained and two candidate lymph. nodes are found, the smallest is inked blue and submitted with a representative section of the largest. submitted for frozen diagnosis #1, thereafter submitted in cassette A1. The remnant of the largest lymph. node is transected and entirely submitted in cassettes A2-A3, and the remnant of the yellow fatty tissue is. submitted in cassette A4. Part B, additionally labeled. consists of a single fragment of yellow,. fibrofatty tissue measuring 2 x 1.8 x 0.4 cm. The specimen is entirely submitted in cassette B1. Part C, additionally labeled. consists of a right breast specimen oriented. with a short superior and a long stitch lateral. The specimen measures 3.2 cm from anterior to posterior,. 5 cm from medial to lateral and 6.5 cm from superior to inferior. The resection margins are inked as. follows for microscopic evaluation: anterior superior in blue, anterior inferior in green and posterior in. black. The specimen is serially sectioned from medial to lateral into twelve slices. There is gray-white,. fibrous tissue in the superior half of the specimen in slices 3-11, measuring 2.4 x 2 x 1.5 cm. White. fibrous tissue extends from this area to the anterior inferior aspect in slices 5-8. The gray-white fibrous. tissue appears extend to the inked margin in the posterior superior aspect of slices 3 and 4, and appears. to be 0.5 cm from the anterior superior inked margins in slices 5 and 9. Representative sections are. submitted as follows: Cassette C1: Representative medial margin, slice 1, bread-loafed. Cassette C2: Representative section of slice 3. Cassettes C3-C5: Slice 4. Cassette C6: Representative section of slice 5. Cassette C7: Representative section of slice 6. Cassette C8: Representative section of slice 8. Cassette C9: Representative section of slice 9. Cassettes C10-C11: Representative sections of slice 10. Cassette C12: Representative section of slice 11. Cassette C13: Representative lateral margin, slice 12, bread-loafed. Part D, additionally labeled. consists of a single, yellow, fibrofatty tissue fragment. measuring 2.5 x 1.5 x 0.4 cm. The specimen is entirely submitted in cassette D1. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as. investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (\"CLIA\"). as qualified to perform high-complexity clinical testing. Fee Codes: Other Specimens. pecimen Class: Accessioned: Specimen(s) Received: Right axillary contents. Final Diagnosis. Axilla, right, \"contents,\" excision: 1. Scar tissue, fat necrosis and suture with giant cell reaction. No malignancy is. identified. Working Draft. 2. No metastatic tumor identified in five lymph nodes. (0/5). Specimen Class: Accessioned: Specimen(s) Received: Final Diagnosis. Review of. from : Breast, right, 10 o'clock, core biopsies: Infiltrating ductal carcinoma, SBR Grade 2; see. comment. FND OF REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size of the invasive tumor. The T stage is classified as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, and T4 - Tumor is any size with direct extension to the chest wall or skin. The provided pathology report mentions the invasive tumor size as 2.1 cm, which is more than 2 cm but not more than 5 cm. Therefore, based on the tumor size, the pathologic T stage is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The pathology report provided sufficient information to determine the size and extent of the tumor, which aligns with the criteria for T2 staging.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Lymph node, sentinel node #1, excision: No carcinoma (0/1). B. Lymph node, sentinel node #2, excision: No carcinoma (0/1). C. Breast, left, partial mastectomy: 1. Invasive ductal carcinoma, SBR grade 2, 2.1 cm; see comment. 2. Ductal carcinoma in situ, solid and micropapillary types, 1 cm; see. comment. 3. Lobular carcinoma in situ, classic type; see comment. 4. Atypical ductal hyperplasia involving fibroadenoma. Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 2.1 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 2, 2 points. Mitotic count: <10 mitotic figures/10 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in <10%, 3 points. Total points and overall grade = 6,7 points = grade 2. - Lymphatic-vascular invasion: Present (Slide C11). - Resection margins for invasive tumor: - Deep margin: Negative; tumor is 3 mm away, on Slide C5. - Medial margin: Negative; tumor is 5 mm away, on Slide C11. - Lateral margin: Negative (widely clear, >1 cm). - Anterior/superior margin: Negative; tumor is 6 mm away, on Slide C10. - Anterior/inferior margin: Negative (tumor is widely clear, >1 cm). Ductal carcinoma in situ (DCIS) type: Solid-micropapillary. - Ductal carcinoma in situ size: Working Draft. DCIS present in contiguous sections, 1 cm maximum diameter (Slide C10). Ductal carcinoma in situ nuclear grade: Intermediate grade. - Necrosis in DCIS: Comedonecrosis, focal (<1/3). - Microcalcifications: None. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative; tumor is <1 mm away, on Slide C13. - Medial margin: Negative; tumor is 1 mm away, on Slide C13. - Lateral margin: Negative (widely clear, >1 cm). - Anterior/superior margin: Negative; tumor is <1 mm away, on Slide C13. - Anterior/inferior margin: Negative (widely clear, >1 cm). - Lobular carcinoma in situ (LCIS): Present. - Number of lobules involved: Few. Nuclear type/size: Classic, small cell type. - Lymph node status: - Number of positive lymph nodes: 0. - Total number sampled: 2. - AJCC/UICC stage: pT2N0(S)MX. - Nontumorous breast tissue: Atypical ductal hyperplasia involving fibroadenoma. In Slide C11, a few lobules show round shaped nucleated cells with powdery blue vesicular cytoplasm. proliferating within lobule lumens. Immunohistochemistry for E cadherin is obtained and is necessary. to evaluate these cells. The stain is negative in these areas and supports the diagnosis of lobular. carcinoma in situ. An immunohistochemical test for estrogen and progesterone receptors was performed on block C5 and. C10. The test for estrogen receptors is negative. There is no nuclear staining in any tumor cells. Internal. positive control is positive. The test for progesterone receptors is positive. There is strong nuclear staining in >95% of tumor. cells. Internal positive control is present. Result of HER2/neu test: This carcinoma is indeterminate for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block C5 using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 2 on a scale of 0-3. Carcinomas with staining Intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Intraoperative Consult Diagnosis. FS1 (A) Left axillary SLN #1, biopsy: No carcinoma in one lymph node (0/1). (Dr. FS2 (B) Left axillary SLN #2, biopsy: No carcinoma in one lymph node (0/1). (Dr. Clinical History. The patient is a. year-old woman with palpable lesion in the left upper inner quadrant. She now. Working Draft. undergoes partial mastectomy. Gross Description. The specimen Is received fresh in three parts, each labeled with the patient's name and medical record. number. Part A, additionally labeled. consists of one piece of pink-yellow,. fatty tissue measuring 2 x 1.4 x 0.7 cm. The specimen is trimmed, and one candidate lymph node is. found, inked green and bisected, entirely submitted for frozen section diagnosis 1, and subsequently. submitted in cassette A1. The remaining yellow, fatty tissue is entirely submitted in cassette A2. Part B, additionally labeled. consists of one soft, tan-yellow,. fatty tissue fragment measuring 3 x 1.5 x 0.5 cm. The specimen is trimmed, and one candidate. lymph node is entirely submitted for frozen section diagnosis 2, and subsequently submitted in. cassette B1. The remaining yellow, fatty tissue is entirely submitted in cassette B2. Part C is additionally labeled. It consists of. a yellow-white, fatty mastectomy specimen, measuring 3 (anterior to posterior) x 4.9 (medial to. lateral) x 6.2 (superior to inferior) cm and weighing 21.3 gm. There is a yellow-white, firm, irregular. mass, measuring 2 (anterior to posterior) x 2.1 (inferior to superior) x 1.5 (medial to lateral) cm, with. a central stellate appearance abutting the anterior-superior and posterior margins; it is 1.5 cm from. the anterior-inferior margin and 1 cm from the lateral and medial margins. The specimen is inked for. microscopic diagnosis so as the anterior-superior surface is blue, the anterior-inferior surface is green,. and the posterior surface is black. A portion of the tumor is taken for tissue banking. The specimen is. serially sectioned into seven 0.5-cm slices, from lateral to medial, and representative sections are. submitted as follows: Cassette C1: Representative section of slice 1, lateral margin, perpendicular. Cassette C2: Slice 2, superior portion. Cassette C3: Slice 2, inferior portion. Cassettes C4-C6: Tumor, slice 3, three pieces, superior to inferior. Cassettes C7-C8: Tumor, slice 4, two pieces, superior to Inferior. Cassettes C9-C10: Tumor, slice 5, two pieces, superior to inferior. Cassette C11: Slice 6. Cassettes C12-C13: Slice 7, medial margin, perpendicular. /Pathology Resident. /Pathologist. Signed: : Fee Codes: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic pattern. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Peritoneal Washing. Final Diagnosis. Peritoneal Washing. BENIGN. Reactive mesothelial cells. Specimen Class: Accessioned: Specimen(s) Received: A: Right ovary and tube (fresh), B: Left ovary and tube (fresh). Final Diagnosis. A. Right ovary and fallopian tube, risk-reducing salpingo-oophorectomy: - Ovary: Serosal calcifications, benign epithelial inclusion glands, adhesions and. endosalpingiosis. - Fallopian tube: No significant pathologic abnormality. B. Left ovary and fallopian tube, risk-reducing salpingo-oophorectomy: - Ovary: Serosal calcifications, benign epithelial inclusion glands, adhesions and. endosalpingiosis. - Fallopian tube: No significant pathologic abnormality. QA Review(s). Immuno. Problem? N. Reviewers: Result(s): Informed Pathologist (Name): Resolution(s): Repeat extra slides available: repeat and make up p53. Reason(s): Immuno Stain . No Staining: no stain in p53 control. related specimen(s): Specimen Class: Accessioned. Specimen(s) Received: right breast capsule. Final Diagnosis. Right breast, periprosthetic capsulectomy: Organizing granulation tissue. MD. MD. Specimen Class: Accessioned. Specimen(s) Received: Rectum, biopsy. Final Diagnosis. Rectum, biopsy: Focal cryptitis; see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: A: Left Breast, B: Left Nipple Aerolar Margin, C: Right Breast, D: Right Breast Aerolar Margin. Final Diagnosis. A. Left breast, mastectomy: 1. Intraductal papilloma (A10). 2. Breast with previous treatment effect. B. Left nipple areola margin, excision: Subareolar tissue with lactiferous ducts, no. carcinoma. C. Right breast, mastectomy: 1. Atypical lobular hyperplasia. 2. Breast with previous treatment effect. D. Right breast, areola margin, excision: Apocrine metaplasia, no carcinoma. pecimen Class: Accessioned: Specimen(s) Received: Cervical, Thin Prep Imaged. Final Diagnosis. Cervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Adenocarcinoma (see comment). Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Working Draft. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: A) POC. Final Diagnosis. UTERINE CONTENTS, ABORTION: IMMATURE PLACENTAL VILLI AND DECIDUA, CONSISTENT WITH. PRODUCTS OF CONCEPTION. Conversion. MD. FNN OF REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the invasive tumor. The T stage is classified as follows: T1 - tumor is 2 cm or less in greatest dimension, T2 - tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - tumor is more than 5 cm in greatest dimension, and T4 - tumor is any size with direct extension to the chest wall or skin. According to the pathology report, the invasive tumor size is 2.1 cm, which is more than 2 cm. Therefore, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "The user has provided a pathology report for a breast cancer patient. The report includes information about the tumor size, grade, and lymph node status. To determine the pathologic T stage, I need to extract the relevant information from the report and apply the AJCC Cancer Staging Manual (7th edition) rules. I will use the extract_information tool to gather the necessary data and then apply the get_t_stage_rule tool to determine the T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size and extent of invasion were evaluated to determine the T stage.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Sentinel lymph node #1, right axilla, biopsy: No tumor identified in one lymph. node (0/1). B. Non-sentinel lymph node #2, right axilla, biopsy: One lymph node positive for. metastatic carcinoma (1/1). C. Sentinel lymph node #2, right axilla, biopsy: No tumor identified in one lymph. node (0/1). D. Non-sentinel lymph node #1, right axilla, dissection: No tumor identified in one. lymph node (0/1). E. Non-sentinel lymph node #3, right axilla, dissection: Fibrofatty tissue, no tumor. or lymph node tissue seen on level sections. Working Draft. F. Right breast, lumpectomy: 1. Invasive ductal carcinoma, SBR grade II, 2.6 cm; see comment. 2. Lymphovascular invasion present. 3. Usual ductal hyperplasia. G. Lymph nodes, right axillary contents, dissection: No tumor identified in nineteen. lymph nodes (0/19). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive ductal carcinoma NOS. - Invasive tumor size: 2.6 cm maximum diameter (tumor spans slices 2-8, best seen in slides F4, F6,. F8, F10, F12, F13, and F15). - Invasive tumor grade (modified Bloom-Richardson): II. Nuclear grade: 2, 2 points. Mitotic count: 3 mitotic figures/10 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in less than 10%, 3 points. Total points and overall grade = 6 points = grade 2. - Lymphatic-vascular invasion: Present (slide F15). - Resection margins for invasive tumor: - Deep margin: Negative; tumor is within less than 0.1 cm on slide F6 (black ink). - Medial margin: Negative. - Lateral margin: Negative. - Anterior/superior margin: Negative; tumor is within less than 0.1 cm on slide F10 (blue ink). Anterior/inferior margin: Negative; tumor is within 1 cm on slide F8 (green ink). - Ductal carcinoma in situ (DCIS) type: None identified. - Lobular carcinoma in situ (LCIS): None identified. - Lymph node status: - Number of positive lymph nodes: 1. - Total number sampled: 23. - Diameter of largest metastasis: 3 mm. - Extranodal extension: Absent. - AJCC/UICC stage: pT2N1MX. - Nontumorous breast tissue: Usual ductal hyperplasia. - Nipple: Unremarkable. - Skin/dermis: Unremarkable. Additional comments: ER, PR, and HER-2/neu stains have been ordered and will be reported in an. addendum. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node #1, right axilla, biopsy: One lymph node with no evidence of metastatic. carcinoma. (Dr. FS2 (B) Non-sentinel lymph node #2, right axilla, biopsy: Metastatic carcinoma. (Dr. FS3 (C) Sentinel lymph node #2, right axilla, biopsy: One lymph node with no evidence of metastatic. carcinoma. (Dr. Clinical History. The patient is a. year-old woman who undergoes a right breast lumpectomy with axillary lymph. node dissection. Gross Description. The specimen is received in seven parts, each labeled with the patient's name and unit number. Working Draft. Part A, labeled. consists of a single soft, irregular, red-tan. candidate lymph node measuring 1.2 X 0.6 x 0.4 cm. The entire specimen is frozen for frozen section. diagnosis 1, and subsequently submitted in cassette A1. Part B, labeled \"non-sentinel lymph node #2 right axilla,\" consists of a single soft, irregular, red-tan. candidate lymph node measuring 1.3 X 0.8 x 0.5 cm. The entire specimen is frozen for frozen section. diagnosis 2, and subsequently submitted in cassette B1. Part C, labeled. consists of a single soft,. irregular piece of red-yellow, fatty tissue measuring 1.5 x 1 x 0.4 cm. Fatty tissue is trimmed away,. and a single candidate lymph node is found. The candidate fymph node is entirely submitted for. frozen section diagnosis 3, and subsequently submitted in cassette C1. The remaining unused fatty. tissue is entirely submitted in cassette C2. Part D, received in formalin and labeled. consists of one soft and firm,. tan-yellow, fatty tissue fragment measuring 1.7 x 1 x 0.4 cm. The entire specimen is submitted in. cassette D1. Part E, received in formalin and labeled. consists of one soft and firm,. tan-yellow, fatty tissue fragment measuring 1.6 x 1.2 x 0.4 cm. The entire specimen is submitted in. cassette E1. Part F is received in formalin and additionally labeled. It consists of a 9-gm. breast lumpectomy specimen, measuring 1.5 cm from anterior to posterior, 5 cm from superior to. inferior, and 3.5 cm from lateral to medial. There is a short stitch designated as superior and a long. stitch designated as lateral. The specimen is inked as follows: anterior superior blue, anterior inferior. green, and posterior black. Prior to receipt by me (Dr. the posterior portion of the. breast has been incised and tissue removed for tissue banking. The specimen is serially sectioned,. from medial to lateral, into eight slices and reveals a well-circumscribed, tan, firm nodule (1.5 x 1 x. 0.9 cm) in slices 3 through 6. The tumor nodule is located approximately 1 cm from both the lateral-. and medial-most margins, 0.7 cm from the superior margin, and 1.3 cm from the inferior margin. The. closest approach to a margin is in slice 6, where it appears to abut the anterior-mid portion of the. specimen (<1 mm grossly from the blue/green-inked margin). The specimen is entirely submitted as. follows: Cassette F1: Medial-most margin. Cassette F2: Slice 2, superior. Cassette F3: Slice 2, inferior. Cassette F4: Slice 3, superior (and nodule). Cassette F5: Slice 3, inferior. Cassette F6: Slice 4, superior (and nodule). Cassette F7: Slice 4, inferior. Cassette F8: Slice 5, superior (and nodule). Cassette F9: Stice 5, inferior. Cassette F10: Slice 6, superior (and nodule). Cassette F11: Slice 6, inferior. Cassette F12: Slice 7, superior. Cassette F13: Slice 7, inferior. Cassettes F14-F15: Lateral-most margin. Part G, received in formalin and labeled. consists of multiple soft and firm,. brown-tan and yellow tissue fragments measuring 7 x 6.5 x 1.5 cm in aggregate. The specimen is. trimmed and extensively searched for lymph nodes. Multiple candidate lymph nodes are found and. submitted intact in cassettes G1-G5. Fee Codes: Working Draft. Addenda. Addendum. Date Complete: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors was performed on block F6. The test for estrogen receptors is positive. There is strong nuclear staining in ~50% of tumor cells. The test for progesterone receptors is positive. There is weak to moderate nuclear staining in ~15%. of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block F6 using the CB11 monocional antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of Immunohistochemical and FISH testing, and almost always show. gene amplification. The immunonerovirtase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. s. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should. not be regarded as Investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (\"CLIA\") as qualified to perform high-complexity clinical testing. Other Specimens. Specimen Class: Accessioned. Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Benign breast elements (see comment). Working Draft. Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Vaginal/Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Adenocarcinoma, see note. Procedure/Addenda for. ADDENDUM. Date of Addendum.: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors as well as for HEr-2-neu was. performed on the material submitted for cell block. The test for estrogen receptors is positive There is strong nuclear staining in greater than 90% of. tumor cells. The test for progesterone receptors is Negative. There is no nuclear staining in 100% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein. over-expression on a scant specimen. Repeat testing is recommended on the excisional. specimen. An immunohistochemical assay was performed on the cell button using the CB11 monoclonal antibody. to HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining Intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Working Draft. the stain(s) reborted above were developed and their performance charatteristies determined by the. They have not been cleared or approved by the U. S. Food and Drug Administrauon. FDA. has. determined. that. such. clearance or approval is not necessary. These tests are used for clinical purposes. They should. not be regarded as investigational or for research. This laboratory Is certified under the Clinical Laboratory Improvement. Amendments of 1988 (\"CLIA\") as qualified to perform high-complexity clinical testing. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation; atrophic pattern with no identifiable. endocervical/transformation zone component. Cellular distortion secondary to airdrying artifact. Cellular distortion secondary to mechanical artifact. Specimen Class: Accessioned: Specimen(s) Received: A: 2:00 Right Breast, Fine Needle Aspiration, B: 5:00 Right Breast, Fine Needle Aspiration. Final Diagnosis. A. Right Breast, 2:00 o'clock, Fine Needle Aspiration: Lacatation changes; see comment. B. Right Breast, 5:00 o'clock, Fine Needle Aspiration: Lacatation changes; see comment. Specimen Class: Accessioned. Specimen(s) Received: Right breast core biopsy. Final Diagnosis. Right breast, needle core biopsy: Breast tissue with gestational lobular change and. suppurative inflammation; no in situ or invasive carcinoma seen. See comment. pecimen Class: Accessioned: Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast. 2:00 o'clock, Fine Needle Aspiration: Atypical, see. note. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep. Final Diagnosis. Vaginal/Cervical/Endocervical, Thin Prep. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Specimen(s) Received: Uterine contents. Final Diagnosis. Uterine contents, evacuation: Decidua with chorionic villi. Specimen Class: Accessioned. Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Lipoma; see comment. Specimen Class: Accessioned. Specimen(s) Received: Vaginal, Direct. Final Diagnosis. Vaginal, Direct. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Working Draft. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to understand what each T stage represents in terms of tumor size and extent. The T stages are defined as follows:\\widgets T1: Tumor is 2 cm or less in greatest dimension. T2: Tumor is more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor is more than 5 cm in greatest dimension. T4: Tumor is any size with direct extension to the chest wall or skin.\\widgets Given the information from the pathology report, the key detail for determining the T stage is the size of the invasive tumor. According to the report, the \"Invasive tumor size: 2.6 cm maximum diameter\". Based on this information, we can see that the tumor size falls into the category of more than 2 cm but not more than 5 cm.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to follow these steps: 1) Extract relevant information from the pathology report, such as tumor size, depth of invasion, and lymphovascular invasion. 2) Use the extracted information to apply the T-staging rules and determine the appropriate T stage (T1, T2, T3, or T4). 3) Finally, I will use the produce_final_staging_response tool to format my final response into a JSON schema with 'reasoning' and 'stage' as keys.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.6 cm corresponds to a T2 stage based on the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Sentinel lymph node #1, left axilla (count=4414), biopsy: Metastatic ductal. carcinoma, 2 cm focus, in one (1/1); see comment. B. Lymph node, left axilla, dissection: Metastatic ductal carcinoma in two of fourteen. (2/14). Working Draft. C. Lymph node, left axilla level III, biopsy: No tumor in one (0/1). D. Left breast, modified radical mastectomy: 1. Invasive ductal carcinoma, SBR grade 3, 6.5 cm; see comment. 2. Ductal carcinoma in situ (DCIS), high grade, micropapillary and cribriform. patterns, with comedonecrosis, narrowly excised; see comment. 3. Invasive carcinoma present at inked anterior-superior resection margin; see. comment. 4. Microcalcifications in DCIS. 5. Non-proliferative fibrocystic change with apocrine metaplasia and microcysts. 6. Benign sclerosing papilloma. E. Left breast, anterior/superior/medial margin, excision: Invasive ductal carcinoma,. SBR grade 3, close to inked margin; see comment. F. Skin, left breast nodule, excision: 1. Invasive ductal carcinoma, SBR grade 3, present in dermis, subcutaneous tissue. and fibrous tissue; see comment. 2. Fibrous tissue, suggestive of scar, with invasive tumor; see comment. G. Skin, newest anterior/superior/medial margin, excision: No significant pathologic. abnormality, no tumor. H. Left breast, new nipple margin, biopsy: Benign lactiferous ducts, no in situ or. invasive tumor. I. Non-sentinel lymph node #1, dissection: No tumor in two (0/2). J. Non-sentinel lymph node #2, biopsy: No tumor in one (0/1). Note: The tumor present in the main mastectomy specimen (part D) encompasses a 7.5 cm maximal. area, which includes an area of tumor satellites adjacent to a 6.5 cm solid tumor mass. The tumor. consists of infiltrating trabeculae, nests and glands of cells with ample and mostly clear cytoplasm,. and large pleomorphic nuclei with nucleoli. Abundant mitotic figures are present. Ductal carcinoma in. situ is also present with cribriform, micropapillary, and comedo patterns, and shows cytology similar to. that of invasive tumor, with cells showing clear cytoplasm and pleomorphic high-grade nuclei. The. DCIS is present only as scattered foci admixed within the invasive carcinoma itself. Material from the. patient's prior biopsy (. ) shows analogous features. Invasive carcinoma are present at the inked anterior-superior margin of the main specimen (slides D2,. D3; see details in synoptic below), however, the separately submitted additional margin (part E),. shows invasive tumor that is narrowly (<0.5mm) excised (slide E8). In this specimen (part E), there. is also tumor extending to the edges of the specimen that were indicated by the surgeon as not the. new margin. The skin nodule (part F) shows invasive ductal carcinoma (0.6 cm) within the subcutaneous tissue,. dermis and immediately beneath the epidermis, where it is seen to involve an area of fibrosis that is. suggestive of a skin scar. The tumor is within 0.5 mm of the excision margin, however, the separately. submitted new skin margin (part G) shows no tumor. The extensive clear cell features and nested architecture of the tumor are morphologic features that. are often seen in renal cell carcinoma (RCC). Therefore, this possibility was considered and. immunohistochemical studies were performed and evaluated on a lymph node metastasis (block B7). and interpreted as follows: Working Draft. CD10: Negative (result does not support renal tumor). Renal cell carcinoma Ab (RCC): Positive (result supports renal tumor). Cytokeratin 7: Positive (result does not support renal tumor). E-Cadherin: Positive (result does not support renal tumor). Estrogen receptor: Negative (result does not support renal tumor). Overall, while RCC Ab is positive, all other stains are indicative of this being metastatic breast. carcinoma in a lymph node that has features mimicking RCC. Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 6.5 cm maximum diameter (calculated by the presence of tumor in 4. consecutive 1.6 cm thick slices). Invasive tumor grade (modified Bloom-Richardson): 3. Nuclear grade: 3, 3 points. Mitotic count: >30 mitotic figures/10 HPF, 3 points. Tubule/papilla formation: >10% but <75%, 2 points. Total points and overall grade = 8 points = grade 3. - Lymphatic-vascular invasion: present. - Perineural invasion: None identified. -Tumor necrosis: Present. - Resection margins for invasive tumor: In the main mastectomy specimen (part D), invasive tumor is. present at the inked anterior/superior margin, near the medial end (approximately 10 o'clock,. 10 cm from the nipple; slides D2, D3). However, the separately submitted. \"anterior/superior/medial\" margin shows tumor that is narrowly excised near one edge of the. \"new margin\" of specimen part E K< 0.5 mm; slide E8). - Deep margin: Negative; (tumor is 1 cm away, on slide D6). - Medial margin: Negative; (tumor is 0.2 cm away, on slide D1). - Lateral margin: Widely clear. - Anterior/superior margin: Positive on main specimen (slides D2, D3). - Anterior/inferior margin: Widely clear. - Nipple bed margin: Widely clear. - Ductal carcinoma in situ (DCIS) type: Comedo, cribriform, micropapillary. - Ductal carcinoma in situ size: DCIS is present as scattered foci admixed with the invasive. carcinoma. - Ductal carcinoma in situ nuclear grade: High nuclear grade. - Necrosis in DCIS: Comedonecrosis, focal (<1/3). - Microcalcifications: Present, involving DCIS only. - Resection margins for ductal carcinoma in situ: In the main mastectomy specimen (part D), DCIS is. present < 0.5mm from the anterior/superior margin, near the medial end (approximately 10. o'clock, 10 cm from the nipple; slide D2). However, the separately submitted. \"anterior/superior/medial\" margin has no definite DCIS in it. - Deep margin: Widely clear; (tumor is 1 cm away, on slide D6). - Medial margin: Negative; (tumor is 0.2 cm away, on slide D1). - Lateral margin: Widely clear. - Anterior/superior margin: Close; <0.5mm (slide D2). - Anterior/inferior margin: Widely clear. - Nipple bed margin: Widely clear. - Lobular carcinoma in situ (LCIS): Not present. - Lymph node status: Positive. - Number of positive lymph nodes: 3. - Total number sampled: 19. - Diameter of largest metastasis: 2 cm. - Extranodal extension: Not present. - AJCC/UICC stage: pT3N1aMX. Working Draft. - Nontumorous breast tissue: Cystic changes, apocrine metaplasia, papilloma. - Nipple: Not present. - Skin/dermis: Focus of invasive ductal carcinoma in dermis (see part F above). An immunohistochemical test for estrogen and progesterone receptors was performed on block A1. (lymph node). The test for estrogen receptors is positive. There is strong nuclear staining in > 70% of tumor cells. The test for progesterone receptors is positive. There is at least weak nuclear staining in > 10% of. tumor cells, with strong staining in ~5% of tumor nuclel. Result of HER2/neu test: This carcinoma is indeterminate for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block A1 using the CB11 monocional antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 2 on a scale of 0-3 (HER2 test. interpreted by Dr. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoproteln. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymnh node #1, left axilla, biopsy: Carcinoma, approximately 2 cm (1/1). (Dr. Clinical History. The patient is a. vear-old woman with left breast cancer. She undergoes mastectomy. Gross Description. The specimen is received in ten parts, each labeled with the patient's name and unit number. Parts. A-C are received fresh. Parts E-J are received in formalin. Part A, additionally labeled n. isists of a single, pink,. unorlented tissue fragment measuring 2 x 1.8 x 0.6 cm. The specimen is bisected and entirely. submitted for frozen section diagnosis 1, and subsequently submitted in cassette A1. Part B, additionally labeled \". consists of a brown-yellow,. ovoid piece of fatty tissue with a stitch indicating the apex, measuring 8.5 x 8.5 x 3.3 cm. Also in the. specimen container are two fragments of yellow-tan, soft tissue measuring 5.5 x 4.5 x 2.5 cm in. aggregate. Multiple lymph nodes are found in the specimen. Lymph nodes from the main specimen. are submitted from apex to base and all lymph nodes are submitted as follows: Cassettes B1-B6: Multiple whole lymph nodes. Cassette B7: One lymph node, bisected. Cassette B8: Multiple whole lymph nodes from smaller tissue fragment. Part C, additionally labeled. nsists of two fragments of tan-yellow,. fatty tissue measuring 3.5 x 3.5 x 2.5 cm in aggregate. No lymph nodes are identified in the. specimen. The specimen is entirely submitted in cassettes C1-C3. Part D is additionally labeled. It. consists of a mastectomy, without skin, nippie, or areoia, that has been previously inked and incised. prior to receipt in Pathology. Short suture and long suture are present, in additional to a blue nylon. suture present at the anterior-mid area. Following the provided orientation, the specimen measures. Pape 4 of 7. Working Draft. 22 cm from medial to lateral, 19 cm from superior to inferior, and 6 cm from anterior to posterior. The designated nipple/areolar bed measures 3.5 x 3.5 cm in area. The specimen has been previously. inked as follows: posterior aspect in black, anterior superior blue, and anterior inferior green. A 14. cm long previous incision is present on the posterior surface running vertically that is 5 cm deep and. reveals an irregular firm area in the superior half of the cut surface (upper inner quadrant). The. specimen is further serially sectioned, from medial to lateral, with slice 1 as medial and slice 13 as. lateral and the previous incision present between slice 5 and slice 6. An irregular, ill-defined, firm,. white-to- tan lesion is present in slices 1 through 6, encompassing a 8 cm dimension from medial to. lateral, 5 cm from superior to inferior, and 2.5 cm from anterior to posterior. The majority of this. lesion is present as a solid area in slices 3 through 6 (6.5 cm from medial to lateral). In slices 1 and. 2, the lesion is present as an area of multiple satellite nodules, of up to 0.4 cm each, directly adjacent. to the solid area. The lesion overall abuts the anterior- superior margin and is 0.5 cm from medial. margin, 1.2 cm to deep margin, 3 cm to anterior inferior, 13 cm to lateral, 2.5 cm to the nipple bed,. 3.4 cm to superior edge, and 8.5 cm to inferior edge. Two 0.5 cm, spherical cystic cavities are present. within or adjacent to the lesion, the first in the superior half of slices 4 and 5, and the second in the. mid-portion of slice 5. Up to a 0.5 cm thickness of muscle is present in focal areas of the posterior. aspect. Remainder of the specimen consists almost entirely of unremarkable yellow fat. There are. thin, delicate strands of white, fibrous tissue present throughout most of the remainder of the. specimen. Representative sections are submitted as follows: Cassette D1: Representative medial margins, perpendicular. Cassette D2: Anterior-superior margin, slice 2, in relation to nodular masses. Cassette D3: Anterior-superior margin, slice 3, in relation to mass. Cassette D4: Anterior-superior margin, slice 4, including cavity. Cassette D5: Deep margin in relation to mass, from slice 5. Cassette D6: Deep margin, slice 6, with muscle. Cassette D7: Superior edge, slice 4. Cassette D8: Inferior edge, slice 5. Cassette D9: Anterior-inferior margin, slice 5. Cassette D10: Nipple bed margin, slice 6. Cassette D11: Lateral margin, perpendicular. Cassette D12: Representative section of the mass from slice 5, with cavity. Cassette D13: Inferior edge of mass, slice 6. Cassette D14: Representative upper outer quadrant, slice 8. Cassette D15: Representative upper outer quadrant, slice 10. Cassette D16: Representative lower inner quadrant, slice 6. Cassette D17: Representative lower inner quadrant, slice 4. Cassette D18: Representative lower outer quadrant, slice 9. Cassette D19: Representative lower outer quadrant, slice 8. Part E is additionally labeled. t consists of a segment of. adipose tissue containing a singie suture. The requisition form indicates the suture marks the new. margin. The specimen is 4.5 x 4 x 2 cm with the suture present at one longitudinal end of the. specimen. There is a 1.5 cm maximal dimension area containing irregular, white-firm mass that is 2. cm from the new margin. In addition, there are 2-3 0.2 to 0.3 cm firm nodules present abutting the. new margin. The new margin is inked black. The remainder of the surfaces are inked blue and. representative sections including the entire new margin are submitted as follows: Cassettes E1-E8: Entire new margin. Cassette E9: Representative section of 1.5 cm lesion. Part F is additionally labeled. It consists of a skin ellipse that is 1.2 x 0.6 cm. in area and 0.8 cm in maximal depth, that contains an irregular 0.5-cm area of firm, white nodules. The resection margins are inked blue and the specimen is entirely submitted as follows: Cassette F1: Tips. Cassette F2: Remainder of specimen. Part G is additionally labeled. It consists of a 1.4. x 1.1 x 0.2 cm segment of tissue with apparent skin on one broau surrace. A 0.7 cm central hole is. present. The non-skin surfaces are inked blue and the specimen is entirely submitted as follows: Working Draft. Cassette G1: Tips. Cassettes G2-G3: Remainder of specimen. Part H is additionally labeled. It consists of a segment of. irregular, brown soft tissue sutured to a Telfa pad. There is a single long suture present on the. non-Telfa surface. The requisition form indicates the stitch marks new margin (margin side up) and. this new margin surface is inked black. The opposite surface (Telfa surface) is inked blue. The. specimen is bisected and entirely submitted in cassette H1. Part I, additionally labeled. consists of one soft and firm, tan-yellow piece of fatty tissue. measuring 2.5 x 2 x 0.6 cm. The specimen is trimmed and extensively searched for lymph nodes. One candidate lymph node is found; this is inked blue and bisected, and entirely submitted in cassette. I1. The remaining yellow fatty tissue is submitted in cassette I2. Part J, additionally labeled. consists of one soft and firm, tan-light brown tissue fragment. measuring 2 x 1.6 x 0.7 cm. The specimen is inked black and bisected, and entirely submitted in. cassettes J1-J2. The. immunonernvidace ctain(s) reported above were developed and their performance characteristics determined by the !. They have not been cleared or approved by the U. S. Food and Drug Administration. me FDA has determined that such ciearance or approval Is not necessary. These tests are used for clinical purposes. They should. not be regarded as Investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (\"CLIA\") as qualified to perform high-complexity clinical testing. /Pathologist. Fee Codes: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Final Diagnosis. Review of. A. Left breast, \"#1 with calcs,\" biopsy : 1. Ductal carcinoma in situ, high grade, solid and papillary patterns with comedo. necrosis and extension to lobules; see comment. 2. Microscopic focus (< 1mm) suspicious for invasion; see comment. 3. Microcalcifications present in association with ductal carcinoma in situ. B. Left breast, \"#2 with calcs,\" biopsy: 1. Invasive ductal carcinoma; see comment. 2. Ductal carcinoma in situ, high grade, solid and papillary patterns with comedo. necrosis and extension to lobules; see comment. 3. Microcalcifications present in association with ductal carcinoma in situ and stroma. Working Draft. A. Left breast \"nodule,\" biopsy: 1. No in situ or invasive carcinoma identified. 2. Fibroadenoma. FND OF REPORT.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report. The key factors that influence the T stage include the size of the tumor, whether the tumor has grown into the chest wall or skin, and whether there are any satellite nodules or separate tumor foci. Here’s the step-by-step reasoning:",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report, specifically the tumor size and any evidence of invasion or metastasis.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is more than 5 cm in greatest dimension.",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Sentinel lymph node #1, right axilla, biopsy: No carcinoma identified in one. lymph node (0/1). B. Sentinel lymph node #2, right axilla, biopsy: No carcinoma identified in two. lymph nodes (0/2). C. Right breast, new inferior margin, excision: Benign breast tissue, no carcinoma. identified. D. Sentinel lymph node #3, right axilla, biopsy: No carcinoma identified in one. lymph node (0/1). E. Right breast, partial mastectomy : 1. Neuroendocrine carcinoma, large cell type, high grade, SBR grade 3, 3.8 cm. 201317. diameter, extending to deep resection margin and 0.1cm from anterior/superior. margin; see comment. Working Draft. 2. Microcalcifications associated with benign breast tissue. F. Right breast, new posterior margin, excision: Benign breast tissue, no carcinoma. identified. Note: Immunohistochemical studies were necessary to evaluate this case and establish the correct. diagnosis. The following immunohistochemical stains were performed and evaluated: Keratin cocktail:Patchy positive. CD56: Positive. PAX-5: Positive. LCA: Negative. Chromogranin: negative. Synaptophysin: negative. E-Cadherin: negative. The negative staining with LCA rules against a lymphoid neoplasm. Negative E-Cadherin excludes a. ductal carcinoma. The positive staining with PAX-5, CD56 and patchy cytokeratin staining as well as. the morphology onH& E stain are compatible with a neuroendocrine carcinoma. Negative staining with. chromogranin and synaptophysin, although expected in this entity, does not exclude it. Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Large cell neuroendocrine carcinoma, high grade. - Invasive tumor size: 3.8 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): 3. Nuclear grade: 3 points. Mitotic count: 2 points. Tubule/papilla formation: 3 points. Total points and overall grade = 8 points= Grade 3. - Lymphatic-vascular invasion: Absent. - Resection margins for invasive tumor: - Deep margin: Positive; (slide E12). - Medial margin: Negative; (tumor is > 1 cm away). - Lateral margin: Negative; (tumor is >1 cm away). - Anterior/superior margin: Close; (tumor is less than 0.1 cm away, on slide E7). - Anterior/Inferior margin: Negative; (tumor is 0.25 cm away, on slide E15). - Lymph node status: - Number of positive lymph nodes: 0. - Total number sampled: 4. - AJCC/UICC stage: pT2NOMX. An immunohistochemical test for estrogen and progesterone receptors as well as for HER2 was. performed on block E9. The test for estrogen receptors is negative. There is no nuclear staining in any of tumor cells. Internal positive control is present. The test for progesterone receptors is negative. There is no nuclear staining in any of tumor cells. Internal positive control is present. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed using the CB11 monoclonal antibody to HER2/neu. oncoprotein. The staining intensity of this carcinoma was 0 on a scale of 0-3 (HER2 test interpreted. Working Draft. by Dr. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of Immunohistochemical and FISH testing, and almost always show. gene amplification. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node #1, right axilla, biopsy: No carcinoma. (Dr. FS2 (B) Sentinel lymph node #2, right axilla, biopsy: No carcinoma. (Dr. FS3 (C) Right breast, new inferior margin, biopsy: No carcinoma. (Dr. FS4 (D) Sentinel lymph node #3, right axilla, biopsy: Rare atypical cells in subcapsular space. (Dr. Clinical History. The patient is a. year-old woman with post-operative diagnosis of breast cancer, who undergoes. sentinel lymph node biopsy and right partial mastectomy. Gross Description. The specimen is received fresh in six parts, each labeled with the patient's name and medical record. number. Part A, additionally labeled \". sists of one soft tan-yellow fatty. tissue fragment measuring 2.5 x 1.1 x 0.4 cm. The specimen is trimmed, and one candidate lymph. node is found. The lymph node is bisected. Touch preps and smear preps are made. The node is. submitted for frozen section diagnosis 1 and subsequently submitted in cassette A1. The remaining. yellow fatty tissue is submitted in cassette A2. Part B, additionally labeled \". nsists of one soft tan-yellow fatty. tissue fragment measuring 2.5 x 0.6 x 0.7 cm. The specimen is trimmed, and one large lymph node is. found. The lymph node is bisected. Touch preps and smears are made. The node is submitted for. frozen section diagnosis 2, and subsequently submitted in cassette B1. The remaining yellow fatty. tissue is submitted in cassette B2. Part C, additionally labeled \". \" consists of one. firm, unoriented, off-white/tan and yellow tissue fragment measuring 2.3 x 2 x 0.8 cm. The specimen. is bisected at the long axis and one-half is submitted for frozen section diagnosis 3, and subsequently. submitted in cassette C1. The remaining half is submitted in cassette C2. Part D, additionally labeled u. nsists of one soft and firm pink-red. unoriented tissue fragment measuring 0.8 x 0.7 x 0.4 cm. The specimen is bisected and touch preps. and smears are made. The bisected node is submitted for frozen section diagnosis 4, and. subsequently submitted in cassette D1. Part E, additionally labeled. onsists of an oriented, roughly ovoid. fragment of fibrofatty breast tissue containing a firm palpable mass. The specimen is oriented with. two surgical sutures, per the requisition sheet. The short suture is superior and the long suture is. lateral. Oriented as such, the specimen measures 5.7 cm from superior to inferior, 6 cm from medial. to lateral, and 3.6 cm from anterior to posterior. The specimen is inked for microscopic evaluation,. with the anterior superior surface inked in blue, the anterior inferior surface inked in green, and the. posterior surface inked in black. The specimen has been previously incised, prior to receipt in. Pathology, and the sections removed from the aforementioned central mass. The specimen is serially. Working Draft. sectioned in the sagittal plane into fifteen slices and numbered 1-15, medial to lateral. The medial. slice (slice 1) is 0.9 cm in thickness. The lateral slice (slice 15) is 0.9 cm in thickness. The remainder. of the slices averages 0.4 cm in thickness. Serial sectioning reveals a firm, tan-white, nodular lesion,. which spans serial slices 2-14. This multilobulated mass measures 3.8 cm from superior to inferior, 3. cm from anterior to posterior, measured in slice 7. The mass grossly approaches the posterior margin. in slices 6-8. The mass is 0.2 cm from the anterior superior margin in slice 4 and 0.8 cm from the. anterior margin in slice 7. The medial and lateral margins are grossly clear (>1 cm). Representative. sections are submitted as follows: Cassette E1: Medial margin, slice 1 (representative perpendicular section). Cassette E2: Medial one-third, slice 2 (medial-most extent of lesion). Cassette E3: Superior posterior, slice 4. Cassette E4: Superior anterior, slice 4. Cassette E5: Anterior superior, slice 5. Cassette E6: Superior posterior, slice 5. Cassette E7: Anterior superior, slice 7. Cassette E8: Superior posterior, slice 7. Cassette E9: Anterior inferior, slice 7. Cassette E10: Inferior posterior, slice 7. Cassette E11: Anterior superior, slice 8. Cassette E12: Superior posterior, slice 8. Cassette E13: Anterior superior, slice 11. Cassette E14: Superior posterior, slice 11. Cassette E15: Anterior inferior, slice 11. Cassette E16: Inferior posterior, slice 11. Cassette E17: Superior half, slice 14. Cassette E18: Inferior half, slice 14. Cassettes E19-E20: Medial portion of lateral margin, slice 15 (perpendicularly sectioned). Part F, additionally labeled. consists. of a grossly unremarkable fragment of fibrofatty breast tissue sutured to Telfa and oriented by two. surgical sutures, per the specimen container labels. The short stitch is superior and the long stitch is. lateral. Oriented as such, the specimen measures 4.5 cm from superior to inferior, 3.7 cm from. medial to lateral, and 1.6 cm from anterior to posterior. The specimen is inked for microscopic. evaluation, with the anterior superior surface inked in blue, the anterior inferior surface inked in. green, and the posterior surface inked in black. The specimen is serially sectioned from medial to. lateral into ten slices. These are numbered 1-10, from medial to lateral. The specimen is grossly. unremarkable on serially sectioning. The entire specimen is submitted as follows: Cassette F1: Slice 1. Cassette F2: Slice 2. Cassette F3: Slice 3. Cassette F4: Slice 4. Cassette F5: Slice 5. Cassette F6: Slice 6. Cassette F7: Slice 7. Cassette F8: Slice 8. Cassette F9: Slice 9. Cassette F10: Slice 10. /Pathology Resident. 'Pathologist. Fee Codes: Working Draft. Other Specimens. _Specimen Class: Accessioned: Specimen(s) Received: A: Right chest wall tumor (fresh), B: Subclavian vein margin. Final Diagnosis. A. Right chest wall, tumor, excision: Metastatic high-grade neuroendocrine. carcinoma, 7.5 cm; see comment. B. Subclavian vein, margin, biopsy: Segment of vein with chronic inflammation, no. tumor; see comment. pecimen Class: Accessioned: Specimen(s) Received: Final Diagnosis. Review of slides from. Right breast, upper outer quadrant, biopsy: Neuroendocrine carcinoma,. large-cell type, high-grade; see comment. Right anterior chest wall, fine-needle aspiration: Consistent with metastatic. neuroendocrine carcinoma; see comment. Specimen Class: Accessioned: Specimen(s) Received: A: Surgical scar right breast, B: New anterior superior margin right breast, C: New deep margin, D: New. anterior inferior margin. Final Diagnosis. A. Skin, right breast surgical scar, excision: Scar with mild chronic inflammation and. foreign body giant cell reaction, no tumor. B. Right breast, new anterior superior margin, excision: Scar with chronic. inflammation, foreign body reaction, and fat necrosis, no tumor. C. Right breast, new deep margin, excision: 1. Scar with chronic inflammation, foreign body reaction, and fat necrosis, no tumor. 2. Microcalcifications associated with benign ducts. D. Right breast, new anterior inferior margin, excision: 1. Scar with chronic inflammation, foreign body reaction, and fat necrosis, no tumor. 2. Microcalcifications associated with benign ducts. Working Draft. FND OF REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The T stage is classified as follows: T1 (tumor 2 cm or less in greatest dimension), T2 (tumor more than 2 cm but not more than 5 cm in greatest dimension), T3 (tumor more than 5 cm in greatest dimension), and T4 (tumor of any size with direct extension to the chest wall or skin). Based on the provided pathology report, the invasive tumor size is given as 3.8 cm maximum diameter. This measurement directly corresponds to the criteria for determining the T stage. Since the tumor is more than 2 cm but not more than 5 cm in greatest dimension, it falls into the T2 category. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the size of the tumor (3.8 cm), the pathologic T stage is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report and apply the appropriate T-staging rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size and extent of invasion were evaluated to determine the T stage.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Left axillary sentinel lymph node #1, biopsy: No tumor in one lymph node (0/1). B. Left axillary sentinel lymph node #2, biopsy: No tumor in one lymph node (0/1). C. Left axillary minor sentinel lymph node #3, biopsy: No tumor in one lymph node. (0/1). D. Left breast, mastectomy: 1. Invasive ductal carcinoma, 3.5 cm, grade 2, associated with microcalcifications;. see comment. 2. Ductal carcinoma in situ, cribriform, intermediate grade. 3. Gynecomastia. Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 3.5 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): Grade 2. Nuclear grade: 3 = 3 points. Mitotic count: <10 mitotic figures/10 HPF = 1 point. Tubule/papilla formation: Definite tubule formation in <10% = 3 points. Total points and overall grade: 7 points = grade 2. - Lymphatic-vascular invasion: None. - Perineural invasion: None. - Resection margins for invasive tumor: - Deep margin: Negative; (tumor is 0.3 cm away, on slide D4). Working Draft. Medial margin: Negative; (tumor is >1 cm away). - Lateral margin: Negative; (tumor is >1 cm away). - Anterior/superior margin: Negative; (tumor is >1 cm away). - Anterior/inferior margin: Negative; (tumor is 0.8 cm away, on slide D3). - Ductal carcinoma in situ (DCIS) type: Cribriform. - Ductal carcinoma in situ size: 0.3 cm. Ductal carcinoma in situ nuclear grade: Intermediate nuclear grade. - Necrosis in DCIS: None. - Microcalcifications: Present in invasive carcinoma. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative; (tumor is >1 cm away). - Medial margin: Negative; (tumor is >1 cm away). Lateral margin: Negative; (tumor is >1 cm away). - Anterior/superior margin: Negative; (tumor is >1 cm away). - Anterior/inferior margin: Negative; (tumor is >1 cm away). - Lymph node status: Negative (0/3). - AJCC/UICC stage: pT2NOMX. - Nontumorous breast tissue: Gynecomastia. - Nipple: No tumor. - Skin/dermis: No tumor. - Additional comments: Each sentinel lymph node was examined with level sections. No metastatic. carcinoma was identified. has reviewed selected slides and concurs with the findings. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node #1. left axilla, biopsy: No carcinoma. Cytologic preparations and frozen. section. FS2 (B) Sentinel lymph node #2, left axilla, blopsy: No carcinoma. Cytologic preparations and frozen. section. (. Clinical History. The patient is a. -year-old. with invasive ductal carcinoma of the left breast. This diagnosis was. established by core biopsy at another institution That hinnev showed that the carcinoma is ER, PR,. and HER-2-positive. Gross Description. The specimen is received fresh in four parts, each labeled with the patient's name and unit number. Part A, labeled \". consists of a single soft irregular. red-yellow candidate lymph node measuring 2.7 X 1.8 x 1.3 cm. Extraneous fatty tissue is removed. The candidate lymph node is bisected. Touch and scrape preparations are made. The remaining. lymph node is submitted for frozen section, and subsequently submitted in cassette A1. The unused. fatty tissue is entirely submitted in cassette A2. Part B, labeled \". insists of a single soft irregular red-yellow. candidate lymph node measuring 1.. x 0.8 X 0./ cm. Extraneous fatty tissue is removed. The lymph. node is bisected. Touch and scrape preparations are made. The remaining lymph node is submitted. for frozen section diagnosis 2, and subsequently submitted in cassette B1. The unused fatty tissue is. entirely submitted in cassette B2. Part C, additionally labeled 1. consists of a single fragment of yellow fibrofatty. tissue measuring 2 x 1.5 x 0.5 cm. One candidate lymph node is palpated within the fatty tissue. The. Working Draft. specimen is entirely submitted in cassette C1. Part D, additionally labeled. consists of a mastectomy specimen oriented with. a short suture superior and ¿ suture lateral. The specimen measures 14.2 cm from superior to. inferior, 14.5 cm from medial to lateral and 3 cm from anterior to posterior. On the anterior surface,. there is a skin ellipse measuring 12.4 x 4.6 cm. Within the skin ellipse is a nipple/areola measuring. 2. cm in diameter. A firm mass is palpated deep and medial to the nipple in the inner upper and lower. quadrants. The specimen is inked for microscopic evaluation, with the anterior superior inked in blue,. the anterior inferior inked in green and the posterior inked in black. The specimen is then sectioned. into fifteen slices, numbered from medial to lateral. The nipple-areolar complex appears in slices 5-7. Sectioning shows an irregular, lobulated, pink-tan mass measuring 3.5 cm; this is located in the inner. lower quadrant deep to the nipple, in slices 5-7. The cyst mass extends to within 0.7 cm of the deep. margin, 1.7 cm from the anterior superior margin, and 1.9 cm from the anterior inferior margin. The. remainder of the breast parenchyma consists of yellow fatty tissue and is unremarkable. Cassettes. are submitted as follows: Cassettes D1-D2: Nipple. Cassettes D3-D4: Mass, slice 5. Cassettes D5-D7: Mass, slice 6 (widest cross-section superior to inferior). Cassette D8: Representative medial margin. Cassette D9: Representative lateral margin. Cassette D10: Representative unremarkable inner upper quadrant, slice 2. Cassette D11: Representative unremarkable inner upper quadrant, slice 4. Cassette D12: Representative unremarkable inner lower quadrant, slice 3. Cassette D13: Representative unremarkable inner lower quadrant, slice 4. Cassette D14: Representative unremarkable outer upper quadrant, slice 9. Cassette D15: Representative unremarkable outer upper quadrant, slice 12. Cassette D16: Representative unremarkable outer lower quadrant, slice 10. Cassette D17: Representative unremarkable outer lower quadrant, slice 13. /Pathology Resident. Fee Codes: Addenda. Addendum. Date Complete: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors as well as for HER2 was. performed on block D6. The test for estrogen receptors is positive. There is variable nuclear staining (ranging from weak to. strong) in ~20% of tumor cells. The test for progesterone receptors is negative. There is no nuclear staining in any of tumor cells. Internal positive control is present. Result of HER2/neu test: This carcinoma is positive for HER2/neu oncoproteln over-expression. Working Draft. An immunohistochemical assay was performed using the CB11 monoclonal antibody to HER2/neu. oncoprotein. The staining intensity of this carcinoma was 3 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. The immunoneroxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should. not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (\"CLIA\") as qualified to perform high-complexity clinical testing. Specimen Class: Accessioned: Working Draft. Working Draft. Specimen Class: Working Draft. Working Draft.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SM.4F047F5B-EF3A-4590-8E7A-D90A52860324",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the invasive tumor. The pathologic T stage is based on the size of the tumor as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the invasive ductal carcinoma measures 3.5 cm in maximum diameter. Based on this information, we can classify the tumor as follows:",
    "BaselineChoice": "T2",
    "Monologue": "I need to extract information from the pathology report to determine the pathologic T stage of the breast cancer patient.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 3.5 cm, absence of lymphatic-vascular invasion or perineural invasion, and negative resection margins led to the stage conclusion based on the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Lymph node, left axillary sentinel node #1, excision: No metastatic carcinoma in. one lymph node (0/1). B. Lymph node, left axillary sentinel node # +2, excision: Metastatic carcinoma in one. lymph node with extension into peri-nodal fat (1/1). C. Lymph node, left axillary sentinel node # 3, excision: Metastatic carcinoma in one. lymph node (1/1). D. Lymph node, left axillary non-sentinel node # 1, excision: Metastatic carcinoma in. one lymph node (1/1). Working Draft. E. Lymph node, left axillary non-sentinel node #2, excision: Metastatic carcinoma in. one lymph node (1/1). F. Breast, left, partial mastectomy: 1. Infiltrative ductal carcinoma, SBR grade 2, 1.1 cm in maximum dimension,. margins negative; see comment. 2. Ductal carcinoma in situ, high-grade, solid and comedo types, 1.1 cm in maximum. dimension, intermixed with invasive ductal carcinoma, margins negative. G. Breast, left lateral anterior, excision: Benign breast tissue, no carcinoma. identified. H. Breast, medial superior anterior, excision: Benign breast tissue, no carcinoma. identified. I. Lymph node, left axillary contents, excision: No metastatic carcinoma in eight. lymph nodes (0/8). Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 1.1 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: <10 mitotic figures/10 HPF, 1 point. Tubule/papilla formation: <10%, 3 points. Total points and overall grade = 7 points = grade 2. - Lymphatic-vascula invasion: Extensive lymphatic-vascular invasion is noted with intra-lymphatic. metastasis noted in lymphatics at least 1 cm from the main tumor. - Perineural Invasion: Not present. - Resection margins for invasive tumor: - Deep margin: Negative; (tumor is 0.2 cm away, on slide F6). - Medial margin: Negative; (tumor is greater than 1 cm). - Lateral margin: Negative; (tumor is greater than 1 cm). - Anterior/superior margin: Negative; (tumor is 0.2 cm away, on slide F6). - Anterior/inferior margin: Negative; (tumor is 0.3 cm away, on slide F4). - Ductal carcinoma in situ (DCIS) type: Comedo and solid. - Ductal carcinoma in situ size: 1.1 cm, intermixed with invasive ductal carcinoma. - Ductal carcinoma in situ nuclear grade: High-grade. - Necrosis in DCIS: Comedonecrosis. - Microcalcifications: Not identified. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative; (tumor is 0.6 cm away, on slide F6). - Medial margin: Negative; (tumor is greater than 1 cm). - Lateral margin: Negative; (tumor is greater than 1 cm). - Anterior/superior margin: Negative; (tumor is 0.25 cm away, on slide F6). - Anterior/inferior margin: Negative; (tumor is 0.25 cm away, on slide F6). - Lobular carcinoma in situ (LCIS): None. - Lymph node status: Positive. - Number of positive lymph nodes: 4. - Total number sampled: 13. - Diameter of largest metastasis: 0.8 cm. Working Draft. - Extranodal extension: Present. - AJCC/UICC stage: pT1cN1MX. An immunohistochemical test for estrogen and progesterone receptors was performed by manual. morphometry on block #. The test for estrogen receptors is positive. There isstrong nuclear staining in 90% of tumor cells. Internal positive control is positive. The test for progesterone receptors is positive. There is moderate nuclear staining in 60% of tumor. cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is positive for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed by manual morphometry on block F8 using the CB11. monocional antibody to HER2/neu oncoprotein. The staining Intensity of this carcinoma was 3 on a. scale of 0-3 (HER2 test interpreted by Dr. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Intraoperative Consult Diagnosis. FS1 (A) Left axillary sentinel lymph node #1, biopsy: No tumor seen. (Tissue section and. cytopreparation) (Dr. FS2 (B) Left axillary sentinel lymph node #2, biopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. FS3 (C) Left axillary sentinel lymph node #3, blopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. 1. FS4 (D) Left axillary non-sentinel lymph node #1, biopsy: Positive for metastatic carcinoma. (Tissue. section and cytopreparation) (Dr. Clinical History. The patient is a. year-old woman with left breast invasive ductal carcinoma. She undergoes partial. mastectomy. Gross Description. The specimen is received fresh in nine parts, each labeled with the patient's name and medical record. number. Part A is additionally labeled. It consists of a single irregular piece of. soft-firm, pink-red tissue, measuring 0.5 x 0.3 X 0.2 cm. The specimen is bisected, and cytologic. touch and scrape preparations are prepared. The specimen is then entirely submitted for frozen. section diagnosis as FS1, with the frozen section remnant submitted in cassette A1. Part B is additionally labeled. It consists of a single oval piece of soft-to-firm,. red-pink tissue, measuring 0.9 x 0.6 x 0.6 cm. The specimen is bisected, and cytologic touch and. scrape preparations are made. The specimen is then entirely submitted for frozen section diagnosis as. FS2, with the frozen section remnant submitted in cassette B1. Part C is additionally labeled. It consists of a single ovoid piece of soft-to-firm,. Working Draft. pink-red tissue, measuring 0.8 x 0.5 x 0.4 cm. The specimen is bisected, and cytologic touch and. scrape preparations are prepared. I he specimen is then entirely submitted for frozen section. diagnosis as FS3, with the frozen section remnant submitted in cassette C1. Part D is additionally labeled. It consists of a single ovoid piece of. soft-to-firm, pink-red tissue, measuring 1.3 x U.I x 0.5 cm. The specimen is bisected, and cytologic. touch and scrape preparations are prepared. The specimen is then entirely submitted for frozen. section diagnosis as FS4, with the frozen section remnant submitted in cassette D1. Part E is additionally labeled. It consists of a single ovoid piece of firm,. off-white/tan tissue, measuring 1.5 x 0.7 x 0.4 cm. The specimen is bisected and entirely submitted. in cassette E1. Part F is additionally labeled. t consists of. an oriented portion of fat, measuring 10.3 (anterior- posterior) x 7.4 (medial-lateral) x 6.4. (superior-inferior) cm and weighing 13 gm. There is a 1.1 cm in diameter white-yellow hard mass. with a white homogeneous interior located within the specimen (slices 3-6). This mass abuts the. posterior margin, is 0.6 cm from the anterior-inferior and anterior-superior margins, 1 cm from the. lateral margin, and 7 cm from the medial margin. The specimen is inked so as the anterior-superior. surface is blue, the anterior- inferior surface is green, and the posterior surface is black. A. representative section is taken for tissue banking. The specimen is serially sectioned, from lateral to. medial into thirteen 0.5 cm slices. Representative sections are submitted as follows: Cassette F1: Lateral margin, slice 1, perpendicular. Cassettes F2-F3: Slice 2, two pieces. Cassettes F4-F5: Slice 3, two pieces, mass. Cassettes F6-F7: Slice 4, two pieces, mass. Cassette F8: Representative section of slice 5, mass. Cassette F9: Representative section of slice 6, mass. Cassette F10: Slice 12. Cassette F11: Medial margin, slice 13. perpendicular. Part G is additionally labeled. It consists of a. small fragment of fat, measuring 0.6 x 0.7 x 0.7 cm. A stitch marks a portion of the specimen. indicating the true margin. The specimen is inked so as this true margin is blue, and the rest of the. specimen is black. The specimen is entirely submitted in cassette G1. Part H is additionally labeled. It. consists of a fragment of yellow-white, soft fat, measuring 1 x 0.6 x 0.7 cm. A stitch marks the true. margin of the specimen. The specimen is inked so as this true margin is blue, and the remaining. portion of the specimen is black. The specimen is entirely submitted in cassette H1. Part I is additionally labeled. It consists of a portion of fat measuring 4.2 x 3.8. x 0.9 cm. Multiple pink-tan lymph nodes are noted within the specimen ranging in size from 0.6-1.3. cm in diameter. Many of these nodes are previously bisected or trisected. Representative sections. of. the specimen are taken and submitted as follows: Cassette 11: Six lymph nodes attached. Cassette 12: Two lymph nodes, one bisected and one trisected. 'Pathology Resident. Fee Codes: Working Draft. Other Specimens. Specimen Class: i. Accessioned: Specimen(s) Received: Skin, biopsy, punch bx, right posterior calf. Final Diagnosis. {Final Report Not Signed Out}. (Not Entered}. Specimen Class: Accessioned: Specimen(s) Received: SP Consult. Final Diagnosis. Review. from. Breast, left, 1 o'clock, core needle biopsy: 1. Invasive carcinoma; see comment. 2. Microscopic focus of ductal carcinoma in situ, high nuclear grade; see comment.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size and extent of the primary tumor. The T stage is based on the size of the tumor and whether it has spread to the chest wall or skin. Here's the step-by-step reasoning:\\n1. **Tumor Size**: The pathologic diagnosis mentions an \"infiltrative ductal carcinoma\" with a size of \"1.1 cm in maximum dimension.\" This information directly pertains to the T staging.\\n2. **T Stage Definitions**:\\n   - **T1**: Tumor is 2 cm or less in greatest dimension.\\n   - **T2**: Tumor is more than 2 cm but not more than 5 cm in greatest dimension.\\n   - **T3**: Tumor is more than 5 cm in greatest dimension.\\n   - **T4**: Tumor of any size with direct extension to the chest wall or skin.\\n3. **Assessment**: Given the tumor size is 1.1 cm, which is less than 2 cm, we can directly apply this to the T stage definitions.\\n4. **Conclusion**: Based on the tumor size of 1.1 cm, the pathologic T stage for this breast cancer is **T1**.\", ",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The invasive tumor size is 1.1 cm in maximum dimension, which falls into the T1 category.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Right axillary sentinel lymph node, excision: Metastatic carcinoma involving one. lymph node(1/1). B. Breast, right, mastectomy: Invasive ductal carcinoma,4.8 cm, SBRgrade 3 and. high-grade intraductal carcinoma; see comment. C. Lymph nodes, axillary, excision: Seven lymph nodes negative for tumor, (0/7). D. Lymph nodes, axillary, excision: One lymphnode, no tumor seen (0/1). E. Lymph nodes, axillary, excision: No lymph node seen, no tumor,(0/0). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive ductal carcinoma. Invasive tumor size: 4.8 cm maximum diameter. Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 3, 3 points. Mitotic count: 10-20 mitotic figures/10 HPF, 2 points. Tubule/papilla formation: Definite tubule formation is apparent in <10%, 3 points. Total points and overall grade = 8 points = grade 3. - Lymphatic-vascular invasion: Not present. - Resection margins for invasive tumor: - Deep margin: Negative (tumor is 1.5 cm away, on slide B4). - Medial margin: Negative (>3 cm). - Lateral margin: Negative (>3 cm). Working Draft. - Anterior/superior margin: Negative (tumor is 1 cm away, on slide B6). - Anterior/inferior margin: Negative (tumor is 3 cm away, on slide B7). - Ductal carcinoma in situ (DCIS) type: Solid. - Ductal carcinoma in situ size: - DCIS present as scattered microscopic foci up to 0.1 cm in diameter, involving one of twelve. total slides. - Ductal carcinoma in situ nuclear grade: High grade. - Necrosis in DCIS: A small amount of necrosis is seen. - Microcalcifications: None. - Resection margins for ductal carcinoma in situ: - Deep margin: Negative (tumor is >1 cm away, on slide B5). - Medial margin: Negative (tumor is >3 cm away). - Lateral margin: Negative (tumor is >3 cm away). - Anterior/superior margin: Negative (tumor is >1 cm away, on slide B6). - Anterior/inferior margin: Negative (tumor is >1 cm away, on slide B7). Lymph node status: Sentinel lymph node positive for carcinoma, metastasis 0.4cm diameter, no. capsular penetration. - Number of positive lymph nodes: 1. - Total number sampled: 9. - Diameter of largest metastasis: 1.6 cm. - Extranodal extension: None. - AJCC/UICC stage: pT2N1MX. - Nontumorous breast tissue: Unremarkable. - Nipple: Uninvolved. - Skin/dermis: Uninvolved. - Additional comments: Preliminary results were discussed with medical oncology team. on. PR , ER not requested. This report was amended due to a typographical error. The diagnoses have not been altered. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node #1, right axilla, biopsy: Metastatic adenocarcinoma. (Frozen section. and cytologic preparation.) (Dr. Clinical History. The patient is a -year-old woman with right breast cancer. Right breast tumor. The patient now. undergoes right mastectomy and right axillary lymph node dissections. Gross Description. The specimen is received fresh in five parts, each labeled with the patient's name and medical record. number. Part A is additionally labeled. consists of a single soft, oval,. pink lymph node, measuring 2.1 x 1.1 x 1 cm. me surgeon warks the hot spot with a stitch. This. stitched area is subsequently inked black. The node is bisected. Touch preparations and scrape. preparations are made. The remaining tissue is submitted for frozen section diagnosis as FS1, with. the frozen section remnant submitted in cassette A1. Part B, additionally labeled. consists of a single mastectomy. specimen. The breast tissue weigns 827 gin and measures 20.5 cm from medial to lateral, 20.7 cm. from superior to inferior, and 5.7 cm from anterior to posterior. Anteriorly, the specimen exhibits a. skin ellipse measuring 19.9 x 9.2 cm. The breast areola is 4.5 x 3.9 cm and the nipple is 1.1 x 1.1 x. 0.7 cm. The specimen is inked for microscopic evaluation: anterior superior surface in blue, the. anterior inferior surface in green, the posterior surface in black. On the posterior surface, a large, 12. cm incision is noted, representing the site from which the tumor sample was banked. The specimen is. serially sectioned from medial to lateral to reveal a chalky white tumor with irregular borders. The. Working Draft. tumor measures 3.5 x 3.2 x 4.8 cm (medial to lateral) and exhibits punctate hemorrhages. The. specimen is sliced into twenty-one slices. The tumor is located between slices 6 and 11. Furthermore,. in slice 9, there is a cystic mass measuring 1.5 x 1.5 x 1 cm. It is filled with clear serosanguinous. fluid. The tumor margins are as follows: tumor is 1.2 cm from the posterior (black) margin, 0.8 cm. from the closest skin margin, 2.3 cm from the closest green margin, and 1.5 cm from the closest blue. margin. The remainder of the fatty breast parenchyma is unremarkable. Representative sections are. submitted as follows: Cassettes B1-B3: Nipple. Cassette B4: Tumor with posterior margin. Cassette B5: Tumor with skin margin. Cassette 86: Tumor with blue margin. Cassette B7: Tumor with green margin. Cassette B8: Cystic mass. Cassette B9: Lateral inferior, representative section. Cassette B10: Lateral superior, representative section. Cassette B11: Medial superior, representative section. Cassette B12: Medial inferior, representative section. Part C, additionally labeled. consists of an unoriented irregularly shaped piece of. fatty tissue measuring 5.5 x 5 x 4 cm. It is yellow to tan. Within the tissue, seven firm nodes are. palpated, as well as two large matted nodes. All nodes are submitted as follows: Cassettes C1-C2: Large matted lymph node mass 1. Cassettes C3-C4: Large matted lymph node mass 2. Cassette C5: Lymph nodes, three pieces. Cassette C6: Lymph nodes, two pieces. Cassette C7: Lymph node, one piece. Cassette C8: Lymph nodes, two pieces (bivalved). Part D, additionally labeled. consists of a single piece of unoriented,. irregularly shaped, fatty tissue measuring 3.5 x 2 x 1.5 cm. The specimen exhibits a single ovoid. nodule measuring 1 x 0.8 x 0.3 cm. The nodule is firm; this is entirely submitted in cassette D1. Part E, additionally labeled. consists of a single piece of unoriented,. irregularly shaped fatty tissue measuring 5 x 5 x 2 cm. The specimen is yellow to tan and palpation of. the specimen reveals fourteen firm nodes ranging from 0.3 to 1.5 cm in diameter. The nodes are. entirely submitted as follows: Cassette E1: Lymph nodes, two pieces. Cassette E2: Lymph nodes, two pieces. Cassette E3: Lymph nodes, three pieces. Cassette E4: Lymph nodes, two pieces (bivalved). Cassette E5: Lymph nodes, three pieces. Cassette E6: Lymph nodes, three pieces. Cassette E7: Lymph nodes, two pieces (bivalved). Cassette E8: Lymph node, one piece. Pathology Resident. /Pathologist. Fee Codes: Amendments. Amended: Reason: Typographical Error. Typographical Error in synoptic comment. Working Draft. Prevíous Signout Date: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: immunohistostaining & interpretation only. Final Diagnosis. Immunostaining and interpretation for ER, PR, and HER2/neu on. B4: Breast, right, mastectomy: Invasive ductal carcinoma negative for ER and PR, and. indeterminate for HER2 protein overexpression; see comment.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the invasive tumor. The T stages are defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report states that the invasive tumor size is 4.8 cm. Based on this information, the tumor size falls into the category of T2, as it is greater than 2 cm but less than or equal to 5 cm.",
    "BaselineChoice": "T2",
    "Monologue": "The pathology report mentions an invasive ductal carcinoma with a maximum diameter of 4.8 cm. I need to extract information from the report and apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition).",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        UTD:01992912-611F-4A48-8570-B062CBCCAF7@. Final Pathologic Diagnosis: A. Left axilla sentinel lymph nodes, dissection: No tumor (0/3). B. Right medial breast, excision: 1. No tumor. 2. Usual ductal hyperplasia, sclerosing adenosis and calcifications. C. Right breast, partial mastectomy: 1. Invasive ductal carcinoma, 2.2 cm, grade 3; see comment. 2. Ductal carcinoma in situ, high nuclear grade with necrosis; see comment. Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive ductal carcinoma. - Invasive tumor size: 2.2 cm. - Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 3 points. Mitotic count: 3 points. Tubule/papilla formation: 3 points. Total points and overall grade = 9 points = grade 3. - Lymphatic-vascular invasion: None. - Skin/nipple: Not sampled. - Margins for invasive tumor: Negative. - Deep margin: Negative; (tumor is <0.1 cm away, on slide C7). - Medial margin: Negative; (tumor is at least 0.8 cm away). - Lateral margin: Negative; (tumor is at least 2.4 cm away). - Anterior/superior margin: Negative; (tumor is 0.3 cm away, on slide C5). - Anterior/inferior margin: Negative; (tumor is 0.3 cm away, on slide C3). Ductal carcinoma in situ (DCIS): Comedo and solid. - Ductal carcinoma in situ size: DCIS present admixed with invasive cancer. Ductal carcinoma in situ nuclear grade: High grade. Working Draft. - Necrosis in DCIS: Present. Microcalcifications: Present in DCIS and benign ducts. Resection margins for ductal carcinoma in situ: Negative. - Deep margin: Negative; (tumor is 1.5 cm away, on slide C7). - Medial margin: Negative. - Lateral margin: Negative. - Anterior/superior margin: Negative; (tumor is 0.6 cm away, on slide C7). - Anterior/inferior margin: Negative. - Lymph node status: Negative. - Number of positive lymph nodes: 0. - Total number sampled: 3. - AJCC/UICC stage: pT2NOMX. Select slides (C2, C3, C4) were also reviewed by Dr. who concurs with the diagnosis. Immunostains for ER/PR and Her2 neu will be performed the results reported in an addendum. All margins were oriented, inked and examined microscopically. Intraoperative Consult Diagnosis. FS1 (A) Right axilla, sentinel lymph node #1, biopsy: Three lymph nodes, no carcinoma. (Dr. FS2 (B) Right medial fibrosis, rule out carcinoma, biopsy: Fibrocystic change, calcification, no tumor. (Dr. Clinical History. The patient is a. year-old woman with a history of right breast adenocarcinoma diagnosed by fine. needle aspiration. She now undergoes right breast partial mastectomy and right sentinel lymph node. biopsy. Gross Description. The specimen is received fresh in three parts, each labeled with the patient's name and unit number. Part A, additionally labeled IF. ,\" consists of a single soft irregular piece of red-yellow. fibrofatty tissue measuring 3 x 2 x 0.5 cm (stitch marks highest count). One candidate lymph node is. identified at the stitched area; this is inked blue. Additionally, two more lymph node candidates are. identified. Three lymph node candidates are submitted for frozen section diagnosis 1, and. subsequently submitted in cassette A1. The remaining fibrofatty tissue is submitted in cassette A2. Part B, additionally labeled \". consists of a single firm, unoriented, oval piece of. yellow-pink fibrofatty tissue measuring 2.5 x 1.7 x 0.7 cm. One side of the specimen is inked blue. and the opposite side is Inked green. The specimen is bread-loafed, and two central representative. sections are submitted for frozen section diagnosis 2, with the frozen section remnant submitted in. cassette B1. The remaining tissue is submitted in cassettes B2-B3. Part C is additionally labeled \". - SPECIMEN TYPE: Partial mastectomy. - SKIN ELLIPSE: Not present. - NIPPLE: Not present. - ORIENTATION: - Long suture: Lateral. - Short suture: Superior. - INKING (for microscopic evaluation): - Black: Deep. - Green : Anterior inferior. - Blue: Anterior superior. - SIZE OF SPECIMEN: Working Draft. - Medial-Lateral dimension: 4.3 cm. - Superior-Inferior dimension: 4 cm. - Anterior-Posterior dimension: 1.8 cm. - TOTAL NUMBER OF SLICES: Eight. - First slice (slice #1): Medial margin. - Last slice (slice #8): Latera margin. - GROSS PATHOLOGY: The specimen consists of a 22 gm partial mastectomy specimen. A tan-pink,. irregular, firm mass is noted in the more superior aspect of the specimen, which measures 1.5 x 0.7 x. 0.7 cm. A portion is taken for tissue banking. The mass appears to be present in slices 3-6. The. mass appears to come within <0.1 cm away from the deep and anterior-superior margins in slice 4. The mass comes within 0.2 cm away from the anterior- inferior margin in slice 3. No localization. needle or specimen mammogram are included in the specimen. Representative sections are submitted. as follows: Cassette C1: Perpendicular representative sections of medial margin, slice 1. Cassette C2: Middle slice 2. Cassettes C3-C4: Closest approach to anterior inferior margin, entire slice 3. Cassettes C5-C6: Closest approach to deep and anterior superior margins, entire slice. 4. Cassette C7: Superior slice 5. Cassette C8: Middle slice 6. Cassette C9: Inferior slice 8. Cassette C10: Perpendicular sections of slice 8, lateral margin. Pathology Resident. /Patholoalst. Fee Codes: Addenda. Addendum. Date Complete: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors was performed by manual. morphometry on block C7. The test for estrogen receptors is negative. There is no nuclear staining in any of tumor cells. Internal positive control is present. The test for progesterone receptors is negative. There is no nuclear staining in any of tumor cells. Internal positive control is present. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed by manual morphometry on block C7 using the CB11. monoclonal antibody to HER2/neu oncoprotein. The staining intensity of this carcinoma was 0 on a. scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of. HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas wit. Working Draft. staining Intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the HISH test are Issued directly frum the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. The immunonernvidaep stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration. ine FDA has determined that such Crearance or approval is not necessary. These tests are used for clinical purposes. They should. not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (\"CLIA\") as qualified to perform high-complexity clinical testing. sthologist. Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Cyst contents; see comment. Specimen Class: Accessioned. Specimen(s) Received: A: Right breast scar, B: Right breast, partial mastectomy w/o lymph nodes. Final Diagnosis. A. Skin, right breast, excision: 1. Skin with scar and surgical site changes. 2. No carcinoma. B. Right breast, partial mastectomy: 1. Benign breast tissue. 2. Surgical site changes. 3. No carcinoma. Specimen Class: Accessioned: Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Adenocarcinoma, see. comment. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Working Draft. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. FND OF REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SP.01992912-611F-4AA8-8570-B062CBCCAF70",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the invasive tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the invasive ductal carcinoma measures 2.2 cm. Since the tumor size is greater than 2 cm but less than or equal to 5 cm, it falls into the T2 category.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract the tumor size from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 2.2 cm",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Final Pathologic Diagnosis: A. Lymph node, left axilla, sentinel #1, biopsy: No carcinoma in one lymph. node (0/1). B. Lymph node, left axilla, sentinel #2, , biopsy: Metastatic carcinoma in one. lymph node (1/1). Working Draft. C. Lymph node, left axilla, sentinel #3, biopsy: No carcinoma in one. node (0/1). D. Right breast, skin-sparing mastectomy: 1. Non-proliferative fibrocystic change. 2. Focal lactational change. 3. No carcinoma. E. Right breast, nipple tissue, excision: No significant pathologic. abnormality; no carcinoma. F. Left breast, skin-sparing mastectomy: 1. Invasive ductal carcinoma, 3.8 cm, SBR grade 2; see comment. 2. Ductal carcinoma in situ, intermediate grade, associated with invasive. carcinoma. 3. Microcalcifications associated with invasive carcinoma. G. Left breast, nipple tissue, excision: No significant pathologic abnormality;. no carcinoma. H. Right axilla, accessory nipple, excision: Findings consistent with. accessory nipple tissue; no carcinoma. I. Lymph nodes, left axilla, levels 1 and 2, dissection: No carcinoma in. twelve lymph nodes (0/12). J. Left axilla, accessory nipple, excision: Findings consistent with accessory. nipple tissue; no carcinoma. Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Invasive ductal carcinoma with mucinous features. - Invasive tumor size: 3.8 cm (slices 1 to 5 contiguous at 0.75 cm thickness per slice). - Invasive tumor grade (modified Bioom-Richardson): Grade 2. Nuclear grade: 3, =3 points. Mitotic count: <10 mitotic figures/10 HPF, =1 point. Tubule/papilla formation: 10 to 75%, = 2 points. Total points and overall grade = 6 points = grade 2. - Lymphatic-vascular invasion: Present. - Skin/nipple: On main specimen there is no nipple tissue. In separately submitted left nipple. specimen (Part G) there is no Involvement by carcinoma. - Margins for invasive tumor; Negative. - Deep margin: Close; (tumor is 0.05 cm (0.5 mm) away, on slide F3). - Medial margin: Negative; (tumor is >5 cm away). - Lateral margin: Negative; (tumor is 1.4 cm away, on slide F1). - Anterior/superior margin: Negative; (tumor is 0.4 cm away, on slide F16). - Anterior/inferior margin: Negative; (tumor is 0.2 cm away, on slide F1). - Ductal carcinoma in situ (DCIS): Solid with mucinous features. - Ductal carcinoma in situ size: - DCIS present in contiguous sections, spanning 5.3 cm. - Ductal carcinoma in situ nuclear grade: Intermediate. Working Draft. - Necrosis in DCIS: None. Microcalcifications: Present, involving invasive carcinoma. - Resection margins for ductal carcinoma in situ: Negative. - Deep margin: Close; (tumor is 0.5 mm away, on slide F3). - Medial margin: Negative; (tumor is >5 cm away). - Lateral margin: Negative; (tumor is > 1 cm away). - Anterior/superior margin: Negative; (tumor is 0.2 cm away, on slide F16). - Anterior/inferior margin: Negative; (tumor is 0.2 cm away, on slide F1). - Lymph node status: Positive. - Number of positive lymph nodes: 1. - Total number sampled: 15. - Diameter of largest metastasis: 0.5 cm (slides B1, FS2 (B)). - Extranodal extension: None. - AJCC/UICC stage: pT2N1MX. Hormone receptor status was previously evaluated on this tumor. However,. receptor status was requested again on the specimen and the results will be reported in an addendum. Intraoperative Consult Diagnosis. FS1 (A) Left axilla, sentinel lymph node #1, biopsy: No tumor in one lymph node (0/1). (Dr. FS2 (B) Left axilla, sentinel lymph node #2, biopsy: Metastatic carcinoma in one lymph node, 5 mm. focus, with no extranodal extension noted (1/1). (Dr. FS3 (C) Left axilla, sentinel lymph node #3, biopsy: No tumor in one lymph node (0/1). (Dr. Clinical History. The patient is a. year-old woman with infiltrating ductal carcinoma of the left breast, diagnosed by. needle core blopsy. She now undergoes bilateral skin-sparing mastectomy, left axillary. sentinel lymph node viopsy, left axillary lymph node dissection, and excision of bilateral axillary. accessory nipples. Gross Description. The specimen is received in ten parts, each labeled with the patient's name and medical record. number. Part A is received fresh and is additionally labeled. It. consists of a single pink-tan, ovoid lymph node candidate with attached fibrofatty tissue, Measuring 1. x 0.8 x 0.5 cm in greatest dimensions. The fibrofatty tissue is trimmed, and the lymph node. candidate is bisected and entirely submitted for frozen section diagnosis #1. The frozen section. remnant is subsequently submitted in cassette A1. The remaining fibrofatty tissue is submitted in. cassette A2. Part B is received fresh and is additionally labeled. It consists. of a single roughly ovoid, pink-tan lymph node candiaate will autacned sort riproratty tissue,. measuring 1.6 x 1 x 0.6 cm in greatest dimensions. The fibrofatty tissue is trimmed, and the lymph. node candidate is bisected and entirely submitted for frozen section diagnosis #2. The frozen section. remnant is subsequently submitted in cassette B1. The remaining fibrofatty tissues are submitted in. cassette B2. Part C is received fresh and is additionally labeled. It. consists of a single small, soft, roughly ovoid, pink-tan lymph node candidate with attached fibrofatty. tissue, measuring 1.3 x 0.7 x 0.5 cm in aggregate. The fibrofatty tissue is trimmed, and the lymph. node candidate is bisected and entirely submitted for frozen section diagnosis #3. The frozen section. remnant is subsequently submitted in cassette C1. The remaining fibrofatty tissue is submitted in. cassette C2. Working Draft. Part D ie areived fresh labeled. SPECIMEN TYPE: Skin-sparing mastectomy. - SKIN ELLIPSE: Not present. - NIPPLE: Not present. - ORIENTATION: - Long suture: Lateral. - Short suture: Superior. - Double suture: Nipple remnant. - INKING (for microscopic evaluation): - Black: Posterior margin. - Green: Anterior inferior margin. - Blue: Anterior superior margin. - Yellow: Nipple remnant. - SIZE OF SPECIMEN: - Medial-Lateral dimension: 13.5 cm. - Superior-Inferior dimension: 13.8 cm. - Anterior-Posterior dimension: 1.7 cm. - TOTAL NUMBER OF SLICES: 19. - First slice (slice 1): Lateral margin. - Last slice (slice 19): Medial margin. GROSS PATHOLOGY: On cut section, the specimen consists of unremarkable pink-white breast. parenchyma and tan-yellow fibroadipose tissue. No gross lesions are identified. Representative. sections are submitted as follows: Cassette D1: Slice 4, upper outer quadrant, two sections. Cassette D2: Slice 7, upper outer quadrant. Cassette D3: Slice 5, lower outer quadrant, two sections. Cassette D4: Slice 7, lower outer quadrant. Cassette D5: Slice 13, upper inner quadrant. Cassette D6: Slice 15, upper inner quadrant. Cassette D7: Slice 14, lower inner quadrant. Cassette D8: Slice 16, lower inner quadrant. Cassette D9: Slice 12, nipple remnant. Part E is received fresh and is additionally labeled \". It consists of a single. irregular, unoriented fragment of pink-white soft tissue, measuring 0.3 x 0.3 x 0.2 cm. The specimen. is inked blue, bisected and entirely submitted in cassette E1. Part F is received fresh, labeled \". SPECIMEN TYPE: Skin-spariny mastectomy. - SKIN ELLIPSE: Not present. - NIPPLE: Not present. - ORIENTATION: - Long suture: Lateral. - Short suture: Superior. - Double suture: Nipple remnant. - INKING (for microscopic evaluation): - Black: Posterior. - Green: Anterior inferior. - Blue: Anterior superior. - Yellow: Nipple remnant. - SIZE OF SPECIMEN: - Medial-Lateral dimension: 12 cm. - Superior-Inferior dimension: 12.5 cm. - Anterior-Posterior dimension: 1.6 cm. - TOTAL NUMBER OF SLICES: Sixteen. - First slice (slice #1): Lateral margin. Working Draft. - Last slice (slice # 16): Medial margin. GROSS PATHOLOGY: An irregular, firm, poorly circumscribed, pink-white soft tissue mass is. present in slices 2-6. The soft tissue mass measures 5 cm from medial to lateral, 4.5 cm from. superior to inferior, and 1.1 cm from anterior to posterior. It is 1.5 cm from the lateral specimen. margin (slice 2), 3 cm from the inferior specimen margin (slice 2), 4.5 cm from the superior margin. (slice 4), abuts the deep margin (slices 2-5), and >5 cm from the medial margin. The remainder of. the breast parenchyma consists of yellow fibroadipose tissue and unremarkable pink-white soft tissue. and no additional mass lesions are identified. Gross photographs are taken for future correlation. A. portion of the tumor is taken for tissue banking. Representative sections are submitted as follows: Cassettes F1-F2: Slice 1, lateral margin, adjacent to soft tissue mass in slice 2, perpendicularly. sectioned. Cassette F3: Slice 2, mid-inferior portion. Cassette F4: Slice 2, inferior portion. Cassettes F5-F8: Slice 3, mid-superior to inferior portion, submitted sequentially from superior to. inferior. Cassettes F9-F13: Slice 4, mid-superior to inferior portion, submitted sequentially from superior to. inferior. Cassettes F14-F19: Slice 5, entirely submitted submitted sequentially from superior to inferior. Cassette F20: Slice 6, mid-superior portion. Cassette F21: Slice 6, mid portion. Cassette F22: Slice 6, mid inferior portion. Cassette F23: Slice 14, mid superior. Cassette F24: Slice 14, mid inferior. Cassette F25: Slice 12, mid superior and mid inferior. Cassette F26: Slice 13, mid superior. Cassette F27: Slice 11, mid superior. Cassette F28: Slice 16, medial margin, perpendicularly sectioned. Cassette F29: Slice 7, mid superior. Cassette F30: Slice 8, mid superior. Cassette F31: Slice 9, mid superior. Cassette F32: Slice 10, mid superior. Part G is received fresh and is additionally labeled. It consists of a single irregular,. unoriented fragment of white-tan soft tissue, measuring 0.7 x 0.5 x 0.4 cm. The specimen is inked. blue, bisected, and entirely submitted in cassette G1. Part H is received fresh and is additionally labeled. It consists of a. single ellipse of unremarkable, tan-white skin, measuring 1.3 x 0.9 cm. A short suture marks the. superior margin, and a long suture marks the posterior-lateral margin. The superior margin is inked. blue, the inferior margin is inked green, and the deep margin is Inked black for microscopic evaluation. The specimen is serially sectioned, from lateral to medial, into four slices and is entirely submitted in. cassette H1. Part I is received fresh and is additionally labeled. It. consists of multiple irregular, unoriented fragments of yellow-tan soft tissue, measuring 4.6 x 4.3 x. 1.5 cm in aggregate. The specimen is carefully dissected to reveal fourteen candidate lymph nodes,. ranging from 1.1 to 0.3 cm in maximum dimensions. The candidate lymph nodes are submitted in. cassettes as follows: Cassette I1: Three candidate lymph nodes, inked and bisected. Cassette 12: Six candidate lymph nodes, submitted intact. Cassette I3: Five candidate lymph nodes, submitted intact. Part J is received fresh and is additionally labeled. It consists of an. ellipse of unremarkable, tan-white skin, measuring 0.9 x 0.4 cm. A short suture marks the superior. margin, and a long suture marks the lateral margin. The superior margin is inked blue, the inferior. margin is inked green, and the deep margin is inked black for microscopic evaluation. The specimen is. bisected, from superior to inferior, and entirely submitted in cassette J1. Working Draft. /Pathology Resident. Fee Codes: Addenda. Addendum. Date Complete: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors was performed by manual. morphometry on block F3. The test for estrogen receptors is positive. There is 3+ nuclear staining in >90% of tumor cells. Internal positive control is positive. The test for progesterone receptors is positive. There is 2-3+ nuclear staining in >90% of tumor cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein. over-expression. An immunohistochemical assay was performed by manual morphometry on block # using the CB11. monoclonal antibody to HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a. scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of. HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed. that many carcinomas with staining intensity scores of 2 do not show gene amplification. All. carcinomas with staining intensity scores of 2 are therefore submitted for FISH testing. The results of. the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu. oncoprotein. Tumors in this category show an excellent correlation between the results of. immunohistochemical and FISH testing, and almost always show gene amplification. HER2/neu. Interpreted by Dr. Surgical Pathology - 1 -. Working Draft. Other Specimens. _Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Reactive cellular changes. Inflammation. See Below. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: A: Left chest lesion, B: Left Breast, implant capsule, C: Right Breast, implant capsule. Final Diagnosis. A. Skin, left chest, excision: 1. Skin with papillary epidermal hyperplasia and focal dermal smooth muscle. proliferation; see comment. 2. No carcinoma. B. Left breast, capsulectomy: 1. Implant capsule. 2. Benign breast tissue. 3. No carcinoma. C. Right breast, capsulectomy: 1. Implant capsule. 2. No carcinoma. Specimen Class: Accessioned. Specimen(s) Received: Left breast, needle core biopsy. Final Diagnosis. Left breast, needle core biopsy: 1. Infiltrating ductal carcinoma with prominent mucinous component, modified BR. grade 2, 0.25 cm; see comment. 2. Ductal carcinoma in situ without necrosis, not otherwise specified, intermediate. grade; see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Fibrocystic change, see note.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the invasive ductal carcinoma measures 3.8 cm. This size falls into the category of T2, as it is greater than 2 cm but less than or equal to 5 cm. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage for this breast cancer is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The invasive tumor size is 3.8 cm, and the presence of lymphatic-vascular invasion and positive lymph node status support this staging decision.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: (Age: )F Race: WHITE. FAMENDED. SPECIMEN: A: WIDE LOCAL EXCISION RIGHT BREAST B: SENT LN #1. C: SENT LN #2 D: SENT LN #1 (. E: SENT LN #2 (. F: NONSENT LN #3. FINAL DIAGNOSIS: A. BREAST, RIGHT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED. (BLOOM-RICHARDSON: TUBULAR FORMATION-2, NUCLEI- - MITOSES-2 = 6) ,. 1. CM, NEGATIVE FOR LYMPHVASCULAR INVASION, MARGINS NEGATIVE. - FIBROCYSTIC CHANGES TO INCLUDE CYSTS, FIBROSIS, APOCRINE METAPLASIA,. AND DUCT ECTASIA. - MULTIFOCAL FAT NECROSIS. - ER/PR IMMUNOSTAINS ARE STRONGLY POSITIVE. - HER2-NEU OVEREXPRESSION BY FISH: NOT AMPLIFIED (1.2). B. LYMPH NODE, NON-SENTINAL #1, BIOPSY: TWO LYMPH NODES NEGATIVE FOR MALIGNANCY (0/2) . C. LYMPH NODE, NON-SENTINAL #2, BIOPSY: TWO LYMPH NODES NEGATIVE FOR MALIGNANCY (0/2) . D. LYMPH NODE, SENTINAL #1. BIOPSY. NEGATIVE FOR MALIGNANCY BY IMMUNOHISTOCHEMICAL STAINS. E. LYMPH NODE, SENTINAL #2. BIOPSY: NEGATIVE FOR MALIGNANCY BY IMMUNOHISTOCHEMICAL STAINS. F. LYMPH NODE, NON-SENTINAL #3, BIOPSY: BENIGN ADIPOSE TISSUE, NO LYMPHOID TISSUE PRESENT. PATHOLOGIC STAGING : Tlc NO MX. COMMENT: CYTOKERATIN IS NEGATIVE IN SPECIMEN D AND E. Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with 2.5 cm right outer mid breast tumor. Fine. needle aspiration positive for atypical cells consistent with carcinoma. FROZEN SECTION DIAGNOSIS: A: RIGHT BREAST - INFILTRATING DUCTAL CARCINOMA. Results relayed to Dr. in person. GROSS DESCRIPTION: A. WIDE LOCAL EXCISION RIGHT BREAST received fresh and consists of a piece. of fatty tissue measuring 9.0 X 8.0 x 3.0 cm. The specimen is oriented. with sutures by surgeon. Ink code: Red=medial lateral, blue=superior,. green=inferior, yellow=anterior, black=posterior. Sectioning reveals a. firm, tan, well-circumscribed mass, 1.7 cm in greatest dimension in the. mid portion of the specimen; the mass is located 0. 8 cm from the deep. margin. A frozen section is prepared (block A1). There. is. a. second. well-circumscribed, tan nodule, 0.7 cm in diameter, located 0.5 cm. superior anterior to the main mass. Sections harvested for breast. protocol include (1) mass, OCT embedded (2) mass, flash frozen, and. (3) grossly normal breast from the medial end of the specimen, flash. frozen (matching paraffin sections=A1 and A2, respectively) . Additional. representative sections are submitted in sequential order from lateral to. medial in cassettes A3 through A12. First mass in cassettes A1, A5, A6,. A8, and the second mass in A7, A9, A10, and All. 12CF. B. SENTINEL LYMPH NODE NUMBER ONE \"NON-SENTINEL NODULE NUMBER ONE\". received in formalin and consists of two irregular fragments of tan soft. tissue with attached yellow adipose tissue measuring 2.0 and 1.7 cm in. greatest dimension. The fragments are bisected and submitted in their. entirety in two cassettes, one node per cassette. 2C4. C. SENTINEL LYMPH NODE NUMBER TWO NON-SENTINEL NODE NUMBER TWO\" received. in formalin and consists of two irregular fragments of yellow, lobular. adipose tissue measuring 2.5 cm in greatest dimension each. The. fragments. are bisected and submitted in their entirety in two cassettes, one. fragment per cassette. 2C4. Specimen # : GROSS DESCRIPTION (continued). D. SENTINEL LYMPH NODE NUMBER ONE. received in formalin and consists. of one ovoid fragment of tan, fibrous tissue with attached yellow adipose. tissue measuring 2.5 cm in greatest dimension. The specimen is serially. sectioned and submitted in its entirety in two cassettes. 2C4. E. SENTINEL LYMPH NODE NUMBER TWO. received in formalin and consists. of a fragment of tan soft tissue measuring 2.5 cm in greatest dimension. The specimen is trisected and submitted in its entirety in two cassettes. 2C3. F. NON-SENTINEL LYMPH NODE NUMBER THREE received in formalin and consists. of one ovoid fragment of tan soft tissue with adherent yellow adipose. tissue measuring 1.7 cm in greatest dimension. The specimen is bisected. and submitted in its entirety in one cassette. 1C2:\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to understand what each T stage represents in terms of tumor size and extent. The T stages are defined as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided pathology report, the key information for determining the T stage is the size of the tumor. The report mentions a 'firm, tan, well-circumscribed mass, 1.7 cm in greatest dimension' as the primary tumor and a second 'well-circumscribed, tan nodule, 0.7 cm in diameter.' Since the largest dimension of the primary tumor is 1.7 cm, which is less than 2 cm, we would initially consider this as T1. However, it's crucial to note if there's any mention of the tumor extending to the chest wall, skin, or if the overall description suggests a size or extent that would classify it differently. The report does not indicate any such extension or size that would move it beyond T1 based on the size criteria. Therefore, based on the tumor size being 1.7 cm, the pathologic T stage for this breast cancer is T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and depth of invasion, and then apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition).",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size and extent of invasion were evaluated, and based on the provided information, the cancer was determined to be at an early stage with minimal invasion.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: Physician (s) : SPECIMEN: A: LEFT BREAST LUMPECTOMY B: AXILLARY CONTENTS. C: LEFT SUPRACLAVICULAR LYMPH NODE. FINAL DIAGNOSIS: A. LEFT BREAST, LUMPECTOMY: RESIDUAL INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. RESIDUAL TUMOR SIZE: 2.5 X 2.0 X 1.5 CM. DEEP SURIGIAL MARGIN INVOLVED BY MAIN TUMOR. MEDIAL, SUPERIOR, AND INFERIOR MARGINS FOCALLY INVOLVED BY. DISCONTINUOUS TUMOR FOCI (LOCAL MICROMETASTASES). EXTENSIVE LYMPHATIC INVOLVEMENT. B. LEFT AXILLARY CONTENTS, DISSECTION: METASTATIC CARCINOMA INVOLVING 18 OF 20 EXAMINED LYMPH NODES. EXTENSIVE EXTRANODAL EXTENSION AND NON-NODAL METASTASES. C. LEFT SUPRACLAVICULAR LYMPH NODE, EXCISON: METASTATIC CARCINOMA INVOLVING 1 EXAMINED LYMPH NODE. COMMENT: The findings were discussed with. by phone. The deep surgical margin is involved by residual gross tumor (Block A24) . The medial, superior, and inferior margins are involved K< 0.6mm) by. microscopic foci, separate from the tumor. (Blocks A5, A10, A11, A23, A39) . Of the 18 involved axillary lymph nodes, 1 has a micrometastasis (B3) . An. additional lymph node (B22) has isolated tumor cells. These were. identified by routine light microscopy and hematoxylin-eosin stain. ==. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: A. year old. female with left breast cancer with a positive margin. Palpable lymph node. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. POST-OPERATIVE DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION: A. LEFT BREAST LUMPECTOMY Received fresh, labeled with the patient's. name, and designated \"LEFT BREAST TISSUE, SKIN INTERIOR, ONE STITCH. MEDIAL, TWO STITCHES SUPERIOR\" is a specimen which consists of a piece of. fibrofatty tissue, 6.5 x 6.5 x 5.3cm with an overlying ellipse of skin,. 5.0 x 2.0cm. There is a 3. 5cm scar on the skin surface. Posteriorly a. small patch of skeletal muscle is noted. The specimen is oriented with. sutures (one - medial; two - superior) . Inked as follows: blue -. superior; green - inferior; yellow - medial, red - lateral, and black -. posterior. Sectioning reveals a 3. 0cm biopsy cavity with hemorrhagic. walls and surrounding fat necrosis in the medial half of the specimen. Medially. adjacent to the cavity and involving the deep margin is a firm,. tan tumor measuring 2.5 x 2.0 x 1.5cm. The remaining tissue is fat and. fibrous tissue. Sections of skin, tumor, and grossly normal fibrous. tissue are harvested for the CBCP protocol with matching paraffin sections. as follows: A1, skin, lateral tip; A2, tumor, medial portion; A3, tumor,. lateral aspect; A4, grossly normal fibrous, mid medial - superior, 2.5cm. from the tum; A5-A6, medial margin; A7-A8, adjacent representative. section; A9-A12, biopsy cavity; A13-A17, representative biopsy cavity; A18. A19, biopsy cavity; A20-A22, biopsy cavity; A23-A25, biopsy cavity;. A26-A28, biopsy cavity; A29-A30, biopsy cavity; A31-A33, adjacent left mid. section; A34, representative section; A35, representative section;. A36-A39, lateral margin. 39CF. B. AXILLARY CONTENTS Received fresh, labeled with the patient's name,. anddesignated \"AXILLARY CONTENTS, LEFT TAG AT HIGHEST AXILLARY NODE\" is. a. specimen which consists of a piece of soft yellow tissue, 14.5 x 6.5 x. 3 5cm, containing numerous and large lymph nodes. There are several. cyst-like structures found on serial sectioning ranging in size from 2.5. x 2.0 x 1.0cm to 1.5 x 1.5 x 1. Ocm. The cyst are filled with a red. viscous fluid. Further sectioning reveals a 3.5 x 3.0 x 2.0cm hemorrhagic. cyst-like structure that has a tan-red surface and is poorly defined. Its. mass trails to the lateral edge biopsy tail. Multiple possible lymph nodes. are identified ranging in size from 2.0 x 2.0 x 1.5cm to 0.4 x 0.3 x. 0.2cm. Two grossly positive lymh nodes and one grossly benign lymph node. Specimen # : GROSS DESCRIPTION (continued) : are harvested for the CBCP protocol with matching paraffin sections as. follow: Cassette B1, lymph node with tumor, 2.0 x 2.0 x 1.2cm, lower. axillary tale; B2, lymph node with tumor, 1.6cm, lower axillary tail; B3,. grossly benign lymph node, 0. 7cm, upper axillary tail; B4, grossly. positive single lymph node; B5, single lymph node in multiple pieces;. B6-B7, multiple possible lymph nodes; B8, bisected possible lymph node;. B9, single positive possible lymph node; B10, single possible bisected. lymph node; B11, fragments of possible lymph node; B12, fragments of. possible lymph node; B13-B14, bisected possible lymph node; B15, possible. lymph node; B16, single possible lymph node; B17-B18, skeletal muscle with. cyst wall; B19-B22, representative sections of axillary mass; B23-B25,. area of possible lymph nodes. 25CF. C. LEFT SUPRACLAVICULAR LYMPH NODE Received in formalin, labeled with the. patient's name, and designated \"LEFT SUPRACLAVICULAR LYMPH NODE\" is a. specimen which consists of a 1.3 x 0.7cm lymph node containing a 0. .8cm. tumor. A portion of the lymph node is submitted for the CBCP protocol. 1CF.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The pathologic T stage is based on the largest dimension of the invasive tumor. Here are the steps to follow:\\n1. **Identify the size of the tumor**: The residual tumor size is given as 2.5 x 2.0 x 1.5 cm. The largest dimension of this tumor is 2.5 cm.\\n2. **Consider the extent of the tumor**: The tumor involves the deep surgical margin and has discontinuous tumor foci (local micrometastases) with extensive lymphatic involvement. However, for the T stage, we primarily focus on the size of the tumor and its direct extension, not the lymph node involvement or distant metastasis.\\n3. **Apply the AJCC T staging criteria**:\\n   - T1: Tumor >0.1 cm but = 2 cm in greatest dimension.\\n   - T2: Tumor >2 cm but = 5 cm in greatest dimension.\\n   - T3: Tumor >5 cm in greatest dimension.\\n   - T4: Tumor of any size with direct extension to the chest wall or skin.\\nGiven the tumor's largest dimension is 2.5 cm, which falls into the category of >2 cm but = 5 cm, we can determine the pathologic T stage.\", ",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report, such as tumor size and margin involvement. Then, I can apply the AJCC Cancer Staging Manual (7th edition) rules to determine the T stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor has direct extension to the chest wall and/or skin, with involvement of the deep surgical margin and discontinuous tumor foci in the margins.",
    "Choice": "T4"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : AMENDED. SPECIMEN: A: SENTINAL B: RIGHT BREAST TISSUE C: NON SENTINAL LYMPH. D: SENTINAL LYMPH NODE. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL NUMBER ONE, BIOPSY: - ONE LYMPH NODE NEGATIVE FOR TUMOR BY H&E AND IMMUNOHISTOCHEMISTRY. B. BREAST, RIGHT, SIMPLE MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, POORLY-DIFFERENTIATED BY COMBINED. HISTIOLOGIC CRITERIA. - TUMOR SIZE 1.8 CM. - ASSOCIATED DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE III WITH NECROSIS. AND PROMINENT LYMPHOID INFILTRATE COMPRISING 10-15% OF TUMOR. ESTROGEN RECEPTOR: NEGATIVE IN INFILTRATING AND IN SITU CARCINOMA. PROGESTERONE RECEPTOR: NEGATIVE IN INFILTRATING AND IN SITU. CARCINOMA. - HER2 NEU BY IMMUNOHISTOCHEMISTRY: 2+ (WEAKLY POSITIVE). - HER2 NEU BY FISH: NOT AMPLIFIED (1.4). - MARGINS NEGATIVE FOR TUMOR. - NO RESIDUAL PAGET'S DISEASE OR LACTIFEROUS DUCT INVOLVEMENT. - MICROCALCIFICATIONS IN NEOPLASTIC BREAST TISSUE. - UNINVOLVED BREAST TISSUE SHOWS FIBROCYSTIC CHANGES AND SCLEROSING. ADENOSIS. C. LYMPH NODE, NON SENTINEL, BIOPSY. - ONE BENIGN LYMPH NODE. D. LYMPH NODE, SENTINEL NUMBER TWO, BIOPSY: - ONE LYMPH NODE NEGATIVE FOR TUMOR BY H&E AND IMMUNOHISTOCHEMISTRY. COMMENT: The above results were reported in. L on. Estrogen and progesterone receptors were evaluated by immunohistochemical. Specimen # : FINAL DIAGNOSIS (continued) : methods. A positive test is defined as easily discernable nuclear. staining in more than 5% of the tumor cells. The specimen was evaluated for HER-2/Neu (c-erbB2) overexpression by. immunohistochemical methods (DAKO Hercep Test) . Staining is interpreted. on a scale of 0 to 3+ with positivity defined as 2+ or greater. Specimens. with a weakly positive (2+) Hercep Test are further evaluated by. fluorescence in situ hybridization (PathVysion FISH assay) to detect. presence or absence of Her-2/neu gene amplification. CLINICAL DIAGNOSIS AND HISTORY: (None Given}. GROSS DESCRIPTION: A. SENTINEL Received in formalin, labeled with the patient's name,. and designated \"SENTINEL LYMPH NODE NUMBER ONE\" is a specimen consisting. of a 2.0 x 1.4 x 1.0 cm lymph node. A small portion was submitted for the. CBCP protocol. 1C1NS. B. RIGHT BREAST TISSUE Received fresh, labeled with the patient's name,. and designated \"RIGHT BREAST TISSUE\" is a specimen consisting of a 245.0. gram simple mastectomy, 18.0 cm x 13.5 cm x 3.0 cm in dimension. There is. a 15.0 cm x 4.0 cm ellipse of nipple-bearing skin. The deep margin is. inked in black. On sectioning, a 1.8 cm tumor is identified in the. mid-center portion of the breast. The tumor abuts, but does not grossly. involve the deep margin. The remaining tissue is extensively fibrosis with. admixed fat. Sections of tumor, grossly normal fibrous breast tissue, and. skin harvested for the CBCP protocol; mirror images for Histology are as. follows: Slide Key: B1: Tumor (CBCP) ; B2: Fibrous tissue, 1.0 cm medial to tumor. (CBCP) i B3: Fibrous tissue, 2.0 cm medial to tumor (CBCP) ; B4: Fibrous. tissue, 5.0 cm medial to tumor (CBCP) ; B5: Skin, near medial tip (CBCP) ;. Specimen #: GROSS DESCRIPTION (continued) : B6: Nipple; B7: Tumor and deep margin; B8-B10 Representative tumor; B11: Medial upper quadrant; B12: Medial lower quadrant; B13 : Lateral lower. quadrant; B14: Lateral upper quadrant. 14CFSS. C. NON SENTINEL LYMPH Received fresh, labeled with the patient's name,. and designated \"NON-SENTINEL LYMPH NODE\" is a specimen consisting of a. 1.5. cm x 0.8 cm x 0.5 cm tan lymph node with a scant amount of attached. yellow, lobular adipose tissue. 1CF. D. SENTINEL LYMPH NODE Received fresh, labeled with the patient's. name, and designated \"SENTINEL LYMPH NODE NUMBER TWO\" is a specimen. consisting of a 1.4 cm x 0.8 cm x 0.4 cm yellow, white soft tissue. fragment with two staples and an unoriented suture. CA. i.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report regarding the size of the tumor and its extent. The AJCC Cancer Staging Manual (7th edition) defines the T stages as follows:\\Backend T1: Tumor is 2 cm or less in greatest dimension.\\Backend T2: Tumor is more than 2 cm but not more than 5 cm in greatest dimension.\\Backend T3: Tumor is more than 5 cm in greatest dimension.\\Backend T4: Tumor is any size with direct extension to the chest wall or skin.\\Backend The pathology report states that the tumor size is 1.8 cm, which is less than 2 cm. Additionally, it mentions that the tumor abuts but does not grossly involve the deep margin and there's no mention of direct extension to the chest wall or skin.\\Backend Given this information, the pathologic T stage for this breast cancer patient would be T1, as the tumor is 2 cm or less in greatest dimension.",
    "BaselineChoice": "T1",
    "Monologue": "I need to extract the tumor size from the pathology report and then use it to determine the pathologic T stage according to the AJCC Cancer Staging Manual (7th edition).",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 1.8 cm, which is greater than 1 cm but less than or equal to 2 cm, indicating a T2 stage.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen # : F. Race: BLACK. AMENDED. SPECIMEN: A: LEFT SENTINEL LYMPH NODE B: LEFT BREAST TISSUE. FINAL DIAGNOSIS: A. LYMPH NODE, LEFT SENTINEL, EXCISION: - NEGATIVE FOR MALIGNANCY BY IMMUNOHISTOCHEMISTRY. B. BREAST, LEFT, LUMPECTOMY: - INFILTRATING DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED BY COMBINED. HISTOLOGIC CRITERIA. - MAXIMUM TUMOR DIMENSION = 2.0 CM. - ASSOCIATED DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 2 WITH NECROSIS. - SURGICAL MARGINS ARE NEGATIVE FOR TUMOR. MICROCALCIFICATIONS IDENTIFIED IN THE DUCTAL CARCINOMA IN SITU. AND THE INFILTRATING CARCINOMA COMPONENTS. ESTROGEN RECEPTOR POSITIVE (80% nuclear staining). PROGESTERONE RECEPTOR: POSITIVE ( 90% nuclear staining). (SEE COMMENT) . AMMENDMENT 2: FOLLOWING INTRADEPARTMENTAL REVIEW, RESULTS OF HER2 STUDIES. ARE REVISED. HER2 BY IMMUNOHISTOCHEMISTRY: WEAKLY POSITIVE (2+). HER2 BY FISH: NOT AMPLIFIED (1. 1). COMMENT: Estrogen and progesterone receptors were evaluated by immunohistochemical. methods. A positive test is defined as easily discernable nuclear. staining in more than 58 of the tumor cells. The specimen was evaluated for HER-2/Neu (c-erbB2) overexpression by. immunohistochemical methods (DAKO Hercep Test) . Staining is interpreted. on a scale of 0 to 3+ with positivity defined as 2+ or greater. Specimens. with a weakly positive (2+) Hercep Test are further evaluated by. Specimen #. FINAL DIAGNOSIS (continued) : fluorescence in situ hybridization (PathVysion FISH assay) to detect. presence or absence of Her-2/neu - gene amplification. CLINICAL DIAGNOSIS AND HISTORY: -year-old. female with T1NOMO infiltrating ductal. carcinoma of left breast on physical exam and core biopsy. GROSS DESCRIPTION: A. LEFT SENTINEL LYMPH NODE received fresh, labeled with the patient's. name, designated \"LEFT SENTINEL LYMPH NODE\" consists of a 2.0 cm x 0.7 cm. x 0.4 cm soft, tan tissue fragment. Bisected. 1CF. B. LEFT BREAST TISSUE received fresh, labeled with the patient's name,. designated \"LEFT BREAST TISSUE\" consists of a piece of fibrofatty tissue,. measuring 9.7 cm anterior to posterior, 6.8 cm medial to lateral, and 5.0. cm superior to inferior. The overlying ellipse of brown skin, with a 0.4. cm linear incision, measures 2.6 cm x 0.8 cm. Ink code: Red=lateral,. yellow=medial, black=posterior, blue=superior, and green=inferior. The. specimen is sectioned anterior to posterior revealing a 2.0 cm tumor, with. ell-defined margins and white, gritty cut surface, 0.4 cm from the. nearest margin superior. The remaining tissue is mostly fatty with a few. patches of white fibrous tissue. One section of skin, one section of. grossly normal fibrous tissue, and two sections of tumor are submitted for. the CBCP protocol (matching paraffin section=B1, B2, and B3-B4,. respectively) . Slide key: B1: Representative skin. B2: Grossly normal fibrous tissue. B3-B4: Tumor. B5-B6: Anterior margin. B7: Representative fibrous tissue. B8-B9: Tumor. B10-B12: Section of B3. B13-B14: Representative sections. B15-B16: Section of B4. B17: Representative sections. B18-B22 Posterior. margin. 22CF.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. The key information from the pathology report is the 'MAXIMUM TUMOR DIMENSION = 2.0 CM.' This dimension directly corresponds to the criteria for determining the T stage. Since the maximum tumor dimension is 2.0 cm, which is less than or equal to 2 cm, the pathologic T stage is T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and other characteristics, and then apply the AJCC Cancer Staging Manual (7th edition) rules to classify the cancer into one of the T stages (T1, T2, T3, or T4).",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.0 cm corresponds to the T2 stage according to the AJCC Cancer Staging Manual (7th edition)",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 B : SENTINEL LYMPH NODE #2. C: LEFT BREAST TISSUE. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA, EXCISION: TWO LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA BY HEMATOXYLIN AND. EOSIN AND IMMUNOHISTOCHEMICAL STAINING. B. SENTINEL LYMPH NODE #2, LEFT AXILLA, EXCISION: ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA BY HEMOTOXYLIN AND. EOSIN AND IMMUNOHISTOCHEMICAL STAINING. C. BREAST, LEFT, EXCISIONAL BIOPSY: OORLY-DIFFERENTIATED ADENOCARCINOMA CONSISTENT WITH INFILTRATING. DUCTAL CARCINOMA, HIGH GRADE (SEE COMMENT). TUMOR SIZE = 2.2 CM. THE TUMOR IS ONE CENTIMETER FROM THE SUPERIOR POSTERIOR. AND SUPERIOR ANTERIOR MARGINS OF RESECTION. BIOPSY SITE CHANGES. FIBROCYSTIC CHANGES. COMMENT: This tumor was graded using the modified Bloom and Richardson scheme with. a score as follows: mitoses = 3, tubules = 3, nuclei - 3; for a total. score of 9/9, high grade. No in situ carcinoma is identified. CLINICAL DIAGNOSIS AND HISTORY: -year-old - white female with left infiltrating ductal carcinoma of. breast. Specimen #: PRE-OPERATIVE DIAGNOSIS: Left breast cancer. POST-OPERATIVE DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION: A. The specimen is received in formalin, labeled with the patient's name,. is designated as \"SENTINEL LYMPH NODE #1\". It. consists of multiple fragments of pink to yellow/tan, irregularly shaped. tissue, which measure 2.5 x 2.0 x 1.0 cm in loose aggregate. The. specimen is submitted entirely. 1CF. R The specimen is received fresh, labeled with the patient's name,. and is designated as \"SENTINEL LYMPH NODE #2\". It. consists of a 3.5 x 2.5 x 1.3 cm piece of fatty tissue containing a 2.5 x. 1.3 x 1.2 cm lymph node. The node is bisected, revealing extensive. fat infiltration. One half of the node is submitted for CBCP protocol; the. remaining half is submitted for paraffin section in cassette B2. 2CF. C. The specimen is received fresh, labeled with the patient's name,. and is designated \"LEFT BREAST TISSUE - ONE STITCH. MED1AL, TWO STITCHES SUPERIOR, THREE STITCHES ANTERIOR\". It consists of. a. 210 gm portion of fatty tissue, which measures 11.5 x 8.5 x 2.7 cm. The. specimen is oriented with sutures (long single medial, two stitches. superior, three stitches anterior) Ink code: blue superior posterior,. orange, superior anterior, black inferior posterior, green inferior. anterior. Sectioning reveals a well circumscribed, slightly lobulated tan. tumor in the lateral portion of the specimen, measuring 2.2 x 1.8 x 1.5. cm. On cut section, the tumor has a centrally placed hemorrhage filled. cavity, consistent with prior biopsy. The tumor is at least 1.0 cm from. the near margin (black, orange) . The remaining tissue is predominantly. fatty with a 1.0 cm area of fibrous tissue punctuated with yellow flecks. about 3.0 cm medial to the tissue abutting the green inked margin. Multiple sections are submitted for CBCP protocol with matching paraffin. sections as follows: C1: grossly normal fibrofaty tissue, approximately 5.0 cm medial to tumor. C2: fibrous area with yellow flecks. C3 : tumor. C4: tumor. Additional sections are submitted. C5 and C6: lateral margin. specimen #: GROSS DESCRIPTION (continued) : C7: section adjacent to C4. C8 and C9: well defined mass in section medial to section containing C4. and C7. C10-C15: fibrous areas submitted lateral to medial. C16 and C17: medial margin. 17CF.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report. The key factor in determining the T stage is the size of the tumor and its extent. Here are the steps to follow:",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I will first extract the relevant information from the pathology report, such as tumor size and distance to margins. Then, I will compare the tumor size to the thresholds for each T stage. Finally, I will use the extracted information and comparison results to determine the appropriate T stage and produce a final response.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 2.2 cm, which corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition) since it is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: (Age: F Race: WHITE. Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 B: SENTINEL LYMPH NODE #2. C: SENTINEL LYMPH NODE #3 D: RIGHT BREAST. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE #1, EXCISIONAL BIOPSY : NEGATIVE FOR TUMOR BY H&E AND IMMUNOHISTOCHEMISTRY. B. SENTINEL LYMPH NODE #2, EXCISIONAL BIOPSY: RARE SINGLE CYTOKERATIN POSITIVE CELLS BY IMMUNOHISTOCHEMISTRY,. NO GROUPS MEASURING MORE THAN 0.2 MM IN DIAMETER. C. SENTINEL LYMPH NODE #3, EXCISIONAL BIOPSY: NEGATIVE FOR TUMOR BY H&E AND IMMUNOHISTOCHEMISTRY. D. BREAST, RIGHT, MASTECTOMY: INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED (BLOOM AND. RICHARDSON GRADE: TUBULES=3, NUCLEAR PLEOMORPHISM=3, MITOSES=3, TOTAL. SCORE=9). TUMOR SIZE 4.0 CM. NO DUCTAL CARCINOMA IN SITU IDENTIFIED. TUMOR 1.2 CM FROM DEEP MARGIN (NEAREST MARGIN). NO LYMPH VASCULAR INVASION IDENTIFIED. EXTENSIVE FIBROCYSTIC CHANGES CONSISTING OF FIBROSIS, ADENOSIS,. SCLEROSING ADENOSIS, AND DUCT ECTASIA. COMMENT: Immunostains for hormone receptors and HER 2 neu were performed. on the previous biopsy. with the following results: ESTROGEN RECEPTOR: NEGATIVE. PROGESTERONE RECEPTOR: NEGATIVE. HER 2 NEU (BY HERCEPTEST) : 1+ (NEGATIVE). The AJCC stage is pT2pNO (i+) MX. Specimen #: FINAL DIAGNOSIS (continued). Report Signed Out. CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with T2MXNX right breast cancer. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #1 BIOPSY\" is a single lymph node. measuring 1.6 x 0.9 x 0.4 cm with an attached portion of fat. A portion of. the lymph node is submitted for CBCP protocol. The remaining tissue is. submitted for microscopic examination. One cassette, none saved. B. Received in formalin, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #2\" consists of a white/tan,. somewhat fibrous tissue fragment consistent with a lymph node. Sectioning. reveals a dense, white, fibrous nodule located within the specimen. measuring 0.8 cm in its greatest dimension. No areas of hemorrhage or. necrosis are identified. Entirely submitted. One cassette, none saved. C. Received in formalin, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #3\" consists of a tan/brown,. irregularly shaped tissue fragment measuring 2.5 x 2.0 x 1.5 cm. Sectioning reveals a tan/brown, unremarkable cut surface. Entirely. submitted. Two cassettes, some saved. D. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST\" is an 883.0 gram total mastectomy specimen,. measuring 22.0 cm from the superior to inferior margin, 20.5 cm from the. medial to the lateral, and 4.7 cm from the posterior margin. The overlying. ellipse of nipple bearing skin measuring 4.6 x 4.2 cm and is without. obvious scars or other abnormalities. An ink code is as follows : Blue=superior to anterior margin, green=inferior anterior margin,. black=posterior margin. Sectioning reveals a well-defined, firm, tan. tumor, measuring 4.0 x 3.2 x 2.5 cm in the mid anterior - left upper. quadrant, approximately 1.5 cm from the deep margin. The remaining tissue. is mostly fatty with patches of white, fibrous tissue especially. inferiorly. Multiple sections are submitted for the CBCP protocol. Paraffin sections as follows: Specimen #: GROSS DESCRIPTION (continued) : D1: Skin and lateral tip. D2: Tumor. D3: Fibrous left lower quadrant. D4: Random section upper inferior quadrant. D5: Random section upper most quadrant. D6 : Fibrous sections of the tumor. D7: Section of nipple and underlying connective tissue. D8: Tumor deep margin. D9: Tumor deep margin. D10: Tumor deep margin. 10 CASSETTES.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report. The T stage is based on the size and extent of the primary tumor. The key information for determining the T stage is the size of the tumor and whether it has invaded nearby tissues or structures. According to the report, the tumor size is 4.0 cm. There is no mention of the tumor invading the chest wall or skin, which would be characteristics of T3 or T4 tumors, respectively. The report specifically mentions that the tumor is 1.2 cm from the deep margin and that there is no lymphovascular invasion identified. Given this information, we can apply the AJCC staging criteria for the T category: - T1: Tumor ≤ 2 cm - T2: Tumor > 2 cm but ≤ 5 cm - T3: Tumor > 5 cm - T4: Tumor of any size with direct extension to the chest wall or skin. Since the tumor is 4.0 cm in size and there is no mention of it extending to the chest wall or skin, it falls into the T2 category.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the pathology report provided. The report mentions the tumor size as 4.0 cm and its distance from the deep margin as 1.2 cm. We also need to check for any lymphovascular invasion and the presence of ductal carcinoma in situ. Based on this information, we can apply the T-staging rules to determine the correct stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 4.0 cm, with no lymphovascular invasion or ductal carcinoma in situ, and according to the AJCC Cancer Staging Manual (7th edition), a tumor more than 2 cm but not more than 5 cm in greatest dimension is classified as T2.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. SPECIMEN: A: RIGHT BREAST B : ADDITIONAL RIGHT BREAST TISSUE. C: MUSCLE, LEFT BREAST, DEEP D: LEFT BREAST. E: ADDITIONAL LEFT BREAST TISSUE. F: RIGHT AXILLARY SENTINEL LYMPH NODE. G: RIGHT AXILLARY SENTINEL LYMPH NODE. H: ADDITIONAL LEFT BREAST TISSUE, INFRAMAMMARY CREASE. I: LEFT AXILLARY SENTINEL LYMPH NODE. J: LEFT AXILLARY SENTINEL LYMPH NODE #2. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, GRADE II (3 FOR TUBULE FORMATION, 2. FOR PLEOMORPHISM, 1 FOR MITOSES = 6). - TUMOR MEASURES 2.2 X 2.0 X 1.5 CM (GROSS). - MARGINS NEGATIVE FOR TUMOR (APPROACHES 2.0 CM FROM DEEP MARGIN). - NO DUCTAL CARCINOMA IN SITU IDENTIFIED. - NO LYMPHVASCULAR INVASION IDENTIFIED. - USUAL DUCTAL HYPERPLASIA (A11). - BIOPSY SITE CHANGES. - UNREMARKABLE SKIN AND NIPPLE. - AJCC STAGE pT2NOMX. B. BREAST, RIGHT, EXCISION: - UNREMARKABLE FIBROADIPOSE TISSUE. - NO EVIDENCE OF MALIGNANCY. C. SOFT TISSUE, DEEP LEFT BREAST, EXCISION: - UNREMARKABLE SKELETAL MUSCLE AND MATURE ADIPOSE TISSUE. - NO EVIDENCE OF MALIGNANCY. D. BREAST, LEFT, MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, GRADE II (3 FOR TUBULE FORMATION, 2. FOR PLEOMORPHISM, 1 FOR MITOSES = 6) WITH ASSOCIATED NECROSIS. - TUMOR MEASURES 2.2 x 1.8 x 1.8 CM (GROSS) . - TUMOR ABUTS THE DEEP MARGIN WITHOUT DEFINITIVE INVOLVEMENT (D4). - FOCAL ASSOCIATED DUCTAL CARCINOMA IN SITU, SOLID TYPE (D6 AND D7). - FOCAL VASCULAR INVASION (D6). - BIOPSY SITE CHANGES. specimen #: FINAL DIAGNOSIS (continued) : - UNREMARKABLE SKIN AND NIPPLE. - AJCC STAGE pT2NOMX. E. BREAST, LEFT, EXCISION: - UNREMARKABLE FIBROADIPOSE TISSUE. F. LYMPH NODE, RIGHT AXILLARY, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO- -. HISTOCHEMICAL STAINS (0/1). G. LYMPH NODE, RIGHT AXILLARY, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO-. HISTOCHEMICAL STAINS (0/5). H. SOFT TISSUE, LEFT INFRAMAMMARY CREASE, EXCISION: - BENIGN BREAST TISSUE. I. LYMPH NODE, LEFT AXILLA, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO-. HISTOCHEMICAL STAINS (0/2). J. LYMPH NODE, LEFT AXILLA, EXCISION: - NO EVIDENCE OF MALIGNANCY BY HEMATOXYLIN AND EOSIN AND IMMUNO- -. HISTOCHEMICAL STAINS (0/1). CLINICAL DIAGNOSIS AND HISTORY: white female with synchronous bilateral infiltrating. breast carcinoma. FROZEN SECTION DIAGNOSIS: C. SPECIMEN TYPE: CHEST WALL. REPORTED TO: DR. REPORTED BY: DR. # BLOCKS : 2. Specimen #: FROZEN SECTION DIAGNOSIS (continued) : # SCRAPE PREPS 0. FROZEN SECTION DIAGNOSIS: - -NEGATIVE FOR TUMOR BASED ON TISSUE SUBMITTED. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST\" is a 980 gram simple mastectomy specimen. measuring 23.5 cm superior to inferior, 18.0 cm medial to lateral, and 5.1. cm anterior to posterior. The overyling ellipse of nipple bearing skin. measures 7.4 x 3.8 cm, and is without gross abnormalities. Ink code. blue=superior/anterior, green=inferior/anterior, and black=posterior. Sectioning reveals a 2.2 x 2.0 x 1.5 cm stellate tumor with a tan, gritty,. and focally hemorrhagic cut surface in the lower outer quadrant, 2.0 cm. from the deep margin, and 2.5 cm from the inferior/anterior margin. The. remaining tissue is mostly fatty with interspersed lengths of soft, white,. parenchyma. Multiple tissue sections are submitted for CBCP protocol. with. matching paraffin sections in cassette A1, A2, A3, and A7. Slide key: A1: Skin. A2: Tumor. A3: Tumor. A4-A6: Margins nearest tumor. A7: Fibrosis (central). A8: Nipple. A9: Upper inner quadrant. A10: Lower inner quadrant. All: Lower outer quadrant. A12: Upper outer quadrant. 12CF. B. Received in formalin, labeled with the patient's name,. designated 'ADDITIONAL RIGHT BREAST TISSUE\" are two fragments of. can-yellow, fibrofatty, non-oriented, soft tissue. The larger measures. 11.0 x 9.5 x 3.5 cm. The smaller measures 7.5 x 7.0 x 3.8 cm. The outer. portion of both specimens is inked entirely in black. Sectioning reveals. a uniform, glistening, yellow, lobular cut surface admixed with a scant. portion of white, fibrous appearing connective tissue. Representative. sections are submitted. Specimen #: GROSS DESCRIPTION (continued) : Slide key : B1-B6: - Random sections of larger fragment. B7-B10 Random sections of smaller fragment. 10CF. C. Received fresh for intraoperative consultation, labeled with the. patient's I designated \"ADDITIONAL CHEST WALL DEEP AT. SITE OF TUMOR, LEFT BREAST SHORT SUPERIOR, LONG LATERAL DOUBLE DEEP\" is a. 7.5 x 3.5 x 0.8 cm fragment of red-brown, soft tissue. The surface. appears to be muscle grossly. Sectioning reveals a white, fibrous. appearing band 0.3 cm thick, running the length of the center of the. specimen parallel to the deep margin. The specimen is inked deep in. black, superior in yellow, and inferior in green. The specimen is. entirely submitted lateral to medial. Slide key. C1: Inferior portion of section 1.0 cm from the lateral margin contiguous. with C5. C2: Inferior portion of section submitted for frozen contiguous with C10. 14CF. D. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST\" is a 984 gram simple mastectomy specimen. The. specimen measures 26.0 cm superior to inferior, 18.0 cm medial to lateral,. and 5.8 cm anterior to posterior. The overlying ellipse of nipple bearing. skin measures 7.2 x 3.5 cm, and is notable for an inverted nipple. Ink. code: blue=superior/anterior, green=inferior/anterior, and. black=posterior. Sectioning reveals a 2.2 x 1.8 x 1.8 cm tumor with. stellate margins, and tan, gritty, hemorrhagic cut surface in the lower. outer quadrant abutting the deep margin. The remaining tissue is mostly. fatty with interspersed widths of soft, white parenchyma. Multiple tissue. sections are submitted for CBCP protocol with matching paraffin sections. in cassettes D1, D4, and D5. Slide key: D1: Skin (medial tip) . D2-D4: Tumor with margin. D5: : Fibrous, upper outer quadrant, 5.0 cm from tumor. D6-D8: Remaining lateral portion of tumor including deep black inked. margin. D9: Two sections of nipple. Specimen #: GROSS DESCRIPTION (continued) : D10: Upper outer quadrant. D11: Lower outer quadrant. D12: Lower inner quadrant. D13: Upper inner quadrant. 13CF. E. Received in formalin, labeled with the patient's name,. designated \"ADDITIONAL LEFT BREAST TISSUE\" is an unoriented,. yellow-tan,. fibrofatty fragment measuring 8.3 x 6.5 x 3.5 cm. The entire outer. portion of the specimen is inked in black. Sectioning reveals a uniform,. can-yellow, glistening, lobular, cut surface admixed with widths of soft,. white, parenchyma. Representative sections are submitted. 4C6. F. Received fresh, labeled with the patient's name,. designated \"RIGHT AXILLARY SENTINEL LYMPH NODE\" is a 1.9 x 1.4 x 1.2 cm. lymph node with adherent fat. Half of the node is submitted for the CBCP. protocol. The remaining half is submitted for paraffin sections. 1C1. G. Received fresh, labeled with the patient's name,. designated \"RIGHT AXILLARY SENTINEL LYMPH NODE #2\" is a 1.4 x 1.3 x 0.8 cm. lymph node with adherent fat. Half of the node is submitted for the CBCP. protocol. The remaining half is submitted for paraffin section in G1. The remaining fatty tissue is bisected, and entirely submitted in. cassettes G2 and G3. 3CF. H. Received in formalin, labeled with the patient's name,. designated \"ADDITIONAL LEFT BREAST TISSUE, INFRAMAMMARY CREASE\" is a 9.5 x. 7. x 4.5 cm fragment of tan-yellow, glistening, fibrofatty, lobulated,. soft tissue. The specimen arrives unoriented. The entire outer portion. is inked in black. Sectioning reveals a smooth, glistening, lobulated,. fibrofatty, yellow-tan, cut surface admixed with widths of soft, white. parenchyma. Representative sections are submitted. 8CF. I. Received fresh, labeled with the patient's name,. designated \"LEFT AXILLARY SENTINEL LYMPH NODE\" are two lymph nodes with. adherent fat measuring 2.2 and 2.0 cm in greatest dimension. Half of the. larger node is submitted for the CBCP protocol. The remaining half is. submitted for paraffin section in cassette Il. The smaller node is in. cassette I2. The remaining fatty tissue is submitted in cassettes I3. through I6. 6CF. J. Received in formalin, labeled with the patient's name,. designated \"LEFT AXILLARY SENTINEL LYMPH NODE #2\" is a 3.2 x 2.0 x 1.2 cm. Specimen #: GROSS DESCRIPTION (continued) : yellow-tan fragment of fibrofatty, soft tissue. Within the soft tissue. there is a single identifiable lymph node measuring 0.9 cm in greatest. dimension. The node is submitted in J1. The remainder of fibrofatty,. soft tissue is submitted in J2. 2C2.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size and extent of the tumor. The T stage is defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. Looking at the provided pathology report, we see that there are two tumors described, one in the right breast and one in the left breast, both of which are described in detail. For the right breast, the tumor measures 2.2 x 2.0 x 1.5 cm, and for the left breast, the tumor measures 2.2 x 1.8 x 1.8 cm. Both tumors are larger than 2 cm but less than or equal to 5 cm. There is no mention of direct extension to the chest wall or skin for either tumor that would classify them as T4. Therefore, based on the size of the tumors, both would be classified as T2 according to the AJCC Cancer Staging Manual (7th edition).",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract the tumor size from the pathology report and compare it with the AJCC Cancer Staging Manual (7th edition) criteria.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension, according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        LOGY REPORT. Specimen # : (Age. F. Race: WHITE. AMENDED ICD-0-3. SPECIMEN: A: RIGHT BREAST AND AXILLARY CONTENTS. B: ADDITIONAL RIGHT BREAST TISSUE. FINAL DIAGNOSIS: A & B. BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY WITH AXILLARY LYMPH. NODES, EXCISION: TUMOR TYPE: APOCRINE CARCINOMA, INFILTRATING (A2,A3,A14, A15). (HISTIOCYTOID SUBTYPE) (SEE COMMENT). NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED (G2). NOTTINGHAM SCORE: 7/9. (Tubules= 3, Nuclei= 3, Mitoses= 1i mitotic count 3 per 10 HPF at. 40x power). TUMOR SIZE (GREATEST DIMENSION) : 4.5 CM (MEASURED GROSSLY; See. comment). TUMOR NECROSIS: ABSENT IN INFILTRATING COMPONENT, PRESENT (COMEDO,. N-SITU TYPE) IN DCIS. MICROCALCIFICATIONS PRESENT IN STROMA. VENOUS / LYMPHATIC INVASION: PRESENT (A10,A14). MARGINS : NEGATIVE. -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 1.1 CM, FROM DEEP MARGIN. (A3). INTRADUCTAL COMPONENT: EXTENSIVE. LYMPH NODES: ONE OF 18 POSITIVE FOR TUMOR BY IHC ONLY (SEE COMMENT). NIPPLE INVOLVEMENT: ABSENT. SKIN INVOLVEMENT : ABSENT. MULTICENTRICITY ABSENT. ESTROGEN RECEPTORS: NEGATIVE (PREVIOUSLY EVALUATED FROM. PROGESTERONE RECEPTORS: NEGATIVE (PREVIOUSLY EVALUATED FROM. HER 2 NEU by IHC: POSITIVE (3+) (PREVIOUSLY EVALUATED FROM. $05-12958). PATHOLOGIC STAGE: pT2 NO (i+) MX (AJCC Stage II). ADDITIONAL PATHOLOGIC CHANGES CYSTIC CHANGE, SCLEROSING ADENOSIS,. FIBROADENOMATOID CHANGE, APOCRINE METAPLASIA. COMMENT: COMMENT #2 (. Specimen #: FINAL DIAGNOSIS (continued) : This case is amended to change the lymph node assessment to the above from. a prior assessment of. \"LYMPH NODES: 18 NEGATIVE FOR TUMOR. \", and to change the stage to. T2 NO (i+) from T2 NO. Dr. requested additional evaluation of the. lymph nodes on this patient to collaborate with the PET findings of a. positive node, so the nodes in A10, A11, A12, A19 and A20 were evaluated. with keratin. In A10, the node originally showing pericapsular lymphatic. involvement, the keratin shows individual cells and one subcapsular. cluster of tumor cells less than 0.2 mm in diameter. Dr. was informed of this change in report today by email. ORIGINAL COMMENT: The tumor was too large for microscopic measurement, so exact. measurement is not possible. Some of the DCIS component may have been. included in the gross measurement, but the bulk of tumor is infiltrative. and represents at least a T2 lesion. Slide A10 contains a lymph node with lymphvascular space invasion just. outside of the capsule. We are interpreting this as a negative node. This report was amended. due to a typographical error in the. patient history listing her age incorrected as years. Additionally, the. pathologic stage was changed from N1 to NO, another typographical error. CLINICAL DIAGNOSIS AND HISTORY: year old female with invasive ductal carcinoma of right breast and. positive for axillary lymph nodes. Presents for modified radical. mastectomy. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. POST-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION. A. Received fresh consists of a 504 gram right mastectomy specimen single. stitch medial and double stitch superior. Specimen measures 24 cm superior. to inferior, 21 cm medial to lateral, and 3 cm anterior to posterior. The. jightly pigmented skin ellipse measures 12 x 5 cm, centrally located. 3. Specimen #: GROSS DESCRIPTION (continued) : everted nipple measuring 1.5 x 1.5 x 1.2 cm with no discharge. No scars. inked black. Specimen serially sectioned to reveal fairly well. identified. Superficial upper outer quadrant is inked blue and deep margin. circumscribed pink firm mass measuring 4.5 x 2.5 x 2.0 cm. The mass. focal hemorrhage and lies within a bed of dense, diffusely nodular,. shows. and 0.5 cm from blue superficial margin. Remaining tissue shows scattered margin. focally necrotic fibrous tissue. The mass is located 1 cm from deep. cysts measuring up to 0.4 cm. Multiple indurated foci are also seen. node is seen within the upper outer quadrant. within the upper inner quadrant and lower inner quadrant. A 0.7 cm lymph. A separately received portion of axillary tail measures 10 x 3 x 1. 0 cm. and oriented with stitch on high end. Five lymph nodes are identified. measuring 0.7 to 1.0 cm. The specimen is submitted as follows: A1: skin. A2 mass, central. A3 : margin. A4: lateral mass. A5: upper outer quadrant. A6: lower outer quadrant. A7: lower inner quadrant. A8: upper inner quadrant. A9: intramammary lymph node. A10: two high axillary lymph nodes bisected. All: two mid axillary lymph nodes bisected. A12: one low axillary lymph node. A13: nipple. A14-A17: upper outer quadrant mass lateral to medial. A18: high axillary lymph node. A19: middle axillary lymph node. A20: low axillary lymph node. 20CF. B. Received in formalin labeled with patient's name. designated \"RIGHT BREAST TISSUE WITH AXILLARY CONTENTS\" consists of a 1.0. x 1.0 x 0.4 cm piece of red and yellow soft tissue. Specimen submitted. entirely in one cassette.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the tumor and its extent. The pathologic T stage is based on the size of the invasive component of the tumor. The given information states that the tumor size (greatest dimension) is 4.5 cm, as measured grossly. According to the AJCC Cancer Staging Manual (7th edition), a tumor size of more than 2 cm but not more than 5 cm is classified as T2. Therefore, based on the tumor size of 4.5 cm, the pathologic T stage for this breast cancer is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules. First, I will extract the tumor size and other relevant details from the report. Then, I will use the extracted information to determine the T stage according to the AJCC rules. Finally, I will produce a final response with the predicted T stage and my reasoning.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 4.5 cm, which falls within the T2 category according to the AJCC Cancer Staging Manual (7th edition), with no skin involvement, chest wall involvement, or other factors that would warrant a higher T stage.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: LEFT BREAST B: SENTINEL LYMPH NODE #1. C: SENTINEL LYMPH NODE #2 AND #3 D: RIGHT BREAST. FINAL DIAGNOSIS: A. BREAST, LEFT, MASTECTOMY: -INFILTRATING DUCTAL CARCINOMA, MODERATELY-DIFFERENTIATED. -NOTTINGHAM SCORE IS 7 (3 TUBULES, 2 NUCLEI, 2 MITOSIS). -TUMOR SIZE 3.5 CM (GROSS MEASUREMENT). -DCIS PRESENT, CRIBRIFORM, NUCLEAR GRADE II WITH NECROSIS. -NO LYMPHOVASCULAR INVASION PRESENT. -SKIN AND NIPPLE ARE NOT INVOLVED. -MARGINS ARE NEGATIVE. B. SENTINEL LYMPH NODE, EXCISION: -ONE LYMPH NODE NEGATIVE BY H&E AND IMMUNOHISTOCHEMICAL STAINS. C. SENTINEL LYMPH NODE #2 AND #3, EXCISION: -TWO LYMPH NODES NEGATIVE FOR MALIGNANCY BY H&E AND IMMUNOHISTOCHEMICAL. STAINS. D. RIGHT BREAST, MASTECTOMY: -MILD FIBROCYSTIC CHANGES CONSISTING OF APOCRINE METAPLASIA, FOCAL. DUCTAL DILATATION AND MILD FIBROSIS. AJCC STAGING:p T2 NO MX. CLINICAL DIAGNOSIS AND HISTORY: -year-old female with breast carcinoma. Specimen #: GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST, LONG LATERAL, SHORT SUPERIOR\" is a left. mastectomy specimen. The specimen consists of a 921 gram left mastectomy. specimen received fresh and oriented with a short suture superior and long. stitch lateral. The specimen measures 23.0 cm from superior to inferior,. 21.0 cm from medial to lateral, and 4.0 cm anterior to posterior. The 9.0. x 5.0 cm superficial skin ellipse is essentially located, 0.8 cm near the. nipple free of discharge. No scars are noted. The superficial surface is. partially inked blue, the deep margin is inked black. Serial sections. reveal a 3.5 x 2.5 x 2.2 cm firm, pink-tan, fairly well circumscribed mass. in the mid outer breast. The mass is located 3.5 cm from the deep margin,. and 0.8 cm from the superficial inked surface. Located 2.0 cm medial. to. this mass (also at the mid outer breast) is a 1.0 x 1.0 x 0.5 cm irregular. nodularity, which, upon resection, appears to consist of a cystic fibrous. tissue. The cystic tissue is located 2.0 cm from the deep margin. The. remainder of the specimen is composed of lobulated adipose tissue admixed. with 50% focally cystic fibrous tissue, with this area located in the. lower quadrant. No additional lesions are identified. No lymph nodes are. identified. Representative sections are submitted as follows. Cassette Key. A1: Skin. A2: Mass. A3: Mass with superficial margin. A4: Mid outer cystic tissue. A5: Upper outer quadrant. A6: Upper inner quadrant. A7: Lower inner quadrant with margin 1.5 cm away. A8: Lower outer quadrant. Matched sections of A1, A2, A4-A8 are submitted. in OCT for CBCP protocol. Additional sections are submitted as follows: A9: Nipple. A10-A11: Additional sections of mass. A12-A13 Sections of the possible smaller mass and outer quadrant. 13CFSS. B. Received fresh, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #1\" is a firm, tan fragment of soft tissue. measuring 0.7 x 0.6 x 0.3 cm. The specimen is bisected, and submitted. entirely. Cut section reveals a variegated, tan, soft tissue. C. Received fresh, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #2 AND #3\" are two intact pink-tan lymph. Specimen #: GROSS DESCRIPTION (continued) : nodes with attached fatty tissue measuring 1.5 x 1.0 x 0.1 cm, and 1.0 x. 0.7 x 0.4 cm. These lymph nodes are submitted as follows. Cassette Key: C1: One lymph node bisected. C2: Largest lymph node. A matched section of lymph node is submitted in. OCT for CBCP protocol. There is also an additional portion of yellow,. adipose tissue that is submitted separately measuring 1.5 x 1.0 x 0.2 cm. This is submitted in cassette C3. 3CF. D. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST, LONG LATERAL, SHORT SUPERIOR\" is a right. mastectomy specimen. Received fresh is a 609 gram right mastectomy. specimen oriented with a short suture superior, and long stitch lateral. The. specimen measures 19.0 cm superior to inferior, 18.0 cm medial to. lateral, and 3.0 cm anterior to posterior. The superficial skin ellipse. measures 10.0 x 4.5 cm and displays a 1.0 cm centrally located, nipple. free of discharge. No scars are identified. The deep margins are inked. black. Serial sections reveal densely fibrous breast tissue admixed with. approximately 10% adipose tissue. No discreet masses or lymph nodes are. identified. Representative sections are submitted as follows. Cassette Key : D1: Skin. D2: Upper outer quadrant . D3: Lower outer quadrant . D4: Left inner quadrant . D5: Upper inner quadrant. Matched sections of D1 and D5 are submitted in. OCT for CBCP protocol. Additional sections are submitted as follows : D6: Nipple. D7: Upper outer quadrant. D8: Lower outer quadrant. D9: Upper inner quadrant. D10: Lower inner quadrant. 10CF.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the tumor size and extent as described in the pathology report. The key information for staging is the size of the tumor and whether it has invaded nearby tissues or structures such as the skin or chest wall.\\Image 1: Tumor size is crucial for determining the T stage.\\Image 2: Invasion into skin, chest wall, or other structures affects T staging.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract the tumor size from the pathology report and compare it with the AJCC Cancer Staging Manual (7th edition) criteria.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.5 cm, which is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        specimen #: Race: WHITE. SPECIMEN: A: RIGHT BREAST B: RIGHT SENTINEL LYMPH NODE #1. C: LEFT BREAST D: LEFT SENTINEL LYMPH NODE. FINAL DIAGNOSIS: A&B. RIGHT BREAST, SIMPLE MASTECTOMY AND SENTINEL NODE BIOPSY. - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). - NOTTINGHAM SCORE: 8/9. (Tubules = 3, Nuclei = 3, Mitoses = 2). - TUMOR SIZE (GREATEST DIMENSION) : 2.5 CM, MEASURED GROSSLY. - TUMOR NECROSIS: ABSENT. - MICROCALCIFICATIONS: PRESENT, IN BENIGN LESION. - VENOUS / LYMPHATIC INVASION: PRESENT. - MARGINS : NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.3 CM, FROM. SUPERFICIAL / SKIN MARGIN; 5.0 CM FROM DEEP MARGIN. - INTRADUCTAL COMPONENT: ABSENT. - LYMPH NODE: 1 OF 1 POSITIVE FOR MICROSCOPIC FOCUS OF TUMOR. (0.47 MM) ; PRESENT WITHIN SUBCAPSULAR SINUS. - NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. - MULTICENTRICITY: ABSENT. - HORMONE RECEPTORS. - ESTROGEN RECEPTOR: POSITIVE (90%). - PROGESTERONE RECEPTOR: POSITIVE (10%). - HER2: NEGATIVE (BY IMMUNOSTAINS AND FISH) . - ADDITIONAL PATHOLOGIC CHANGES FIBROADENOMA, WITH CALCIFICATION. C&D. LEFT BREAST, SIMPLE MASTECTOMY AND SENTINEL NODE BIOPSY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). - NOTTINGHAM SCORE: 9/9. (Tubules =3, Nuclei = 3, Mitoses = 3). - TUMOR SIZE (GREATEST DIMENSION) : 5.0 CM, MEASURED GROSSLY. - TUMOR NECROSIS: ABSENT. - MICROCALCIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: ABSENT. Specimen #: FINAL DIAGNOSIS (continued) : - MARGINS: NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.3 CM FROM SUPERFICIAL /. SKIN MARGIN; 1.0 CM FROM THE DEEP MARGIN. - INTRADUCTAL COMPONENT: ABSENT. - LYMPH NODES: ONE LYMPH NODE, NEGATIVE BY ROUTINE AND IMMUNO STAINS. - NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. - MULTICENTRICITY ABSENT. - HORMONE RECEPTORS (PREPARED ON. - ESTROGEN RECEPTOR: POSITIVE (NEARLY 100%). - PROGESTERONE RECEPTOR: POSITIVE (40%). HER2 : POSITIVE (3+ ON IHC, POSITIVE BY FISH) . - ADDITIONAL PATHOLOGIC CHANGES: : FIBROADENOMA. COMMENT: The lesion from the right side would be stage pT2 N1mi MX;. the lesion from the left side would be stage pT2 NO (i-) MX. CLINICAL DIAGNOSIS AND HISTORY: Bilateral breast cancer. GROSS DESCRIPTION: A. Received fresh labeled with the patient's name. designated \"RIGHT BREAST\" consists of a 1134 gram mastectomy specimen. oriented with a short stitch superior and a long stitch lateral. The. specimen measures 27 cm medial to lateral, 21 cm superior to inferior and. 4.5 cm superficial to deep. The lightly pigmented superficial skin ellipse. measure $6.0 x 3.5 cm and displays a 1.0 cm centrally located, everted. nipple free of discharge. The deep margin is inked black and a portion of. superficial margin is inked blue. Serial sections reveal a 2.5 x 1.5 x 1.0. cm well circumscribed pink white mass located in the upper mid breast. The. mass comes to within 0.3 cm of the inked superficial margin and is located. 5 cm from the deep margin. Located in the lower outer quadrant is a 1.0 x. 0. x 0.7 cm well circumscribed markedly calcified nodule (consistent with. a calcified fibroadenoma) The remainder of the breast is predominantly. composed of lobulated yellow tan adipose tissue admixed with unremarkable. ibrous tissue. No additional lesions are identified. No lymph nodes are. Specimen # : GROSS DESCRIPTION (continued) : identified. Sections are submitted as follows : A1: skin. A2: mass. A3-A4: mass with superficial margin. A5: upper outer quadrant. A6: lower outer quadrant. A7: central. A8: lower inner quadrant. A9: upper inner quadrant. A10: nipple. All: upper outer quadrant. A12: lower outer quadrant with calcified nodule. A13: lower inner quadrant. A14 upper inner quadrant. Matched section of A1, A2 and A6-A9 are preserved in OCT for CBCP. protocol. B. Received fresh labeled with the patient's name. designated \"SENTINEL NODE #1 RIGHT SIDE\" consists or a 2.4 x 2.0 x 0.8 cm. irregular portion of soft tissue. Sectioning reveals 2.0 x 1.0 x 0.5 cm. pink tan lymph node. The lymph node is unevenly bisected. The specimen is. entirely submitted as follows: B1: lymph node. B2: adipose tissue. A matched section of B1 is submitted in OCT for CBCP protocol. C. Received fresh labeled with the patient's name. designated \"LEFT BREAST\" consists of a 1321 gram mastectomy specimen. oriented with a short stitch superior and long lateral. The specimen. measures 28.0 cm superior to inferior, 23 cm medial to lateral, and 4.0 cm. anterior to posterior. The lightly pigmented superficial skin ellipse. measures 7.0 x 4.0 cm and displays a 1.0 cm centrally located everted. nipple. Scattered irregular portions of red brown muscle are noted on deep. resection margin. The deep margin is inkd black and a portion of. superficial margin is inked blue. Serial sections reveal a well. circumscribed gritty pink tan mass involving the upper mid and upper inner. quadrant of the breast. The mass measures 5.0 x 4.2 x 2.7 cm and is. located 3.0 cm from deep margin and 0.2 cm from superficial surface. Located 1.0 cm from the mass, within the central portion of the breast, is. a. 1.0 cm tan white rubbery nodule consistent with a fibroadenoma. The. remainder of the breast is composed of lobulated yellow tan adipose tissue. Specimen #: GROSS DESCRIPTION (continued) : admixed with a small amount of tan white fibrous tissue. No additional. lesions are identified. No lymph nodes are identified. Sections are. submitted as follows. C1: skin. C2: mass. C3: mass with superficial margin. C4: mass. C5: upper inner quadrant. C6: lower inner quadrant. C7: central nodule. C8: lower outer quadrant. C9: upper outer quadrant. C10: nipple. C11: upper inner quadrant. C12: lower inner quadrant. C13: lower outer quadrant. C14: upper outer quadrant . Matched sections of C1-C2 and C4-C9 are submitted in OCT for CBCP. protocol. D. Received fresh labeled with the patient's name. designated \"LEFT SIDE SENTINEL NODE #1\" consists of a 2.5 x 2.0 x 0.5 cm. irregular portion of soft tissue. The specimen is bisected to reveal a 1.7. x 1.0 x 0.5 cm pink tan lymph node. The specimen is entirely submitted in. D1. A matched section of D1 is submitted in OCT for CBCP protocol.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the tumor. The T stage is classified as follows: T1 (tumor ≤ 2 cm), T2 (tumor > 2 cm but ≤ 5 cm), T3 (tumor > 5 cm), and T4 (tumor of any size with direct extension to the chest wall or skin). The pathology report provides information on two breast tumors, one from the right breast and one from the left breast. For the right breast, the tumor size is 2.5 cm, which falls into the T2 category. For the left breast, the tumor size is 5.0 cm, which also falls into the T2 category since it is not greater than 5 cm but exactly 5 cm. There is no mention of direct extension to the chest wall or skin for either tumor, which would be required for a T4 classification. Therefore, based on the tumor sizes provided, both tumors are classified as T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to identify the tumor size, skin involvement, chest wall involvement, and other relevant details from the pathology report. Then, I can apply the appropriate T staging rule based on these factors.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is within the T2 criteria of being more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        I. Specimen #: (Age : ) F Race : WHITE. Physician (s) : AMENDED / ADDENDUM: SPECIMEN: RIGHT BREAST TISSUE. FINAL DIAGNOSIS: BREAST, RIGHT INFERIOR LATERAL RETRO-AREOLA, EXCISION : INFILTRATING LOBULAR CARCINOMA. SURGICAL MARGINS POSITIVE FOR TUMOR. TUMOR SIZE: 0.5 CM BY MICROSCOPY. LOBULAR CARCINOMA IN SITU. PERINEURAL INVOLVEMENT BY CARCINOMA. MICROCALFICIATIONS IDENTIFIED. AJCC STAGING: STAGE I (T1, NX, MX), SEE COMMENT. COMMENT: (visiting pathology resident from. discussed the. above diagnosis with Dr. on. at. AMENDMENT. At the request of the clinician, tumor was evaluated for HER2-neu -. overexpression by immunohistochemical methods (DAKO HercepTest) with. the. following results: HER2/neu overexpression: NEGATIVE (1+). COMMENT: Membranous staining is interpreted on a scale of 0 to 3+ with. positivity defined as 2+ or qreater. Test performed at. Interpretation rendered by. -5. Specimen #: ADDENDUM: HER2/NEU BY FISH = 1.1 NOT AMPLIFIED. TEST: FISH for detection of HER2-neu gene amplification (Path Vision Her2. DNA probe by Vysis) Ratio of Her2-neu over chromosome 17 signals. RANGE FOR INTERPRETATION. Ratio less than 2.0 HER2-neu gene amplification not observed. Ratio equal to or greater than 2.0: HER2-neu gene amplification. observed. ER/PR IMMUNOSTAINS ARE NEGATIVE. C. INICAL DIAGNOSIS AND HISTORY: YO FEMALE WITH SMALL 1X.6CM COMPLEX MASS BY U/S AT INFERIOR/LATERAL. RETROAREOLAR. PRE-OPERATIVE DIAGNOSIS: FIBROUS TISSUE VS MALIGNANCY. POST-OPERATIVE DIAGNOSIS: Post-operative Diagnosis: SAA. GROSS DESCRIPTION: RIGHT BREAST TISSUE \"inferior lateral retro-areola\" consists of a single. irregularly shaped fragment of fibro fatty tissue, which previously has. been inked and sectioned. When reapproximated, the specimen measures 2 x. 1 x 1 cm. The previous sectioning reveals that the specimen is mostly fat. with admixed fibrous tissue. The specimen is placed in its entirety. in the 5 gray cassettes marked. A1-A5. The specimen was previously. inked blue before being received by this observer.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the tumor size, as the T stage is primarily based on this factor. The provided pathology report mentions the tumor size as 0.5 cm by microscopy. According to the AJCC Cancer Staging Manual (7th edition), the pathologic T stage is defined as follows: T1 - Tumor >0.1 cm but = 2 cm in greatest dimension, T2 - Tumor >2 cm but = 5 cm in greatest dimension, T3 - Tumor >5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Given that the tumor size is 0.5 cm, it falls into the category of T1, as it is greater than 0.1 cm but less than or equal to 2 cm in greatest dimension. The positive surgical margins, perineural involvement, and other factors such as HER2/neu status and ER/PR status are important for overall staging and treatment planning but do not directly affect the T stage classification based on the AJCC 7th edition criteria provided.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage, I need to extract the tumor size from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 0.5 cm, which corresponds to a T1 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: (Age: F Race: BLACK. Physician (s) : SPECIMEN: RIGHT BREAST AND AXILLARY CONTENT. FINAL DIAGNOSIS: BREAST, RIGHT, MASTECTOMY WITH AXILLARY LYMPH NODES : TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. NOTTINGHAM GRADE: POORLY DIFFERENTIATED. NOTTINGHAM SCORE: 9 OF 9. (Tubules= 3, Nuclei= 3, Mitoses= 3). TUMOR SIZE (GREATEST DIMENSION) : 5.6 CM (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT IN INFILTRATING COMPONENT. MICROCALCIFICATIONS: PRESENT IN TUMOR. VENOUS / LYMPHATIC INVASION: PRESENT (EXTENSIVE). MARGINS : DEEP MARGIN IS INVOLVED BY INFILTRATING TUMOR. -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0 CM, FROM DEEP MARGIN. INTRADUCTAL COMPONENT: PRESENT. LYMPH NODES: 9 OF 12 POSITIVE FOR TUMOR; LARGEST METASTATIC FOCUS IS. 1.5 CM. ESTROGEN RECEPTORS: POSITIVE (20%) (PERFORMED ON. PROGESTERONE RECEPTORS: NEGATIVE (less than 5%) (PERFORMED ON. HER 2 NEU by IHC: NEGATIVE (1%) (PERFORMED ON. PATHOLOGIC STAGE: pT3 N2a M# (AJCC Stage IIIA). CLINICAL DIAGNOSIS AND HISTORY: year old female with right breast cancer. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. Specimen #: GROSS DESCRIPTION: A. Received fresh and consists of 553 gram right mastectomy specimen with. axillary tail. Specimen measures 22 cm medial to lateral, 18 cm superior. to inferior, 3 cm anterior to posterior. Superficial skin ellipse is. darkly pigmented and measures 18 x 7 cm. Centrally everted nipple is. surrounded by nodular areolar. No scar or discharge is noted. Deep. resection margin is inked black. Specimen serially sectioned to reveal. 6. x 3.5 x 1.5 cm poorly circumscribed firm gritty mass within the lateral. outer quadrant. Located 5 cm from this mass at the mid inner aspect at. 3:00 there is a second similar appearing mass measuring 2.5 x 2.5 x 1. o. cm. The surrounding tissue shows marked hemorrhage consistent with. previous biopsy located within lateral inner quadrant is a 1 x 0.8 x 0.5. cm similar mass located 5 cm from 3:00 mass. Also within lateral inner. quadrant is a 1.5 X 0. x 0.5 cm similar mass abutting deep margin. Remainder of breast parenchyma is composed of 40% dense slightly nodular. fibrous tissue. Fatty tissue is unremarkable. Attached axillary tail measures 8 x 5 x 1 cm and contains twelve lymph. nodes ranging from 0. to 2 cm in greatest dimension. Upon sectioning the. cut surfaces are predominantly firm, pink white and appear involved by. lesion. Cassette key: A1: skin. A2: nipple. A3: LOQ mass inferior portion. A4: LOQ mass superior portion. A5: mid inner quadrant 3:00 mas. A6: LIQ mass. A7: LIQ mass at margin. A8: LOQ. A9: LIQ. A10: UIQ. All: UOQ. A12: largest lymph node, low axillary. A13: low axillary lymph node. A14: low axillary lymph node. A15: high axillary lymph node. A15-A18: two lymph nodes bisected in each cassette. A19-A20: one bisected lymph node in each cassette. Matched sections of A1-A6 and A8-A15 placed in. for CBCP protocol.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0CL.17950062-E052-4FC2-A437-A17669B4DD01",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The T stage is defined as follows: T1 - Tumor 2 cm or less in greatest dimension, T2 - Tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor more than 5 cm in greatest dimension, and T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report states that the tumor size (greatest dimension) is 5.6 cm, which directly corresponds to the criteria for T3. Although there is involvement of the deep margin and lymph nodes, these factors do not change the T stage but are relevant for the N stage. The description of the tumor being poorly circumscribed, having necrosis, and extensive venous/lymphatic invasion, as well as the presence of microcalcifications and an intraductal component, provides additional information about the tumor's characteristics but does not alter the T stage based on size. Therefore, based on the tumor size of 5.6 cm, the pathologic T stage is T3.",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size, and then apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition). I will use the extract_information tool to gather the necessary data and the get_t_stage_rule tool to determine the T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 5 cm in greatest dimension.",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: BLACK. Physician (s) : AMENDED ICD-0-3. SPECIMEN: LEFT BREAST MASS. FINAL DIAGNOSIS: BREAST, LEFT, BIOPSY: POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA (GRADE III/III PER. MODIFIED BLOOM RICHARDSON GRADING) WITH EXTENSIVE NECROSIS. TUMOR SIZE = 3.0 CM (MEASURED GROSSLY). MINIMAL IN-SITU COMPONENT (HIGH GRADE). LYMPHVASCULAR SPACE INVASION IS IDENTIFIED. TUMOR EXTENDS TO WITHIN 1 MM OF THE DEEP SURGICAL MARGIN. HYALINIZED FIBROADENOMA. COMMENT: Dr. was notified of the above diagnosis via e-mail on. ESTROGEN AND PROGESTERONE RECEPTORS WERE PERFORMED. THE TUMOR IS NEGATIVE. FOR ESTROGEN RECEPTORS AND FOCALLY POSITIVE FOR PROGESTERONE RECEPTORS. HER2/neu BY IMMUNOHISTOCHEMISTRY (HERCEPTEST) : NEGATIVE (0+) . CLINICAL DIAGNOSIS AND HISTORY: (None Given}. GROSS DESCRIPTION: LEFT BREAST MASS received fresh and consists of a fibrofatty tissue. fragment measuring 8.0 x 2.5 x 2.3 cm. The deep margin is designated with. a suture. The deep margin is inked black, while the remainder of the. specimen is inked blue. At the deep margin there is a firm,. well-circumscribed - mass measuring 3.0 x 2.5 x 2.5 cm with a tan, gritty,. and focally hemorrhagic cut surface. The remaining tissue is predominantly. Specimen #: GROSS DESCRIPTION (continued) : fatty and unremarkable. Multiple sections of tumor and grossly normal. breast tissue are harvested for CBCP protocol. Mirror images for histology. are as follows : A1-Tumor. A2-Tumor. A3-Gross normal. Additional sections are as follows: A4-10-Tumor. -. A11-12-Gross normal.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The pathologic T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the tumor size is 3.0 cm, which falls into the category of T2. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Additionally, the tumor does not exceed 5 cm, so it does not qualify as T3. Therefore, based on the tumor size and the information provided in the pathology report, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "I need to extract the tumor size from the pathology report and compare it with the AJCC Cancer Staging Manual (7th edition) to determine the pathologic T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.0 cm, which corresponds to the T2 stage according to standard cancer staging guidelines.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: (Age. F. Race WHITE. Physician (s) : AMENDED. SPECIMEN: RIGHT BREAST AND AXILLARY CONTENTS Site: breast, NOS C50.9 1/24/11 to. FINAL DIAGNOSIS: BREAST AND AXILLARY CONTENTS, RIGHT, MASTECTOMY: - INFILTRATING LOBULAR CARCINOMA. FOCAL LOBULAR CARCINOMA IN SITU AND CANCERIZATION OF TERMINAL DUCTS. - FOCAL DUCTAL CARCINOMA IN SITU,SOLID AND CRIBRIFORM TYPE. - SIZE: 5.2 CM BY GROSS MEASUREMENT. - MARGINS DEEP MARGIN POSITIVE FOR TUMOR. - NEGATIVE FOR LYMPHVASCULAR INVASION. - MICROCALCIFICATIONS ASSOCIATED WITH TUMOR. - FIBROCYSTIC CHANGES TO INCLUDE FIBROSIS, CYST FORMATION, AND APOCRINE. METAPLASIA. - 11 LYMPH NODES ARE NEGATIVE FOR TUMOR. - AJCC STAGE. COMMENT: THE AMENDMENT REFLECTS A CHANGE IN NUMBER OF LYMPH NODES FROM NINE. TO ELEVEN. COMMENT: AMENDMENT. Case amended to report results of HER2-neu - status by fluorescence in situ. hybridization. HER2-NEU: AMPLIFIED (5.0) . Note: The patient's prior core biopsy,. was negative for. HER2-neu. The tumor in the current case has areas of poorly. differentiated carcinoma (so-called pleomorphic lobular carcinoma) not. identified in the initial core biopsy; these areas are strongly positive. for HER2-neu gene amplification. Specimen # : CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with two site core biopsy breast cancer. RE-OPERATIVE DIAGNOSIS: Right breast cancer. POST-OPERATIVE DIAGNOSIS: Post-Operative Diagnosis: Same as above. GROSS DESCRIPTION: RIGHT BREAST AND AXILLARY CONTENTS received fresh and consists of a 362. gram mastectomy, 15.0 x 14.0 x 2.6 cm, with attached axillary tail, 15.0 x. 3.0 x 1.0 cm. The skin ellipse measures 10.0 X 3.5 cm. The specimen is. inked as follows Axillary tail=blue dot on inferior portion,. mastectomy - blue=superior superficial, green=inferior superficial,. black=deep. Sectioning reveals an area of firmness with the superior. portion of the specimen measuring 5.2 cm approximately 5.0 mm from the. deep margin. Palpation reveals 5.0 cm area of firmness in the superior. portion of the breast. The remainder of the cut surface is yellow,. lobular, with focal areas of white fibrous tissue and small cystic. structures measuring up to 0.2 cm. No additional well-defined lesions or. nodules are noted. Sectioning thorugh the attached axillary tail reveals 11 possible lymph. nodes ranging in size from 0.3 to 2.0 cm in greatest dimension. Four representative sections are submitted for. protocol with mirror. image sections in the following cassettes: A1: Lymph node 0.7 cm. A2: Skin from lateral edge of ellipse. A3: Tumor lateral. A4: Tumor medial. A5: Grossly normal fibrous tissue approximately 5.0 cm from tumor. Additional representative sections are submitted in cassettes A6 through. A20 as follows: A6-A12: Tumor from medial to lateral in sequential order. A13: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Two possible lymph nodes. A18: Five possible lymph nodes. A19: Three possible lymph nodes. A20: Section of nipple. 20CF'.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The pathologic T stage is based on the largest dimension of the invasive component of the tumor. The provided pathology report mentions that the size of the tumor is 5.2 cm by gross measurement.",
    "BaselineChoice": "T2",
    "Monologue": "Extract tumor size from pathology report, compare with T stage thresholds, apply AJCC Cancer Staging Manual (7th edition) rules, and determine the pathologic T stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of approximately 5.2 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: F. Race: WHITE. Physician (s) : 'AMENDED. SPECIMEN: A: SENTINEL LYMPH NODE #1 B: SENTINEL LYMPH NODE #2. C: RIGHT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE #1, EXCISION: NEGATIVE FOR MALIGNANCY VIA LIGHT MICROSCOR. 1. NEGATIVE FOR MALIGNANCY VIA IMMUNOHISTOCHMICAL STAINS. B. SENTINEL LYMPH NODE #2, EXCISION: NEGATIVE FOR MALIGNANCY VIA LIGHT MICROSCOPY . NEGATIVE FOR MALIGNANCY VIA IMMUNOHISTOCHEMICAL STAINS. C. BREAST, RIGHT, LUMPECTOMY: WELL DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA, BLOOM-RICHARDSON. GRADE 4 (TUMOR SIZE= 2.0 CM) ANCILLARY STUDIES PENDING. DUCTAL CARCINOMA IN SITU, LOW NUCLEAR GRADE, CRIBIFORM PATTERN, LESS. THAN 25% OF TUMOR VOLUME. MARGINS CLEAR OF DUCTAL CARCINOMA IN SITU AND INFILTRATING DUCTAL. CARCINOMA. Comment: The Estrogen and Progesterone receptors are detectable in 40 and 80% of. the tumor nuclei resepctively, by immunohistochemical protocol. CLINICAL DIAGNOSIS AND HISTORY: year-old white female with right breast cancer. Specimen #: GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 received fresh is a piece of red soft tissue,. 3.0 x 1.5 x 0.3 cm, containing at least one lymph node measuring 1.0 cm in. greatest dimension. A small portion of the node is harvested for the CBCP. protocol and submitted in cassette A1. The remainder of the specimen is. submitted entirely in cassette A2. B. SENTINEL LYMPH NODE #2 received fresh, labeled with the patient's name,. designated \"SENTINEL NODE NUMBER TWO\" is a soft, red tissue fragment, 2.3. x 1. 7 x 0.3 cm, containing at least one lymph node, 0.7 cm in greatest. dimension. A small portion of the lymph node is submitted for the CBCP. protocol in cassette B1. C. RIGHT BREAST LUMPECTOMY received fresh, labeled with the patient's. name, designated \"RIGHT BREAST LUMPECTOMY\" is a piece of fibrofatty. tissue, 5.5 x 4.5 x 3.0 cm, with overlying skin ellipse, 3.0 x 0.9 cm. The. specimen is oriented with sutures and inked as follows: Blue=superior,. green=inferior, red=lateral, yellow=medial, black=posterior. Sectioning. reveals a 2.0 cm, well-defined tumor with a tan, gritty cut surface,. approximately 0.2 cm from the superior-deep margin. Sections of skin,. tumor, and fibrous tissue at 1.0 2.0, 5.0 cm increments from tumor are. submitted for the CBCP protocol (matching paraffin sections=C1, C2-C5, C6,. C7, and C8, respectively) .\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to identify the size of the tumor. The pathologic T stage is based on the size and extent of the primary tumor. According to the provided pathology report, the tumor size is given as 2.0 cm. The AJCC Cancer Staging Manual (7th edition) defines the pathologic T stages as follows: T1 - Tumor ≤ 2.0 cm, T2 - Tumor > 2.0 cm but ≤ 5.0 cm, T3 - Tumor > 5.0 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. Since the tumor size in this case is exactly 2.0 cm, it falls into the T1 category. The fact that the margins are clear of both ductal carcinoma in situ and infiltrating ductal carcinoma, and there is no mention of the tumor extending to the chest wall or skin, further supports this classification.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: BLACK. Physician (s) : AMENDED. SPECIMEN: A: RIGHT SENTINEL LYMPH NODE #1. B: LEFT SENTINEL LYMPH NODE #1 C: LEFT BREAST LUMPECTOMY. D: LEFT BREAST FINAL SUPERIOR MARGIN. E: RIGHT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. LYMPH NODE, RIGHT SENTINEL #1, EXCISION: - NEGATIVE FOR MALIGNANCY BY H&E AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. B. LYMPH NODE, LEFT SENTINEL #1, EXCISON: - NEGATIVE FOR MALIGNANCY BY H&E AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. C. BREAST, LEFT, 9:00 POSITION, NEEDLE LOCALIZATION, LUMPECTOMY: - PAPILLARY CARCINOMA IN-SITU WITH SURROUNDING DUCTAL. CARCINOMA IN-SITU, COMEDO TYPE (SEE COMMENT) . - TUMOR SIZE: 1.2 CM (GROSS MEASURMENT). - LOBULAR CARCINOMA IN-SITU, MULTIFOCAL. - DUCTAL CARCINOMA IN-SITU IS PRESENT LESS THAN 1.0 MM FROM SUPERIOR. MARGIN (NOTE: SPECIMEN D, DESIGNATED \"FINAL SUPERIOR MARGIN\" IS. NEGATIVE FOR TUMOR). - MICROCALCIFICATIONS IDENTIFIED IN DUCTAL CARCINOMA IN-SITU AND BENIGN. BREAST TISSUE. D. BREAST, LEFT, FINAL SUPERIOR MARGIN, EXCISON. - BENIGN BREAST TISSUE. - NEGATIVE FOR MALIGNANCY. E. BREAST, RIGHT, 6:00 POSITION, NEEDLE LOCALIZATION, LUMPECTOMY: - INFILTRATING DUCTAL ADENOCARCINOMA, MODERATELY DIFFERENTIATED BY. COMBINED NUCLEAR-HISTOLOGIC GRADE. - MAXIMUM TUMOR DIMENSION 1.8 CM (INVASIVE COMPONENT, MICROSCOPIC. MEASUREMENT). - ASSOCIATED PAPILLARY CARCINOMA AND DUCTAL CARCINOMA IN-SITU,. NUCLEAR GRADE 2 WITH NECROSIS. - LOBULAR CARCINOMA IN-SITU, MULTIFOCAL. Specimen #: FINAL DIAGNOSIS (continued) : - INVASIVE CARCINOMA INVOLVES THE SUPERIOR MARGIN, IS LESS THAN 1.0 MM. FROM THE ANTERIOR MARGIN, AND IS 1.5 MM FROM THE POSTERIOR MARGIN. INTRADUCTAL PAPILLARY CARCINOMA IS PRESENT LESS THAN 1.0 MM FROM. THE POSTERIOR MARGIN. - MICROCALCIFICATIONS IDENTIFIED IN DUCTAL CARCINOMA IN-SITU AND BENIGN. BREAST TISSUE. - AJCC STAGE: pT1 pNO(i-) MX. COMMENT: On interdepartmental review, slide C4 (left breast) shows an area. suspicious for invasive, micropapillary carcinoma. The size of this focus. is 1. 7mm. was notified of this amended diagnosis on. at. HRS by 1. CLINICAL DIAGNOSIS AND HISTORY: year-old female status post core biopsies, bilateral breast consistent. with, on the right, infiltrating ductal carcinoma; on the left DCIS with. cribiform features. GROSS DESCRIPTION: A. RIGHT SENTINEL LYMPH NODE #1 Received fresh, labeled with the patient's S. name, designated \"RIGHT SENTINEL LYMPH NODE #1\". The specimen consists of. a piece of fatty tissue, 3.0 cm x 1.7 cm x 0.2 cm, containing a 1.2 cm. lymph node. A small portion of this node is submitted for the CBCP. protocol. B. LEFT SENTINEL LYMPH NODE #1 Received fresh, labeled with the patient's. name, designated \"LEFT SENTINEL LYMPH NODE #1\". The specimen consists of a. 1.2 cm lymph node. A small portion is submitted for the CBCP protocol. C. LEFT BREAST LUMPECTOMY Received fresh, labeled with the patient's. name, designated \"LEFT BREAST LUMPECTOMY 9:00 POSITION (NEEDLE. LOCALIZATION) \". The specimen consists of a piece of fatty tissue, 9.8 cm x. 5.0 cm x 1.4 cm with an overlying ellipse of brown skin, 2.4 cm x 0.3 cm. A needle localization wire is in place and enters the specimen anteriorly,. Specimen #: GROSS DESCRIPTION (continued) : through the skin. The accompanying radiograph is reviewed and shows a. well-defined density anteriorly. The specimen is oriented with sutures. and. inked as follows: Yellow=medial, red=lateral, blue=superior,. green=superior, black=posterior. Sectioning anterior to posterior reveals. a well-defined, 1.2 cm tan, friable lesion with focal cavitation and. hemorrhage anteriorly. Two sections of this lesion, as well as a section. of skin and grossly normal fibrofatty tissue are submitted for the CBCP. protocol (matching paraffin sections=C2-C4, C1, and C5 respectively). Sections are submitted from anterior to posterior. Slide key: C1: Skin. C2-C4: Tumor. C5: Representative normal. C6-C7: Single representative section. C8-C10: Single representative section. C11-C12: Single representative section. C13: Single representative. section. C14-C16: Single representative section. C11-C16 sections. through the area sampled for CBCP protocol. C17-C18: Representative. section. C20-21: Representative sections. C22: Cassette not submitted. C23-25: Representative sections. D. LEFT BREAST FINAL SUPERIOR MARGIN Received fresh, labeled with the. patient's name, designated \"LEFT BREAST FINAL SUPERIOR MARGIN\". The. unorientated specimen consists of a 4.5 cm x 2.1 cm x 0.5 cm fatty tissue. fragment. Serial sectioning reveals abundant yellow adipose tissue admixed. with a moderate amount of white, dense, interdigitating fibrous tissue. One side is arbitrarily inked in black. E. RIGHT BREAST LUMPECTOMY Received fresh, labeled with the patient's. name, designated \"RIGHT BREAST LUMPECTOMY 6:00\". The specimen consists of. a piece of fatty tissue, 8.5 cm x 4.5 cm x 2.8 cm impaled with a needle. localization wire. A radiograph accompanies the specimen and shows a. vell-defined mass. The specimen is oriented with sutures; per discussion. with Dr. the long stitch indictates lateral and the short stitch. superior. Ink code: Red=medial and lateral, blue=superior, green=inferior,. yellow=anterior, black=posterior. On sectioning, the specimen reveals a. firm, well-defined, tan tumor, 2.2 cm in greatest dimension, closely. approximating the black inked margin. A portion of the tumor appears. tan and friable. One section of tumor and one section of fibrofatty. tissue is submitted for CBCP protocol (matching paraffin sections-E1 and. E2 respectively). Slide key: E1: Tumor. E2: Rest of the fibrofatty tissue. E3-E6: Single. Specimen #: GROSS DESCRIPTION (continued) : representative sections medial to lateral. E7-E10: - Mass. E11-E13 : Sections. through area of E1 mass. E14-E16: Single section of adjacent mass. E17-E19 - Single section of adjacent mass. E20: Representative section. E21: Lateral portion. 21CF.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The key information for determining the T stage is the size of the invasive component of the tumor. According to the provided pathology report, the maximum tumor dimension of the invasive component in the right breast is 1.8 cm (microscopic measurement), and there is also mention of a 1.2 cm tumor in the left breast, but this is described as papillary carcinoma in-situ with surrounding ductal carcinoma in-situ, which does not indicate invasive cancer. However, an amended diagnosis mentions an area suspicious for invasive, micropapillary carcinoma in the left breast, with a size of 1.7 mm. Since the largest invasive tumor size is less than 2 cm, we can rule out T3 (which would require a tumor size greater than 5 cm) and T4 (which involves the chest wall or skin). For T1 and T2 classification, T1 typically refers to tumors 2 cm or less in greatest dimension, and T2 refers to tumors more than 2 cm but not more than 5 cm. Given the information, the invasive tumor in the right breast is 1.8 cm, which fits the criteria for T1 since it's less than 2 cm, and the mention of invasive cancer in the left breast is very small (1.7 mm), also fitting within the T1 criteria. Thus, based on the size of the invasive components, the pathologic T stage for this breast cancer patient would be T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "Tumor sizes are 1.2 cm and 1.8 cm, both less than or equal to 2 cm, with no lymph node involvement.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: F. Race: WHITE. Physician (s) : SPECIMEN: LEFT BREAST MASTECTOMY. FINAL DIAGNOSIS: BREAST, LEFT, MASTECTOMY: INFILTRATING LOBULAR CARCINOMA. - ELL-DIFFERENTIATED BY COMBINED HISTOLOGIC CRITERIA. - SIZE: 9 CM. - ANGIOLYMPHATIC INVASION IDENTIFIED (A12) . - FOCAL DERMAL LYMPHATIC INVOLVEMENT (NIPPLE, SLIDE A8). - TUMOR WITHIN 1 MM OF DEEP MARGIN (A9, A10). - 16 LYMPH NODES IDENTIFIED, ALL NEGATIVE FOR MALIGNANCY. - AJCC STAGE IIB (T3 NO MX). - FOCAL LOBULAR CARCNOMA IN SITU (A5) . - INTRADUCTAL HYPERPLASIA, FLORID. - FIBROCYTSTIC CHANGES. COMMENT: Hormone receptor and HER2 studies previously reported. CLINICAL DIAGNOSIS AND HISTORY: -year-old female with breast carcinoma, left. GROSS DESCRIPTION: LEFT BRFAST MASTECTOMY received fresh, labeled with the patient's name,. designated \"LEFT BREAST AND AXILLARY CONTENTS\" consists. of a 1,044.0 gram modified radical mastectomy specimen. It measures 20.5. cm medial to lateral, 20.0 cm superior to inferior, 4.5 cm anterior to. posterior, with an attached axillary tail, 11.0 x 7.0 x 3.7 cm, and an. overlying ellipse of nipple bearing skin, measuring 18. x 9.5 cm. The. nipple is inverted and the skin is otherwise unremarkable. Ink code: Blue=superior superficial, green=inferior superficial, black=deep. Sectioning reveals a poorly defined, indurated mass in the upper inner. quadrant focally abutting the deep margin. Continuous with this lesion and. extending laterally to the outer portion of the breast is a broad area of. Specimen # : GROSS DESCRIPTION (continued). variably indurated fibrous tissue (overall maximum dimension of mass plus. indurated fibrous tissue = 9.0 cm) . Multiple sections are harvested for. the. protocol with matching paraffin sections as follows : A1: Skin (medial tip). A2: Lymph node, 1.8 cm, mid/upper axillary tail. A3: Tumor, upper inner quadrant. A4: Indurated fibrous tissue (5.0 cm from medial extent of tumor). central. A5: Indurated fibrous tissue (7.0 cm from medial extent of tumor) ,. central. A6: Indurated fibrous tissue (9.0 cm from medial extent of tumor) ,. mid center. A7: Grossly normal fibrofatty tissue, lower outer quadrant. Sectioning through the axillary tail reveals 14 possible lymph nodes. ranging in size from 0.2 cm to 3.0 cm in greatest dimension. Additional. representative sections are submitted in cassettes A8 through A22, as. follows: A8: Nipple. A9-A11: Mass upper inner quadrant . A12: Centralized fibrous area. Al3: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Five possible lymph nodes. A18: Five possible lymph nodes. A19: Two possible lymph nodes, largest lymph node bisected and submitted. in its entirety. A20: One lymph node bisected and submitted in its entirety. A21-A22: One lymph node bisected and submitted in its entirety in two. cassettes. 22CF.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extension to nearby tissues. The key information from the pathology report includes: \\\\n1. **Tumor Size**: The report mentions that the overall maximum dimension of the mass plus indurated fibrous tissue is 9.0 cm. This size is crucial for determining the T stage. \\\\n2. **Extension and Involvement**: The tumor is described as being within 1 mm of the deep margin, and there is focal dermal lymphatic involvement. However, these factors are more relevant to assessing the potential for local spread rather than the T stage itself, which primarily focuses on tumor size and chest wall or skin involvement. \\\\n3. **AJCC Staging Manual (7th edition) Criteria for T Stage**: \\\\n  - T1: Tumor ≤ 2 cm \\\\n  - T2: Tumor > 2 cm but ≤ 5 cm \\\\n  - T3: Tumor > 5 cm \\\\n  - T4: Tumor of any size with direct extension to the chest wall or skin \\\\nGiven the tumor size is 9.0 cm, which exceeds 5 cm, we can directly apply the AJCC criteria to determine the T stage without needing to consider the chest wall or skin involvement for T4 classification in this context, as the size itself dictates the T stage. \\\\n**Conclusion**: Based on the tumor size being greater than 5 cm, the pathologic T stage for this breast cancer patient is T3, according to the AJCC Cancer Staging Manual (7th edition).",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer based on the provided pathology report, I need to extract relevant information such as tumor size, depth of invasion, and presence of lymph node involvement. Then, I will apply the AJCC Cancer Staging Manual (7th edition) rules to determine the appropriate T stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor has extended beyond the outer layer of the organ or has invaded nearby tissues or structures, but has not spread to distant parts of the body.",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: F. Race: WHITE. Physician (s) : AMENDED. SPECIMEN: A: INTERPECTORAL NODE B: LEFT BREAST AND AXILLARY CONTENTS. FINAL DIAGNOSIS: A. LYMPH NODE, LEFT INTERPECTORAL, EXCISION: - METASTATIC DUCTAL CARCINOMA WITH EXTRACAPSULAR EXTENSION. SIZE OF DEPOSIT: 0.6 CM. EXTENT OF EXTRANODAL TUMOR: 4 MM (See comment;. ONE LYMPH NODE EXAMINED. B. BREAST AND AXILLARY CONTENTS, LEFT, MASTECTOMY WITH REGIONAL LYMPH NODE. DISSECTION: INVASIVE DUCTAL CARCINOMA, WELL DIFFERENTIATED (NOTTINGHAM SCORE 5). TUBULE FORMATION 20% = 2. NUCLEAR PLEOMORPHISM = 2. MITOSES 9 per 10 HPF AT 40X FIELD AREA 0.2376 SQ. MM = 1. - INVOLVING THE DERMIS, EPIDERMIS, AND NIPPLE; WITH ULCERATION. - SIZE = 7.0 CM (GROSS DIMENSION). - DEEP (SKELETAL MUSCLE) MARGIN IS INVOLVED BY TUMOR. - LYMPH VASCULAR AND PERINEURAL INVASION IS IDENTIFIED. - SEVEN OF ELEVEN EXAMINED LYMPH NODES WITH METASTATIC CARCINOMA;. EXTRACAPSULAR EXTENSION IS PRESENT, EXTENT OF EXTRANODAL TUMOR : AT LEAST 6 MM (See comment;. MAXIMUM DIMENSION OF LARGEST DEPOSIT: 1.8 CM. - AJCC CLASSIFICATON pT4b (ulceration) N2aMX. COMMENT: The report is amended on. to add the extent of extracapsular. extension of tumor in response to a request from the tumor board. The. measurement is the distance from the estimated location of the obliterated. lymph node capsule to the outer extent of the tumor deposit on the. microscopic slide. FOR OFFICIAL USE ONLY - PERSONAL DATA. Specimen #: FINAL DIAGNOSIS (continued) : I. CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with left breast cancer. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. POST-OPERATIVE DIAGNOSIS: Operative Findings Left breast cancer. Post-Operative Diagnosis: Left breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \" INTERPECTORAL NODE\" consists of an apparent lymph node,. measuring 1.3 x 0.9 x 0.6 cm. The node is bisected revealing firm, yellow. and tan tissue. One half of the specimen is submitted for the CBCP. protocol. The remaining half is submitted for permanent section. B. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST AND AXILLARY CONTENTS\" consists of a 508.0 gram. modified radical mastectomy specimen. The breast measures 17.5 x 14. 5 x. 3.8 cm, attached axillary contents measure 13.0 x 5.2 x 1.5 cm, and. overlying nipple-bearing skin measures 13.0 x 9.5 cm. INK CODE: Blue=superior superficial, green=inferior superficial, and. black=deep. The axillary contents are examined and disected from the breast and has. multiple palpable lymph nodes, many of which are suspcious for metastasis. A large portion of the skin is covered with gauze dressing, which is. removed, revealing areas of retraction and ulceration (largest 2.2 x 1.6. cm) superior to the nipple/areolar complex, overlying a large palpable. tumor. The breast is sectioned from the posterior aspect revealing a 7.0 x 5.1 x. 3.5 cm tumor, which anteriorly erodes through the skin and posteriorly. involves a 3.0 x 2.5 cm segment of skeletal muscle. The tumor is. centrally-located and extends into the upper mid and upper inner portions. of the breast. It has a firm, tan, gritty cut surface. The remaining. Specimen # : GROSS DESCRIPTION (continued) : breast tissue is predominantly fatty and unremarkable Multiple sections. are submitted for the CBCP protocol with matching paraffin sections as. follows: B1: Lymph node, lower portion of axillary tail, 1.8 x 1.7 x 1.3 cm. B2: Grossly normal lymph node, mid upper portion of tail. B3: Grossly normal skin (medial tip). B4: Skin with underlying tumor. B5: Skeletal muscle with tumor. B6: Tumor, medial aspect. B7: Tumor, lateral aspect. B8: Grossly normal fibrous tumor, inferior to tumor. B9: LIQ, 3.5 cm from tumor. B10: LOQ, 4.0 cm from tumor. B11: UOQ, 3.5 cm from tumor. B12: UIQ, 2.0 cm from tumor. B13: : Nipple. B14-B17: One lymph node, bisected, in each cassette. B18: Five potential lymph node candidates. 18CFSS.\n        ",
    "Answer": 3,
    "Filename": "TCGA-A2-A0CS.A985FB5C-9E91-40E1-864E-CEA887B3866D",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report. The key details for determining the T stage include the size of the tumor and whether it has invaded nearby tissues or structures. Here's the step-by-step analysis:\\adminisStep 1: Identify the size of the tumor. The report states that the size of the tumor is 7.0 cm (gross dimension). This information is crucial because the T stage is partly determined by the tumor's size.\\adminisStep 2: Determine if the tumor has invaded nearby structures. The report mentions that the tumor involves the dermis, epidermis, and nipple, with ulceration. This indicates that the tumor has grown through the skin, which is an important factor for staging.\\adminisStep 3: Assess if the tumor has invaded the chest wall or skin. The report specifies that the tumor anteriorly erodes through the skin and posteriorly involves a segment of skeletal muscle. This invasion of the skin and muscle is critical for determining the T stage.\\adminisBased on these details, we can apply the AJCC Cancer Staging Manual (7th edition) criteria for T staging:\\adminis- T1: Tumor ≤ 2 cm\\adminis- T2: Tumor > 2 cm but ≤ 5 cm\\adminis- T3: Tumor > 5 cm\\adminis- T4: Tumor of any size with direct extension to the chest wall or skin, including ulceration or skin nodules.\\adminisGiven that the tumor is 7.0 cm in size and has eroded through the skin with ulceration, it meets the criteria for T4 due to the direct extension to the skin, regardless of its size. The presence of ulceration and the tumor's extension into the skin place it in the T4 category.\\adminisTherefore, the pathologic T stage for this breast cancer, according to the AJCC Cancer Staging Manual (7th edition), is T4.",
    "BaselineChoice": "T4",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules), and there is ulceration of the skin.",
    "Choice": "T4"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: )F Race: WHITE. SPECIMEN: A: SENTINEL LYMPH NODE#1 B: SENTINEL LYMPH NODE #2. C: RIGHT BREAST. FINAL DIAGNOSIS: A. RIGHT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY: ONE LYMPH NODE NEGATIVE FOR TUMRO BY H&E AND IMMUNOHISTOCHEMISTRY. B. RIGHT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY: ONE LYMPH NODE NEGATIVE FOR TUMRO BY H&E AND IMMUNOHISTOCHEMISTRY. C. RIGHT BREAST, MASTECTOMY: INFILTRATING DUCTAL CARCINOMA, WELL DIFFERENTIATED BY COMBINED. HISTOLOGIC CRITERIA (TUBULES- - 2; NUCLEAR GRADE- 2; MITOTIC RATE- 1). -MAXIMUM TUMOR SIZE: 2.4 CM, MEASURED GROSSLY. -DUCTAL CARCINOMA IN SITU, SOLID, CRIBRIFORM, AND MICROPAPILLARY. TYPES, NUCLEAR GRADE 2, WITH FOCAL NECROSIS, COMPRISING 10% OF. TUMOR. - -NO LYMPH VASCULAR OR PERINEURAL INVASION. -MARGINS NEGATIVE FOR TUMOR. -AJCC STAGE pT2NOMX. CLINICAL DIAGNOSIS AND HISTORY: new pleo calcifications. PRE-OPERATIVE DIAGNOSIS: r/o dcis. POST-OPERATIVE DIAGNOSIS: Operative Findings same. Post-operative Diagnosis: same. Specimen #: GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #1\" and consists of a 0.7 x 0.7 x 0.4 cm. lymph node. One half of the node is submitted for the CBCP protocol. The. remainder is submitted in cassette A1. B. Received in formalin, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #2\" and consists of a 2.0 x 1.3 x 0.4 cm. fragment of fatty tissue containing a 0.2 cm lymph node. The specimen is. bisected and submitted in its entirety for paraffin section in one. cassette. C. Received fresh, labeled with the patient's name,. designated. \"RIGHT BREAST ONE TAG MEDIAL, TWO TAGS SUPERIOR\" and consists of a 505.0. gram simple mastectomy specimen, measuring 19.7 cm superior to inferior,. 19.8 cm medial to lateral, and 2.2 cm anterior to posterior. The overlying. ellipse of nipple bearing skin measures 10.5 x 5.2 cm, which is tagged for. its abnormalities Ink code: Superior superficial=blue, inferior. superficial=orange, deep=black. Sectioning reveals a 2.4 x 2.4 x 1.7 cm. ell-circumscribed, tan tumor in the central portion of the upper outer. quadrant, 0.6 cm from the deep margin. The tumor is surrounded by dense. fibrous tissue, which extends medially to the inner portions of the. breast. Within this fibrous tissue in the central portion of the breast. (1.0 to 2.0 cm from the tumor and 1.5 cm from the deep margin) is a 0.7. cm. Mammomark site without associated mass. Representative sections are. submitted in 13 cassettes as follows. C1: Skin, lateral tip. C2: Tumor, upper outer quadrant. C3: Tumor with deep margin upper outer quadrant . C4: Tumor with deep margin upper outer quadrant. C5: Fibrous tissue immedial medial to tumor. C6: Mammomark biopsy site. C7: Mammomark biopsy site. C8: Deep margin underlying Mammomark site. C9: Random fibrous tissue lower inner quadrant . C10: Random fibrous tissue upper inner quadrant. C11: Random fibrofatty tissue upper outer quadrant peripheral. C12: Random fibrofatty tissue lower outer quadrant. C13: Cross section of nipple. Specimen #: GROSS DESCRIPTION (continued) : Mirror images of the following sections are submitted for the CBCP. protocol: C1, C2, C3, C5, C6, C7, C9, C10, C11, and C12.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CT.FDF38AA6-DC65-4043-8277-71BAE47902B1",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the pathology report, the maximum tumor size measured grossly is 2.4 cm. This size falls into the category of T2, as it is greater than 2 cm but less than or equal to 5 cm. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "I need to determine the pathologic T stage for breast cancer based on the provided pathology report. I will extract the relevant information from the report, compare the tumor size to the AJCC Cancer Staging Manual (7th edition) criteria, and then apply the T-staging rules to determine the final stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The maximum tumor size is 2.4 cm, which falls within the criteria for T2 according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 B: RIGHT BREAST TISSUE Site: breast, NOS C50.9. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, EXCISION: - ISOLATED TUMOR CELLS IDENTIFIED. - SEE COMMENT. B. BREAST, RIGHT, SIMPLE MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED. (MODIFIED. BLOOM RICHARDSON T=3, N=2, M1). - TUMOR IS PRESENT WITHIN 0. CM OF INFERIOR-ANTERIOR MARGIN (B19). - TUMOR DIMENSION (GREATEST) : 3.4 CM. - NO DEFINITIVE LYMPH-VASCULAR INVASION IDENTIFIED. - FIBROCYSTIC CHANGES INCLUDING STROMAL SCLEROSIS, CYST FORMATION,. AND APOCRINE METAPLASIA. - NIPPLE WITH NO SIGNIFICANT PATHOLOGICAL CHANGES. - AJCC PATHOLOGIC STAGE: pT2, pNO (i+), Mx. COMMENT: Isolated tumor cells and clusters (less than 0.2 mm in dimension) are. identified in the lymph node capsule on H&E examination and confirmed by. a positive pancytokeratin immunohistochemical stain. CLINICAL DIAGNOSIS AND HISTORY: year-old female with right breast cancer. Specimen #: GROSS DESCRIPTION: A. Received in formalin, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #1\" is a 2.0 x 1.0 x 0.5 cm. yellow-white, soft tissue fragment. Bisected. B. Received in fresh, labeled with the patient's name,. designated \"RIGHT BREAST TISSUE\" is a 441.0 gram, simple mastectomy. specimen, oriented with sutures (short superior, long lateral) measuring. 20.0 x 15.5 x 3.2 cm. The overlying nipple/areolar complex measures 3.4 x. 2.5 cm. Ink code: blue = superior-anterior, green = inferior-anterior,. black = posterior. Sectioning reveals a 3.4 x 2.7 x 2.5 cm tumor with. firm, tan, focally hemorrhagic cut surface in the lower outer quadrant. The tumor grossly involves the anterior margin, and is approximately 2.0. cm from the posterior margin. The remaining tissue is mostly fatty with. admixed patches of white, fibrous tissue. This tissue is centrally. adjacent to the tumor. Multiple tissue sections submitted for CBCP. protocol with matching paraffin sections as follows: Slide key. B1: Skin. B2: Tumor with anterior margin. B3 : Tumor with anterior margin. B4 : Grossly normal fibrous, central, 2.0 cm from the tumor. B5: : Representative nipple. B6-B7: Representative upper outer quadrant. B8-B9: Representative lower outer quadrant . B10-B11: - : Representative upper inner quadrant. B12-B13 - : Representative lower inner quadrant. B14-B15 - : Representative tumor. B16-B19 : Representative tumor. 19CF.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CU.D503E73D-8B94-46A0-A24F-93069A56DC7D",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is based on the largest dimension of the invasive tumor. The provided pathology report gives us the necessary information to make this determination. The key points from the report are: 1) The tumor dimension (greatest) is 3.4 cm. 2) The tumor is described as an infiltrating ductal carcinoma, moderately differentiated, with no definitive lymph-vascular invasion identified. 3) The tumor is present within 0 cm of the inferior-anterior margin, indicating close proximity to the margin but not explicitly stating invasion through the margin. According to the AJCC Cancer Staging Manual (7th edition), the T stages are defined as follows: - T1: Tumor >0.1 cm but =2 cm in greatest dimension. - T2: Tumor >2 cm but =5 cm in greatest dimension. - T3: Tumor >5 cm in greatest dimension. - T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Given the information that the tumor's greatest dimension is 3.4 cm, which falls into the category of >2 cm but =5 cm, we can determine the pathologic T stage.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, compare numerical values, and apply T-staging rules according to the AJCC Cancer Staging Manual (7th edition). I will use the extract_information tool to gather data, compare_numerical_values to analyze the tumor size, and get_t_stage_rule to determine the final T stage. Finally, I will call produce_final_staging_response to format my response.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.4 cm, which falls within the criteria for T2 according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: F. Race: ASIAN - PACIFIC ISLANDERTaken: Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 LEFT. B: NON SENTINEL LYMPH NODE LEFT. C: LEFT BREAST AND AXILLARY CONTENT. FINAL DIAGNOSIS: A-C. TUMOR BREAST, TYPE: LEFT, MASTECTOMY WITH AXILLARY AND SENTINEL LYMPH NODES. INVASIVE (70-80% intraductal DUCTAL CARCINOMA WITH AN EXTENSIVE INTRADUCTAL COMPONENT. NOTTINGHAM SCORE: 6. NOTTINGHAM GRADE: GRADE tumor II (MODERATELY largely intermixed DIFFERENTIATED) with invasive). TUMOR TUMOR (Tubules= NECROSIS: SIZE (GREATEST 2, Nuclei= NOT IDENTIFIED. DIMENSION) 3, Mitoses= : 4.1 1; CM mitotic (MEASURED count GROSSLY) <1 per 10 HPF). MICROCALCIFICATIONS. MARGINS LYMPHATIC INVASION: PRESENT. VENOUS PRESENT / IN INVASIVE AND IN SITU TUMOR AND IN BENIGN DUCTS. NEGATIVE. NEAREST NEAREST MARGIN, MARGIN, IN-SITU INVASIVE TUMOR: TUMOR: 2.5 MM (DEEP, SLIDE C6). INTRADUCTAL NUCLEAR GRADE: COMPONENT: 3 DUCTAL CARCINOMA 3 MM (DEEP, IN SITU, SLIDE CRIBRIFORM C6) TYPE. LYMPH ONE - NODES: (1) SENTINEL METASTASIS LYMPH IN NODE TWO (SPECIMEN OF EIGHTEEN A) : (2/18) POSITIVE EXAMINED LYMPH NODES. EXTRANODAL EXTENSION: PRESENT, 4 MM. ONE (1) LYMPH NODE (SPECIMEN C, LOW, C12) : POSITIVE. NIPPLE IDENTIFIED. - EXTENSION: PRESENT, 1 MM. SKIN IDENTIFIED. MULTICENTRICITY: NOT. EXTRANODAL INVOLVEMENT: INVOLVEMENT: NOT NOT PRESENT. ESTROGEN, PREVIOUSLY PROGESTERONE RECEPTOR STATUS AND HER 2 NEU WERE REPORTED. IN SURGICAL. ADDITIONAL PATHOLOGIC COLUMNAR pT2N1aMX CHANGES: CASE. STAGE: PATHOLOGIC. SCLEROSING ADENOSIS. CELL CHANGE WITH ATYPIA. FIBROCYSTIC CHANGES, USUAL DUCTAL HYPERPLASIA, FIBROADENOMA. MMENT. Specimen #: FINAL DIAGNOSIS (continued) : The earlier report,. of a core biopsy indicates hormone receptors. are POSITIVE (100% strong staining for both estrogen and progesterone. receptors) and Her2 by immunihistochemistry is NEGATIVE (1+). CLINICAL DIAGNOSIS AND HISTORY: year old with left breast 4 X 4 cm mass in left upper outer quadrant. detected with 1cm lymph node. PRE-OPERATIVE DIAGNOSIS: left breast cancer. POST-OPERATIVE DIAGNOSIS: same. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE: LYMPH NODE. REPORTED TO: DR. REPORTED BY: DR. # BLOCKS: 2. # SCRAPE PREPS 2. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received fresh for intraoperative consultation labeled with patient's. designated \"SENTINEL NODE #1 COUNT 104\" consists of a 1.0 x. 0. 8 x 0.5 cm very firm lymph node with homogeneous yellow tan cut surface. Touch preps are prepared. Half of node submitted for CBCP protocol and. remaining half submitted for paraffin section. B. Received fresh labeled with the patient's name. designated. NON-SENTINEL LYMPH NODE LEFT\" is tan pink soft tissue measuring 0.7 x 0.5. x. 0.2 cm. The presumed lymph node is bisected and submitted entirely. Received fresh labeled with patient's name. designated \"BREAST. Specimen #: GROSS DESCRIPTION (continued) : AND AXILLARY CONTENTS\" consists of 380 gram left mastectomy oriented with. single stitch medial, two stitches superior, stitch on highest axillary. portion. Specimen measures 23 cm medial to lateral 15 cm superior to. inferior, 3 cm anterior to posterior. Attached skin ellipse displays a. centrally located everted nipple measuring 1 cm. No discharge is. identified. No scars are identified. There is a well-defined pink white firm gritty mass in the left outer. quadrant measuring 4.1 x 3.5 x 1.5 cm. Tissue surrounding the mass is. remarkably nodular and firm with possible superior extension of primary. lesion to approximately 5 cm (C4) Focal hemorrhage consistent with. previous biopsy is also noted. Remaining quadrants are also composed of. remarkably nodular focally indurated dense fibrous tissue. No additional. masses identified. Fatty tissue comprises 20% of specimen and is. unremarkable. The attached axillary tail measures 9 x 3.5 x 1.5 cm. Sectioning reveals. sixteen lymph nodes ranging from 0.5 x 0.7 cm in greatest dimension. Sectioning of lowest lymph node shows a firm pink white cut surface with. possible involvement by lesion. INK KEY. blue superficial. black: deep. SUMMARY OF SECTIONS: C1: skin. C2: lower outer quadrant mass. C3: margin of C2. C4: possible extension of tumor. C5 : margin of C4. C6: mass with deep margin. C7: additional mass. C8: lower outer quadrant. C9: upper outer quadrant. C10: upper inner quadrant. C11: lower inner quadrant. C12: one low lymph node. C13: two low bisected lymph nodes, one inked blue. C14: three low lymph nodes. C15: one high lymph node. C16: two high lymph nodes bisected, one blue. C17: one high lymph node intact. Matched sections of C1 C7-C12 and C15 are submitted in OCT for CBCP. rotocol. Specimen #: GROSS DESCRIPTION (continued) : C18 : nipple. C19: mass with deep margin. C20 : : mass with deep and superficial margin. C21: six additional lymph nodes. 21CF.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CV.FBDDD9EE-0A5C-4CAB-9EB3-48B6431A9A84",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to understand what each T stage represents and then apply that to the information provided in the pathology report.\"Yeah T1: Tumor is 2 cm or less in greatest dimension.\"Yeah T2: Tumor is more than 2 cm but not more than 5 cm in greatest dimension.\"Yeah T3: Tumor is more than 5 cm in greatest dimension.\"Yeah T4: Tumor of any size with direct extension to the chest wall or skin.\"Yeah The pathology report describes a well-defined pink-white firm gritty mass in the left outer quadrant measuring 4.1 x 3.5 x 1.5 cm. This measurement indicates the size of the tumor. Based on the AJCC Cancer Staging Manual (7th edition), a tumor that is more than 2 cm but not more than 5 cm in greatest dimension is classified as T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report, such as tumor size and presence of skin or chest wall involvement.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "The tumor size is larger than 2 cm but not larger than 5 cm, with skin involvement and no chest wall involvement, as per AJCC Cancer Staging Manual (7th edition) criteria.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: F Race: WHITE. Physician( (s) : 3. SPECIMEN: A: SENTINEL LYMPH NODE #1 B: NON-SENTINEL - LYMPH NODE. C: RIGHT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL, EXCISION: ONE (1) SENTINEL LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA WITH. THE LARGEST FOCUS MEASURING 0.4 CM. - TUMOR IDENTIFIED IN THE PERINODAL SOFT TISSUE. B. LYMPH NODE, NON-SENTINEL, EXCISION: ONE (1) LYMPH NODE COMPLETELY REPLACED BY METASTATIC CARCINOMA. MEASURING 1.5 CM. EXTRANODAL EXTENSION CANNOT BE ASSESSED DUE TO LACK OF PERINODAL. SOFT TISSUE. C. BREAST. RIGHT, LUMPECTOMY: - INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. - -NOTTINGHAM SCORE: 9/9 (TUBULES=3, NUCLEI=3, MITOSES=3). - TUMOR SIZE: 2.7 CM (MEASURED GROSSLY). - TUMOR NECROSIS: ABSENT. - MICROCALIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: PRESENT. - INVASIVE TUMOR INVOLVES THE SMOOTH MUSCLE OF THE NIPPLE. - MARGINS: NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.6 CM,. FROM NEAREST (SUPERIOR) MARGIN. - INTRADUCTAL COMPONENT DUCTAL CARCINOMA IN SITU, SOLID TYPE,. NUCLEAR GRADE II, WITH NECROSIS (<5% OF TUMOR). - ESTROGEN RECEPTORS, PROGESTERONE RECEPTORS, AND HER 2 NEU. PERFORMED ON PREVIOUS SPECIMEN (SEE COMMENT). - PATHOLOGIC STAGE: pT2 N1a MX. - ADDITIONAL PATHOLOGIC CHANGES: PRIOR BIOPSY SITE CHANGES. COMMENT: E. Hormone receptors performed on previous biopsy. and are as. follows: - Estrogen Receptor: Positive (approximately 100% nuclear staining). - Progesterone Receptor: Positive (25% nuclear staining). - ER-2-NEU - Postive (3+, strongly positive). Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: year old female with right breast invasive cancer. PRE-OPERATIVE DIAGNOSIS: Right breast invasive cancer. POST-OPERATIVE DIAGNOSIS: Right breast invasive cancer. GROSS DESCRIPTION. A. Received fresh labeled with patient's name. designated \"SENTINEL LYMPH NODE\" is a 1.5 x 0.5 x 0.3 cm lymph node with. attached fibrous fatty tissue. Specimen is bisected and entirely submitted. in cassette one. B. Received fresh labeled with patient's name. designated 'NON-SENTINEL LYMPH NODE\" are two irregular portions of. presumed previously intact lymph node each measuring 1.5 x 1.5 x 0. 1 cm. Sectioning reveals uniform tan and whtie cut surface. Specimen entirely. submitted in three cassettes as follows. B1-B2: first portion of node (match of B1 submitted in OCT for CBCP. protocol). B3: remaining portion of lymph node. C. Received fresh labeled with patient's name. designated \"RIGHT BREAST LUMPECTOMY\" consists of an irregular portion of. fibrofatty tissue oriented with single stitch medial and two stitches. superior. The specimen measures 10 cm medial to lateral, 7 cm anterior to. posterior and 3 cm superior to inferior. Superficial surface displays an 8. x 4 cm lightly pigmented skin ellipse with centrally located fimr inverted. nipple. No discharge or scar is identified. Specimen is inked as follows : superior blue, inferior green, medial red, lateral yellow, posterior. black. Serial sections reveal well defined 2.7 x 2.7 x 2.2 cm firm pink. white gritty mass subadjacent to and involving the nipple. Surrounding. breast tissue is fibrofatty and otherwise unremarkable. Cassette key. Specimen # : GROSS DESCRIPTION (continued). C1: mass. C2: normal fibrous 1 cm away. C3: normal skin. C4: : nipple with mass. C5-C10: representative sections of presumed mass with close proximity to. margin. C11: medial margin. C12: lateral margin. 12CM.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. In the provided pathology report, the key information regarding the tumor size is: 'TUMOR SIZE: 2.7 CM (MEASURED GROSSLY)'. This measurement directly corresponds to the criteria for determining the T stage. Since the tumor size is 2.7 cm, which is greater than 2 cm but less than or equal to 5 cm, it falls into the T2 category. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size of 2.7 cm, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "I need to extract the relevant information from the pathology report, such as tumor size and lymph node involvement, to determine the pathologic T stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.7 cm corresponds to a T2 stage based on the pathology report.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : AMENDED. SPECIMEN: A: LEFT BREAST TISSUE B: SENTINEL NODE LEFT AXILLARY. FINAL DIAGNOSIS: A. BREAST, LEFT, EXCISIONAL BIOPSY. - INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE. -NOTTINGHAM GRADE: III/III, POORLY DIFFERENTIATED. -NOTTINGHAM SCORE: 8/9 (TUBULES=3, MITOSES=2, NUCLEI=3). -TUMOR SIZE: 3.1 CM (MEASURED GROSSLY, SEE COMMENT) . - TUMOR NECROSIS: ABSENT. - -MICROCALCIFICATIONS: ABSENT. - LYMPHVASCULAR INVASION: NO UNEQUIVOCAL INVOLVEMENT. -MARGINS: : NEGATIVE. - INTRADUCTAL COMPONENT: LESS THAN 25%, WITH PROMINENT CANCERIZATION. OF THE LOBULES (SEE COMMENT). -LYMPH NODES : TWO NODES NEGATIVE FOR TUMOR (ONE SENTINEL, ONE WITH. THE BREAST BIOPSY ITSELF, SEE COMMENT) . -MULTICENTRICITY: ABSENT. -ESTROGEN RECEPTORS : POSITIVE (>10%). - PROGESTERONE RECEPTORS : NEGATIVE. -HER 2 NEU BY IHC: POSITIVE (3+). - -PATHOLOGIC STAGE: pT2 NO MX. -AJCC STAGE: IN THE ABSENCE OF METASTASES : IIA. B. SENTINEL LYMPH NODE, LEFT AXILLARY, EXCISION: -ONE LYMPH NODE NEGATIVE FOR MALIGNANCY. - IMMUNOHISTOCHEMICAL MARKER FOR CYTOKERATIN CONFIRMS THIS NODE. IS NEGATIVE FOR MALIGNANCY. COMMENT: The there tumor, is cancerization measured grossly, of the is lobules 3.1 cm which in greatest extends dimension. up to 1.5 However cm beyond. the grossly recognizable mass of invasive tumor. ER, PR and Her 2 studies were performed on the previous core biopsy,. the results are copied into this report, but these studies. lave not been repeated. Specimen #: FINAL DIAGNOSIS (continued) : Two lymph nodes are identified, both negative for malignancy. One lymph. node is present in the breast parenchyma and is the nodule identified. grossly near the inferior margin. The second one is the sentinel node in. specimen \"B\". This case has undergone intradepartmental review and the above diagnosis. has been agreed upon. CLINICAL DIAGNOSIS AND HISTORY: year old white female with left breast cancer. GROSS DESCRIPTION: A. Received fresh labeled with patient's name. designated. \"LEFT BREAST LONG STITCH LATERAL, DOUBLE STITCH DEEP, SHORT STITCH. SUPERIOR\" is a 230 gram irregular portion of breast tissue oriented. as follows short suture superior, long lateral and double deep. The. specimen measures 1.0 cm medial to lateral, 10.5 cm superior to inferior,. and 5.0 cm anterior to posterior and is inked as follows: superior. blue, inferior green, lateral yellow, medial red, anterior orange,. posterior black. Serial sectioning reveals a 2.7 x 3.1 x 2.5 cm centrally. located pink white firm gritty mass with well defined borders and comes. closest to the anterior margin (1. 0 cm). A second well circumscribed. tan white fibrous mass is noted at the inferior margin measuring 1. 1 x 0.9. x approximately 0.8 cm and comes to within approximately 0.4 cm of the. inferior green margin and comes to within 0.2 cm of the lateral yellow. margin. This mass is located approximately 1.2 cm from the larger mass. Remainder of cut surface is composed primarily of lobulated adipose tissue. admixed with scant fibrous tissue. No additional lesions identified. Representative sections submitted as follows: A1: mass and adjacent normal. A2: mass and adjacent normal. A3: normal, 1.0 cm from mass. Matched sections of A1-A3 and fresh/frozen tumor submitted for CBCP. protocol. Additional sections. A4- A5 inferior margin. A. Specimen #: GROSS DESCRIPTION (continued) : A6-A8 small nodule inferior margin. A9-A10: tissue from same plane sectioned in A2. All next plane of tissue. A12-A14: tissue from same plane as A1. A15: superior margin. 15CF. B. Received fresh labeled with patient's name. designated. \" SENTINEL LYMPH NODE LEFT AXILLARY\" consists of a single 1.0 x 0.8 x 0.4. cm pink tan lymph node with attached adipose tissue. Specimen is bisected. and one half submitted in B1 and remaining half submitted for CBCP. protocol.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the tumor size as described in the pathology report. The T stage is primarily based on the size of the tumor and whether it has spread to the chest wall or skin. Here's the step-by-step reasoning:\\n1. **Identify the Tumor Size**: The report mentions that the tumor size is 3.1 cm, as measured grossly. This measurement is crucial for determining the T stage.\\n2. **Understand T Staging Criteria**:\\n   - **T1**: Tumor is 2 cm or less in greatest dimension.\\n   - **T2**: Tumor is more than 2 cm but not more than 5 cm in greatest dimension.\\n   - **T3**: Tumor is more than 5 cm in greatest dimension.\\n   - **T4**: Tumor of any size with direct extension to the chest wall or skin.\\n3. **Apply the Criteria to the Given Tumor Size**: Since the tumor is 3.1 cm in its greatest dimension, it falls into the category of being more than 2 cm but not more than 5 cm.\\n4. **Conclusion**: Based on the tumor size (3.1 cm), the pathologic T stage for this breast cancer is T2, as it is more than 2 cm but not more than 5 cm in greatest dimension.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report, compare numerical values where necessary, and apply the appropriate T-staging rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.1 cm, which falls within the criteria for T2 according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST B: LEFT BREAST C: SENTINEL LYMPH NODE #1. D: LEFT AXILLARY CONTENTS E: NON SENTINAL , ,LT AXILLARY L.N. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - BENIGN BREAST TISSUE WITH FIBROCYSTIC CHANGES INCLUDING SCLEROSIS,. MICROCYST FORMATION, USUAL DUCTAL HYPERPLASIA, DUCT ECTASIA, AND. FOCAL MICROCALCIFICATION . B. BREAST, LEFT, MASTECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: III/III. NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3). TUMOR SIZE (GREATEST DIMENSION OF INVASIVE COMPONENT) : 3.5 CM. (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT. VENOUS / LYMPHATIC INVASION: IDENTIFIED. MARGINS : - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.4 CM, FROM THE. SUPERFICIAL LOWER OUTER QUADRANT (BLUE INK) MARGIN. INTRADUCTAL COMPONENT: MULTIFOCAL, HIGH GRADE, SOLID AND COMEDO TYPE. EXTENDING WELL BEYOND THE INVASIVE COMPONENT. NIPPLE INVOLVEMENT: NOT IDENTIFIED. LYMPH NODES 1 OF 22 POSITIVE FOR TUMOR (PARTS C-E). SKIN INVOLVEMENT: NOT IDENTIFIED. ESTROGEN RECEPTORS : POSITIVE (STRONG, >75% OF CELLS, FROM. HER 2 NEU by IHC: NEGATIVE (1+ STAINING, FROM. PROGESTERONE RECEPTORS: NEGATIVE (WEAK, <5% OF CELLS, FROM. PATHOLOGIC STAGE: pT2 N1 MX. ADDITIONAL PATHOLOGIC CHANGES: FIBROCYSTIC CHANGES INCLUDING MICROCYST. FORMATION, FOCAL DUCT ECTASIA, SCLEROIS, USUAL DUCTAL HYPERPLASIA, AND. APOCRINE METAPLASIA. C. LYMPH NODE, LEFT SENTINEL, EXCISION: - AND ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY HEMATOXYLIN. EOSIN AND IMMUNOHISTOCHEMICAL (CYTOKERATIN) STAINS. Specimen #: FINAL DIAGNOSIS (continued) : D. LYMPH NODE, LEFT AXILLA, EXCISION: - TWENTY (20) LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA. E. LYMPH NODE, LEFT NON-SENTINEL, EXCISION: - ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. COMMENT: confirmed on the permanent sections. In specimen \"E\" the frozen section diagnosis of metastic carcinoma is. CLINICAL DIAGNOSIS AND HISTORY: year old white female with history of left breast cancer. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE:LYMPH NODE (SPECIMEN \"E\") . REPORTED TO: AND. # BLOCKS : 1. # SCRAPE PREPS : 1. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received in fresh labeled with the patient's name. of labeled a 927 \"RIGHT BREAST SHORT STITCH SUPERIOR, LONG STITCH LATERAL consists. and gram mastectomy specimen oriented with a short stitch superior. pigmented 1.0 superficial skin ellipse measures 17 x 11.5 cm and. superior to inferior, and 5 cm anterior to posterior. The lightly. long lateral. The specimen measures 24 cm medial to lateral, 19 cm. The deep cm centrally located everted nipple. No discharge or scar displays is noted. a. tan margin is inked in black. Serial sections reveal lobulated yellow. tissue. adipose tissue admixed with 10% moderately dense tan white fibrous. catted grey cysts measuring up to 0.4 cm in greatest dimension. blue The fibrous tissue is predominantly centrally located and shows. 1. Specimen #: GROSS DESCRIPTION (continued) : discrete mass or lesion identified. No lymph nodes are identified. Cassette summary : A1: skin. A2: central. A3: upper outer quadrant. A4: lower outer quadrant. A5: lower inner quadrant. A6: upper inner quadrant. A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant. All: representative section of nipple. Matched sections of A1-A6 are submitted in OCT for CBCP protocol. B. Received fresh labeled with the patient's name. designated \"LEFT BREAST SHORT STITCH SUPERIOR, LONG LATERAL\" is a 954. gram mastectomy specimen oriented with a short stitch superior and long. lateral. The specimen measures 24 cm medial to lateral, 18 cm superior. inferior, and 6 cm anterior to posterior. The lightly pigmented. to. superficial located skin ellipse measures 19 x 12.5 cm and displays a medially. deep inked margin is inked black and the superficial lower outer quadrant is. 1.5 cm everted nipple free of discharge. No scar is noted. The. located lobulated pink white indurated mass with focal hemorrhage. The mass. blue. Serial sections reveal 3.5 x 3.2 x 2.8 cm well defined. deep the margin and 0.4 cm of the inked superficial surface. The remainder. within the lower outer quadrant and comes within 3.5 cm of the is. tissue which is diffusely nodular and focally cystic. The admixed. specimen is composed of approximately 50% dense tan white fibrous. of. adipose tissue is unremarkable. No additional masses are identified. No. lymph nodes identified. Cassette summary: B1: skin. B2: lower outer quadrant mass. B3: lower outer quadrant. B4: upper outer quadrant. B5: upper inner quadrant. B6: lower inner quadrant. B7: representative section of closest deep margin. blue B8-B9: ink representative sections of mass with closest point of approach to. margin. 10: representative section of nipple. 10CF. Specimen #: GROSS DESCRIPTION (continued) : C. Received fresh labeled with the patient's name. designated. SENTINEL LYMPH NODE #1\" consists of a 2.0 x 1.7 x 1.0 cm. pink yellow fatty lymph node. The specimen is trisected. Two thirds of the. lymph node are placed in cassette C1 and C2. Matched section of C1 is. placed in. for CBCP protocol. D. Received fresh labeled with the patient's name. designated \"LEFT AXILLARY CONTENTS\" consists of an unoriented irregular. portion of adipose tissue measuring 9.0 x 9.0 x 2.0 cm. Sectioning reveals. multiple pink yellow fatty lymph nodes ranging in size from 0.4 to 2.4 cm. in greatest dimension. Cassette summary. D1-D3: one lymph node each. D4-D7: one lymph node bisected. D8: two lymph nodes bisected, one inked black. D9: four intact lymph nodes. D10: one lymph node bisected. D11: two lymph nodes. D12: four possible lymph nodes. 12CF. E. Received fresh labeled with the patient's name. designated \"NON SENTINEL CLINCALLY SUSPICOUS LEFT AXILLARY LYMPH NODE'. consists of a 1.7 x 1.5 x 1.3 cm lymph node. Cut surface is homogeneous. and firm. A portion is submitted for frozen section. 1C1.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is classified as follows: T1 (tumor ≤ 2 cm), T2 (tumor > 2 cm but ≤ 5 cm), T3 (tumor > 5 cm), and T4 (tumor of any size with direct extension to the chest wall or skin). The provided pathology report mentions the tumor size as 3.5 cm, which directly corresponds to the T2 classification since it is greater than 2 cm but less than or equal to 5 cm. Other details such as lymph node involvement (N stage) and distant metastasis (M stage) are important for the overall staging but do not affect the T stage determination. Therefore, based on the tumor size of 3.5 cm, the pathologic T stage is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.5 cm, which falls within the criteria for T2 according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        specimen #: : lace: WHITE. Physician (s) : AMENDED. SPECIMEN: A: RIGHT BREAST B: RIGHT BREAST TISSUE FROM INFERIOR FLAP. C: RIGHT SENTINEL LYMPH NODE #1. D: RIGHT SENTINEL LYMPH NODE #2. FINAL DIAGNOSIS: A. RIGHT BREAST, MASTECTOMY: -TUMOR TYPE: INVASIVE DUCTAL CARCINOMA WITH LOBULAR FEATURES. -NOTTINGHAM GRADE MODERATELY DIFFERENTIATED (G2). -NOTTINGHAM SCORE: 6/9 (TUBULES = 3, NUCLEI = 2, MYTOSES= 1) . -TUMOR SIZE: GREATEST DIMENSION: TUMOR 1 (UPPER INNER QUADRANT) : at least 1.1 CM. (measured on microscopic slide, extensively involves margin). TUMOR 2 (CENTRAL MASS) : 2.5 CM (MEASURED GROSSLY) . - TUMOR NECROSIS: ABSENT. -MICROCALCIFICATIONS: - ABSENT. - -VENOUS INVASION ABSENT. -MARGINS: INVASIVE TUMOR EXTENSIVELY INVOLES THE SUPERFICIAL (ANTERIOR,. BLUE INK) MARGIN, UPPER INNER QUADRANT (SLIDES A2-A4) . INTRADUCTAL COMPONENT NEAREST INKED SURGICAL MARGIN: 5 MM. (SUPERIOR, ANTERIOR, SLIDE A2). -INTRADUCTAL COMPONENT MINIMAL. -LYMPH NODES REPORTED SEPARATELY BELOW IN C AND D. -NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. -MULTICENTRICITY: - PRESENT. - -ADDITIONAL STUDIES: (See comment.). -TUMOR 1, UPPER INNER QUADRANT. ESTROGEN RECEPTOR: POSITIVE (95% NUCLEAR STAINING). PROGESTERONE RECEPTOR: POSITIVE (5% NUCLEAR STAINING). HER-2 BY IMMUNOHISTOCHEMISTRY: NEGATIVE (1+). - TUMOR 2, CENTRAL: ESTROGEN RECEPTOR: POSITIVE (95% NUCLEAR STAINING). PROGESTERONE RECEPTOR POSITIVE (15% NUCLEAR STAINING). HER-2 BY FISH NOT AMPLIFIED RATIO 1. 1. Specimen # : FINAL DIAGNOSIS (continued) : (ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, AND HER-2 STUDIES WERE. PERFORMED ON AN EARLIER BIOPSY AT SCOTTSDALE PATHOLOGY CONSULTANTS,. - PATHOLOGIC STAGE: pT2NO (i-)MX -. -ADDITIONAL PATHOLOGIC CHANGES : CYSTIC CHANGE, APOCRINE METAPLASIA,. COLUMNAR CELL CHANGE. B. RIGHT BREAST TISSUE FROM INFERIOR FLAP, EXCISION: -NO SIGNIFICANT PATHOLOGIC CHANGE. C. SENTINEL LYMPH NODE #1, BIOPSY: -NO METASTATIC DEPOSIT IDENTIFIED IN ONE EXAMINED LYMPH NODE. (MULTIPLE SLIDES STAINED WITH HEMATOXYLIN&EOSIN AND WITH IMMUNOSTAIN. FOR CYTOKERATIN). D. SENTINEL LYMPH NODE RIGHT AXILLA #2, BIOPSY: -NO METASTATIC DEPOSIT IDENTIFIED IN ONE EXAMINED LYMPH NODE. (MULTIPLE SLIDES STAINED WITH HEMATOXYLIN&EOSIN AND WITH IMMUNOSTAIN. FOR CYTOKERATIN). COMMENT: The smaller tumor in the upper inner quadrant is present at the margin and. involves an inked surgical margin over a cut arc of 4 to 5 mm. Because. the greatest extent of the tumor cannot be assessed, this tumor might. otherwise be classified pTX. The cenral mass appears to be larger and is. completely excised. Its greatest dimension of 2.5 cm is the basis of the. pathologic T stage of pT2. AMENDMENT COMMENT. The report is amended to add evaluation of markers (ER, PR, Her2). performed on the upper inner quadrant tumor, sections of block A2. The. studies reported for the central tumor are from the report of a biopsy. designated \"12:00\" at another institution. NTER. specimen #: CLINICAL DIAGNOSIS AND HISTORY: breast cancer year old female. GROSS DESCRIPTION: A. Received fresh labeled with the patient's name. designated \"RIGHT MASTECTOMY SPECIMEN\" is a 278 gram right mastectomy. oriented with short stitch superior, long lateral and double deep. The. specimen measures 16 cm medial to lateral, 14 cm superior to inferior and. 3. cm anterior to posterior. The lightly pigmented superficial skin ellipse. measures 10 x 3 cm and displays a 1.7 cm everted nipple free of discharge. No scars are noted. The deep margin is inked black and the superficial. surface of the upper inner quadrant is inked blue. Serially sectioned to. reveal a 0.6 x 0.4 x 0.3 cm firm pink white mass abutting the superficial. margin of the UIQ (1:00) . The cut surface shows focal congestion. consistent with a previous biopsy. The mass comes to within 2.0 cm of the. deep margin. Located approximately 1.0 cm lateral to this mass is a very. poorly defined mass of similar appearance which measures 2.5 x 2.5 x 1.0. cm and involves the upper mid and central portions of the breast. The. central mass comes to within 1.0 cm of the deep margin. The remainder of. the specimen is composed of moderately dense markedly nodular fibrous. tissue. The adipose tissue compromises 20% of the specimen is. unremarkable. No lymph nodes are identified. Summary of sections: A1: one piece, skin. A2-A4: one piece in each, upper inner quadrant mass anterior margin. A5: one piece, central mass deep margin. A6: one piece, central mass. A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant. All: one piece, nipple. A12-A13 one piece each, representative mass. 13CF. Matched sections of A1-A2 and A6-A10 are submitted in. for CBCP. protocol. B. Received in formalin labeled with the patient's name. designated \"BREAST TISSUE FROM INFERIOR FLAP\" are multiple pieces of. yellow tan lobulated adipose tissue measuring 4.7 x 3.5 x 2.0 cm in. aggregate dimension. Sectioning reveals grossly unremarkable fibroadipose. tissue throughout. Representative sections submitted. Summary of sections : B1-B4: one piece in each, 4C4. C. Received fresh labeled with the patient's name. Specimen # : GROSS DESCRIPTION (continued) : designated \"SENTINEL LYMPH NODE #1\" is a single 2 x 1 x 0.3 cm pink yellow. lymph node. On sectioning cut surface shows a fatty hilum. The specimen is. bisected and entirely submitted in C1 and C2. Summary of sections: C1-C2: one piece in each, suspected lymph node. D. Received in formalin labeled with the patient's name. designated \"SENTINEL NODE RIGHT AXILLA #2\" is a single 1.1 x 1.0 x 0.5 cm. pink yellow lymph node. On sectioning the cut surface shows a fatty hilum. The specimen is bisected and entirely submitted in one cassette. Summary. of sections : D1: two pieces.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0CZ.57153075-9055-4D7E-9CD6-9167D165E860",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report regarding the size and extent of the tumor. The AJCC Cancer Staging Manual (7th edition) defines the T stages as follows: T1 - Tumor not more than 2 cm in greatest dimension, T2 - Tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor more than 5 cm in greatest dimension, and T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided report, there are two tumors described: Tumor 1 in the upper inner quadrant with a size of at least 1.1 cm, and Tumor 2, a central mass, measuring 2.5 cm. The report also mentions that the central mass is completely excised and its greatest dimension is the basis for the pathologic T stage of pT2. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Since the largest tumor (Tumor 2) is 2.5 cm, which falls into the more than 2 cm but not more than 5 cm category, the pathologic T stage is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract the tumor size from the pathology report and compare it with the AJCC Cancer Staging Manual (7th edition) criteria.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The greatest dimension of the central mass is 2.5 cm, which falls within the criteria for T2 according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: BLACK. Physician( (s) : SPECIMEN: A: LEFT BREAST B: SKIN FLAP. FINAL DIAGNOSIS: A. BREAST, LEFT, MASTECTOMY WITH AXILLARY TAIL: TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE. NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). NOTTINGHAM SCORE: 9 (Tubules= 3, Nuclei= 3, Mitoses= 3 mitotic count. > 12 per 10 HPF at 40x power). TUMOR SIZE (GREATEST DIMENSION) : 3.5 CM. (MEASURED GROSSLY) . TUMOR NECROSIS: PRESENT IN INFILTRATING COMPONENT. MICROCALCIFICATIONS: ABSENT. VENOUS / LYMPHATIC INVASION: ABSENT. MARGINS : NEGATIVE. -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 2.0 CM. (DEEP MARGIN) . INTRADUCTAL COMPONENT: ABSENT. LYMPH NODES: TEN (10) LYMPH NODES NEGATIVE FOR TUMOR. NIPPLE INVOLVEMENT: ABSENT. SKIN INVOLVEMENT: ABSENT. MULTICENTRICITY: ABSENT. ESTROGEN RECEPTORS: NEGATIVE (REFER TO PRIOR SPECIMEN. PROGESTERONE RECEPTORS: NEGATIVE (REFER TO PRIOR SPECIMEN. HER 2 NEU by IHC: NEGATIVE, 1+ (REFER TO PRIOR SPECIMEN. PATHOLOGIC STAGE: pT2 NO MX. ADDITIONAL PATHOLOGIC FINDINGS: - PERIDUCTAL CHRONIC INFLAMMATION. B. SKIN, LEFT BREAST, EXCISION: - -UNREMARKABLE SKIN AND SUBCUTANEOUS SOFT TISSUE. - -NO EVIDENCE OF MALIGNANCY. 1. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: -year-old - female with breast cancer. PRE-OPERATIVE DIAGNOSIS: Breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST\" is a 1. 466 gram, left mastectomy specimen. oriented with a short stitch superior, long lateral, and double deep. The. specimen measures 31.0 cm medial to lateral, 23.0 cm superior to inferior,. and 6.0 cm anterior to posterior. The darkly pigmented, superficial. skin. ellipse measures 30.0 x 6.0 cm, and displays a 1.0 cm everted, centrally. located, nipple free of discharge. No scars are noted. The deep margin. is remarkable for scattered, irregular portion of attached red-brown. muscle measuring up to 4.5 x 1.5 cm in greatest dimension. The deep. margin is inked in black, and the superficial-lateral surface is inked. blue. Serial sections reveal a 3.5 x 2.8 x 3.0 cm poorly defined mass in. the mid-outer breast. On sectioning, the cut surface ranges from. pink-white, and firm, to pink-white, soft, and cystic. Continuous, with,. and deep to, this mass is a 2.0 x 2.0 x 1.9 cm smooth walled cyst. containing serosanguineous fluid, consistent with the previous biopsy. site. The cyst and mass are located 2.0 cm from the deep margin. The. remainder of the specimen is predominantly composed of lobulated,. yellow-tan, adipose tissue admixed with scant, fibrous tissue. No. additional lesions are identified. Specimen subsequently placed in. formalin for 32 hours. The attached axillary tail measures 13.0 x 9.0 x 3.0 cm. On sectioning,. eight pink-tan, lymph nodes are identified which range in size from 0.8 x. 0. x 0.2 cm to 3.0 x 2.0 x 1.0 cm. Representative sections are. submitted. Cassette Summary: A1: Skin. A2: Mass. A3: Mass. A4: Mass and adjacent cyst. A5: Normal adjacent to mass. A6-A7: Deep margin closest to mass. A8: Upper outer quadrant . A9: Upper inner quadrant . A10: Lower outer quadrant . All: Lower inner quadrant. Specimen #: GROSS DESCRIPTION (continued). A12: Largest lymph node. A13-A14: - Second largest lymph node. A15-A16 One lymph node. A17: Three lymph nodes. A18: One lymph node bisected. A19: One lymph node bisected. A20: Nipple. Matched sections of A1 through A3, A8 through A12, A13, A15, A20 are. submitted in OCT for CBCP protocol. 20CF. B. Received in formalin for twenty-eight hours, labeled with the patient's. designated \"SKIN FLAP\" is an irregular, lobular. fragment of soft tissue with attached brown skin forming a continuous ring. which measures 61.0 cm in circumference with the width of skin ranging. from 1.5 cm at narrowest to 4.8 cm at widest. No lesions are seen on the. skin surface. Representative sections are submitted in one cassette. 1CF.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the pathology report, the tumor size (greatest dimension) is 3.5 cm, which falls into the category of T2. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size and the absence of extension to the chest wall or skin, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 3.5 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition)",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : AMENDED. SPECIMEN: A: SENTINEL NODE #1 B: ADDITIONAL LYMPH NODE. C: SENTINEL LYMPH NODE #2 D: LEFT BREAST LUMPECTOMY. E: FIBROUS TISSUE AT SUP-LAT MARGIN. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, EXCISION: - TWO BENIGN LYMPH NODES, NO MALIGNANCY IDENTIFIED. B. LYMPH NODE, \"ADDITIONAL, \" EXCISION: - NO LYMPH NODE IDENTIFIED. FIBROADIPOSE TISSUE ONLY. C. LYMPH NODE, SENTINEL #2, EXCISION: - ONE BENIGN LYMPH NODE, NO MALIGNANCY IDENTIFIED. D. BREAST, LEFT, LUMPECTOMY: TUMOR FEATURES. TYPE: INFILTRATATING DUCTAL CARCINOMA WITH NEUROENDOCRINE. NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). NOTTINGHAM SCORE: 8/9. (Tubules= 20x 3, Nuclei= 3, Mitoses= 2; mitotic count 8 per 10 HPF at. power-0.50 field diameter). TUMOR NECROSIS: ABSENT. TUMOR SIZE (GREATEST DIMENSION) : 3.0 CM (measured grossly). MICROCALCIFICATIONS: ABSENT. VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. MARGINS : -DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN IS 0.5 CM, FROM. INFERIOR MARGIN. INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, SOLID TYPE, LOW. NUCLEAR GRADE. MULTICENTRICITY: NOT IDENTIFIED. LYMPH NODES : THREE NEGATIVE FOR TUMOR (see specimens A and C). ESTROGEN RECEPTORS : NEGATIVE. (see specimen. PROGESTERONE RECEPTORS: NEGATIVE. (see specimen. HER 2 NEU by IHC: POSITIVE. (see specimen. Specimen # : FINAL DIAGNOSIS (continued) : PATHOLOGIC STAGE: pT2 NO Mx. ADDITIONAL PATHOLOGIC CHANGES: BENIGN INTRADUCTAL PAPILLOMA. E. SOFT TISSUE, \"FIBROUSE TISSUE AT SUPERIOR-LATERAL MARGIN, \" EXCISION : - BENIGN BREAST TISSUE, NO MALIGNANCY IDENTIIFIED. CLINICAL DIAGNOSIS AND HISTORY: -year-old female with diagnosis of left breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"SENTINEL NODE #1\" is a 3.0 x 1.5 x 0.5 cm irregular portion. of. soft tissue. Sectioning reveals a 1.0 x 1.0 x 0.5 cm pink-tan - lymph node. The lymph node is bisected. One half of the lymph node is submitted in. OCT for CBCP protocol, and the remainder is submitted for permanent. 2C2. B. Received in formalin, labeled with the patient's name,. designated \"ADDITIONAL LYMPH NODE\" is a single, tan-brown. fragment of soft tissue measuring 1.0 cm in greatest dimension. The. specimen is submitted in its entirety in one cassette. 1C1. Recaivad in formalin, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #2\" is a lobulated fragment of. yellow, adipose tissue measuring 1.5 x 2.0 x 0.3 cm. The specimen is. bisected to reveal one lymph node measuring 0.7 cm in greatest dimension. The specimen is submitted entirely in one cassette. 1C2. D. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST LUMPECTOMY\" is a globoid portion of soft tissue. oriented with the short stitch superior and long stitch lateral. The. specimen measures 9.0 cm medial to lateral, 7.5 cm anterior to posterior,. and 4.0 cm superior to inferior. The lightly pigmented superficial skin. ellipse measures 6.5 x 1.0 cm and is otherwise unremarkable. The specimen. .S inked as follows: superior = gold, inferior = green, medial = red,. lateral = yellow, anterior = orange, and posterior = black. Serial. Specimen # : GROSS DESCRIPTION (continued) : sections reveal a firm, very well circumscribed, centrally located,. pink-white mass measuring 3.0 x 2.6 x 2.2 cm. The mass approaches the. margins as follows: superior and inferior 0.7 cm, posterior 0.8 cm, and. medial 1.4 cm. The remainder of the cut surface is composed of lobulated,. yellow-tan, adipose tissue admixed with a moderate amount of tan-white,. fibrous tissue. No additional lesions are identified. Representative. sections are submitted as follows: Cassette Summary: D1-D2: Mass. D3: Adjacent normal. D4-D5: Additional mass. D6-D7: Adjacent to mass. D8: Additional mass, same section as D4. D9: Skin. D10: Additional firm, fibrous tissue. 10CF. The specimen was placed in formalin at. The specimen will be in. formalin for a total of approximately 28 hours. E. Received in formalin, labeled with the patient's name,. designated \"FIBROUS TISSUE AT SUPERIOR-LATERAI MARGIN\" is a. fragment of yellow-white, fibrous tissue and adipose tissue measuring 3. 7. x. 2.0 x 0.8 cm. Representative sections are submitted entirely in three. cassettes. 3C3.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0D1.5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided pathology report, we can identify the key information: The tumor size is described as 3.0 cm (measured grossly) in the 'TUMOR FEATURES' section of the report. There is no mention of the tumor extending to the chest wall or skin, which would be necessary for a T4 classification. Given the tumor size is 3.0 cm, which falls into the category of > 2 cm but ≤ 5 cm, we can determine the pathologic T stage.",
    "BaselineChoice": "T2",
    "Monologue": "I need to extract the tumor size from the pathology report to determine the T stage.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.0 cm, which corresponds to the T2 stage according to standard cancer staging guidelines.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST B: SENTINEL NODE #1 C: SENTINEL NODE #2. D: SENTINEL NODE #3 E: SENTINEL NODE #4 F: left breast. FINAL DIAGNOSIS: A. RIGHT BREAST, SIMPLE MASTECTOMY. FIBROCYSTIC CHANGES TO INCLUDE FIBROADENOMAS, SCLEROSING ADENOSIS,. USUAL DUCTAL HYPERPLASIA, DUCT ECTASIA, CYSTIC CHANGE WITH APOCRINE. METAPLASIA. MICROCALCIFICATIONS IDENTIFIED IN BENIGN PROCESSES (A3) . SKIN AND NIPPLE WITH NO SIGNIFICANT PATHOLOGIC CHANGES. B. LYMPH NODE, SENTINEL #1, BIOPSY: ONE LYMPH NODE POSITIVE FOR ISOLATED TUMOR CELLS (ITC) BY IMMUNOSTAINS. AND POSITIVE FOR ISOLATED TUMOR CELL NODULE ON H AND E. (0/1). (SEE COMMENT). C. LYMPH NODE, SENTINEL #2, BIOPSY: ONE OF TWO LYMPH NODES POSITIVE FOR ISOLATED TUMOR CELLS (ITC) BY. IMMUNOSTAINS; NEGATIVE BY H AND E. (0/2). D. LYMPH NODE, SENTINEL #3, BIOPSY: ONE LYMPH NODE POSITIVE FOR ISOLATED TUMOR CELLS (ITC) BY IMMUNOSTAINS. NEGATIVE BY H AND E. (0/1). E. LYMPH NODE, SENTINEL #4, BIOPSY: ONE LYMPH NODE POSITIVE FOR ISOLATED TUMOR CELLS (ITC) BY. IMMUNOSTAINS. NEGATIVE BY H AND E. (0/1). F. LEFT BREAST, MASTECTOMY: TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE (F2-F5;. F12-13) . NOTTINGHAM GRADE: POORLY DIFFERENTIATED. NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3 mitotic count 12 per 10 HPF at. 40x power). TUMOR SIZE (GREATEST DIMENSION) : 2.5 CM (measured grossly). Specimen #: FINAL DIAGNOSIS (continued) : TUMOR NECROSIS: ABSENT. MICROCALCIFICATIONS: PRESENT, IN ASSOCIATION WITH PRIOR BIOPSY (F5). AND IN BENIGN BREAST TISSUE. VENOUS / LYMPHATIC INVASION: PRESENT (F5) . MARGINS : NEGATIVE FOR TUMOR. -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.34 CM, FROM DEEP MARGIN. (measured microscopically, F12) . INTRADUCTAL COMPONENT: ABSENT. LYMPH NODES: FIVE NODES NEGATIVE FOR TUMOR (PARTS B-E ABOVE) . NIPPLE INVOLVEMENT: ABSENT. SKIN INVOLVEMENT: ABSENT. MULTICENTRICITY: UNIFOCAL. ESTROGEN RECEPTORS: NEGATIVE (Previously performed on. PROGESTERONE RECEPTORS: NEGATIVE (Previously performed on. HER 2 NEU by IHC: NEGATIVE (Previously performed on. PATHOLOGIC STAGE: pT2 NO (i+) MX. ADDITIONAL PATHOLOGIC CHANGES. -CYSTIC CHANGE WITH APOCRINE METAPLASIA. -MICROCALCIFICATIONS IN BENIGN TISSUE. (SEE COMMENT). COMMENT: and. were notified of this. diagnosis by email on. The lymph nodes show individual tumor cells but only one cluster was. identified on H&E and was measured microscopically at 89.: 9 micrometers. or 0.09mm, under the total size of allowable for micrometastasis. 1. CLINICAL DIAGNOSIS AND HISTORY: .year-old female with left breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST, ORIENTED SHORT STITCH SUPERIOR AND LONG STITCH. LATIRRAL\" is a 685 gram right breast measuring 21.0 cm superior to. 18.0 cm medial to lateral, and 3.5 cm anterior to posterior. FOR OFFICIAL USE ONLY - PERSONAL DATA -. Specimen #: GROSS DESCRIPTION (continued) : moderately dense, inked black. Serial sections reveal a marked discharge. amount. The deep margin a 1.0 cm is centrally located, everted nipple free 7.0 of x 3.5 cm,. displays The lightly pigmented superficial skin ellipse measures and. adipose blue-gray tissue cysts measuring tan-white, up to fibrous 0.5 cm tissue in greatest with multiple dimension. scattered of. identified in the cm lower bulging, tan-white, well circumscribed nodule is. surface. A 0.8 is yellow-tan, lobulated, and comprises 30% of the The cut admixed. fibroadenoma. No lymph nodes outer are quadrant identified. which is consistent with. a. Time in Formalin =. Time excised is not provided. Cassette Key : A1: Skin. A2: Upper outer quadrant. A3: Lower outer quadrant with nodule. A4: Lower inner quadrant. A5: Upper inner quadrant. A6: Central. A7: Additional upper outer quadrant. A8: Additional lower outer quadrant. A9: Additional lower inner quadrant. A10: Upper inner quadrant. All: Nipple. Matched 11CF sections of A1 through A6 are submitted in. for CBCP protocol. designated B. Received fresh, labeled with the patient's name,. CBCP cassettes lymph node. B1 \"SENTINEL through The specimen B2. NODE A is #1\" matched sectioned, is a 3.0 section x and 1.5 of entirely x B2 0.8 is cm submitted submitted pink-yellow, in fatty. protocol. 2CF. in. for. designated C. Received in formalin, labeled with the patient's. lymph yellow-tan, node. \"SENTINEL soft tissue. NODE Sectioning #2\" is a 1.5 reveals x 1.5 a x single 0.5 cm name 0.5 irregular cm pink-tan portion of. The specimen is entirely submitted as follows: Cassette Key: C1: Lymph node. : Adipose tissue. 2CF. Specimen #: GROSS DESCRIPTION (continued) : D. Received in formalin, labeled with the patient's name,. designated \"SENTINEL NODE #3\" is a 2.0 x 1.2 x 0.4 cm yellow-tan fragment. of adipose tissue. This is submitted entirely in cassette D. 1CI. E. Received in formalin, labeled with the patient's name,. designated \"SENTINEL NODE #4\" is a fragment of yellow-tan, adipose tissue. which measures 0.8 x 0.8 x 0.4 cm. The specimen is submitted entirely in. one cassette. 1CF. F. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST AND ORIENTED WITH A SHORT STITCH SUPERIOR, LONG. STITCH LATERAL\" is an 844 gram left breast measuring 22.0 cm superior to. inferior, 19.0 cm medial to lateral, and 4.0 cm anterior to posterior. The lightly pigmented superficial skin ellipse measures 10.0 x 2.5 cm and. displays a 1.3 cm centrally located everted nipple free of discharge. No. scar is identified. The deep margin is inked black, and the superficial. inferior surface is inked blue. Serial sections reveal a well. circumscribed mass in the lower outer/lower mid breast. The. mass. measures. 2.5 x 2.5 x 2.5 cm and comes to within 0.2 cm of the deep margin, and 1. 0. cm of the superficial inferior surface. The cut surface is pink-white,. firm and gray. The remainder of the specimen is composed of a marked. amount of dense, pink-white, fibrous tissue with scattered blue-gray cysts. measuring up to 0.5 cm in greatest dimension. The admixed adipose tissue. is yellow-tan, lobulated, and otherwise unremarkable. No additional. lesions are identified. No lymph nodes are identified. Representative. sections of the specimen are submitted as follows: Cassette Key. F1: Skin. F2: Mass with margin. F3: Margin of F2. F4: Mass. F5: Mass. F6: Adjacent normal. F7: Upper outer quadrant. F8: Upper inner quadrant . F9: Lower inner quadrant . F10: Lower outer quadrant. F11: Central. F12-F13 : Additional mass plus deep margin. F14: Upper outer quadrant. F15: Lower outer quadrant. Specimen #. GROSS DESCRIPTION (continued) : F16: Lower inner quadrant. F17: Upper inner quadrant. F18: Nipple. F19: Possible intraparenchymal lymph node candidates.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and whether it has spread to the chest wall or skin. The T stages are defined as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided pathology report, the tumor size is given as 2.5 cm, which falls into the T2 category since it is more than 2 cm but not more than 5 cm in greatest dimension. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, the pathologic T stage for this breast cancer is T2.",
    "BaselineChoice": "T2",
    "Monologue": "I need to extract the tumor size from the pathology report to determine the T stage.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 2.5 cm, which corresponds to the T2 stage according to standard cancer staging guidelines.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: F. Race: WHITE. Physician (s) : AMENDED. A: RIGHT BREAST TISSUE B: LEFT AXILLA SENTINEL NODE Site: breast, NOS C50.9. SPECIMEN: C: LEFT BREAST TISSUE. D: LEFT BREAST TISSUE LOWER INNER QUADRANT. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - FOCAL USUAL DUCTAL HYPERPLASIA. - FOCAL LACTATIONAL/SECRETORY CHANGE. STROMAL SCLEROSIS AND FOCAL APOCRINE METAPLASIA. - UNREMARKABLE SKIN AND NIPPLE. - NO EVIDENCE OF MALIGNANCY. B. LYMPH NODE, LEFT AXILLA SENTINEL NODE, RESECTION: - ONE LYMPH NODE NEGATIVE FOR TUMOR BY LIGHT MICROSCOPY AND. CYTOKERATIN IMMUNOHISTOCHEMISTRY. C. BREAST, LEFT, MASTECTOMY: WELL DIFFERENTIATED (GRADE I/III) INFILTRATING DUCTAL CARCINOMA. NOTTINGHAM SCORE: 5 OUT OF 9 (TUBULES=2, NUCLEI=2, MITOSES=1). TUMOR SIZE (GREATEST DIMENSION) : 1.9 CM (measured grossly). MICROCALCIFICATIONS: IDENTIFIED WITHIN INTRADUCTAL COMPONENT. AND BENIGN DUCTS. VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. MARGINS : NEGATIVE - DISTANCE FROM NEAREST MARGIN: 0.4 CM FROM. SUPERFICIAL MARGIN (measured grossly). INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, INTERMEDIATE. NUCLEAR GRADE (DCIS, GRADE II) ; SOLID AND CRIBIFORM TYPES WITH. FOCAL INTRALUMINAL NECROSIS AND CALCIFICATIONS. SKIN OR NIPPLE INVOLVEMENT: ABSENT. ESTROGEN RECEPTORS: POSITIVE (please see prior specimen. PROGESTERONE RECEPTORS: POSITIVE (please see prior specimen. HER2 NEU BY IHC: NEGATIVE (please see prior specimen. (see comment). PATHOLOGIC STAGE: pT1cNO (i-)Mx. - ADDITIONAL PATHOLOGIC CHANGES: FOCAL USUAL DUCTAL HYPERPLASIA. Specimen #: FINAL DIAGNOSIS (continued) : D. BREAST, LEFT LOWER INNER QUADRANT, EXCISION. - BENIGN BREAST TISSUE; NEGATIVE FOR TUMOR. Comment: There is no change in the original pathologic diagnosis. This. amendment is issued to reflect a change in the HER2 immunohistochemical. status. The original. report stated that the HER2 was positive. based on the core biopsy material. However, that core biopsy. material has been recently amended to reflect that the HER2 is actually. negative (further supported by confirmatory FISH study showing no. amplification). CLINICAL DIAGNOSIS AND HISTORY: -year-old female with left breast cancer, and strong family. history, desires prophylactic bilateral mastectomy. GROSS DESCRIPTION: A. Received in formalin, labeled with the patient's name,. designated \"RIGHT BREAST TISSUE, LONG = LATERAL, SHORT = SUPERIOR\". is. a. 300 gram right mastectomy specimen oriented with a short stitch superior,. and long stitch lateral. The specimen measures 16.0 x 16.0 x 3.0 cm, and. displays an 8.5 x 3.0 cm lightly pigmented skin ellipse on the superficial. surface. The centrally located everted nipple measures 1.5 cm and is free. of discharge. The deep margin is inked in black. Serial sections reveal. markedly dense, pink-white, fibrous tissue involving 70% of the cut. surface. The tissue is slightly nodular, however, no discreet mass or. lesion is identified. No lymph nodes are identified. Representative. sections are submitted as follows. Cassette Key. A1: Skin. A2: Upper outer quadrant. A3: Lower outer quadrant . A4: Lower inner quadrant. A5: Upper inner quadrant. A6: : Central. Matched sections of A1 through A6 are submitted in OCT for CBCP protocol. . Specimen #: GROSS DESCRIPTION (continued) : A7: Nipple. A8: Upper outer quadrant. A9: Lower outer quadrant. A10: Lower inner quadrant. All: Upper inner quadrant. 11C11. B. Received in formalin, labeled with the patient's name,. designated \"LEFT AXILLA SENTINEL NODE\" is a single 1.8 x 1.8 x 0.6 cm. pink-tan lymph node. The lymph node is trisected, and entirely submitted. in cassettes B1 and B2. Matched section of B1 is submitted in OCT for. CBCP protol. C. Received in formalin, labeled with the patient's name,. designated \"LEFT BREAST TISSUE, LONG LATERAL, SHORT SUPERIOR\" is. a. 284. gram left mastectomy specimen oriented with a short stitch superior and. long stitch lateral. The specimen measures 14.5 cm medial to lateral,. 14. 0 cm superior to inferior, and 2.5 cm anterior to posterior. The. lightly pigmented superficial skin ellipse measures 7.0 x 3.: cm and. displays a centrally located, everted nipple measuring 1.8 x 1.5 x 1.3 cm. The nipple is free of discharge. The deep margin is inked in black,. and. the superficial inferior half is inked in blue. Serial sections reveal. a. 1.9. x 1.6 x 1. 6 cm well defined, pink-tan, gritty, indurated mass in the. lower outer quadrant at the junction of the deep and superficial margins. The mass is located 1.0 cm from the deep margin, and 0.4 cm from the. superficial margin. The remainder of the specimen is composed of 70% of. markedly dense, diffusely nodular fibrous tissue with scattered gray-blue. cysts measuring up to 0.3 cm in greatest dimension. No lymph nodes are. identified. Representative sections are submitted: Cassette Summary : C1: Skin. C2 : Nipple. C3: Mass, lower outer quadrant . C4-C6: - Deep and superficial margins of C3. C7: Mass with superficial margin. C8 : Additional superficial margin. C9: Adjacent normal with cyst (lower outer quadrant) . C10: Upper outer quadrant. C11: Upper inner quadrant. C12: Lower inner quadrant. Matched sections of C1-C3, C7, and C9-C12 are submitted in OCT for CBCP. protocol. C13-C15: Additional representative sections of breast mass. 15CF: Specimen # : GROSS DESCRIPTION (continued) : D. Received in formalin, labeled with the patient's name,. designated \"LEFT BREAST TISSUE LOWER INNER QUADRANT\" are multiple. fragments of yellow, lobular, adipose tissue. The first fragment measures. 5.! x 3.0 x 0.4 cm. The second fragment measures 5.0 x 2.5 x 0.5 cm. Serial sectioning is remarkable for an area of focal hemorrhage measuring. 0. 4 x 0.3 x 0.2 cm located 0.2 cm from the nearest inked margin. Representative section is submitted in cassette D1. Also noted is a. fibrotic band measuring 0.4 x 0.4 X 0.2 cm abutting the closest inked. margin. Two representative sections are submitted in cassette D2. The. second specimen is inked in blue, and is serially sectioned to reveal. unremarkable, yellow, cut surfaces. Representative sections are submitted. in cassettes D3-D4. 4CF.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is based on the largest dimension of the invasive tumor. The information provided in the pathology report includes the size of the tumor, which is crucial for determining the T stage. Here's the step-by-step reasoning:",
    "BaselineChoice": "T1",
    "Monologue": "The pathology report provided indicates that the tumor size is 1.9 cm, which corresponds to a T1c stage according to the AJCC Cancer Staging Manual (7th edition). To confirm this, I will extract the relevant information from the report and apply the T-staging rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 1.9 cm corresponds to a T1c stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: BLACK. Physician (s) : SPECIMEN: A: LEFT BREAST QUADRANTECTOMY. B: LEVEL #1 & #2 AXILLARY LYMPH NODES. FINAL DIAGNOSIS: A. BREAST, LEFT, QUADRANTECTOMY: - MODERATELY DIFFERENTIATED (GRADE II) INFILTRATING DUCTAL CARCINOMA. NOTTINGHAM SCORE: 7 OUT OF 9 (TUBULES=3, NUCLEI=2, MITOSES=2) . MAXIMUM TUMOR SIZE: 3.0 CM (MEASURED GROSSLY). VENOUS/LYMPHATIC INVASION: PRESENT (E.G., SLIDES A3 AND A4). MARGINS NEGATIVE. TUMOR PRESENT 0.27 CM FROM THE ANTERIOR (BLUE. INKED) TISSUE EDGE (SLIDE A1). INTRADUCTAL COMPONENT: PRESENT. DUCTAL CARCINOMA IN SITU,. INTERMEDIATE NUCLEAR GRADE (DCIS, GRADE II) i SOLID TYPE WITH. FOCAL INTRALUMINAL NECROSIS AND MICROCALCIFICATIONS. LYMPH NODES: 1 OF 23 LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. (1/23; PLEASE SEE PART \"B\"). ESTROGEN RECEPTORS: POSITIVE (>95% NUCLEAR STAINING; PLEASE SEE. PROGESTERONE RECEPTORS: POSITIVE (60-70% NUCLEAR STAINING; PLEASE. SEE. HER 2 NEU BY IHC: 2+ (PLEASE SEE. HER 2 NEU BY FISH: PENDING (PLEASE SEE. PATHOLOGIC STAGE: pT2N1MX. - ADDITIONAL FINDINGS: PRIOR BIOPSY SITE CHANGES. B. LYMPH NODES, LEFT AXILLA LEVELS 1 AND 2, AXILLARY DISSECTION: - ONE OF TWENTY-THREE - LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. (1/23) . LARGEST METASTATIC FOCUS: 1.4 CM WITH FOCAL EXTRANODAL. EXTENSION (LESS THAN 0.1 CM) . Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: yo black female with breast cancer, left inner mid breast g2 (7/9). +lvi, er/pr+, her2/neu 2+, fna+ of left axillary lymph node. Time in. formalin: 84 hours. PRE-OPERATIVE DIAGNOSIS: breast cancer. POST-OPERATIVE DIAGNOSIS: none provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name,. : and. designated \"Left Breast Quadrantectomy\" is a 408 gm lumpectomy specimen. oriented with a single short black stitch superior, long black lateral,. double blue deep, triple blue medial, and anterior margin is inked blue. The specimen measures 19.0 cm superior to inferior, 14.0 cm medial to. lateral, and 4.0 cm anterior to posterior. The specimen is inked as. follows: anterior-blue, superior-orange, lateral-yellow, medial-red,. inferior-green, and deep-black. Serial sections reveal a 3.0 x 2.0 x 1.7. cm well-defined, tan-pink, gritty mass with focal congestion. The mass. comes to within 0.5 cm of the closest margin (anterior). On sectioning. through the mass a 0.4 cm red-brown biopsy cavity is identified, with an. embedded metallic clip. The remainder of the specimen is predominantly. composed of lobulated, yellow-tan adipose tissue admixed with. approximately 20% fibrous tissue. No additional lesions are identified. Representative sections are submitted. Cassette. Summary: A1-A2- anterior margin; A3-A4- mass; A5-A6- mass with. cavity; A7- mass; A8- adjacent normal; A9- section with medial (red inked). tissue edge adjacent to sections from A1-A6; A10- - adjacent section of. medial-posterior (red and black inked) tissue edges; A11-A12- sections of. white fibrous area with lateral (yellow inked) tissue edge in plane. immediately next to plane of sections A1-A10; A13 - sections of anterior. (blue inked) tissue edge adjacent to tumor area taken from A7; A14-. medial-anterior (red and blue inked) tissue edges taken from area adjacent. to A7. Matched sections of A3, A5-A8 are submitted in OCT for CBCP Protocol. Specimen #: GROSS DESCRIPTION (continued). B: Received fresh, labeled with the patient's name,. and. designated \"Level 1 and 2 Axillary Lymph Node\" is a 10.0. x. 7.5. x. 2.0. cm. irregular portion of soft tissue. Sectioning reveals multiple pink-red to. pink-tan - lymph nodes ranging in size from 0.7 cm in greatest dimension to. 3.0 x 1.0 x 0.7 cm. Sectioning through the larger lymph nodes reveals a. markedly congested cut surface. The lymph nodes are submitted entirely as. follows: Cassette Summary: B1-B2- one lymph node; B3-B4- - one lymph node; B5- one. lymph node, bisected; B6 - one lymph node; B7 - four lymph nodes; B8- one. lymph node; B9- one lymph node, bisected; B10- one lymph node, bisected;. B11- - one lymph node; B12 - one lymph node, bisected; B13- - two lymph nodes. bisected (one inked green) ; B14-21: additional lymph node candidates. Matched sections of B1, B3,B6,B8 are submitted in OCT for CBCP Protocol.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the maximum tumor size is 3.0 cm, which directly corresponds to the T2 classification since it is greater than 2 cm but less than or equal to 5 cm.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract the maximum tumor size from the pathology report and apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition).",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.0 cm, which according to the AJCC Cancer Staging Manual (7th edition) corresponds to a T2 stage because it is more than 2 cm but not more than 5 cm.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: F. Race : WHITE. Physician (s) : AMENDED. SPECIMEN: A: SENTINEL LYMPH NODE B: RIGHT BREAST TISSUE. C: SUPERIOR MEDIAL BORDER. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE, BIOPSY : - 1 LYMPH NODES NEGATIVE FOR TUMOR BY H&E. - NEGATIVE FOR CITOKERATIN BY IMMUNOHISTOCHEMISTRY. B. BREAST, RIGHT, LUMPECTOMY: - INFLITRATIVE DUCTAL CARCINOMA WITH CRIBRIFORM PATTERN, WELL. DIFFERENTIATED. - SIZE: 1 CM. - MARGINS NEGATIVE. NEAREST MARGIN, SUPERIOR, 2.0 MM. - NO LYMPHVASCULAR SPACE INVASION IDENTIFIED. - FIBROCYSTIC CHANGES. TO. INCLUDE FIBROSIS, CYSTS, AND APOCRINE METAPLASIA. - MICROCALCIFICATIONS ASSOCIATED WITH BENIGN AND MALIGNANT BREAST. TISSUE. - AJCC T1bNOMx. C. SUPERIOR MEDIAL BORDER TISSUE, EXCISION: - BENIGN FIBROFATTY CONNECTIVE TISSUE. CLINICAL DIAGNOSIS AND HISTORY: -year-old - white female with right breast cancer. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. éage. Specimen #: GROSS DESCRIPTION: A. SENTINEL LYMPH NODE received fresh and consists of multiple irregular. fragments of tan/yellow soft tissue measuring 3.0 x 2.0 x 0.5 cm in. aggregate. The specimen is submitted in its entirety in two cassettes. B. RIGHT BREAST TISSUE received fresh and consists of a 9.0 x 6.5 x 2.3 cm. piece of fatty tissue oriented with sutures (one=medial, two=superior,. three=anterior) Ink code: Red=medial and lateral, blue=superior,. green=inferior, yellow=anterior, black=posterior. Sectioning reveals a 0.6. cm white/tan, ovoid mass with gritty cut surface, on sectioning-3.0 mm. from superior/posterior margin. The remaining tissue is mostly fatty with. admixed patches of white fibrous tissue. One section of each tumor and. grossly normal fibrous tissue harvested for CBCP protocol; mirror images. for Histology in cassettes B1 and B3 respectively. B2 tissue adjacent to. tumor in the same plane. Additional representative sections are. submitted in sequential order in 15 cassettes, the following pairs of. cassettes representing one section in multiple cassettes: B4-B5, B7-B8,. B9-B11. B7 and B8, and B9-B11 are tissue on either side of tumor. C. SUPERIOR MEDIAL BORDER received in formalin and consists of one. irregular shaped fragment of tan/yellow, lobular, fibrofatty adipose. tissue measuring 3.0 x 2.4 x 1.5 cm. Orientation is not provided. The. specimen is inked and serially section to reveal a yellow, lobular,. glistening cut surface with no well-defined lesions or nodules identified. The specimen is submitted in its entirety in sequential order in three. cassettes.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report mentions that the size of the infiltrative ductal carcinoma is 1 cm, which directly corresponds to the T1 category since it is less than or equal to 2 cm. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, the pathologic T stage for this breast cancer patient is T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report, such as tumor size and other characteristics that could affect staging. Then, I can apply the appropriate T-staging rule based on this information.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 1 cm, which corresponds to a T1 stage.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Patient: : Specimen #: ge: Race: WHITE. Physician (s) : AMENDED: SPECIMEN: RIGHT BREAST NEEDLE LOC. FINAL DIAGNOSIS: BREAST; RIGHT, NEEDLE LOCALIZATION BIOPSY: - MULTIFOCAL INFILTRATING LOBULAR CARCINOMA, ELL-TO-MODERATELY. DIFFERENTIATED. - THE MAXIMAL TUMOR SIZE IS ESTIMATED TO BE 2.8 CM (SEE COMMENT). - THE SURGICAL MARGIN IS POSITIVE FOR TUMOR (SLIDE A5) . - MULTIFOCAL LOBULAR CARCINOMA IN SITU. COMMENT: The tumor is multifocal and present on seven consecutive. sections. Based on this finding, the tumor size is estimated to. be 2.8 cm in the largest dimension. ADDENDUM: Immunostains for hormone receptors are as follows: ESTROGEN RECEPTOR: POSITIVE (70% OF CELLS, STRONG STAINING). PROGESTERONE RECEPTOR: POSITIVE (30% OF CELLS, STRONG STAIING). HER 2 NEU: 2+ by Herceptest, FISH pending. ADDENDUM 2: HER 2 NEU (by FISH) : 1.4, NOT AMPLIFIED. Report Rlectroni-ally Signed Out. CLINICAL DIAGNOSIS AND HISTORY: BIRADS IV mammogram. PRE-OPERATIVE DIAGNOSIS: Rule out breast cancer. Specimen #: GROSS DESCRIPTION: RIGHT BREAST NEEDLE LOC received fresh, labeled with the patient's name,. designated \"RIGHT BREAST NEEDLE LOCALIZATION\" is fibrofatty tissue, 6.3 x. 4.4 x 1.5 cm, impaled with a needle localization wire. A radiograph. accompanies the specimen. No orientation is provided. The surface is inked. black. Sectioning reveals a 1.0 cm indurated mass with poorly defined. margins, abutting the inked surgical margin. The fibrous tissue. immediately adjacent to the mass is somewhat nodular and focally indruated. as well. One section of each mass and grossly normal fibrous tissue is. submitted for CBCP protocol (matching paraffin sections=A5 and A14,. respectively) . All remaining tissue is serially submitted for paraffin. sections in 17 cassettes. The following pairings represent sections taken. from the same tissue plane: A5-A6, A7-A8, A9-A10, A11-A12, A14-A15, and. A16-A17.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor 2 cm or less in greatest dimension, T2 - Tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor more than 5 cm in greatest dimension, and T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report mentions that 'THE MAXIMAL TUMOR SIZE IS ESTIMATED TO BE 2.8 CM' which directly corresponds to the criteria for T2, as the tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract the tumor size from the pathology report and compare it with the AJCC Cancer Staging Manual (7th edition) criteria. Then, I can use the extracted information to determine the T stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 2.8 cm, which according to the AJCC Cancer Staging Manual (7th edition) corresponds to a size of more than 2 cm but not more than 5 cm.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : I. SPECIMEN: A: SENTINAL LYMPH NODE #1. B: SENTINAL LYMPH NODE #2. C: LEFT BREAST TISSUE. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, EXCISIONAL BIOPSY: - TWO (2) LYMPH NODES NEGATIVE FOR MALIGNANCY BY ROUTINE AND. IMMUNOHISTOCHEMICAL STAINS. B. LYMPH NODE, SENTINEL #2, EXCISIONAL BIOPSY: - ONE (1) LYMPH NODE NEGATIVE FOR MALIGNANCY BY ROUTINE AND. IMMUNOHISTOCHEMICAL STAINS. C. BREAST, LEFT, BIOPSY: -MULTIFOCAL INFILTRATING DUCTAL CARCINOMA (TWO FOCI, 1.5 CM AND 0.6 CM. IN GREATEST DIMENSION), INTERMEDIATE GRADE BY COMBINED HISTOLOGIC. CRITERIA. -SURGICAL MARGINS : LARGER TUMOR 2.0 MM FROM SUPERIOR MARGIN. SMALLER TUMOR 1.5 MM FROM SUPERIOR MARGIN. -NO EVIDENCE OF LYMPHVASCULAR INVASION. -IN-SITU COMPONENT: DUCTAL CARCINOMA IN-SITU (INTERMEDIATE GRADE,. CRIBRIFORM PATTERN, COMPRISING 10% OF THE TUMOR) . CLINICAL DIAGNOSIS AND HISTORY: female with infiltrating ductal carcinoma of the left breast. diagnosed on core biopsy. Specimen #: GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1. received in formalin, labeled with the. patient's name, designated \"SENTINEL LYMPH NODE NUMBER ONE\" consists of a. tan, fibrofatty tissue fragment measuring 2.0 x 1.3 x 0.4 cm in size. Sectioning reveals two ovoid, tan nodules suggestive of lymphoid tissue. The largest one is 0.5 cm in size, the smaller is 0.4 cm in size. The specimen is bisected and entirely submitted in cassette A. B. SENTINEL LYMPH NODE #2. received in formalin, labeled with the. patient's name, designated \"SENTINEL LYMPH NODE NUMBER TWO\" is a roughly. ovoid, tan, firm tissue fragment measuring 0.6 x 0.5 x 0.4 cm in size. Sectioning reveals a well-delineated homogeneous tan nodule suggestive of. a lymch node. The specimen is trisected and entirely submitted in B1. C. LEFT BREAST TISSUE received in formalin, labeled with the patient's. name, designated \"LEFT BREAST TISSUE\" is a fibrofatty tissue fragment. originally received fresh measuring 6.8 x 6.5 x 2.1 cm, impaled with a. needle localization wire. A radiograph accompanies the specimen. The. specimen is oriented with sutures (one stitch=medial, two. stitches=superior, wire=anterior) The specimen is inked as follows. Red=medial and lateral, blue=superior, green=inferior, yellow=anterior,. and black=posterior. Sectioning reveals a 1.5 cm tumor with well-defined. margins and abutting the superior margin. The tumor has a tan, gritty. cut surface. Approximately 1.0 cm lateral to the tumor is a second firm,. well-defined nodule. The remaining tissue is mostly fat with patches of. white, fibrous tissue. Two sections of the tumor and one section of. grossly normal fibrous tissue (lateral margin, approximately 3.0 cm from. tumor) are submitted for the CBCP protocol (matching paraffin. sections=A1-A3 respectively) The remaining specimen is sectioned and. submitted from lateral to medial in additional cassettes labeled C4-C15. Slide key: C4: Lateral most margin. C5-C6: Paired sections. C7-C8: Previously described smaller mass. C9-C10: Paired sections. C11: Same area as C2. C12: Same area as C1. C13-C14 Sections of largest tumor mass. C15: Section demonstrating medial most margin. 15CFSS.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0EO.61BC91AE-CD06-432D-BCBA-6FAE2209C610",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor. The pathology report mentions a multifocal infiltrating ductal carcinoma with two foci: one measuring 1.5 cm and the other measuring 0.6 cm in greatest dimension. Since the largest tumor size is 1.5 cm and there's no mention of the tumor being larger than 2 cm or any skin or chest wall involvement, we can directly apply the T staging criteria based on tumor size.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The largest tumor size is 1.5 cm, which is less than or equal to 2 cm in greatest dimension, meeting the criteria for T1 according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: ,Age: )F Race: WHITE. SPECIMEN: A: RIGHT AXILLIARY SENTINAL L.N. B: RIGHT BREAST MASTECTOMY C: RIGHT BREAST TISSUE. D: LEFT BREAST MASTECTOMY. FINAL DIAGNOSIS: A. RIGHT AXILLIARY SENTINEL LYMPH NODE, BIOPSY: - ONE LYMPH NODE WITH RARE INDIVIDUAL CYTOKERATIN-POSITIVE CELLS. BY IMMUNOHISTOCHEMISTRY, (LESS THAN 0.2 MM IN DIAMETER) . B. RIGHT BREAST, MASTECTOMY: INFILTRATING LOBULAR CARCINOMA, MODERATELY DIFFERENTIATED (BLOOM-. RICHARDSON SCORE 6). -MAXIMUM TUMOR SIZE 2 CM (GROSS MEASUREMENT). - EXTENSIVE LOBULAR CARCINOMA IN SITU (LN3). -ANTERIOR MARGIN POSITIVE FOR INVASIVE CARCINOMA. -ESTROGEN RECEPTOR POSITIVE; PROGESTERONE RECEPTOR NEGATIVE (SEE. S04- -. -HER 2 NEU NOT AMPLIFIED (SEE. C. RIGHT BREAST TISSUE, EXCISION: -NEGATIVE FOR TUMOR. D. LEFT BREAST, MASTECTOMY: FOCAL LOBULAR CARCINOMA IN SITU (LN3) . USUAL DUCTAL EPITHELIAL HYPERPLASIA. COLUMNAR CELL CHANGE. COMMENT : The AJCC stage for the right breast carcinoma is. TICNO (i+) (sn) MX. ER/PR and Her2 neu studies were performed on the previous biopsy, and are. not repeated. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: -year-old with diagnosis of breast cancer, 1.0 cm spiculated mass right. breast. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"RIGHT AXILLARY SENTINEL LYMPH NODE\" consists of a 2.0 x 1. 6 x. 1.0 cm piece of fatty tissue containing a 1.0 cm lymph node. The node is. bisected and a 1.0 mm thick section of one of the halves is submitted for. the CBCP protocol. Cassette key: A1: Bisected lymph node. A2: Remainder of the fatty tissue. B. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST MASTECTOMY\" consists of a 950.0 gram simple. mastectomy specimen, measuring 22.5 cm medial to lateral, 21.0 cm superior. to inferior, and 3.8 cm anterior to posterior. The overlying ellipse of. nipple bearing skin measures 15.0 x 7.5 cm and is notable for a. vell-healed, curvilinear scar 4.3 cm in length, near the superior lateral. edge. The specimen is oriented with sutures. The anterior margin is inked. blue, the posterior margin is inked black. Sectioning reveals a 2.0 cm. area of indurated area in the lower inner quadrant at the 5:00 position,. abutting the anterior medial margin. The remaining tissue is predominantly. fatty and unremarkable. Multiple tissue sections taken for the. protocol; matching paraffin sections are as follows. B1: Skin, lateral tip. B2-B4: : Tumor. B5: Fibrofatty tissue, 2.0 cm from tumor, lower inner quadrant. B6: Fibrofatty tissue, 14.0 cm from tumor, lower outer quadrant. B7: Fibrous tissue, 15.0 cm from tumor, upper outer quadrant. B8: Fibrofatty tissue, 9.0 cm from the tumor, upper inner quadrant. B9-B10: Nipple. 10C16. C. Received in formalin, labeled with the patient's name,. designated \"RIGHT BREAST INFERIOR TISSUE\" consists of a 6.5 x 6.0. x. 3.5 cm fragment of fatty tissue. The surface is inked in black. Sectioning. reveals predominantly fatty tissue with a minimal fibrous component. Representative sections from throughout the lesion are placed in cassettes. C1 through C5. D. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST MASTECTOMY\" consists of a 1540.0 gram simple. mastectomy specimen measuring 24.5 cm medial to lateral, 19.0 cm superior. ^GY. 1. Specimen #: GROSS DESCRIPTION (continued) : to inferior, and 5.0 cm anterior to posterior. The overlying ellipse of. nipple bearing skin measures 21.0 x 11.5 cm. The specimen is oriented with. sutures and inked as follows : Blue=anterior black=posterior Sectioning. reveals predominantly fat and admixed patches of white, fibrous tissue. No. discrete masses are identified. One section of skin and one section of. fibrofatty tissue from each quadrant is submitted for the. protocol. Matching paraffin sections are as follows: D1: Skin. D2: Upper outer quadrant. D3: Upper inner quadrant. D4: Lower inner quadrant. D5: Lower outer quadrant . D6: Nipple. D7: Upper outer quadrant. D8: Upper inner quadrant. D9: Lower inner quadrant. D10: Lower outer quadrant.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0EP.F76120C1-B2B2-46EE-AAE1-57B05D258ED1",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is defined as follows: \\\\nT1: Tumor <= 2 cm in greatest dimension. \\\\nT2: Tumor > 2 cm but <= 5 cm in greatest dimension. \\\\nT3: Tumor > 5 cm in greatest dimension. \\\\nT4: Tumor of any size with direct extension to the chest wall or skin. \\\\n\\\\nFrom the provided pathology report, the key information for determining the T stage is: \\\\n- The maximum tumor size is 2 cm (as stated in the gross measurement). \\\\n- There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. \\\\n\\\\nGiven that the tumor size is 2 cm, which falls into the category of <= 2 cm, the pathologic T stage for this breast cancer patient is T1.",
    "BaselineChoice": "T1",
    "Monologue": "Determine the pathologic T stage for breast cancer based on the provided pathology report.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The maximum tumor size is 2 cm, which falls within the criteria for a T2 classification according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: BLACK. Physician (s) : SPECIMEN: A: LEFT BREAST LUMPECTOMY B: SENTINEL LYMPH NODE #1. C: NON-SENTINEL LYMPH NODE D: SENTINEL LYMPH NODE #2. E: ADDITIONAL LEFT BREAST INFERIOR MARGIN. FINAL DIAGNOSIS: A. BREAST, LEFT, LUMPECTOMY: INFILTRATING DUCTAL CARCINOMA, HIGH GRADE, NOTTINGHAM SCORE 9/9. TUMOR SIZE = 2.5 CM (MEASURED GROSSLY). INVASIVE CARCINOMA WITHIN 1 MM OF THE ANTERIOR (YELLOW INK) MARGIN. (SLIDE A20). DUCTAL CARCINOMA IN-SITU, COMEDO-TYPE. FOCUS OF DUCTAL CARCINOMA IN-SITU, COMEDO-TYPE WITHIN 1.3 MM OF THE. INFERIOR (GREEN INK) MARGIN (SLIDE A18) . NEGATIVE FOR LYMPH VASCULAR SPACE INVASION. FIBROCYSTIC CHANGES INCLUDING FIBROSIS AND APOCRINE METAPLASIA. AJCC PATHOLOGIC STAGE: pT2 NO (i-) Mx. B. SENTINEL LYMPH NODE #1, EXCISION: ONE LYMPH NODE NEGATIVE FOR TUMOR BY H AND E AND IMMUNOHISTOCHEMSTRY. C. NON-SENTINEL LYMPH NODE, EXCISION: ONE LYMPH NODE NEGATIVE FOR TUMOR. D. SENTINEL LYMPH NODE #2, EXCISION: NO LYMPHOID TISSUE IDENTIFIED. E. BREAST, LEFT, ADDITIONAL INFERIOR MARGIN, EXCISION: FIBROCYSTIC CHANGES INCLUDING FIBROSIS AND APOCRINE METAPLASIA. NEGATIVE FOR TUMOR. Specimen # : CLINICAL DIAGNOSIS AND HISTORY: -year-old female with IDC. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST LUMPECTOMY\" consists of a fibroratty tissue. fragment, oriented with sutures (long is lateral, short is superior). measuring 8.2 cm medial to lateral, 7.: cm superior to inferior, and 2.7. cm anterior to posterior. Ink code: Red=medial and lateral, blue=superior,. green=inferior, yellow=anterior, black=posterior. Sectioning from medial. to lateral reveals a well-defined, irregular, tan tumor in the. anterior/inferior portion of the specimen, measuring 2.5 x 1.5 x 1.5 cm in. greatest dimension. The tumor is within 2.0 mm of the anterior margin. The. remaining tissue is mostly fatty with patches of dense, fibrous tissue,. especially lateral to the tumor. One section of the tumor, and one section. of the grossly normal fibrous tissue (2.0 cm lateral to tumor) submitted. for the CBCP protocol with matching paraffin section in cassettes A1-A3,. respectively. The specimen is submitted from medial to lateral,. concentrating on the fibrous areas. Cassette summary: A6-A7: One paired slice. A10-A11: One paired slice, from which blocks A1 and A2 were taken. A12-A13: : Paired slices. A14-A15: Paired slices. A18-A19: One paired slice together. A23: Lateral most portion of specimen. B. Received in formalin, labeled with the patient's name,. B, designated \"SENTINEL LYMPH NODE #1\" consists of a single lymph node. measuring 0.9 x 0.5 x 0.4 cm. The lymph node is bisected and half is. submitted for the CBCP protocol. The remainder is submitted for permanent. section. C. Received in formalin, labeled with the patient's name,. B, designated \"NON-SENTINEL LYMPH NODE\" consists of a fragment of. yellow/tan fibroadipose tissue, 2.5 x 0.6 x 0.3 cm. One potential lymph. node candidate is identified, measuring 0.5 cm in greatest dimension. The. specimen is entirely submitted. D. Received in formalin, labeled with the patient's name,. B, designated \"SENTINEL LYMPH NODE #2\" consists of a fragment OL pink/tan. to yellow fibroadipose tissue, 2.6 x 1.6 x 0.9 cm. The specimen is. bisected revealing mottled, pink/tan to red cut surfaces. The specimen is. Specimen #: GROSS DESCRIPTION (continued) : entirely submitted. E. Received in formalin, labeled with the patient's name,. B, designated \"ADDITIONAL LEFT BREAST INFERIOR MARGIN\" consists of a. fragment of fibroadipose tissue, 2.1 x 1.5 x 0.8 cm. The specimen is not. oriented and is inked blue and serially sectioned. The cut surfaces reveal. yellow/tan adipose tissue admixed with bands of white, fibrous tissue. There is a focus of pink/white, firmer tissue measuring 0.5 cm in greatest. dimension. The specimen is entirely submitted.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0EQ.60569C8B-7209-4A3F-A177-F337085E9146",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size of the tumor and its extension. The T stage is defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report mentions that the tumor size is 2.5 cm (measured grossly). Based on this information, we can determine the T stage.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.5 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition)",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : AMENDED. SPECIMEN: A: SENTINEL LYMPH NODE #1 B: SENTINEL LYMPH NODE #2. C: RIGHT BREAST TISSUE D: FINAL DEEP MARGIN. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, BIOPSY: - POSTIVE FOR MICROME'TASTASIS (largest deposit 0.6 mm). IN ONE OF TWO LYMPH NODES (1 of 2). B. LYMPH NODE, SENTINEL #2, BIOPSY: - NEGATIVE FOR METASTASIS IN ONE EXAMINED LYMPH NODE. (Multiple sections stained by hematoxylin & eoson and by. immunohistochemistry for keratin). C. BREAST TISSUE, RIGHT, LUMPECTOMY: - INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED BY COMBINED. HISTOLOGICAL CRITERIA (TUBULES=3, NUCLEAR SIZE=2, MITOSES=1,. TOTAL=6). - MAXIMUM SIZE = 1.4CM (SLIDE C1). SUPERIOR-ANTERIOF MARGIN INVOLVED BY TUMOR (SLIDE C23) . OTHER. MARGINS NEGATIVE FOR TUMOR. DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM-TYPE WITH NECROSIS. (SLIDE C15). - FIBROADENOMA. - FIBROCYSTIC CHANGES INCLUDING APOCRINE METAPLASIA AND USUAL DUCTAL. HYPERPLASIA. D. BREAST, DEEP MARGIN, EXCISION: - BENIGN FIBROADIPOSE TISSUE AND SKELETAL MUSCLE. - NEGATIVE FOR TUMOR. COMMENT: The report is ammended. to report evaluation. of sentinal lymph nodes during. absence. Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: year old female with history of a right breast mass. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 Received fresh is a 2.5 x 1.7 x 1.5 cm fatty. tissue fragment containing 2.2 x 1.4 x 1.6 cm lymph node. Half of the node. is submitted for the CBC protocol. The remaining half is submitted for. paraffin section in one cassette. B. fresh is a 2.0 x 1.8 x 1.5 cm fatty tissue fragment containing. a 1.5 x 1.2 x 1.2 cm lymph node. Half of the node is submitted for the CBC. protocol. The remaining half is submitted for paraffin sections in a. single cassette. C. Received fresh is a fibrofatty tissue fragment, oriented with sutures. (short-superior, Long-lateral) measuring 7.5 x 5.5 x 1 cm. A needle. localization wire is in place. The accompanying radiograph is reviewed and. shows a well defined density alongside the locaation wire and about 1 cm. from a metallic clip. Inked: blue- superior-anterior, green- inferior- -. anterior, black-posterior. The specimen is sectioned from lateral to. medial revealing a 1.3 x 1.0 x 0.7 cm tumor with tan gritty cut surface in. the. mid. portion of the specimen. The tumor is located 0.3 cm from the deep. margin and 0.3 cm from the inferior anterior margin. The remaining tissue. is variably fatty and fibrous. Two tissue sections submitted for CBC. protocol with matching paraffin sections as follows : C1: tumor. C2: fibrous area near lateral margin approximately 2 cm from tumor. Additional sections are submitted as follows: C3-C4: lateral to fibrous area paired cassettes. C5-C6: medial to fibrous area paired cassettes. C7-C8: paired cassettes. Specimen #: GROSS DESCRIPTION (continued) : C9-C10: paired cassettes. C11-C13: matched cassettes. C14-C16: matched cassettes lateral to tumor. C17-C18: paired cassettes medial to tumor. C19-C21: matched cassettes. C22-C23: paired cassettes. C24-C25: paired cassettes. D. Received in formalin and labeled with the patient's name. and designated FINAL DEEP MARGIN is a single fragment of yellow-tan -. fibrous tissue measuring 3.5 x 2 x 1 cm. Inked entirely in black. Serial. sectioning reveals unremarkable fibroadipose tissue mostly adipose. Tissue. is entirely submitted.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the tumor and its extent. The key information from the pathology report is the size of the invasive ductal carcinoma, which is stated as having a maximum size of 1.4 cm. ",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage of the breast cancer patient, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 1.4 cm corresponds to a T1 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        I. Specimen #: (Age: F Race: WHITE. Physician (s) : SPECIMEN: LEFT BREAST. FINAL DIAGNOSIS: BREAST, LEFT, MASTECTOMY: - MODERATELY DIFFERENTIATED (GRADE II/III) INFILTRATING LOBULAR CARCINOMA. NOTTINGHAM SCORE: 6 OF 9 (Tubule formation = 3 Nuclear pleomorphism =. 2, and Mitotic activity = 1). TUMOR SIZE (GREATEST DIMENSION) : 3.5 CM (MEASURED GROSSLY) (SEE. COMMENT). TUMOR NECROSIS: NOT PRESENT. MICROCALCIFICATIONS: FOCALLY PRESENT, ASSOCIATED WITH INVASIVE. CARCINOMA, AS WELL AS, BENIGN DUCTS. VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. MARGINS NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST INKED BLACK (DEEP) TISSUE EDGE IS 0.5. CM (SLIDE A7) . INTRADUCTAL COMPONENT: LOBULAR CARCINOMA IN SITU. NIPPLE INVOLVEMENT: NOT PRESENT. SKIN INVOLVEMENT: NOT PRESENT. LYMPH NODES: ONE (1) SENTINEL LYMPH NODE NEGATIVE PER PRIOR. SURGICAL SPECIMEN. ESTROGEN RECEPTORS: POSTTIVE (95% NUCLEAR STAINING PER PRIOR. SURGICAL SPECIMEN. PROGESTERONE RECEPTORS: NEGATIVE (NO DETECTABLE NUCLEAR. STAINING PER PRIOR SURGICAL SPECIMEN. HER2/NEU: WEAKLY POSITIVE BY IMMUNOHISTOCHEMISTRY (2+). NEGATIVE BY. FISH (HER2/CEP17 RATIO: 0.9) PER PRIOR SURGICAL SPECIMEN. PATHOLOGIC STAGE: pT2 NO MX. - ADDITIONAL PATHOLOGIC CHANGES. FLORID USUAL DUCTAL HYPERPLASIA. FIBROADENOMATOID CHANGE. FIBROCYSTIC CHANGES TO INCLUDE STROMAL FIBROSIS, CYST FORMATION, AND. APOCRINE METAPLASIA. PRIOR BIOPSY SITE CHANGES. Comment: The lobular differentiation is supported by negative E-cadherin. cytoplasmic staining and strongly positive 34betaEl2 ( ) perinuclear. cytoplasmic staining. There are microscopic foci of infiltrating lobular. carcinoma and LCIS in a random representative section of the lower outer. quadrant (slide A10) The morphology is identical to the main tumor. Specimen #: FINAL DIAGNOSIS (continued) : mass. These foci likely represent extension of the main tumor rather than. true multifocal carcinoma. CLINICAL DIAGNOSIS AND HISTORY: {None Given}. GROSS DESCRIPTION: A. Received fresh labeled with the patient's name. and. designated \"LEFT BREAST\" is a 413 gram simple mastectomy specimen oriented. with sutures (long lateral, short superior) measuring 22 cm medial to. lateral, 16 cm superior to inferior, and 4. 8 cm anterior to posterior. An. ellipse of unremarkable nipple bearing skin measuring 5.5 x 3 cm is. present. The specimen is inked as follows: blue superior superficial,. green inferior superficial, black deep. Sectioning reveals a 3.5 x 3.5 x 3. cm firm poorly defined mass at the 2-3:00 position, 0.2 cm from the inked. deep margin. The cut surface of the tumor is yellow tan and gritty. The. remaining tissue is mostly fatty with admixed patches of white fibrous. tissue located centrally. Two sections of tumor, a single section of. skin, and a single section of grossly normal breast are collected for CBCP. protocol with matched paraffin sections in A2, A3, A1, and A4. respectively. The specimen was in formalin for 76 hours and 5 minutes. Summary of cassettes: A1: skin. A2: tumor lateral. A3: tumor medial. A4: grossly normal breast central. A5-A7: random additional sections of tumor. A8: left upper outer quadrant. A9: left upper inner quadrant. A10: left lower outer quadrant. A11: left lower inner quadrant. A12: nipple.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the pathology report provided, the tumor size (greatest dimension) is measured grossly to be 3.5 cm. There is no mention of the tumor extending to the chest wall or skin; in fact, the report explicitly states \"SKIN INVOLVEMENT: NOT PRESENT\" and \"NIPPLE INVOLVEMENT: NOT PRESENT\", which rules out a T4 classification. Given that the tumor size is 3.5 cm, which is greater than 2 cm but less than or equal to 5 cm, the pathologic T stage for this breast cancer patient would be T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage of the breast cancer patient, I need to extract relevant information from the pathology report, compare numerical values, and apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition). First, I will extract the tumor size from the report. Then, I will compare this value against the thresholds for each T stage. Finally, I will use the extracted information and comparison results to determine the pathologic T stage and produce a final response.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 3.5 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST LUMPECTOMY. B: RIGHT AXILLARY NODE DISSECTION. FINAL DIAGNOSIS: A. BREAST, RIGHT, LUMPECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED (G2). NOTTINGHAM SCORE: 6/9. (Tubules= 2, Nuclei=2, Mitoses= 2; mitotic count 10 per 10 HPF at. 20x power-0.5 field diameter). TUMOR SIZE (GREATEST DIMENSION) : 1.9 CM (measured microscopically) . TUMOR NECROSIS: ABSENT. MICROCALCIFICATIONS: ABSENT. VENOUS / LYMPHATIC INVASION: ABSENT. MARGINS : - INVASIVE CARCINOMA PRESENT 1.2 CM FROM ANTERIOR MARGIN. DUCTAL CARCINOMA IN SITU PRESENT 0.5 CM FROM INFERIOR MARGIN. INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, CRIBIFORM TYPE, LOW. NUCLEAR GRADE. LYMPH NODES: FIVE OF SIXTEEN POSTIVE FOR TUMOR. (see specimen B). SKIN INVOLVEMENT: ABSENT. MULTICENTRICITY: ABSENT. ESTROGEN RECEPTORS: POSITIVE. (see. PROGESTERONE RECEPTORS NEGATIVE. (see. HER 2 NEU by IHC: NEGATIVE. (see. PATHOLOGIC STAGE: pT1c N2a Mx. ADDITIONAL PATHOLOGIC CHANGES: BENIGN FIBROCYSTIC CHANGES. B. SOFT TISSUE, RIGHT AXILLA, LYMPH NODE DISSECTION: - FIVE OF SIXTEEN LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: -year-old female with 2.0 cm right breast mass found on routine. mammagram. Patient was also found to have two lymph nodes seen. largest 1.5 cm, BIRIDS-5 Ultrasound guided biopsy of breast mass showed. Grade I Invasive Ductal Carcinoma with DCIS and FNA of axillary lymph node. showing metastatic carcinoma from primary breast on. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST LUMPECTOMY\" is an irregular, oblong portion of. soft tissue oriented with a short stitch superior and a long stitch. medial. The specimen measures 14.0 cm in medial to lateral, 7.0 cm. superior to inferior, and 2.5 cm anterior to posterior. The lightly. pigmented superficial skin ellipse measures 8.5 x 2.2 cm and is otherwise. unremarkable. The specimen is inked as follows superior = blue, inferior. = green, medial = red, lateral = yellow, anterior = orange, and posterior. = black. Serial sections reveal a firm, pink-white, gray mass measuring. 3.3. x 2.2 x 1.5 cm. The mass is well circumscribed, and approaches the. margins as follows: 0.2 cm from the deep margin, 0.5 cm from the anterior. margin, 1.5 cm from the inferior margin, and 1.8 cm from the superior. margin. The remainder of the specimen is predominantly composed of. lobulated, yellow-tan, adipose tissue. The fibrous tissue comprises. 5%. of. the cut surface, and is tan-white, markedly dense, and otherwise. unremarkable. Representative sections are submitted as follows: Cassette Summary : A1: Mass. A2: Adjacent normal. A3: Skin. A4-A5: Additional sections adjacent to mass. A6-A9: Additional sections of mass. A10-12 Additional sections adjacent to A1 and A9. Matched sections of A1-A2 are submitted in. or CBCP protocol. The specimen was placed in formalin at. pm for a total time in. formalin for approximately 28 hours. B. Received fresh, labeled with the patient's name,. designated \"RIGHT AXILLARY NODE DISSECTION\" is an 11.0 x 8.0 x 2.5 cm. irregular, unoriented portion of soft tissue. Serial sectioning reveals. Y. Specimen # : GROSS DESCRIPTION (continued). 16 lymph nodes ranging in size from 0.7 x 0.7 x 0.5 cm to 4.0 x 2.0 x 1. . 0. cm. On sectioning, four of the lymph nodes show a firm, pink-tan, cut. surface consistent with metastatic involvement. The remaining lymph nodes. are pink-yellow and otherwise unremarkable. Representative sections are. submitted as follows: Cassette Summary : B1-B4: Largest lymph node. B5: Lymph node #1. B6: Lymph node #2. B7: Lymph node #3. B8: Lymph node #4. B9: One lymph node. B10: One lymph node. B11: One lymph node bisected. B12: One lymph node bisected. B13: One lymph node bisected. B14: Two lymph nodes, each bisected. B15: Four lymph nodes. Matched sections of B1, B5-B10 - are submitted in. or CBCP protocol.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor. The T stage is defined as follows: T1 - tumor size is 2 cm or less, T2 - tumor size is more than 2 cm but not more than 5 cm, T3 - tumor size is more than 5 cm, and T4 - any size with direct extension to the chest wall or skin. According to the pathology report, the tumor size (greatest dimension) is 1.9 cm, which is less than 2 cm. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T1c, which corresponds to a tumor size of more than 1 cm but not more than 2 cm. However, since T1 is the option that encompasses T1c and given the choices provided (T1, T2, T3, T4), the best answer is T1.",
    "BaselineChoice": "T1",
    "Monologue": "Based on the pathology report, I need to extract the tumor size and other relevant information to determine the pathologic T stage.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 1.9 cm corresponds to T2 according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race WHITE. Physician (s) : SPECIMEN: A: SENTINEL NODE RIGHT BREAST B: RIGHT BREAST TISSUE. FINAL DIAGNOSIS: A. SENTINEL NODE, RIGHT, AXILLARY: - ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY H&E AND. IMMUNOHISTOCHEMISTRY. B. BREAST, RIGHT, NEEDLE-LOCALIZED EXCISION: TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA, NOS, MULTIFOCAL. NOTTINGHAM GRADE: III/III (G3). NOTTINGHAM SCORE: 8/9. (Tubules= 3, Nuclei= 3, Mitoses= 2; mitotic count 13 per 10 HPF at. 40x power - field diameter = 0.63 mm). TUMOR SIZE (greatest dimension, measured grossly) : MASS #1: 1.0 CM. MASS #2: 0.5 CM. MASS #3 : 1.2 CM. TUMOR NECROSIS: PRESENT. MICROCALCIFICATIONS: PRESENT ASSOCIATED WITH CARCINOMA AND IN THE. MEDIA OF VESSELS (MEDIAL CALCIFIC SCLEROSIS) . VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. MARGINS INVASIVE (B7) AND IN SITU (B4, 7) CARCINOMA PRESENT LESS THAN. 0.1 CM FROM THE MEDIAL MARGIN (YELLOW). INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 3. (SOLID AND COMEDO TYPES). LYMPH NODES: SEE SPECIMEN \"A\". ESTROGEN RECEPTORS: : POSITIVE (95%). PROGESTERONE RECEPTORS: POSITIVE (95%). HER 2 NEU by IHC: NEGATIVE (1+). PATHOLOGIC STAGE: pT1c NO MX. ADDITIONAL PATHOLOGIC CHANGES: : FIBROCYSTIC CHANGES, MAMMOMARK. IDENTIFIED. COMMENT: Three clearly separate tumor foci have been identified grossly. and on the accompanying specimen radiograph, favoring the designation of. 'multifocal' rather than one large tumor. Specimen # : FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: year old female undergoing needle localized lumpectomy of the right. breast with sentinel node biopsy. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"SENTINEL NODE RIGHT BREAST\" is a 2.5 x 2.0 x 1.0 cm irregular. portion. of soft tissue. Sectioning reveals a single, pink-yellow, lymph. node measuring 1.5 x 0.5 x 0.3 cm. The lymph node is bisected. A matched. section of the specimen is submitted in cassette A1 is submitted in. for the CBCP protocol. The specimen is entirely submitted as follows: Cassette Key: A1: Lymph node. A2: Adipose tissue. B. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST TISSUE\" is an irregular portion of soft tissue. oriented as follows: short stitch is superior aspect, long stitch is. lateral aspect, and double stitch is the deep aspect. The specimen. measures 8.5 cm from medial to lateral, 8.5 cm from superior to inferior,. and 2.5 cm from anterior to posterior. The specimen is received with an. accompanying radiograph, and two embedded localization wires. The. specimen is inked as follows superior aspect is inked in blue, inferior. aspect is inked in green, the medial aspect is inked in yellow, the. lateral aspect is inked in red, the anterior aspect is inked in orange,. and the posterior aspect is inked in black. Serial sectioning reveals. three fairly well defined, pink-white masses. Mass #1 measures 1.0 x 0.7. x. 0.5. cm and is located 0.7 cm from the deep margin. Mass #2 measures 0.5. x 0.3 x 0.3 cm, and is located 0.5 cm anterior to mass #1 in approximately. the same plane of tissue, and coming to within 0.2 cm of the anterior and. lateral margins. Mass #3 measures 1.2 x 1.0 x 0.6 cm, and is located 1.0. cm medial to mass #1 and mass #2 coming to within 0.2 cm of the anterior. margin. The remainder of the specimen is composed of lobulated,. yellow-tan, adipose tissue admixed with minimal fibrous tissue. No. Specimen #: GROSS DESCRIPTION (continued). additional lesions are identified. At the time of processing, the. specimen will have spent 51 hours fixing in formalin. The specimen is. submitted as follows: Cassette Key. B1: Representative section of mass #1. B2: : Margins of specimen submitted in cassette B1. B3-B4 - Representative sections from mass #2. B5 : Normal appearing breast tissue adjacent to cassette B4. B6: Representative section of mass #3 with nearest margin. B7: Representative section of mass #3 with nearest margin. B8-B9: - Additional margins from mass #1. B11-B14 : Additional margins from mass #2. B15: Area of fibrous tissue medial to mass #3. Matched sections of specimen is submitted in cassettes B1, B5, and B7 are. submitted in. for the clinical breast care project protocol. Z.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report mentions three separate tumor foci (masses) with sizes: Mass #1 = 1.0 cm, Mass #2 = 0.5 cm, and Mass #3 = 1.2 cm. Since the largest tumor size is 1.2 cm, which is less than or equal to 2 cm, we can classify the tumor as T1. However, we must also consider if the sum of the sizes of the multifocal tumors would change the classification. In this case, even if we were to consider the combined size of the tumors, the total size would still be less than 2 cm (1.0 cm + 0.5 cm + 1.2 cm = 2.7 cm), but the AJCC staging manual for multifocal tumors considers the size of the largest focus for T classification, not the aggregate size of all foci. Therefore, based on the size of the largest tumor focus (1.2 cm), the pathologic T stage is T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for this breast cancer patient, I need to extract relevant information from the pathology report, such as tumor size, depth of invasion, and lymph node involvement. Then, I can apply the AJCC Cancer Staging Manual (7th edition) rules to determine the T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is larger than 2 cm but not larger than 4 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        1. M. Specimen # : Race: WHITE. Locatio. SPECIMEN: A: LEFT BREAST LUMPECTOMY B: SENTINEL LYMPH NODE #1. C: SENTINEL LYMPH NODE #2 D: SENTINEL LYMPH NODE #3. E: NON-SENTINEL NODE TISSUE. FINAL DIAGNOSIS: A. BREAST, LEFT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: 2 OF 3 (MODERATELY DIFFERENTIATED). - NOTTINGHAM SCORE: 7 OF 9. (Tubules=3 , Nuclei= 2, Mitoses= 2; mitotic count 8 per 10 HPF at. 40x power). - TUMOR SIZE (GREATEST DIMENSION) : 1.3 CM (MEASURED GROSSLY). - TUMOR NECROSIS: ABSENT. - MICROCALCIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: ABSENT. - MARGINS : -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.2 CM, FROM ANTERIOR. MARGIN (MEASURED GROSSLY). - INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, INTERMEDIATE. NUCLEAR GRADE (G2) WITH CENTRAL NECROSIS. ESTROGEN RECEPTORS POSITIVE (NEARLY 100% NUCLEAR STAINING, FROM. PREVIOUS BIOPSY. PROGESTERONE RECEPTORS: POSITIVE (95% NUCLEAR STAINING, FROM. PREVIOUS BIOPSY. - HER 2 NEU by IHC: NEGATIVE (1+, FROM PREVIOUS BIOPSY. - LYMPH NODES: SEE PARTS B, C, D, AND E. - PATHOLOGIC STAGE: pT1c NO (i-) MX. - ADDITIONAL PATHOLOGIC CHANGES : - FIBROCYSTIC CHANGES, INCLUDING CYSTS AND FIBROSIS. - CHANGES OF PRIOR BIOPSY. B. LYMPH NODE, SENTINEL #1, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. C. LYMPH NODE, SENTINEL #2, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. Specimen #: FINAL DIAGNOSIS (continued) : AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. D. LYMPH NODE, SENTINEL #3, RESECTION: - TWO LYMPH NODES NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. E. SOFT TISSUE, NON-SENTINEL NODE TISSUE, RESECTION: - TWO LYMPH NODES NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN. COMMENT: Part A: Immunohistochemical stains for e-cadherin (positive in. invasive carcinoma) cytokeratin 903 (positive in invasive carcinoma), ,. and. p63 (positive in myoepithelial cells), are reviewed with appropriate. controls. Parts B-D: Immunohistochemical stains for cytokeratin are reviewed with. controls. This case received prospective quality control review. R. CLINICAL DIAGNOSIS AND HISTORY. female with lump above left nipple. MMG showing. speculaced mass at twelve o' clock position with overlying skin retraction. US guided biopsy confirmed intraductal carcinoma. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST LUMPECTOMY\" is an ovoid portion of soft tissue. oriented with a short stitch superior, long stitch lateral. The specimen. measures 8.0 cm medial to lateral, 6.5 cm superior to inferior, and 3. 0 cm. anterior to posterior. Located on the anterior surface is a 4.5 x 2.0 cm. lightly pigmented, superficial skin ellipse. No scar is identified. The. specimen is inked as follows: superior = blue, inferior = green, medial. =. Specimen #: GROSS DESCRIPTION (continued) : red, lateral = yellow, anterior = orange, and posterior = black. Serial. sections reveal a fairly well defined, firm, gritty, pink-white mass. measuring 1.3 x 1.2 x 0.8 cm. The mass shows focal congestion with an. embedded clip on sectioning. The mass is located subadjacent to the skin. ellipse coming to within 0.2 cm of the anterior inked margin, and 0.4 cm. of the superior margin. The remainder of the specimen is composed of. lobulated, yellow-tan, adipose tissue admixed with a moderate amount of. fibrous tissue. No additional lesions are identified. Cassette Summary : A1: Mass with skin. A2: Adjacent normal with superior margin. A3: Mass with adjacent normal. A4-A5: - Superior and posterior margins. A6: Skin with anterior margin. A7: Medial margin. A8: Medial margin. A9: Lateral and inferior margin. A10: Lateral and anterior margin. A11: Inferior margin. Matched sections of A1 and A3 are submitted in. for CBCP protocol. B. Received fresh, labeled with the patient's name. designated \"SENTINEL LYMPH NODE #1\" is a 2.0 x 2.0 x 1.0 cm portion of. soft tissue. The specimen is bisected to reveal a predominantly fatty cut. surface with a partial thin, rim of pink-tan, lymphoid tissue. The. specimen is submitted in cassettes B1 and B2. C. Received fresh, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #2\" is a 2.5 x 2.5 x 1.0 cm portion UL. soft tissue. The specimen is bisected to reveal a predominantly fatty,. cut surface with minimal lymphoid tissue identified. The specimen is. entirely submitted in cassettes C1 and C2. D. Received fresh, labeled with the patient's name,. designated \"SENTINEL LYMPH NODE #3' is a 1.5 x 1.0 x 0.5 cm portion or. soft tissue. The specimen is bisected to reveal a predominantly fatty,. cut surface with minimal lymphoid tissue identified. The specimen is. entirely submitted in cassette D1. E. Received in formalin, labeled with the patient's name,. Specimen #: GROSS DESCRIPTION (continued). designated 'NON-SENTINEL NODE TISSUE\" are two portions of. yellow-brown, lobulated, soft tissue measuring 2.0 x 1.5 x 0.7 cm, and 1. 1. x 0.4 x 0.4 cm. Both fragments are bisected to reveal a predominantly,. fatty, cut surface admixed with lymphoid tissue. The larger fragment is. submitted in cassette E1. The smaller is submitted in cassette E2.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the tumor. The tumor size is given in the pathology report as 1.3 cm (measured grossly). According to the AJCC Cancer Staging Manual (7th edition), the pathologic T stage is determined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. Since the tumor size is 1.3 cm, which is less than or equal to 2 cm, the pathologic T stage is T1. ",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract the tumor size from the pathology report and compare it with the AJCC Cancer Staging Manual (7th edition) criteria.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 1.3 cm, which corresponds to a T1 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: (Age: )F Race: WHITE. SPECIMEN: A: LEFT BREAST B: RIGHT BREAST. C: LEFT AXILLARY SENTINEL NODE. D: RIGHT AXILLARY SENTINEL NODE. E: RIGHT AXILLARY NON SENTINEL NODE. FINAL DIAGNOSIS: A. BREAST, LEFT, SIMPLE MASTECTOMY: - SKIN WITH NO SIGNIFICANT PATHOLOGIC CHANGES. BREAST TISSUE WITH FIBROCYSTIC CHANGES TO INCLUDE APOCRINE METAPLASIA. AND MICROCYST FORMATION. - NEGATIVE FOR MALIGNANCY. B. BREAST, RIGHT, SIMPLE MASTECTOMY: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, MULTICENTRIC (SEE COMMENT) . TUMOR #1: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, LOW NUCLEAR GRADE. - NOTTINGHAM GRADE: I/III. - NOTTINGHAM SCORE: 5/9. (Tubules= 3, Nuclei= 1, Mitoses= 1; mitotic count 1 per 10 HPF at. 40x power). - TUMOR LOCATION: LOWER OUTER QUADRANT. TUMOR SIZE (GREATEST DIMENSION) : 1.0 CM (MEASURED GROSSLY). - ADDITIONAL DIMENSIONS: 1.0 X 0.5 CM. - TUMOR NECROSIS: NONE IDENTIFIED. - MICROCALCIFICATIONS: NONE IDENTIFIED. VENOUS / LYMPHATIC INVASION: NONE IDENTIFIED. - MARGINS: TUMOR INVOLVES INKED SUPERFICIAL MARGIN (B2) . - INTRADUCTAL COMPONENT: NONE IDENTIFIED. LYMPH NODES FOUR (4) OF FOUR POSITIVE FOR TUMOR BY H&E (SEE PARTS D. AND E). - NIPPLE INVOLVEMENT: NOT IDENTIFIED. - SKIN INVOLVEMENT: NOT IDENTIFIED. TUMOR #2: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, LOW NUCLEAR GRADE. - NOTTINGHAM GRADE: I/III. - NOTTINGHAM SCORE: 5/9. (Tubules= 3, Nuclei= 1, Mitoses= 1; mitotic count 2 per 10 HPF at. Specimen # : FINAL DIAGNOSIS (continued) : 40x power). - TUMOR LOCATION: UPPER MIDDLE. - TUMOR SIZE (GREATEST DIMENSION) : 1.0 CM (MEASURED GROSSLY) (SEE. COMMENT) . - ADDITIONAL DIMENSIONS: 1.0 X 0.5 CM. - TUMOR NECROSIS: NONE IDENTIFIED. MICROCALCIFICATIONS: PRESENT, ASSOCIATED WITH LOBULAR CARCINOMA IN. SITU (B3). - VENOUS / LYMPHATIC INVASION: NONE IDENTIFIED. - MARGINS : TUMOR <0.1 CM FROM INKED SUPERFICIAL MARGIN (B3). - INTRADUCTAL COMPONENT : NONE IDENTIFIED. - LYMPH NODES: SEE ABOVE. - NIPPLE INVOLVEMENT: NOT IDENTIFIED. - SKIN INVOLVEMENT: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (PER. - PROGESTERONE RECEPTORS: POSITIVE (PER. - HER 2 NEU by IHC: 1+ (NEGATIVE) (PER. - PATHOLOGIC STAGE: pT1c N2 MX (AJCC, 6th ED) (SEE COMMENT). - ADDITIONAL PATHOLOGIC CHANGES: - LOBULAR CARCINOMA IN SITU. - ACELLULAR FOREIGN MATERIAL AND BIOPSY SITE CHANGES (SEE COMMENT) . - FIBROCYSTIC CHANGES TO INCLUDE APOCRINE METAPLASIA AND MICROCYST. FORMATION. - MAMMARY DUCT ECTASIA. C. SENTINEL LYMPH NODE, LEFT AXILLA, EXCISIONAL BIOPSY: - THREE (3) BENIGN LYMPH NODES BY CONVENTIONAL H&E AND. IMMUNOHISTOCHEMICAL STAINING. D. SENTINEL LYMPH NODES, RIGHT AXILLA, EXCISIONAL BIOPSY. - THREE (3) LYMPH NODES POSITIVE FOR CARCINOMA BY CONVENTIONAL H&E AND. IMMUNOHISTOCHEMICAL STAINING. E. NON-SENTINEL LYMPH NODE, RIGHT AXILLA, EXCISIONAL BIOPSY: - ONE (1) LYMPH NODE POSITIVE FOR CARCINOMA WITH EXTRACAPSULAR. EXTENSION BY H&E STAINING. Comment: There are two separate tumors in the right breast mastectomy. specimen. Since these tumors are separated by 4. cm and are located in. different quadrants the designation \"multicentric\" is used. Both tumors. are histologically similar. The acellular marker material present in the. specimen is associated with the upper middle tumor (tumor #2) . There are. isolated tumor cells present in a section adjacent to the upper middle. Specimen #: FINAL DIAGNOSIS (continued) : tumor (tumor #2, slide B4) making the exact determination of tumor size. difficult. The largest dimension measured of the tumor is 1.2 cm from the. previous biopsy specimen (S08- - i! making the tumor stage Tlc. The. histologic appearance along with the presence of lobular carcinoma in situ. and the immunohistochemical characterization of the previous biopsy. support the diagnosis of invasive lobular carcinoma. CLINICAL DIAGNOSIS AND HISTORY: year-old female with right breast mass birads four on. mammogram, ultrasound guided biopsy, invasive lobular carcinoma. Bilateral simple mastectomy, skin biopsy, with immediate reconstruction. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated \"LEFT BREAST TISSUE WITH MARKINGS\" is a mastectomy specimen. oriented with a short stitch superior, long stitch lateral, and double. stitch \"down\". The specimen measures 17.0 cm medial to lateral, 16 cm. superior to inferior, and 3.5 cm anterior to posterior. The lightly. pigmented superficial skin ellipse measures 10.0 x 3.0 cm and displays a. 1.0 cm centrally located everted nipple free of discharge. No scar is. identified. The deep margin is inked black. Serial sections reveal. predominantly lobulated, yellow-tan, adipose tissue admixed with evenly. distributed, tan-white, fibrous tissue comprising approximately 20% of the. cut surface. On palpation, no discreet mass or lesion is identified. No. lymph nodes are identified. Cassette Summary : A1: Skin. A2: Upper outer quadrant. A3: Upper inner quadrant. A4: Lower inner quadrant. A5: Lower outer quadrant. A6: Central. A7: Nipple. A8: Upper outer quadrant. Specimen #: GROSS DESCRIPTION (continued) : A9: Upper inner quadrant. A10: Lower inner quadrant. All: Lower outer quadrant . Matched sections of A1 through A6 are submitted in. for CBCP protocol. B. Received fresh, labeled with the patient's name,. designated \"RIGHT BREAST TISSUE WITH MARKINGS\" is a mastectomy specimen. oriented with a short stitch superior, and a long stitch lateral. The. specimen measures 7.0 cm superior to inferior, 17.0 cm medial to lateral,. and 3.5 cm anterior to posterior. The lightly pigmented superficial skin. ellipse measures 10.0 x 3.0 cm and displays a 1.0 cm centrally located,. everted nipple free of discharge. No scar is identified. The deep margin. is inked black, and the superficial surface is partially inked blue. Serial sections reveal a 1.0 x 1.0 x 0.5 cm well defined, tan-white mass. in. the. upper mid breast, abutting the blue inked superficial surface, and. coming to within 4.0 cm of the deep margin. Also identified is a second,. poorly defined mass in the lower outer quadrant measuring approximately. 1.0 x 1.0 x 0.5 cm. The lower outer quadrant mass abuts the blue inked. superficial surface, and is located 4.5 cm from the deep margin. The. masses are separated by a distance of approximately 4.5 cm. The remainder. of the specimen is predominantly composed of lobulated, yellow-tan,. adipose tissue admixed with approximately 20% slightly dense, fibrous. tissue. No additional lesions are identified. No lymph nodes are. identified. Cassette Summary : B1: Skin. B2 Lower outer quadrant mass. B3 : Upper mid mass. B4: Adjacent normal (to B3) . B5: Upper outer quadrant. B6: Lower outer quadrant. B7: Lower inner quadrant. B8: Upper inner quadrant. B9: Nipple. B10: Lower outer quadrant mass. B11: Deep margin of lower outer quadrant mass. B12-B13: Upper mid mass. B14: Deep margin of upper mid mass. C. Received in formalin, labeled with the patient's name,. D, designated \"LEFT AXILLARY SENTINEL NODE\" is a 5.5 x 4.5 x. cm. irregularly shaped, lobulated fragment of tan-yellow, adipose. Sectioning. Specimen #: GROSS DESCRIPTION (continued) : reveals three possible lymph nodes ranging in size from 1.0 x 0.6 x 0.3 cm. to 1.2 x 1.0 X 0.6 cm. The lymph nodes are bisected, and submitted in. cassettes C1 through C3. D. Received in formalin, labeled with the patient's name,. D, designated \"RIGHT SENTINEL NODE\" is a tan-yellow, lobulated,. irregularly shaped fragment of adipose tissue measuring 5.5 x 3.0 X 0.5 cm. in diameter. Examination reveals three possible lymph nodes ranging in. size from 0.2 x 0.2 x 0.2 cm to 2.3 x 1.6 x 1.0 cm. Cassette Summary. D1-D2: First possible lymph node. D3: Second possible lymph node. D4: Third possible lymph node. E. Received fresh for intraoperative consultation, labeled with the. patient's name,. designated \"RIGHT AXILLARY TISSUE, NON. SENTINEL NODE\" is a 4.0 x 3.5 x 2.0 cm irregular portion of yellow-tan,. soft tissue. Sectioning reveals a single, 1.5 x 1.0 x 0.5 cm lymph node. The cut surface is tan-white, suspicious for involvement by lesion. The. lymph node is bisected, and submitted in cassette E1. A matched section. of E1 is submitted in. ior CBCP protocol. Time in formalin for specimen A: 79 hours. Time in formalin for specimen B: 81 hours.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to assess the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report describes two separate tumors in the right breast, both measuring 1.0 cm in greatest dimension. Since the largest dimension of the tumors is 1.0 cm and there is no mention of direct extension to the chest wall or skin, we can classify the tumor based on its size.",
    "BaselineChoice": "T1",
    "Monologue": "Determine the pathologic T stage for breast cancer based on the provided pathology report.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The largest dimension of the tumor is 1.2 cm, which falls within the T1c category according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        ly. BASS. Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: LEFT BREAST LUMPECTOMY B: SENTINEL NODE #1. C: ADDITIONAL SUPERIOR MARGINS D: ADDITIONAL DEEP MARGIN. FINAL DIAGNOSIS: A. BREAST, LEFT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING LOBULAR CARCINOMA, SEE COMMENT. - NOTTINGHAM GRADE: II (MODERATELY DIFFERENTIATED). - NOTTINGHAM SCORE: 6 OF 9 (Tubules= 3, Nuclei= 2, Mitoses= 1) . TUMOR SIZE (GREATEST DIMENSION) : 2.3 CM, SEE COMMENT. - TUMOR NECROSIS NOT IDENTIFIED. - MICROCALCIFICATIONS: PRESENT. - VENOUS / LYMPHATIC INVASION: NO DEFINITIVE EVIDENCE. - PERINEURAL INVASION: PRESENT (A5, A13) . - MARGINS. - PRESENT AT LATERAL MARGIN (A3) AND POSTERIOR MARGIN (A10). - TUMOR MEASURES 0.3 CM FROM CLOSEST SUPERIOR MARGIN (A8). AND 0.3 CM FROM CLOSEST INFERIOR MARGIN (A16). - INTRADUCTAL COMPONENT: LOBULAR CARCINOMA IN SITU PRESENT. - LYMPH NODES : INDIVIDUAL TUMOR CELLS IDENTIFIED (SEE PART \"B\"). - SKIN INVOLVEMENT NOT IDENTIFIED. - MULTICENTRICITY: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (SEE. - PROGESTERONE RECEPTORS: POSITIVE (SEE. - HER 2 NEU by IHC: NEGATIVE (1+) (SEE. - PATHOLOGIC STAGE: pT2 NO (i+) Mx (AJCC, 6th edition) . - ADDITIONAL PATHOLOGIC CHANGES: - FIBROCYSTIC CHANGES TO INCLUDE USUAL DUCT HYPERPLASIA, APOCRINE. METAPLASIA, STROMAL FIBROSIS, AND MICROCYSTS. - COLUMNAR CELL CHANGE WITHOUT ATYPIA. - PREVIOUS BIOPSY SITE CHANGE WITH SURGICAL MARKER IDENTIFIED. - UNREMARKABLE SKIN. B. LYMPH NODE, SENTINEL #1, EXCISION: - RARE INDIVIDUAL TUMOR CELLS FOUND ON CYTOKERATIN. IMMUNOHISTOCHEMISTRY. C. BREAST, LEFT (ADDITIONAL SUPERIOR MARGIN) , EXCISION: Y. Specimen # : FINAL DIAGNOSIS (continued) : - TUMOR PRESENT <0.1 CM (0.9 MM) FROM THE DESIGNATED \"NEW TRUE MARGIN\". (C8) , SEE COMMENT. D. BREAST, LEFT (ADDITIONAL DEEP MARGIN) , EXCISION: - BENIGN BREAST TISSUE. - NEGATIVE FOR MALIGNANCY. COMMENT. PART A. The tumor exhibits a lobular growth pattern, which is confirmed by an. E-cadherin immunohistochemical stain. However, focal tubular formation is. noted in scattered portions of tumor. Based on morphologic and. immunohistochemical features, the tumor type is interpreted as being. infiltrative lobular carcinoma with focal ductal differentiation. Assessment of the greatest dimension of tumor size is hindered by. the multifocal nature of the infiltrating lobular carcinoma. The greatest. dimension of 2.3 CM is based on the combination of microscopic and. radiographic findings in this case. PART C. The tumor exhibits features that are similar to those features seen in the. tumor in Part A. This case received intradepartmental consultation. Previous biopsy material. was reviewed in conjunction with this. case. CLINICAL DIAGNOSIS AND HISTORY: y/o female with history of left breast mass. PRE-OPERATIVE DIAGNOSIS: none provided. Specimen #: POST-OPERATIVE DIAGNOSIS: none provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name. and. designated \"Left Breast Lumpectomy\" is a breast lumpectomy specimen with. accompanying radiograph, measuring 6.0 cm from superior to inferior, 3.5. cm from medial to lateral, and 2.0 cm from anterior to posterior. A. 4.0. x. 0. 6 cm lightly pigmented, loosely adherent skin ellipse is noted on the. superficial surface. The specimen is inked as follows superior - blue;. inferior - green; medial - red; lateral - yellow; anterior - orange;. posterior - black. Serial sectioning reveals a 1.5 x 1.0 x 0.6 cm poorly. defined mass. The cut surface is tan-white, firm and focally congested. with an embedded metallic clip. The mass is located 0.5 cm from the. anterior, medial, and posterior margins, and 0.7 cm from the lateral. margin. The remainder of the specimen is composed of markedly dense. tan-white fibrous tissue admixed with a minimal amount of adipose tissue. Entirely submitted. Cassette Summary : Al-anterior-lateral margin with skin. A2-posterior-medial margin. A3-posterior-lateral margin. A4-posterior margin. A5-mass. A6-mass in relation to deep margin. A7 through A16 - remaining serial sections from superior to inferior, with. matched plane sections in A10-A11 and A12-A13. B: Received fresh, labeled with the patient's name. and. designated \"Sentinel Node #1\" is a single 2.0 x 1.5 x 0.7 cm pink-tan -. lymph node. The specimen is trisected and submitted in cassettes B1-B2. A matched section of B1 is submitted in. for CBCP protocol. C: Received in formalin, labeled with the patient's name,. and designated \"Additional Superior Margin\" is an irregular. fragment of pale yellow adipose tissue measuring 5.2 x 2.9 x 1.0 cm in. overall dimensions. Several metallic staples are present embedded on one. surface of the specimen; this surface is designated as the new true. margin. This surface will be inked orange and the opposing surface will. be inked blue. The specimen is serially sectioned to reveal a dense. tan-white fibrous cut surface. Residual tumor is not grossly identified. The specimen is entirely and sequentially submitted in eight cassettes. scfns. D: Received in formalin, labeled with the patient's name,. Specimen #: 3. GROSS DESCRIPTION (continued) : and designated \"Additional Deep Margin\" is an irregular fragment. or tan-yellow lobulated adipose tissue measuring 2.3 x 1.2 x 0.6 cm in. overall dimensions. Several metallic staples are identified embedded in. one surface of the specimen; this surface is identified as the true new. margin. This surface is inked orange, and the opposing surface is inked. blue. The specimen is serially sectioned to reveal a homogeneous. tan-yellow cut surface without evidence of residual tumor. The specimen. is entirely and sequentially submitted in three cassettes.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the tumor size (greatest dimension) is 2.3 cm. Since the tumor size is greater than 2 cm but less than or equal to 5 cm, it falls into the T2 category. Although there is mention of the tumor being close to margins and having certain characteristics like perineural invasion, the key factor for determining the T stage is the size of the tumor. Therefore, based on the tumor size of 2.3 cm, the pathologic T stage is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and presence of skin involvement or chest wall invasion. Then, I can use the AJCC Cancer Staging Manual (7th edition) rules to determine the T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: : WHITE. SPECIMEN: A: RIGHT BREAST LUMPECTOMY B: ADDITIONAL INFERIOR MARGIN. C: ADDITIONAL DEEP MARGINS D: SENTINEL NODE #1. E: SENTINEL LYMPH NODE #2. FINAL DIAGNOSIS: A. BREAST, RIGHT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED. - NOTTINGHAM SCORE: 6/9. (Tubules= 2, Nuclei= 3, Mitoses= 1). TUMOR SIZE (GREATEST DIMENSION) : 2.8 CM. - TUMOR NECROSIS: NOT IDENTIFIED. - MICROCALCIFICATIONS: PRESENT ASSOCIATED WITH INFILTRATING CARCINOMA. AND BENIGN DUCTS. - VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. - MARGINS : UNINVOLVED. - DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN IS 0.3 CM, FROM. INFERIOR MARGIN. (measured microscopically). INTRADUCTAL COMPONENT: PRESENT; SOLID AND CRIBRIFORM, NUCLEAR GRADE. 3, WITH CENTRAL NECROSIS. - LYMPH NODES: SEE PARTS \"D-E\". - ONE OF TWO SENTINEL LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. - SKIN INVOLVEMENT: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (SEE. - PROGESTERONE RECEPTORS: NEGATIVE (SEE. - HER 2 NEU by IHC: POSITIVE (SEE. - PATHOLOGIC STAGE: pT2 N1a MX. - ADDITIONAL PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, FIBROCYSTIC. CHANGES, SCLEROSING ADENOSIS, UNREMARKABLE EPIDERMIS. B. BREAST, \"ADDITIONAL INFERIOR MARGIN\", EXCISION: - BENIGN BREAST TISSUE. - MARGINS UNINVOLVED. PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, APOCRINE METAPLASIA,. FIBROCYSTIC CHANGES, MICROCALCIFICATIONS. C. BREAST, \"ADDITIONAL DEEP MARGINS\", EXCISION: Specimen #: FINAL DIAGNOSIS (continued) : - BENIGN FIBROADIPOSE TISSUE WITH NO EVIDENCE OF MALIGNANCY. - NO BREAST GLANDULAR ELEMENTS PRESENT. - MARGINS UNINVOLVED. D. LYMPH NODE, SENTINEL NODE #1, BIOPSY: - ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. - LARGEST METASTATIC FOCUS: 0.4 CM. - EXTRACAPSULAR EXTENSION: NOT IDENTIFIED. E. LYMPH NODE, SENTINEL NODE #2, BIOPSY: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY ROUTINE HISTOLOGY. AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. Comment : The prior core biopsy specimen (. right breast,. is reviewed. This case has received intradepartmental prospective. peer review. CLINICAL DIAGNOSIS AND HISTORY: y/o female with history of right breast carcinoma. PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. and. designated \"RIGHT BREAST LUMPECTOMY\" consists of a breast lumpectomy. specimen, measuring 9.0 cm from superior to inferior; 8.8 cm from medial. to lateral; and 3.0 cm from superior to inferior. The specimen is. oriented with a long suture marking the lateral margin; and a short suture. marking the superior margin. The overlying ellipse of tan skin measures. 6. x 1.8 cm. The specimen is differentially inked as follows: blue -. superior; green - inferior; orange - anterior; black - posterior; red -. lateral; and yellow - medial. The specimen is serially sectioned from. R. Y. Specimen #: GROSS DESCRIPTION (continued) : anterior to posterior to reveal a sharply-circumscribed, firm, ovoid mass. with. a. homgenous tan cut surface, measuring 2.8 x 2.6 x 1.6 cm in overall. dimensions. This mass is located in the posterior half of the specimen,. and measures 0.4 cm from the nearest margin (inferior) . The remaining. tissue is mostly fatty with admixed areas of fibrosis, especially. posteriorly. Skin, tumor, and grossly unremarkable fibrous tissue are. sampled for the CBCP Protocol with matching paraffin sections in cassettes. A1, A2-A6 and A7. Representative sections are submitted as follows: A1-. skin; A2-tumor; A3-6 - - tumor with inferior margin; A7-fibrous tissue. with posterior and superior margins; A8 - -fibrous tissue with superior. margin; A9-10- anterior margin; A11-12- lateral margin; A13-14-medial. margin. B: Received in formalin, labeled with the patient's name,. ad designated \"ADDITIONAL INFERIOR MARGIN\" consists of an irregular. fragment of tan-yellow, lobulated adipose tissue, measuring 5.5 x 1.9 x. 0.8 cm in overall dimensions. The specimen is received oriented with. steel surgical clips marking the true new margin. This new margin is. inked blue, and the opposing surface is inked orange. The specimen is. serially sectioned to reveal a tan-yellow, fatty cut surface without. evidence of residual tumor. The specimen is entirely submitted in six. cassettes. C: Received in formalin, labeled with the patient's name,. d designated \"ADDITIONAL DEEP MARGINS\" consists of an irregular. portion of tan-yellow, lobulated adipose tissue measuring 4.7 x 3.9 x. 1.1. cm in overall dimensions. The true new margin is marked with surgical. clips, this margin is inked blue, and the opposing surface is inked. orange. The specimen is serially sectioned to reveal a homogenous. tan-yellow, fatty cut surface without exidence of residual tumor. Representative sections are submitted in six cassettes. D: Received fresh, labeled with the patient's name,. designated \"SENTINEL NODE #1\" consists of a single irregular tragment of. tan-yellow adipose tissue, measuring 2.0 x 1.8 x 0.5 cm in overall. dimensions. Palpation of the specimen reveals a single tan-pink lymph. node, measuring 1.5 x 0.7 x 0.7 cm in overall dimensions. A small portion. of the lymph node is sampled for the CBCP Protocol with matching paraffin. section in D1, and the remainder of the specimen is submitted in cassette. D2. E: Received in formalin, labeled with the patient's name,. and designated \"SENTINEL LYMPH NODE #2\" consists of a similar irregular. Specimen #: GROSS DESCRIPTION (continued) : fragment of tan-yellow, lobulated adipose tissue measuring 2.4 x 2.0 x 1.1. cm in overall dimensions. The specimen is bisected to reveal a 2.2 cm. firm, tan-pink lymph node. The specimen is entirely submitted in two. cassettes.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is based on the largest dimension of the invasive tumor. Here's the step-by-step reasoning:",
    "BaselineChoice": "T2",
    "Monologue": "private planning to address query",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 2.8 cm, which falls within the criteria for T2 staging according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Patient: : Specimen # : Race: WHITE. AMENDED. SPECIMEN: A: RIGHT BREAST BIOPSY B: SENTINEL LYMPH NODE#1. C: SENTINEL LYMPH NODE#2. FINAL DIAGNOSIS: A. BREAST, RIGHT; EXCISION: - INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED (MODIFIED. BLOOM-RICHARDSON GRADE 9: MITOSES=3, NUCLEAR PLEOMORPHISM=3, TUBULE. FORMATION=3). -TUMOR SIZE 2.0 CM. - -TUMOR IS LESS THAN 0.1 CM FROM ANTERIOR AND MEDIAL SURGICAL MARGINS. - -ASSOCIATED FINDINGS: FIBROCYSTIC CHANGES INCLUDING STROMAL SCLEROSIS. AND MICROCYSTS. -MICROCALCIFICATIONS IDENTIFIED, ASSOCIATED WITH BENIGN BREAST TISSUE. - IMMUNOHISTOCHEMICAL STAINS FOR ESTROGEN AND PROGESTERONE AS FOLLOWS. ESTROGEN RECEPTOR: NEGATIVE. PROGESTERONE RECEPTOR: POSITIVE. -HER2/NEU (FISH METHODOLOGY) : NOT AMPLIFIED (1.3). B. LYMPH NODE, SENTINEL LYMPH NODE#1, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN IS APPROXIMATELY 0.5 CM IN SIZE. C. LYMPH NODE, SENTINEL LYMPH NODE#2, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN LESS THAN 0.1 CM IN SIZE. COMMENT: This case is amended to reflect the review of. immunohistochemical stains for estrogen and progesterone receptors and. FISH for Her2/neu amplification. There is no change in diagnosis. COMMENT. ge 1. specimen #: FINAL DIAGNOSIS (continued) : Case amended. to report results of HER2 analysis by. immunohistochemistry (DAKO Hercep Test) : HER2/NEU PROTEIN OVEREXPRESSION: NEGATIVE (SCORE: 1+) . CLINICAL DIAGNOSIS AND HISTORY: -year-old female with palpable mass on right breast with no ultrasound. or mammographic correlation. GROSS DESCRIPTION: A. RIGHT BREAST BIOPSY received in formalin, labeled with the patient's. name, designated \"RIGHT BREAST EXCISIONAL BIOPSY\" is a lumpectomy specimen. measuring 10.2 x 7.0 x 3.0 cm in dimension. The specimen is composed. largely of yellow, lobulated, glistening adipose tissue admixed with white. fibrous areas. The specimen will be inked and oriented as follows: Black=deep, yellow=anterior, blue=medial, green=lateral, and red denotes. superficial and inferior. The specimen is serially sectioned from superior. to inferior revealing a fiarly well-defined, grey/tan nodule, 1.5 cm in. greatest dimension, abutting the anterior margin in the mid portion of the. specimen. Immediately adjacent to this nodule is a 1.5 cm patch of. indurated fibrous tissue involving the anterior and medial margins. The. remaining tissue consists of an admixture of fibrous tissue (approximately. 40%) and fat (approximately 60%) . The fibrous tissue is variably. indurated, particularly in the inferior half of the specimen. Sections of. nodule and fibrous tissue are harvested for the CBCP protocol. Matching. paraffin sections are as follows: A1: Nodule. A2: Indurated fibrous tissue adjacent to A1. A3: Fibrous tissue 3.0 cm inferior to nodule. A4: Fibrous tissue 6.0 cm inferior to nodule at the inferior margin. The remainder of the specimen is serially sectioned and submitted from. superior to inferior as follows: A5-A12: Representative section from each level from superior to inferior. Specimen #: GROSS DESCRIPTION (continued) : A13-A14: Next lower level. A15-A16: Next lower level. A17-A18 Inferior most section. B. SENTINEL LYMPH NODE#1 received in formalin, labeled with the patient'. name, designated \"SUPERIOR LYMPH NODE NUMBER ONE\" is a 1.7 x 1.3 x 0.8 cm. lymph node. A small portion of the node is harvested for the CBCP. protocol. The remaining tissue is entirely submitted in cassette B1. C. SENTINEL LYMPH NODE#2 received in formalin, labeled with the patient' S. name, designated \"SENTINEL LYMPH NODE NUMBER TWO\" is a 1.2 x 0.8 x 0.5 cm. tan/brown lymph node. The tissue is entirely submitted in cassette C1.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extension to nearby tissues or structures. The T stages are defined as follows: T1 - Tumor 2 cm or less in greatest dimension, T2 - Tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report mentions that the tumor size is 2.0 cm, which directly corresponds to one of the T stage definitions. Since the tumor is 2.0 cm, it falls into the T1 category based on size alone, as it is 2 cm or less in greatest dimension. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the provided information, the pathologic T stage for this breast cancer patient is T1.",
    "BaselineChoice": "T1",
    "Monologue": "Determine the pathologic T stage based on the tumor size and distance to margins in the pathology report.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 2.0 cm and it is less than 0.1 cm from the anterior and medial surgical margins.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        This report contains corrections, additions or deletions. Any previous versions are stored internally and are available if necessary,. Specimen: Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSTS. LEFT BREAST CANCER INVASIVE, BREAST ASYMMETRY. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE: LEFT SIMPLE MASTECTOMY, SENTINEL NODE BX, REDUCTION MAMMOPLASTY. PROCEDURE (CONT) : BREAST RECONSTRUCTIN WITH TISSUE EXPANDER. A. LEFT BREAST MASTECTOMY. B. LT BREAST 1ST SENTINEL NODE. C. LT BREAST 2ND SENTINEL NODE. D. LT BREAST 3RD SENTINEL NODE. E. LEFT BREAST TISSUE. F. RIGHT BREAST TISSUE. PART A RECEIVED FRESH LABELED. LEFT BREAST MASTECTOMY. STITCH AT SUPERIOR MEDIAL BORDER, IS A LEFT SIMPLE MASTECTOMY SPECIMEN AS. ORIENTED BY A SUTURE MEASURING 21 x 20 x 4.5 CM. A SKIN ELLIPSE MEASURES. 11.2 x 6.5 CM, WITH A GROSSLY UNREMARKABLE NIPPLE. THE SUPERFICIAL ASPECT. IS MARKED IN BLUE INK, THE DEEP ASPECT IN BLACK INK. IN THE MIDPORTION,. THERE IS A 0.9 X 0.1 X 0.9-CM LESION 2.5 CM FROM THE DEEP MARGIN. A. PORTION OF THIS IS SUBMITTED PER PROTOCOL, THE MIRROR IMAGE IS SUBMITTED. IN A1, AND THE CORRESPONDING DEEP MARGIN IN A2. A SECOND LARGER LESION IS. FOUND LATERAL TO THIS MEASURING 2.2 x 1.6 x 1.5 CM. THIS IS 2 CM FROM THE. DEEP MARGIN. THIS DEEP MARGIN IS SUBMITTED IN A3. THESE TWO AREAS ARE. 1.5 CM APART. MEDIAL TO ALL OF THESE IS A SMALL SUPERFICIAL LESION, 0.5. CM IN GREATEST DIMENSION, 2.5 CM FROM THE FIRST DESCRIBED LESION. THIS. LESION IS SUBMITTED IN A6. A5 REPRESENTS A SECOND SECTION OF THE LARGEST. MOST LATERAL LESION. THE SMALLEST LESION IS 4 CM FROM THE DEEP MARGIN,. WHICH IS SUBMITTED IN A7. THE REMAINING BREAST TISSUE CONSISTS OF BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. ADDITIONAL SECTIONS OF THE. BREAST TISSUE ARE SUBMITTED AS FOLLOWS: A8--PPER OUTER QUADRANT,. A9--UPPER INNER QUADRANT, A10--LOWER INNER QUADRANT, All--LOWER OUTER. QUADRANT, A12--NIPPLE. THE LARGEST LESION IS SUPERIOR TO THE NIPPLE, AND. Specimen: Spec Type: SURGICAL P. THESE LESIONS PROGRESS THEREFORE IN THE UPPER INNER QUADRANT OF THE. BREAST. PART B RECEIVED FRESH LABELED. LEFT BREAST FIRST. SENTINEL NODE HOT, IS A PORTION OF YELLOW FATTY TISSUE MEASURING 2.2 X 1.6. X 0.1 CM. SECTIONING REVEALS A 0.7-CM LYMPH NODE. ONE-HALF IS SUBMITTED. PER PROTOCOL; THE REMAINDER IS SUBMITTED LABELED B. PART C RECEIVED FRESH LABELED. LEFT BREAST SECOND. SENTINEL NODE HOT, IS YELLOW FATTY TISSUE MEASURING 3.8 X 1.1 X 0.8 CM. EXAMINATION REVEALS A 2.2 CM IN LENGTH GROSSLY UNREMARKABLE LYMPH NODE, A. PORTION OF WHICH IS SUBMITTED PER PROTOCOL, AND THE REMAINDER IS SUBMITTED. LABELED C. PART D RECEIVED FRESH LABELED. THIRD SENTINEL NODE, IS. AN OVOID PORTION OF YELLOW FATTY TISSUE MEASURING 2.5 x 1.2 X 1.0 CM. SECTIONING REVEALS FIRM TISSUE BUT NO GROSS NODAL TISSUE. A PORTION IS. SUBMITTED PER PROTOCOL, AND THE REMAINDER IS SUBMITTED LABELED D. PART E RECEIVED LABELED. SECOND BREAST TISSUE. SUPERFICIALLY OVER SUPERIOR MEDIAL ASPECT OVER HARD NODULE STITCH AT NEW. MARGIN, IS AN IRREGULAR PORTION OF YELLOW FATTY TISSUE MEASURING 2.9 x 2.0. x 0.5 CM. A SUTURE DENOTES A NEW MARGIN, AND THIS SIDE IS MARKED WITH. INK. THIS IS SECTIONED AND SUBMITTED LABELED E. PART F RECEIVED LABELED. RIGHT BREAST TISSUE, IS 256. GRAMS OF FIBROFATTY BREAST TISSUE AND SKIN. SECTIONING REVEALS BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THERE ARE NO AREAS OF BROAD. FIBROSIS OR MASSES IDENTIFIED. REPRESENTATIVE TISSUE IS SUBMITTED LABELED. F1 THROUGH 5. PROCEDURES. 88305, 88307/5, IMMUNOPEROXIDAS/3, A1 BLK, A10 BLK, All BLK, A12 BLK,. A2 BLK, A3 BLK, A4 BLK, A5 BLK, A6 BLK, A7 BLK, A8 BLK, A9 BLK, BBX X6,. CBX x6, DBX X6, El BLK, F1 BLK, F2 BLK, F3 BLK, F4 BLK, F5 BLK. NAI. PART A LEFT BREAST, SIMPLE MASTECTOMY: 1. MULTICENTRIC MODERATELY DIFFERENTIATED INTRADUCTAL AND INFILTRATING. DUCT CARCINOMAS (3), NUCLEAR GRADE 2 WITH MODERATE MITOTIC INDEX WITH AN. INSITU COMPONENT OF 5-10% OF SOLID AND CRIBRIFORM TYPE. Specimen : Spec Type: SURGICAL P. FIRAL. 2. THREE TUMORS MEASURING 2.2, 1.0 AND 1.0 CM ARE PRESENT WITH ONE TUMOR. INVOLVING THE SUPERFICIAL MARGIN. 3. DUCTAL CARCINOMA IN SITU IS PRESENT IN THE DEEP DUCTS OF THE NIPPLE. SKIN. THE NIPPLE SKIN AND DEEP MARGINS OF EXCISION ARE FREE OF NEOPLASM. 4. FOCI SUSPICIOUS FOR LYMPHATIC INVASION ARE PRESENT. PART B LEFT BREAST, FIRST SENTINEL NODE, BIOSPY: LYMPH NODE (1) WITH. AN. ISOLATED FOCUS OF TUMOR CELLS, MEASURING 0.01 MM, INDENTIFIED ON THE. CYTOKERATIN STAIN AND ONLY THE FIRST OF THREE STEP-SECTIONS OF THE H&E. STAINS. PART C LEFT BREAST, SECOND SENTINEL NODE, BIOPSY: LYMPH NODE (1). NEGATIVE FOR TUMOR BY ROUTINE AND CYTOKERATIN STAIN. PART D LEFT BREAST, THIRD SENTINEL NODE, BIOPSY: SMALL LYMPH NODES (5),. NEGATIVE FOR TUMOR BY ROUTINE AND CYTOKERATIN STAIN. PART E LEFT BREAST SUPERFICIAL TISSUE RE-EXCSION: FIBROADIPOSE TISSUE,. NEGATIVE FOR TUMOR WITH THE NEW INKED MARGIN FREE OF NEOPLASM. PART F RIGHT BREAST, REDUCTION MAMMOPLASTY: SKIN, ADIPOSE AND BREAST. TISSUE WITH FIBROCYSTIC CHANGE AND A FOCUS OF ATYPICAL LOBULAR. HYPERPLASIA. ONCOTYPE. RESULTS: = 14. CLINICAL EXPERIENCE: PATIENTS WITH A RECURRENCE SCORE OF 14 IN THE. CLINICAL VALIDATIONS STUDY HAD AN AVERAGE RATE OF DISTANT RECURRENCE AT 10. YEARS OF 9% (95% CI: 6%-12%) . (signature on file). 'il.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report regarding the size and extent of the tumor. The report mentions multiple lesions, but the key information for staging is the size of the largest lesion and whether the tumor has invaded nearby tissues or structures. The AJCC staging manual defines the T stages as follows: T1 - Tumor ≤ 20 mm, T2 - Tumor > 20 mm but ≤ 50 mm, T3 - Tumor > 50 mm, T4 - Tumor of any size with direct extension to the chest wall or skin. The report describes the largest lesion as measuring 2.2 x 1.6 x 1.5 cm, which is greater than 20 mm but less than or equal to 50 mm. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Based on the size of the largest lesion, the pathologic T stage would be T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract information about the tumor size and other relevant details from the pathology report.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race: WHITE. Physician (s) : SPECIMEN: WUID:161E2817-7082-46F8-BFEB-256DBBEFE633. A: RIGHT BREAST B: RIGHT AXILLARY CONTENTS. FINAL DIAGNOSIS: A. RIGHT BREAST, MASTECTOMY: TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA, NO SPECIAL TYPE. NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3 mitotic count 14 per 10 HPF at. 40x power). TUMOR SIZE (GREATEST DIMENSION) : 4.5 CM (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT, IN INFILTRATING COMPONENT AND DCIS. MICROCALCIFICATIONS: PRESENT IN INFILTRATING COMPONENT AND BENIGN. PROCESSES. VENOUS / LYMPHATIC INVASION: PRESENT; EXTENSIVE. MARGINS : DEEP MARGIN POSITIVE FOR TUMOR IN TISSUE AND LYMPHATICS. INTRADUCTAL COMPONENT: PRESENT; MINIMAL. NIPPLE INVOLVEMENT: PRESENT (without Pagetoid spread) . SKIN INVOLVEMENT: PRESENT. MULTICENTRICITY: PRESENT; MULTIPLE SEPARATE MICROSCOPIC FOCI IN OTHER. QUADRANTS (SEE COMMENT). ESTROGEN RECEPTORS: Previously ordered and positive. PROGESTERONE RECEPTORS: Previously ordered and positive. HER 2 NEU by IHC: Previously ordered; weakly positive. HER 2 Neu BY FISH: Previously ordered and pending. PATHOLOGIC STAGE: pT4d N2a MX. ADDITIONAL PATHOLOGIC CHANGES. -DUCTAL CARCINOMA IN-SITU, HIGH GRADE. - -CYSTIC CHANGE WITH APOCRINE METAPLASIA. B. LYMPH NODES, RIGHT AXILLA, DISSECTION: EIGHT LYMPH NODES POSITIVE FOR TUMOR, WITH EXTENSIVE EXTRACAPSULAR. EXTENSION IDENTIFIED, AND DEPOSITS LARGER THAN 2 MM. COMMENT: ER, PR, and Her2Neu are performed on the patient's prior material. collected by mammotome biopsy,. and will not be. repeated. This tumor shows satellite nodules throughout all quadrants. Specimen #: FINAL DIAGNOSIS (continued) : sampled except the lower outer quadrant. These nodules are not measured. separately as separate primary tumors; they appear to have arisen from. intramammary lymphatic spread. It is likewise difficult to measure the. degree of extranodal extension of tumor from the lymph nodes due to the. extensive perinodal tumor deposits. CLINICAL DIAGNOSIS AND HISTORY: yo white female with right nipple inversion, right breast. Prior. mammotome biopsy with ductal carcinoma. A. Right breast, Long stitch lateral, short stitch superior (fresh). B. Right axillary contents including thoraco bundle (fresh). GROSS DESCRIPTION: A. Specimen received in formalin labeled with patient's name. consists of a 627 gram right mastectomy specimen oriented with short. stitch superior and long stitch lateral. Specimen measures 24 cm superior. to inferior, 23 cm medial to lateral, 4 cm anterior to posterior. Superficial skin ellipse measures 9.5 x 4 cm and displays a centrally. located inverted nipple. No scar is noted. No discharge is noted. Deep. resection margin shows scant portions of muscular tissue. Deep margin. inked black and superficial margin is inked blue. Serial sections reveal a. centrally located poorly defined firm pink white mass measuring 4.5 x 4.5. x. 2.0. cm. Periphery of the mass shows hemorrhage consistent with previous. biopsy. Mass abuts deep margin. Fibrous parenchyma surrounding mass is. nodular and cystic suggestive of additional foci. Located in the deep. margin of mid inner quadrant is a 0.4 cm firm tan ill defined nodule. consistent with possible additional lesion (located approximately 2 cm. from central lesion) . Sectioning of nipple shows dense fibrous tissue. with possible lesion involvement. Remainder of parenchyma is lobulated. yellow tan and fatty with scant fibrous tissue. No lymph nodes identified. Representative sections: A1: skin. A2: nipple. A3: mass (lateral portion). A4: mass and adjacent fibrous tissue (medial portion). Specimen #: GROSS DESCRIPTION (continued). A5: mid inner quadrant nodule with margins. A6: mass with deep margin (central). A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant . Matched sections of A1-A4 and A7-A10 are. submitted. for CBCP protocol. A11-A20 represent additional sections of mass. Remaining breast tissue is. unoriented, no sutures remain in tissue. Representative samples of lesion. beneath elliptical wedge of skin and nipple are represented. A13-A14. represent one match set. Specimen submitted. B. Received in formalin labeled with patient's name. labeled. \"RIGHT AXILLARY CONTENTS INCLUDING SARCO BUNDLE\" consists of an 11 x 6 x 3. cm irregular unoriented portion of fatty tissue. Sectioning reveals two. matted portions of soft tissue measuring 4 x 3.5 x 1.5 cm and 8 x 4 x 1.2. cm. On sectioing the cut surfaces show dense indurated fibrotic tissue. with red tan lymphoid tissue noted along periphery of the smaller portion. tissue. Single intact discrete lymph node is identified and remaining. tissue which measures 0.6 cm. Exact number of lymph nodes cannot be. determined. Representative sections are as follows: B1-B3: smaller portion of tissue. B4-B6: larger portion of tissue. B7: one bisected lymph node.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the provided pathology report. The key information for determining the T stage includes the size of the tumor and whether the tumor has spread to the chest wall or skin. Here's the step-by-step analysis:\\n1. **Tumor Size**: The report states that the tumor size (greatest dimension) is 4.5 cm, which is an important factor for determining the T stage. According to the AJCC 7th edition, a tumor size of more than 2 cm but not more than 5 cm is classified as T2.\\n2. **Skin Involvement**: The report mentions that there is skin involvement, which is a critical factor for determining the T stage. Skin involvement, including ulceration or skin nodules, typically classifies the tumor as at least T4a.\\n3. **Chest Wall Involvement**: There is no explicit mention of chest wall involvement in the report, which would be classified as T4b if present.\\n4. **Nipple Involvement**: The report notes nipple involvement without Pagetoid spread, but nipple involvement alone does not necessarily dictate a T4 classification unless it's part of more extensive skin involvement.\\n5. **Multicentricity and Satellite Nodules**: The presence of satellite nodules and multicentricity is noted, but these factors do not directly influence the T stage in the AJCC 7th edition unless they indicate more extensive disease that affects the classification based on size or extent of involvement.\\nBased on the information provided, the key factor influencing the T stage is the skin involvement, which directly points towards a T4 classification. The size of the tumor (4.5 cm) would suggest a T2 if considering size alone, but the presence of skin involvement takes precedence for staging purposes.\", ",
    "BaselineChoice": "T4",
    "Monologue": "To determine the pathologic T stage of the breast cancer patient, we need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor has direct extension to the skin, including skin involvement and nipple involvement.",
    "Choice": "T4"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: Right Breast Cancer. POSTOPERATIVE DIAGNOSIS: OPERATION: Lumpectomy Right Breast, Right Sentinel Lymph Node Biopsy. SPECIMEN: A) Right Breast Mass - 1 Short Anterior - 2 Short Superior - 1 Long. Medial, B) Sentinel Node #1 F.S., C) Sentinel Node #2 F.S., D) Axillary Contents E). Gross Margin Additional Inferior Margin Right Breast Mass suture New Inferior Margin. FROZEN SECTION DIAGNOSIS: A) GROSS MARGINS: VERY CLOSE (LESS THAN 1 MM), TO. INFERIOR MARGIN. B) SENT LYMPH NODE #1 - POSITIVE FOR METASTATIC. CARCINOMA. C) SENT LYMPH NODE #2 - POSITIVE FOR METASTATIC. CARCINOMA. Lab No.: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Hosp.No: FINAL DIAGNOSIS: A) RIGHT BREAST TISSUE - POORLY DIFFERENTIATED. INFILTRATING DUCTAL CARCINOMA. SCARFF-BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 3.5 CM. IN MAXIMUM DIMENSION AND. FOCALLY CLOSE TO ANTERIOR AND POSTERIOR SURGICAL. MARGINS, (LESS THAN 1 MM.), SLIDES #5 AND #6. THE REMAINING SURGICAL MARGINS ARE FREE OF THE. LESION. LYMPHOVASCULAR INVASION IS IDENTIFIED. MICROCALCIFICATIONS ARE IDENTIFIED. B) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). C) SENTINEL LYMPH NODE - ONE (1) POSITIVE LYMPH NODE, (1/1). D) AXILLARY CONTENTS - 2 OF 13 LYMPH NODES ARE POSITIVE FOR. MALIGNANCY, (2/13). E) ADDITIONAL RIGHT BREAST TISSUE - NEGATIVE FOR. MALIGNANCY. PTNM CLASSIFICATION: PIIIa, T2, N2, MX.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0SW.8401DFCF-8793-461A-B17E-E6584CE2423B",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided pathology report, the key information for determining the T stage is the size of the tumor. The report states that 'THE TUMOR MEASURES 3.5 CM. IN MAXIMUM DIMENSION.' Since the tumor is greater than 2 cm but less than or equal to 5 cm, it falls into the T2 category. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. The report also mentions that the tumor is 'FOCALLY CLOSE TO ANTERIOR AND POSTERIOR SURGICAL MARGINS, (LESS THAN 1 MM.)' but this detail pertains more to the margin status rather than the T stage. The PTNM classification provided in the report (T2, N2, MX) also supports this determination, as it explicitly states T2 for the tumor size. Therefore, based on the tumor size of 3.5 cm, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "The pathology report mentions the tumor size as 3.5 cm, which directly correlates with the T staging of breast cancer. According to the AJCC Cancer Staging Manual (7th edition), a tumor size of more than 2 cm but not more than 5 cm is classified as T2. Since the report explicitly states the tumor measures 3.5 cm in maximum dimension, this falls within the criteria for T2. Additionally, the report mentions that the tumor is focally close to the anterior and posterior surgical margins, but this does not change the T staging based on size. The presence of lymphovascular invasion and positive lymph nodes affects the N stage, not the T stage. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T2.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 3.5 cm falls within the T2 criteria as it is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: Race : WHITE. SPECIMEN: A: LEFT BREAST LUMPECTOMY B: LEFT AXILLARY CONTENTS. C: SENTINEL NODE #1. FINAL DIAGNOSIS: A. BREAST, LEFT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: POORLY DIFFERENTIATED (Grade 3). - NOTTINGHAM SCORE: 9 OF 9 (Tubules= 3, Nuclei= 3, Mitoses= 3 mitotic. count 24 per 10 high power fields at 40x power). - TUMOR SIZE: MULTIFOCAL, LARGEST CONTIGUOUS FOCUS 1.3 CM (Gross. measurement). - MICROCALCIFICATIONS: NONE IDENTIFIED. - VENOUS/LYMPHATIC INVASION: PRESENT. - MARGINS: - INFILTRATING CARCINOMA 0.8 MM FROM ANTERIOR MARGIN (Slide A10). - FOCI OF ANGIOLYMPHATIC INVASION 0.2 MM FROM POSTERIOR MARGIN. (Slide A2). - INTRADUCTAL COMPONENT: DCIS, FOCAL, HIGH GRADE. - LYMPH NODES : NEGATIVE (See parts B and C). - NIPPLE: NOT SAMPLED. - SKIN: NOT SAMPLED. - HORMONE RECEPTOR AND HER2 STUDIES: PREVIOUSLY REPORTED. - PATHOLOGIC STAGE: pT1 NO MX (AJCC Stage I). B. AXILLARY CONTENTS, REMOVAL: - BENIGN FIBROADIPOSE TISSUE. C. SENTINEL LYMPH NODE, REMOVAL: - NEGATIVE FOR TUMOR BY H&E AND IMMUNOHISTOCHEMISTRY. e 1. Specimen #: CLINICAL DIAGNOSIS AND HISTORY: year old with diagnosis of left breast cancer. PRE-OPERATIVE DIAGNOSIS: left breast cancer. GROSS DESCRIPTION: A. Received fresh is an 8 x 7 x 2.5 cm unoriented irregular piece of soft. tissue with embedded localization wire. The radiograph accompanies the. specimen. The external surface is composed of focally disrupted lobulated. yellow tan adipose tissue. A 3 x 1 cm irregular portion of red brown. muscle is denoted on one surface which is smooth and consistent with a. deep fascia margin. This surface is inked black and the remainder of the. specimen is inked blue. Serial sections reveal a 1.3 x 1.2 x 1.2 cm soft. ink tan Mammomark plug with embedded clip. This lesion comes to within. 0.2 cm of both inked margins. The remainder of the specimen is composed of. unremarkable adipose tissue admixed with scant fibrous tissue. No. additional lesions are identified. Representative sections submitted as. follows: A1: lesion. A2-A3: - margins of A1. A4 adjacent normal. A5: margin (blue ink). A6-A15: representative sections. Matched sections of A1 and A4 are submitted in. for CBCP protocol. R. Received in formalin labeled with the patient's name. designated \"AXILLARY CONTENTS LEFT\" consists of a single. fragment of pink tan tissue measuring 2.5 x 1.9 x 0.9 cm which is grossly. unremarkable. The entire specimen is submitted whole. There are no lymph. nodes identified. C. Received fresh labeled with the patient' name. designated \"SINGLE NODE #1\" is a 1 x 0.7 x 0.3 cm lymph node. The specimen. is bisected to reveal a fatty hilum with a hemorrhagic rim of lymphoid. tissue. The specimen is entirelv submitted in C1. No tissue is taken for. protocol.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is defined as follows: T1 - Tumor 2 cm or less in greatest dimension, T2 - Tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. The pathology report mentions that the tumor size is 'MULTIFOCAL, LARGEST CONTIGUOUS FOCUS 1.3 CM'. This indicates that the largest part of the tumor is 1.3 cm, which falls into the T1 category. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T1.",
    "BaselineChoice": "T1",
    "Monologue": "Determine T stage based on tumor size and other factors from the pathology report.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is 1.3 cm in its largest contiguous focus, which falls within the T1 classification criteria according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Lab No.: Sex: F. Date Collected: Date Received: Doctor: M.R. No.: Room No: Account No: CLINICAL HISTORY: PREOPERATIVE DIAGNOSIS: LEFT BREAST CA. POSTOPERATIVE DIAGNOSIS: LEFT BREAST CA. OPERATION: LEFT SIMPLE MASTECTOMY, SENTINEL LYMPH. NODE BIOPSY, F.S. SPECIMENS: A. LEFT SENTINEL LYMPH NODE #1, F.S. B. LEFT SENTINEL LYMPH NODE #2, F.S. C. SENTINEL LYMPH NODE #3, F.S. D. LEFT BREAST SIMPLE MASTECTOMY. FROZEN SECTION DIAGNOSIS: A. LEFT SENTINEL LYMPH NODE #1 -. NUMEROUS HISTIOCYTES WITH ATYPICAL CELLS. DEFER FOR PERMANENT SECTION. B. LEFT SENTINEL LYMPH NODE #2 -. ONE NEGATIVE LYMPH NODE (0/1). C. SENTINEL LYMPH NODE #3 -. ONE NEGATIVE LYMPH NODE (0/1). FINAL DIAGNOSIS: A. LEFT SENTINEL LYMPH NODE #1 -. POSITIVE FOR METASTATIC CARCINOMA (1/1); THE TUMOR. INVOLVES THREE-FOURTHS OF THE NODE WHICH MEASURES .6. CM. IN DIAMETER, NO PERICAPSULAR SOFT TISSUE EXTENSION. B. LEFT SENTINEL LYMPH NODE #2 -. ONE REACTIVE LYMPH NODE (0/1). Lab No.: C. SENTINEL LYMPH NODE #3 -. ONE REACTIVE LYMPH NODE (0/1). D. LEFT BREAST MASTECTOMY -. INVASIVE LOBULAR CARCINOMA (7 CM.). TUMORAL CALCIFICATION/NECROSIS: NONE IDENTIFIED. DCIS/LCIS: NONE IDENTIFIED. SURGICAL MARGINS/NIPPLE, SKIN AND AREOLA: UNINVOLVED. NON-NEOPLASTIC BREAST: FIBROCYSTIC CHANGES TO INCLUDE DUCTAL EPITHELIAL. HYPERPLASIA. PTNM CLASSIFICATION: T3 N1 MX; STAGE IIIA. COMMENT: The multiple sections from the tumor reveal patchy areas of tumor infiltration. extending up to lactiferous ducts. In addition, the tumor cells also display unfavorable. nuclear features in many areas. The ER, PR and Her-2/neu have been performed on the. previous biopsy. The PanKeratin Immunostain is performed on specimens A, B. and C. GROSS: A. The container is received fresh unfixed labele. eft sentinel lymph node #1. for frozen section\". The specimen consists of an ovoid mass of pink-tan soft rubbery. tissue mixed with fatty tissue measuring 0.6 cm. in greatest dimension. Frozen section is. obtained by. The entire specimen including frozen section in one block. B. The container is received fresh unfixed labele. left sentinel lymph node #2. for frozen section\". The specimen consists of an ovoid mass of tan-gray soft rubbery. tissue with attached fat. Frozen section is obtained by. The entire specimen. including frozen section in one block. Lab No.: C. The container is received fresh unfixed labele. sentinel lymph node #3 for. frozen section\". The specimen consist of an ovoid mass of pink-tan soft rubbery tissue. measuring 1.3 cm. in diameter in the aggregate. Frozen section is obtained by. The entire specimen including frozen section in one block. D. The container is received fresh unfixed labeled. \"left breast\". The specimen. consists of an 809 gm. apparent left breast which is 23 x 15 x 4 cm. in greatest overall. dimension. There is an inverted nipple. The attached skin ellipse is 21 x 9.5 cm. Sectioning through the breast stroma reveals dense gray-white fibrous tissue varying up. to 7.5 cm. in greatest dimension. This area has been previously marked with blue dye. There are scattered cystic spaces varying up to 0.1 cm. in greatest dimension filled with. an amber-colored fluid. Sectioning also reveals a firm tan-gray striated tumor mass. which is 7 x approximately 5.5 cm. in greatest overall dimension and is approximately. 0.7 cm. from the deep/underlying resection margin. The specimen is submitted in ten. blocks. Key Note Block Summary: 1-nipple, 2 through 4-cystic spaces, 5-random,. 6. through 10-tumor mass. MICROSCOPIC EXAMINATION: MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: PanKeratin (specimens A,B,C).\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extension beyond the breast. The key information for this determination is found in the pathology report's description of the tumor size and its relationship to the surrounding tissues.\", \"step 1\": \"Identify the tumor size from the pathology report. The report mentions that the firm tan-gray striated tumor mass is approximately 7 cm in its greatest dimension. This information directly pertains to the T staging, as the size of the tumor is a primary factor in determining the T category.\", \"step 2\": \"Understand the T staging criteria based on tumor size according to the AJCC Cancer Staging Manual (7th edition):\", \"T1\": \"Tumor is 2 cm or less in greatest dimension.\", \"T2\": \"Tumor is more than 2 cm but not more than 5 cm in greatest dimension.\", \"T3\": \"Tumor is more than 5 cm in greatest dimension.\", \"T4\": \"Tumor of any size with direct extension to the chest wall or skin.\", \"step 3\": \"Apply the T staging criteria to the tumor size identified in the pathology report. Since the tumor is described as being approximately 7 cm in its greatest dimension, it falls into the category of T3 according to the AJCC Cancer Staging Manual (7th edition). There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification.\", \"conclusion\": \"Based on the information provided in the pathology report and applying the criteria from the AJCC Cancer Staging Manual (7th edition), the pathologic T stage for this breast cancer patient is T3.\" }, ",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and depth of invasion, and then apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition). I will use the extract_information tool to gather the necessary data and then use the get_t_stage_rule tool to determine the appropriate T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is more than 5 cm in greatest dimension.",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Account Number. Doctor: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT BREAST LUMPECTOMY WITH AXILLARY LYMPH NODE DISSECTION. TISSUES. A. BREAST EXCISION NEEDLE LOC, SIMPLE, MARGINS,ETC - LEFT. B. AXILLARY - CONTENTS LEFT. C. AXILLARY - ADDITIONAL CONTENTS LEFT. D. MARGINS - ADDITIONAL LATERAL. E. MARGINS - ADDITIONAL MEDIAL. ADDENDUM 2. HER-2 (IHC) -. o. NOT AMPLIFIED. SPECIAL STAINS PERFORMED: Her-2 (IHC) (HA). Revlewed and electronically signed out by: ADDENDUM. ESTROGEN AND PROGESTERONE RECEPTOR RESULTS: ESTROGEN RECEPTORS -. NEGATIVE IN THE MALIGNANT CELLS (0%). PROGESTERONE RECEPTORS- -. NEGATIVE IN THE MALIGNANT CELLS (0%). Comment: The control tissues for Estrogen and Progesterone Receptor. Immunohistochemical Studies display appropriate staining pattern. 3. SURGICAL REPORT. FS DIAGNOSIS. A. LEFT BREAST LUMP (GROSS MARGINS) -. PORTION OF BREAST TISSUE WITH TUMOR (3.2 X 3.1 X 3.0 CM.) EXTENDING TO. LATERAL SURGICAL MARGIN AND WITHIN 0.1 CM. OF THE MEDIAL SURGICAL. MARGINS. ALL OF THE REMAINING DESIGNATED SURGICAL MARGINS ARE WITHIN 0.6 CM. OF THE TUMOR (GROSS). (REPORTED TO SURGEON: Diagnosed by: FINAL DIAGNOSIS. A. LEFT BREAST LUMP -. BREAST TISSUE DISPLAYING INVASIVE POORLY DIFFERENTIATED DUCTAL. ADENOCARCINOMA OF THE BREAST, 3+3+3, 3.2 CM. IN GREATEST DIMENSION. TUMOR EMBOLI SEEN IN ANGIOLYMPHATIC SPACES. MARGINS ARE FREE. THE NEAREST MARGIN IS 0.1 CM. TO THE TUMOR AS REPORTED IN THE GROSS. EXAMINATION. B. AXILLARY CONTENTS LEFT -. LYMPH NODE, METASTATIC DUCTAL ADENOCARCINOMA IN TWO LYMPH. NODES FROM A TOTAL OF TWELVE LYMPH NODES (2/12). THE LARGEST NODE WITH TUMOR IS 1 CM. IN GREATEST DIMENSION. THE TUMOR TOTALLY OCCUPIES THE NODE WITH EXTRACAPSULAR. EXTENSION TO THE FAT. C. ADDITIONAL AXILLARY CONTENTS, LEFT -. LYMPH NODES, TWO REACTIVE. D. ADDITIONAL LATERAL MARGINS -. FIBROADIPOSE TISSUE AND BREAST TISSUE, NO TUMOR SEEN; HOWEVER, THERE IS. MICROSCOPIC FOCUS OF TUMOR EMBOLI SEEN IN ANGIOLYMPHATIC SPACES. E. ADDITIONAL MEDIAL MARGINS- -. FIBROADIPOSE TISSUE AND BREAST TISSUE, NO TUMOR SEEN. PTNM CLASSIFICATION: T2 N1 MX, STAGE IIB, DUCTAL ADENOCARCINOMA, G3. PQRI CATEGORY II: 3260F. Diagnosed by: /. COMMENT. This case is discussed with. SURGICAL REPORT. GROSS DESCRIPTION. The specimen is received in five separate containers labeled. designated A. through E. A. The container is received fresh unfixed labeled \"left breast lump\" and consists of a 30 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 4.5 x 3.5 x 2.8 cm. in greatest overall. dimension. There is a single short suture indicating superior margin inked with orange, inferior. is. inked red. There is a single long suture indicating lateral margin inked with black dye, medial. is. inked blue. There are two short sutures indicating anterior margin inked with green dye, deep. is. inked yellow. Sectioning reveals a tumor, a gray-white irregular bordered tumor which is 3.2 x 3.1. x 3 cm. in greatest overall dimension and has scattered yellow-tan chalky areas varying up to 0.3. cm. in greatest dimension and a central 0.4 cm. slightly gelatinous hemorrhagic area. The tumor. mass grossly appears to involve the lateral/black margin is 0.1 cm. from the medial/blue, 0.5 cm. from the anterior/green, 0.5 cm. from the deep/yellow, 0.5 cm. from the superior/orange and 0.5. cm. from the inferior/red. Gross margins are obtained by Dr. The entire specimen is. submitted in seventeen blocks. Key Note Block Summary: 1-lateral/black, 2-medial/blue, 3-anterior/green, 4. deep/yellow, 5-superior/orange, 6-inferior/red (all are perpendicular), 7 through 17-remaining. B. The container is received fixed labeled \"left axillary contents\" and consists of an irregular mass of. apparent fat 3.5 x 3 x 2.5 cm. Sectioning reveals pink-tan nodules varying up to 2 cm. in greatest. dimension. The larger nodes are hemisected and placed in cassettes 2 through 5. C. The container is received fixed labeled \"additional axillary contents\" and consists of an irregular. mass of apparent fatty tissue which is 1 x 0.6 x 0.4 cm. Sectioning reveals a 0.4 cm. pink-tan. nodule. The entire specimen is submitted as one section in one block. D. The container is received fresh unfixed labeled \"additional lateral margin\" and consists of an 8. gm. ovoid mass of apparent fatty and fibrous encased tissue is 3 x 2.5 x 2 cm. in greatest overall. dimension. There is an attached suture indicating new lateral margin inked with red dye. Sectioning reveals fat and a scant amount of fibrous tissue. The entire specimen is submitted in. four blocks. E. The container is received fresh unfixed labeled \"additional medial margin - suture on new medial. margin\" and consists of an 8 gm. ovoid mass of apparent fatty and fibrous encased tissue is 3 x. 3. x 2.5 cm. in greatest overall dimension. There is a suture indicating new medial margin inked. with blue dye. The entire specimen is submitted in four blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the tumor and its extent. The T stages are defined as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. Looking at the provided pathology report, the tumor size is described as 3.2 x 3.1 x 3.0 cm, which means the greatest dimension of the tumor is 3.2 cm. This size falls into the category of more than 2 cm but not more than 5 cm. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract the tumor size from the pathology report and compare it against the T stage criteria.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 3.2 cm in greatest dimension",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH FULL AXILLARY NODE DISSECTION. TISSUES. A. BREAST EXCISION, NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST. LUMPECTOMY. B. AXILLARY - CONTENTS. C. MARGINS - RIGHT BREAST. FS DIAGNOSIS. A. RIGHT BREAST LUMP (GROSS MARGINS) -. TUMOR EXTENDS TO SUPERIOR MARGIN, NEAR SKIN. (Reported to surgeon: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT BREAST LUMP NEEDLE LOC -. POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA, 7.5 CM. IN GREATEST. DIMENSION, EXTENDING TO SUPERIOR INKED SURGICAL MARGIN. SCARFF-BLOOM-RICHARDSON BREAST CANCER HISTOLOGIC SCORE, 9. (3+3+3). HIGH NUCLEAR GRADE DUCTAL CARCINOMA IN-SITU (DCIS) COMPONENT WITH. CENTRAL NECROSIS AND CALCIFICATION EXTENDS WITHIN LESS THAN 0.1 CM. OF THE SUPERIOR SURGICAL MARGIN. REMAINING DESIGNATED SURGICAL MARGINS ARE FREE OF TUMOR. PATHOLOGIC TNM STAGE: T3 N3 MX, STAGE IIIC, G3, INVASIVE DUCTAL CARCINOMA. PQRI CATEGORY II: 3260F. B. AXILLARY CONTENTS -. TEN (10) REGIONAL LYMPH NODES POSITIVE FOR METASTATIC INVASIVE. SURGICAL REPORT. DUCTAL CARCINOMA. C. RIGHT BREAST MARGINS -. SKIN AND ATTACHED FIBROFATTY BREAST TISSUE, NEGATIVE FOR. MALIGNANCY. Diagnosed by: (. Revlawed and alecimnicallu signed out by: GROSS DESCRIPTION. The specimen is received in three separate containers labele. unated A, B,. C. A. The container is received fresh unfixed labeled \"right breast lump\" and consists of a 67 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 7.5 : 7.5 x 3 cm. in greatest overall. dimension. The attached skin ellipse is 4 x 1 cm. There is a single short suture indicating. superior margin inked with black dye, inferior is inked orange. There is a single long suture. indicating lateral margin inked with blue dye, medial is inked green. The skin represents the. anterior margin, posterior is inked with red dye. Sectioning reveals an irregular bordered tan-gray. firm slightly whorled nodule with scattered hemorrhagic areas varying up to 3.5 cm. in greatest. overall dimension and grossly appears to be less than 0.1 cm. from the superior margin and. directly beneath the ellipse of skin. Gross margins are observed by Dr. The tumor. mass grossly appears to be approximately 1.5 cm. from the inferior, 1 cm, from the lateral, 1 cm. from the medial directly beneath the anterior, and 1 cm. from the posterior. The specimen is. submitted in tweive blocks. Key Note Block Summary: 1-superior, 2-inferior, 3-lateral, 4-medial, 5-anterior, 6-. posterior, 7 through 12-random. B. The container is received fresh unfixed labeled \"axillary contents\" and consists of an irregular. mass of apparent fat which is 13 x 12 x 4 cm. in greatest overall dimension. Sectioning reveals. firm tan-gray nodules varying up to 7 cm. in greatest dimension. The largest has scattered green-. black areas and scattered yellow-tan chalky material. The specimen is submitted in seven. blocks. C. The container is received fresh unfixed labeled \"additional right breast margin -skin represents. the anterior margin, suture on new superior margin\" and consists of an ellipse of skin with. attached underlying soft tissue which is 7 x 2.5 x 0.4 cm. in greatest overall dimension. There is. an attached suture indicating new superior margin inked with black dye. The entire specimen is. submitted in five blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the tumor and its extension. The T stage is classified as follows: T1 (tumor ≤ 2 cm), T2 (tumor > 2 cm but ≤ 5 cm), T3 (tumor > 5 cm), and T4 (tumor of any size with direct extension to the chest wall or skin). The pathology report states that the tumor is 7.5 cm in its greatest dimension. This size directly corresponds to the criteria for a T3 classification since the tumor is greater than 5 cm. Although the tumor extends to the superior margin near the skin, it does not explicitly state that the tumor has invaded the skin or chest wall, which would be required for a T4 classification. Therefore, based on the size of the tumor being greater than 5 cm and the information provided, the pathologic T stage is T3.",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is more than 5 cm in greatest dimension.",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Numbe. PRE-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. POST-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. PROCEDURE. MODIFIED RADICAL MASTECTOMY RIGHT BREAST, INSERTION MEDIPORT. TISSUES. BREAST MASTECTOMY (WMV) NODES - RIGHT BREAST AND AXILLARY CONTENTS. FINAL DIAGNOSIS. RIGHT BREAST AND AXILLARY CONTENTS -. POORLY DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA, SCARFF-. BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 10.5 CM. IN MAXIMUM. DIMENSION. LYMPHOVASCULAR INVASION IDENTIFIED INSIDE THE TUMOR. ALL SURGICAL MARGINS ARE FREE OF THE LESION. THE CLOSEST SURCICAL. MARGIN IS THE DEEP SURGICAL MARGIN WHICH IS 1.2 MM. FROM THE TUMOR (JUST. ABOVE THE MUSCLE). BENIGN SKIN AND NIPPLE. TEN OF FOURTEEN LYMPH NODES ARE POSITIVE FOR METASTATIC. CARCINOMA (10/14). TUMOR STAGE: STAGE IIIC, T3, N3, MX. PQRI CATEGORY II: 3260F. Diagnosed by: COMMENT. This case is discussed with. GROSS DESCRIPTION. The container is received fresh unfixed labele. ight breast and axillary contents\" and. consists of a 788 gm. apparent right breast which is 24x 17 x 5 cm. in greatest overall dimension. The. attached skin ellipse is 11.5 x 8.5 cm. There is an eccentrically attached nipple. There is also an. SURGICAL REPORT. of 2. attached suture indicating superior lateral/upper outer aspect inked with an orange dye. The lower outer. is inked green, the upper inner is inked black, the lower inner is inked red. The deep surgical margin is. inked yellow. Sectioning reveals a dense gray-white slightly swirled tumor mass which is 10.5 x 5.5 x 4. cm. in greatest overall dimension and grossly appears to be 3 cm. from the superior lateral/upper outer, 3. cm. from the upper inner and appears to be 3.5 cm. from the lower outer and 4 cm. from the lower inner. It grossly appears to be 0.8 cm. from the deep surgical margin. The tumor mass has scattered yellow-tan. chalky areas varying up to 0.2 cm. and hemorrhagic areas varying up to 0.1 cm. Sectioning through the. axillary fat reveals tan-gray nodules varying up to 2.5 cm. in greatest dimension, each are bisected, one-. half submitted. Twenty blocks. Key Note Block Summary: 1-nipple, 2-deep surgical margin, 3-superior lateral/upper. outer, 4--lower outer, 5-upper inner, 6-lower inner, 7 through 10-tumor, 11 through 13-random, 14. through 20-apparent nodes. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the tumor measures 10.5 cm in maximum dimension. This measurement directly corresponds to the criteria for T3, as the tumor is greater than 5 cm. There is no mention of the tumor extending to the chest wall or skin, which would be required for a classification of T4. Therefore, based on the size of the tumor, the pathologic T stage is T3.",
    "BaselineChoice": "T3",
    "Monologue": "The user has provided a pathology report for a breast cancer patient and is asking to determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). The report mentions that the tumor measures 10.5 cm in maximum dimension. I need to extract the relevant information from the report and apply the T-staging rules to determine the correct T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor measures more than 5 cm in greatest dimension.",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen: Req# : Spec Type: RIGHT BREAST CANCER INVASIVE. DOCTOR (s) : PROCEDURE: RIGHT PARTIAL MASTECTOMY-SENTINEL NODE BX. A. RT BREAST PARTIAL MASTECTOMY. B. RT BREAST MEDIAL RE-EXCISION. C. RT BREAST SENTINEL NODE #1. D. RT BREAST SENTINEL NODE #2. PART A RECEIVED FRESH LABELED. RIGHT BREAST PARTIAL. MASTECTOMY LONG STITCH EQUALS LATERAL SHORT STITCH EQUALS POSTERIOR, IS. AN OVOID PORTION OF YELLOW-PINK FIBROFATTY TISSUE MEASURING 6.8 x 6.2 x. 3.6 CM. TWO SUTURES ORIENT THE SPECIMEN. THE MARGINS ARE MARKED AS. FOLLOWS: LATERAL ORANGE, SUPERIOR GREEN, MEDIAL RED, INFERIOR BLUE,. SUPERFICIAL BLACK, DEEP YELLOW. SECTIONING REVEALS TWO MASS LESIONS. THE SMALLER IS MEDIAL MEASURING 1.5 x 0.9 x 0.9 CM. THE CLOSEST MARGIN. IS SUPERFICIAL AT 0.5 CM, WITH ALL OTHER MARGINS GREATER THAN 1 CM. THE. SECOND IS LATERAL AND MEASURES 1.6 x 1.5 x 2.3 CM. THE CLOSEST MARGIN IS. SUPERFICIAL TOWARD THE LATERAL BORDER, WHERE IT IS 0.5 CM FROM THIS. MARGIN AND 0.5 CM FROM THE SUPERFICIAL MARGIN SUPERIORLY. A RIBBON CLIP. IS IDENTIFIED IN THE MORE LATERAL ASPECT OF THE SPECIMEN. TISSUE IS. TAKEN FROM BOTH NODULES PER PROTOCOL. SECTIONS ARE SUBMITTED AS FOLLOWS: A1 - PERPENDICULAR MEDIAL MARGIN; 12--PERPENDICULAR LATERAL MARGIN;. A3 - PERPENDICULAR LATERAL LESION WITH SUPERFICIAL MARGIN LATERALLY;. A4--LATERAL LESION WITH SUPERFICIAL MARGIN SUPERIORLY; A5--MIRROR IMAGE. OF THE AREA TAKEN PER PROTOCOL OF THE LARGER TUMOR TO INCLUDE SUPERFICIAL. MARGIN; A6 THROUGH A8--THE REMAINDER OF THIS CROSS-SECTION TO INCLUDE THE. INFERIOR, DEEP AND SUPERIOR MARGINS, RESPECTIVELY; A9 AND 10--FULL. CROSS-SECTION OF LATERAL LESION TO INCLUDE SUPERFICIAL MARGIN; All. THROUGH A14--FULL CROSS-SECTION TO INCLUDE THE MORE MEDIAL SMALLER. LESION, WITH All THE MIRROR IMAGE OF THAT SUBMITTED PER PROTOCOL TO. INCLUDE THE SUPERIOR SUPERFICIAL MARGIN. THE REMAINING CROSS-SECTION IS. SUBMITTED AS SUPERIOR DEEP, DEEP INFERIOR AND INFERIOR SUPERFICIAL,. RESPECTIVELY. A15 THROUGH A18 IS THE LATERAL PORTION OF THE LESION TO. INCLUDE THE LESION WITH THE SUPERFICIAL SUPERIOR MARGIN, THE SUPERIOR. DEEP MARGIN, THE DEEP INFERIOR MARGIN AND THE INFERIOR SUPERFICIAL. MARGIN, RESPECTIVELY. A19 IS A FIRM AREA BETWEEN THESE TWO NODULES. GREATER THAN 1 CM FROM ALL MARGINS MEASURING 1 x 1 x 0.4 CM. A20 IS THE. TISSUE BETWEEN BLOCK A19 AND THE MOST LATERAL LARGER LESION WHICH IS. GROSSLY UNREMARKABLE. Specimen: Spec Type: SURGICAL P. PART B RECEIVED FRESH LABELED. RIGHT BREAST MEDIAL. REEXCISION STITCH AT NEW MARGIN, IS AN OVOID PORTION OF YELLOW FATTY. TISSUE WITH FOCAL BLUE DYE MEASURING 4.9 x 2.8 x 1.5 CM. A SUTURE. DENOTES A NEW MARGIN, AND THIS SIDE IS MARKED WITH BLUE INK WITH A. PERIMETER OF BLACK INK, SECTIONED AND SUBMITTED LABELED B1 THROUGH 5. PART C RECEIVED FRESH LABELED. RIGHT BREAST FIRST. SENTINEL NODE HOT AND BLUE, IS A 1.8 x 1.2 x 0.9-CM OVOID PORTION OF. YELLOW FATTY TISSUE. SECTIONING REVEALS A 1.1-CM LYMPH NODE WITH BLUE. DYE. ONE-HALF IS SUBMITTED PER PROTOCOL. THE REMAINDER IS SUBMITTED. LABELED C. PART D RECEIVED FRESH LABELED. RIGHT BREAST SECOND. SENTINEL NODE BLUE, IS A 1.5 x 1.0 x 0.7-CM OVOID PORTION OF PINK-TAN. TISSUE AND ADJACENT YELLOW FAT. SECTIONING REVEALS A GROSSLY. FAT-REPLACED LYMPH NODE WITH FOCAL BLUE DYE MEASURING 1.1 CM IN DIAMETER. ONE-HALF IS SUBMITTED PER PROTOCOL. THE REMAINDER IS SUBMITTED LABELED. D. PROCEDURES: 88307/4, IMMUNOPEROXIDAS/2, A BLK/20, B BLK/5, CBX X6, DBX X6. PART A RIGHT BREAST, PARTIAL MASTECTOMY: IN SITU AND INFILTRATING DUCT. CARCINOMA WITH TWO SEPARATE NODULES OF INFTLTRATING DUCT CARCINOMA. PRESENT IN THE SPECIMEN. THE LARGER (1.7 CM) NODULE IS POORLY. DIFFERENTIATED, NUCLEAR GRADE III/III WITH A HIGH MITOTIC INDEX. FOCAL. DUCT CARCINONA WITH COMEDONECROSIS IS PRESENT ASSOCIATED WITH. THIS LESION AND EXTENDING INTO BREAST FAT AT LEAST 1.5 CM FROM THE TUMOR. THE SECOND (1.2 CM) LESION IS MODERATELY DIFFERENTIATED, NUCLEAR GRADE. III/III WITH A HIGH MITOTIC INDEX. THIS LESION IS ALSO ADMIXED WITH. AREAS OF HIGH-GRADE DUCT CARCINOMA IN SITU OF THE CRIBRIFORM,. MICROPAPILLARY, AND COMEDOCARCINOMA TYPES. INVASIVE CARCINOMA IS LOCATED. 3. MM FROM THE SUPERFICIAL MARGIN ON THE LATERAL SIDE. THERE IS A. MICROSCOPIC FOCUS OF SOLID TYPE DUCT CARCINOMA IN SITU AT THE MEDIAL. MARGIN. DUCT CARCINOMA IN SITU INVOLVES THE SUPERIOR MARGIN AND THERE IS. A MICROCALCIFICATION WITH COMEDONECROSIS SUSPICIOUS FOR DUCT CARCINOMA IN. SITU AT THE INFERIOR MARGIN, ALTHOUGH THE POSSIBILITY THAT THIS IS A. DETACHED ARTIFACTUALLY DISPLACED FOCUS OF DCIS CANNOT BE TOTALLY. EXCLUDED. THE DEEP MARGIN IS FREE OF TUMOR BY AT LEAST 1 CM. PART B RIGHT BREAST MEDIAL MARGIN, REEXCISION: FATTY BREAST TISSUE WITH. NO RESIDUAL TUMOR IDENTIFIED. PART C RIGHT FIRST AXILLARY SENTINEL LYMPH NODE BIOPSY: METASTATIC. INFILTRATING DUCT CARCINOMA IDENTIFIED IN THE SUBCAPSULAR PORTION OF THE. &. Specimen: Req# : Spec Type: SURGICAL P. LYMPH NODE WITH SEVERAL FOCI PRESENT. THE LARGEST CONTIGUOUS FOCUS OF. TUMOR SPANS A DISTANCE OF APPROXIMATELY 1 MM. THE TUMOR IS VISIBLE ON. BOTH ROUTINE H&E AND CYTOKERATIN IMMUNOHISTOCHEMICAL STAIN. PART D RIGHT SECOND AXILLARY LYMPH NODE BIOPSY: LYMPH NODE WITH NO. EVIDENCE OF METASTATIC DISEASE, SUPPORTED BY NEGATIVE CYTOKERATIN. IMMUNOHISTOCHEMISTRY. 1. (prelim.). (signature on file).\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0T3.E339A88E-3B39-465A-9545-FBA4F79727CC",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The T stage is defined as follows: T1 - Tumor 2 cm or less in greatest dimension, T2 - Tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor more than 5 cm in greatest dimension, and T4 - Tumor of any size with direct extension to the chest wall or skin.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report, such as tumor size and location, and then apply the appropriate T-staging rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The larger tumor nodule is approximately 1.7 cm in size, which falls within the criteria for a T2 classification according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen: Spec Type: SURGICAL P. RIGHT BREAST CANCER - IN SITU, LEFT FIBROCYSTIC BREAST CANCER. OPELATION HE FORNED. DOCTOR (s) : PROCEDURE: BILATERAL SIMPLE MASTECTOMY-SENTINEL NODE BX. A. RT BREAST MASTECTOMY. B. LT BREAST MASTECTOMY. RT AXILLA SENTINEL NODE #1. D. RT AXILLA NON SENTINEL NODE. E. LT AXILLA SENTINEL NODE #1. F. LT AXILLA SENTINEL NODE #2. GPOSS. PART A RECEIVED FRESH LABELED. RIGHT BREAST INK MARKS. TUMOR STITCH 12 'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN WITH OVERALL. DIMENSIONS OF 24.5 X 21 X 3.5 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 6. X -CM ELLIPSE OF SKIN. A SUTURE DENOTES 12 D'CLOCK. ADJACENT TO THIS. SUTURE IN THE UPPER INNER QUADRANT IS BLACK INK DENOTING THE TUMOR AREA. THIS AREA IS OVERMARKED WITH RED INK. THE SUPERFICIAL ASPECT OF THE. SPECIMEN IS MARKED IN BLUE, THE DEEP IN BLACK INK. IN THE UPPER INNER. QUADRANT, THERE IS A FIRM PALPABLE MASS MEASURING 2.3 x 3.3 x 1.7 CM. THIS IS 0.6 CM FROM THE DEEP MARGIN. A RIBBON CLIP IS IDENTIFIED WITHIN. THIS MASS. A PORTION OF THIS IS SUBMITTED PER PROTOCOL. THE BREAST TISSUE CONSISTS OF A MIXTURE OF BLAND YELLOW FATTY TISSUE AND. PINK-TAN FIBROUS TISSUE WHICH PRIMARILY IS CENTRAL AND COMPRISES NO MORE. THAN 20% OF THE PARENCHYMA. THIS MASS IS 1.5 CM FROM THE SUPERFICIAL. MARGIN. ADDITIONALLY WITHIN THE CONTAINER ARE TWO IRREGULAR PORTIONS OF. YELLOW FATTY TISSUE MEASURING 8.5 X 8.3 X 1.5 CM TOGETHER. THIS TISSUE. IS GROSSLY UNREMARKABLE AND NO SECTIONS ARE SUBMITTED. SECTIONS ARE. SUBMITTED AS FOLLOWS: A1--NIPPLE AND ADJACENT SKIN (MIRROR IMAGE TO. PROTOCOL) A2--SUPERIOR PORTION OF LESION TO INCLUDE DEEP MARGIN (MIRROR. IMAGE TO PROTOCOL) A3 -THE REMAINDER OF THE FULL CROSS-SECTION TO A2 TO. INCLUDE THE INFERIOR ASPECT OF THE LESION, A4 --SECTION OF TISSUE IN AREA. OF RIBBON CLIP (MIRROR IMAGE TO TUMOR BLOCK), A5--TISSUE TAKEN FROM UPPER. OUTER QUADRANT 6 CM FROM THE LESION (MIRROR IMAGE TO PROTOCOL),. A6-MEDIAL ASPECT OF LESION TO INCLUDE DEEP MARGIN, A7--TISSUE. IMMEDIATELY LATERAL TO A6 NOT GROSSLY TUMOR, --REPRESENTATIVE LOWER. OUTER QUADRANT, A9 -REPRESENTATIVE LOWER INNER QUADRANT. A10 - - -ADDITIONAL. SECTION OF DEEP MARGIN. All--TUMOR ADJACENT TO DEEP MARGIN WITHOUT INKED. MARGIN PRESENT IN THE SECTION. PART B RECEIVED FRESH LABELED. LEFT BREAST STITCH AT 12. O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 22 x 18.5 x 3.3 CM. Specimen: (. Spec Type: SURGICAL P. CHOSS. THE NIPPLE IS UNREMARKABLE WITHIN A 6.3 X 3.9-CM SKIN ELLIPSE. A SUTURE. DENOTES 12 O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE. DEEP MARGIN WITH BLACK INK. SECTIONING REVEALS CENTRAL GRAY FIBROTIC. TISSUE INTERMINGLED WITH YELLOW FATTY TISSUE WITH A PERIMETER OF BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THE FIBROUS TISSUE. COMPRISES 20% OF THE SPECIMEN. SECTIONS ARE SUBMITTED AS FOLLOWS : B1 - -NIPPLE, B2--UPPER INNER QUADRANT. (MIRROR IMAGE TO PROTOCOL) ,. B3 - -UPPER INNER QUADRANT, B4 AND --LOWER INNER QUADRANT, B6 AND 7 - LOWER. OUTER QUADRANT, B8 AND 9--UPPER OUTER QUADRANT, B10 - --CENTRAL WITH DEEP. MARGIN. PART C RECEIVED FRESH LABELED. RIGHT AXILLA FIRST. SENTINEL. NODE. HOT, IS AN OVOID PORTION OF YELLOW FATTY TISSUE MEASURING 3. X 2.2 x 1.2 CM. SECTIONING REVEALS A 1.2-CM GROSSLY FAT-REPLACED LYMPH. NODE, SUBMITTED ENTIRELY LABELED C1. A SECOND 1-CM GROSSLY FAT-REPLACED. LYMPH NODE IS IDENTIFIED. THIS IS SUBMITTED LABELED C2. PART D RECEIVED FRESH LABELED. RIGHT AXILLA NONSENTINEL. NODE, IS AN OVOID PORTION OF YELLOW FATTY TISSUE MEASURING 3 X 1.8 X 1.0. CM. SECTIONING REVEALS A 1.5-CM GROSSLY FAT-REPLACED LYMPH NODE,. SUBMITTED LABELED D. PART E RECEIVED FRESH LABELED. LEFT AXILLA FIRST SENTINEL. NODE HOT, IS AN OVOID PORTION OF YELLOW FATTY TISSUE MEASURING 3.5 x 1.5. X 1.5 CM. SECTIONING REVEALS A 4-CM GROSSLY FAT-REPLACED LYMPH NODE,. ENTIRELY SUBMITTED AS E1 AND 2. PART F RECEIVED FRESH LABELED. LEFT AXILLA SECOND. SENTINEL NODE, IS YELLOW FATTY TISSUE MEASURING 3.5 x 3.2 x 1.5 CM. EXAMINATION REVEALS A 1.2-CM IN GREATEST DIMENSION CENTRALLY FAT-REPLACED. LYMPH NODE, SUBMITTED LABELED F. ONE ADDITIONAL 0.5-CM LYMPH NODE IS. SUBMITTED ALSO LABELED F. PROCEDURES: 88305, 88307/5, IMMUNOPEROXIDAS/3, A BLK/11, B BLK/10, CBX x6/2, D BLK,. EBX x6/2, FBX X6. FINAL DIAGHOSIS. PART A RIGHT SIMPLE MASTECTOMY: IN SITU AND INFILTRATING LOBULAR. CARCINOMA. THE TUMOR IS NUCLEAR GRADE II/III WITH A LOW MITOTIC INDEX. THE TUMOR SPANS A MICROSCOPIC DISTANCE OF 3.3 CM IN THE UPPER INNER. QUADRANT OF THE BREAST. THE TUMOR DOES HAVE A MICROSCOPIC MULTIFOCAL. APPEARANCE WITHIN THIS QUADRANT, BUT SECTIONS OF BREAST TISSUE FROM OTHER'. QUADRANTS OF THE BREAST DO NOT SHOW EVIDENCE OF MALIGNANCY. THE DEEP. MARGIN IS FREE OF TUMOR BY A DISTANCE OF 5 MM. Specimen: Rea#: Spec Type: SURGICAL P. PART B LEFT SIMPLE MASTECTOMY: DIFFUSE PROLIFERATIVE FIBROCYSTIC. CHANGES WITH AREAS OF ATYPICAL DUCT AND LOBULAR HYPERPLASIA AND EXTENSIVE. MICROCALCIFICATION. NO EVIDENCE OF INVASIVE CARCINOMA. PART C RIGHT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY: LYMPH NODE WITH. NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED BY NEGATIVE CYTOKERATIN. IMMUNOHISTOCHEMICAL STAINING. PART D RIGHT AXILLARY NONSENTINEL LYMPH NODE, BIOPSY: LYMPH NODE WITH R. NO EVIDENCE OF METASTATIC DISEASE. PARTS E AND F LEFT AXILLARY SENTINEL LYMPH NODES NUMBERS 1 AND 2,. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMISTRY. COND. (prelim.). (signature on file).\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the provided pathology report. The key information for staging is the size of the tumor and its extent, including any involvement of the chest wall or skin. ",
    "BaselineChoice": "T2",
    "Monologue": "Determine the pathologic T stage for breast cancer based on the provided pathology report.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.3 x 3.3 x 1.7 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen: Spec Type: SURGICAL P. BREAST CANCER. DOCTOR (s) : A. LEFT BREAST SUPERFICIAL MARGIN RE-EXCISION. B. RIGHT BREAST. C. LEFT BREAST. PART A RECEIVED LABELED. LEFT BREAST UPPER OUTER QUADRANT. SUPERFICIAL MARGIN REEXCISION STITCH NEW MARGIN, IS AN IRREGULAR PORTION. OF YELLOW-PINK FATTY TISSUE MEASURING 12.5 x 7.5 x 1.0 CM IN GREATEST. DIMENSIONS. A SUTURE DENOTES THE NEW MARGIN. THIS SIDE IS MARKED WITH. BLUE INK WITH A PERIMETER OF BLACK INK. REPRESENTATIVE SECTIONS TO. INCLUDE APPROXIMATELY 40% OF THE SPECIMEN ARE SUBMITTED LABELED A1. THROUGH 10. PART B RECEIVED LABELED. RIGHT BREAST STITCH AT 12. O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 24 x 18.5 x 5.5 CM. THE NIPPLE IS GROSSLY UNREMARKABLE WITHIN A 7 x 3.5-CM SKIN ELLIPSE. A. SUTURE DENOTES 12 O' CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE. INK, THE DEEP WITH BLACK. SECTIONING REVEALS DENSE GRAY-TAN FIBROUS. TISSUE INTERMIXED WITH YELLOW FATTY TISSUE. THE FIBROUS TISSUE IS. PRIMARILY IN THE MID TO LOWER OUTER QUADRANT AREAS. THIS IS SURROUNDED. BY BLAND YELLOW FATTY TISSUE. THE FIBROUS TISSUE COMPRISES UP TO 40% OF. THE SPECIMEN. SECTIONS ARE SUBMITTED AS FOLLOWS: 31--NIPPLE,. B2 --CENTRAL DEEP MARGIN, B3 AND 4--UPPER INNER QUADRANT, B5 AND --UPPER. OUTER QUADRANT, B7 AND 8 -LOWER OUTER QUADRANT, B9 AND 10--LOWER INNER. QUADRANT. PART C RECEIVED FRESH LABELED. LEFT BREAST STITCH AT 12. O'CLOCK, IS A 26 x 18 x 6-CM SIMPLE MASTECTOMY SPECIMEN. THE NIPPLE IS. UNREMARKABLE WITHIN AN 8 x 4.2-CM SKIN ELLIPSE. A SUTURE DENOTES 12. O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP WITH. BLACK. SECTIONING REVEALS A PINK-TAN FIRM GRITTY MASS AT, 30 O'CLOCK. LATERAL BREAST. THIS AREA MEASURES 4.5 x 2.4 x 4.0 CM IN GREATEST. DIMENSIONS. THE TISSUE BETWEEN THIS LESION AND THE DEEP MARGIN CONSISTS. OF YELLOW FATTY TISSUE AND PINK-TAN FIBROUS TISSUE. THE MARGIN GROSSLY. A. SECOND PALPABLE AREA OF FIRMNESS IN THE UPPER OUTER QUADRANT AT THE. IS 0.8 CM AWAY. THIS IS 0.8 CM FROM THE PROXIMAL MARGIN. THERE IS. LATERAL EDGE OF THE SPECIMEN WHICH WHEN SECTIONED REVEALS NO GROSS. LESION. BY PALPATION, THIS AREA IS 2 CM IN GREATEST DIMENSION. THIS. AREA DOES DEMONSTRATE YELLOW-WHITE COLORATION SUGGESTIVE OF GROSS FAT. specimen. Spec Type: SURGICAL P. NECROSIS. THIS AREA IS 5 CM FROM THE LESION. CENTRALLY, THE BREAST DOES. DEMONSTRATE GRAY-TAN FIBROUS TISSUE. THE PERIMETER OF THE SPECIMEN IS. BLAND YELLOW FATTY TISSUE. THE FIBROUS TISSUE COMPRISES NO MORE THAN 25%. OF THE SPECIMEN. SECTIONS ARE SUBMITTED AS FOLLOWS: C1--NIPPLE AND SKIN. (MIRROR IMAGE TO PROTOCOL), C2 AND 3--FULL CROSS-SECTION OF LESION. (MIRROR IMAGE TO TISSUE TAKEN PER PROTOCOL), C4--LESION AND DEEP MARGIN,. C5 AND 6--LESION AND SUPERFICIAL MARGIN, C7 AND 8--FULL CROSS-SECTION OF. LESION (MIRROR IMAGE TO TISSUE TAKEN PER PROTOCOL), C9 AND 10--TISSUE. EXTREME UPPER OUTER QUADRANT WITH INDURATION, 11--CENTRAL BREAST TISSUE. WITH FIBROSIS, C12--UPPER OUTER QUADRANT, 11--UPPER INNER QUADRANT,. C14 - -LOWER INNER QUADRANT, C15--LOWER OUTER QUADRANT. PROCEDURES: 88307/3, A BLK/10, B BLK/10, C BLK/15. PART A LEFT BREAST UPPER OUTER QUADRANT SUPERFICIAL MARGIN REEXCISION: FIBROADIPOSE TISSUE WITH NO EVIDENCE OF NEOPLASM. THE NEW INKED MARGIN. IS FREE OF NEOPLASM. FOCUS OF PREVIOUS BIOPSY SITE CHANGE WITH. ORGANIZING FAT NECROSIS WITH REACTIVE FIBROSIS. PART B RIGHT BREAST, SIMPLE MASTECTOMY: FIBROCYSTIC DISEASE WITH PATCHY. FIBROSIS, APOCRINE METAPLASIA, CYST FORMATION AND A SMALL FIBROADENOMA. NO EVIDENCE OF ATYPIA OR MALIGNANCY. UNREMARKABLE NIPPLE SKIN. PART C LEFT BREAST, SIMPLE MASTECTOMY: 1. MODERATELY DIFFERENTIATED INTRADUCTAL AND INFILTRATING DUCT. CARCINOMA, NUCLEAR GRADE II WITH LOW MITOTIC INDEX, WITH AN IN SITU. COMPONENT OF APPROXIMATELY 10% OF SOLID AND CRIBRIFORM TYPE WITH FOCI. OF INTRADUCTAL NECROSIS. 2. THE TUMOR GROSSLY MEASURES 4.5 CM IN GREATEST DIMENSION. THE NIPPLE,. DEEP AND SUPERFICIAL MARGINS ARE FREE OF NEOPLASM. 3. FOCI SUSPICIOUS FOR LYMPHATIC INVASION ARE PRESENT. 4. BIOPSY SITE CHANGE WITH REACTIVE FIBROSIS AND ORGANIZING FAT NECROSIS. INCLUDING AN AREA FROM THE UPPER OUTER QUADRANT WHICH MAY REPRESENT A. PREVIOUS SENTINEL NODE BIOPSY SITE. 5. FIBROCYSTIC CHANGE WITH PATCHY DENSE FIBROSIS AND CYST FORMATION. Specimen: Spec Type: SURGICAL p. 1. (prelim.). (signature on file).\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the provided pathology report. The key information for staging is the size of the tumor and its extension to nearby tissues or structures. The report mentions multiple specimens and findings, but the critical information for T staging is the size and characteristics of the tumor in the left breast, as described in Part C of the report. According to Part C, the tumor grossly measures 4.5 cm in its greatest dimension. There is no mention of the tumor extending to the chest wall or skin, which would be necessary for a T3 or T4 classification. The description does not indicate the tumor is smaller than 2 cm (which would be T1) or between 2 cm and 5 cm (which would be T2 if it were exactly 5 cm or less). However, since the tumor is described as being 4.5 cm, which falls into the category of being more than 2 cm but not more than 5 cm, we can determine the T stage based on this size.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report, compare numerical values, and apply T-staging rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is larger than 2 cm but not larger than 4 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        /F. Acct# : Unit# : Specimen: Spec Type: SURGICAL P. LEFT BREAST CANCER INVASIVE. DOCTOR (s) : PROCEDURE: BILATERAL SIMPLE MASTECTOMY-SENTINEL NODE BX. A. LT SENTINEL NODE #2 - FS. B. LT SENTINEL NODE #1. C. LT SIMPLE MASTECTOMY. D. RT SIMPLE MASTECTOMY. E. RT SENTINEL NODE #10/1. F. RT SENTINEL NODE #2 0/1. 4. POSSIBLE LT SENTINEL NODE. LT SENTINEL NODE # $91. A. BENIGN. and. PART A RECEIVED FRESH LABELED. LEFT SECOND SENTINEL NODE. PALPABLE, CONSISTS OF AN IRREGULAR PORTION OF YELLOW-RED FATTY TISSUE. MEASURING 2.5 X 1.0 X 1.0 CM. SECTIONING REVEALS 2 LYMPH NODES, THE. LARGER 0.9 CM IN DIAMETER DEMONSTRATES A RIBBON CLIP THE SECOND IS 0.5. CM. SECTION OF THE LARGER IS SUBMITTED AS FSA. THE REMAINDER OF THE. SPECIMEN IS SUBMITTED LABELED A. PART B RECEIVED FRESH LABELED. LEFT FIRST SENTINEL NODE. HOT AND BLUE, IS A PORTION OF YELLOW-RED FATTY TISSUE MEASURING 2.2 X 1.5. x 1.0 CM. SECTIONING REVEALS GROSSLY UNREMARKABLE NODAL TISSUE WITH. FOCAL BLUE DYE. ONE HALF IS SUBMITTED PER PROTOCOL, THE REMAINDER IS. SUBMITTED LABELED B. PART C RECEIVED FRESH LABELED. LEFT SIMPLE MASTECTOMY. STITCH AT 12 O'CLOCK, IS A MASTECTOMY SPECIMEN WITH OVERALL DIMENSIONS OF. 23.5 X 20.5 X 4.5 CM. THE NIPPLE IS UNREMARKABLE AND IS WITHIN AN. IRREGULAR SHAPED SKIN EXCISION MEASURING 8.0 x 4.3 CM IN GREATEST. 1. à. Specimen. Spec Type: SURGICAL P. GROSS. DIMENSIONS. A SUTURE DENOTES 12 O'CLOCK AND BLUE DISCOLORATION IS NOTED. IN THE UPPER INNER QUADRANT. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE. INK, THE DEEP MARGIN IN BLACK INK. SECTIONING REVEALS DENSE PINK-TAN. FIBROUS NODULE IN THE MIDPORTION OF THE SPECIMEN WHICH IS CENTRAL AND IN. THE SUPERIOR ONE-HALF OF THE SPECIMEN TO INCLUDE BOTH THE OUTER AND INNER. QUADRANTS. IT HAS AN IRREGULAR SHAPE WITH NO PERCEPTIBLE DIFFERENTIATION. BETWEEN THE LOBULATED ARMS CREATING A 7.0 CM SPAN FROM MEDIAL TO LATERAL. 3.5 CM FROM SUPERIOR TO INFERIOR AND UP TO 2.5 CM FROM ANTERIOR TO. POSTERIOR. THIS EXTENDS TO WITHIN 0.7 CM OF THE DEEP MARGIN. THERE ARE. SMALL PALPABLE NODULES SURROUNDING THIS. ONE OF THESE IN THE UPPER INNER. QUADRANT MEASURES 0.5 CM AND IS 1.3 CM FROM THE DEEP MARGIN. GROSSLY. THIS IS NOT IN CONTINUATION WITH THE LESION AND SEPARATED BY 1 CM. THE. PERIMETER TISSUE IS BLAND YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: C1 --NIPPLE AND SKIN (MIRROR IMAGE TO PROTOCOL), C2--THE - FAR. MEDIAL PORTION OF THE LARGE LESION IN THE UPPER INNER QUADRANT, C3 - - THE. SMALL NODULE IN THE UPPER INNER QUADRANT, C4--TISSUE FROM LOWER INNER. QUADRANT 2 CM INFERIOR TO C2, C5 THROUGH C7--A SUPERIOR TO INFERIOR. CROSS-SECTION OF THE LESION IMMEDIATELY SUBAREOLAR, C8--LESION AND DEEP. MARGIN (MIRROR IMAGE TO PROTOCOL SECTION). C9 AND C10--SECTIONS OF. PALPABLE LESION FAR LATERAL, SUPERIOR, AND INFERIOR, C11--LESION AND. SUPERFICIAL MARGIN, --THE SUPERFICIAL PORTION OF THE LESION AND SKIN. CORRESPONDING TO C8, C13--LOWER OUTER QUADRANT 3 CM FROM TUMOR,. C14--UPPER OUTER QUADRANT 3 CM FROM TUMOR, C15--TUMOR (MIRROR IMAGE TO. PROTOCOL), C16--TISSUE 6 'CLOCK. PART D RECEIVED FRESH LABELED. RIGHT SIMPLE MASTECTOMY. STITCH AT 12 O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 16.0 x. 15.5 x 4.0 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 7.2 X 4.3 CM SKIN. ELLIPSE. A SUTURE DENOTES 12 O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED. WITH BLUE INK, THE DEEP WITH BLACK. SECTIONING REVEALS A CENTRAL PORTION. OF THE BREAST TO CONSIST OF PINK-TAN FIBROUS TISSUE WITH MULTIPLE. FLUID-FILLED CYSTS. THIS IS SURROUNDED BY A PERIMETER OF BLAND YELLOW. FATTY TISSUE WITH FINE FIBROUS BANDS. THE FIBROUS COMPONENT IS 50% OF. THE SPECIMEN. ONE CYST IN THE 9 O'CLOCK AREA CONTAINS TAN PUTTY-LIKE. MATERIAL (D3) THE SPECIMENS ARE SUBMITTED AS FOLLOWS D1--NIPPLE,. D2--9 O' 'CLOCK AREA (MIRROR IMAGE TO PROTOCOL BLOCK), D3-CYST IN 9. 'CLOCK AREA, D4 - LOWER OUTER QUADRANT, D5 --UPPER OUTER QUADRANT,. D6--CENTRAL DEEP MARGIN, D7 AND 08--LOWER INNER QUADRANT, D9 AND. 010--UPPER INNER QUADRANT. PART E RECEIVED FRESH LABELED. RIGHT SENTINEL NODE BLUE. NOT HOT, IS FATTY TISSUE MEASURING 2.8 X 2.5X 1.0 CM. SECTIONING. REVEALS A 0.8 CM IN DIAMETER RED-TAN NODE. HALF IS SUBMITTED FOR. PROTOCOL, THE REMAINDER IS SUBMITTED LABELED E. PART F RECEIVED FRESH LABELED. SECOND RIGHT SENTINEL NODE. Specimen: Req# : Spec Type: SURGICAL P. GROSS OMSCRIPTION. HOT BLUE, IS AN OVOID PORTION OF RED-TAN TISSUE MEASURING 2.5 x 1.3 x 1.0. CM, IS A 1.2 CM LYMPH NODE SHOWING BLUE DISCOLORATION. ONE-HALF IS. SUBMITTED PER PROTOCOL, THE REMAINDER IS SUBMITTED LABELED F. PART G RECEIVED FRESH LABELED. LEFT FOURTH SENTINEL. NODE_ HOT ONLY, IS YELLOW FATTY TISSUE MEASURING 2.3 X 1.5 X 0.8 CM. IT. REVEALED A 1 CM GROSSLY UNREMARKABLE LYMPH NODE. ONE HALF IS SUBMITTED. PER PROTOCOL, THE REMAINDER IS SUBMITTED LABELED G. PART H RECEIVED FRESH LABELED. POSSIBLE LEFT SENTINEL. NODE HOT NOT BLUE, YELLOW-FATTY TISSUE. THIS NODAL TISSUE IS IDENTIFIED. AND THE SPECIMEN IS SUBMITTED ENTIRELY LABELED H. PROCEDURES: 88307/8, IMMUNOPEROXIDAS/6, PATH FS , ABX X6, BBX X6, C BLK/16, D BLK/10,. EBX X6, FBX X6, FROZ.SEC. A, GBX X6, HBX X6. PARTS A AND B LEFT SECOND AND FIRST AXILLARY SENTINEL LYMPH NODE. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMICAL STAINING. PART C LEFT SIMPLE MASTECTOMY: MULTICENTRIC IN SITU AND INFILTRATING. LOBULAR CARCINOMA. THE TUMOR IS NUCLEAR GRADE II/III WITH A LOW MITOTIC. INDEX. INVASIVE CARCINOMA SPANNED A GROSS DISTANCE OF 7.0 CM FROM MEDIAL. TO LATERAL IN THE SUPERIOR CENTRAL PORTION OF THE SPECIMEN, SPANNING THE. OUTER AND INNER QUADRANTS, WITH A DISTINCT AND SEPARATE 1 0-CM NODULE. INVASIVE LOBULAR CARCINOMA IN THE UPPER OUTER QUADRANT OF THE BREAST. THE SUPERFICIAL AND DEEP MARGINS ARE FREE OF TUMOR BY AT LEAST 1 CM. PART D RIGHT SIMPLE MASTECTOMY FIBROCYSTIC CHANGES WITH FOCALLY MARKED. NON-ATYPICAL INTRADUCTAL EPITHELIAL HYPERPLASIA PRESENT. NO EVIDENCE OF. MALIGNANCY. PARTS E AND F RIGHT FIRST AND SECOND AXILLARY SENTINEL LYMPH NODE. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED. BY NEGATIVE CYTOKERATIN IMMUNOHISTOCHEMISTRY. PART G LEFT FOURTH AXILLARY SENTINEL LYMPH NODE, BIOPSY: LYMPH NODE. WITH NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED BY NEGATIVE CYTOKERATIN. IMMUNOHISTOCHEMICAL STAINING. Speciment. Spec Type: SURGICAL P. PART H POSSIBLE LEFT AXILLARY LYMPH NODE, BIOPSY ADIPOSE TISSUE WITH p. NO LYMPH NODE PRESENT. (signature on file).\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0T6.377F7050-F900-4345-A326-568F00050BC3",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided pathology report, the invasive carcinoma spans a gross distance of 7.0 cm from medial to lateral in the superior central portion of the specimen, indicating that the tumor size exceeds 5 cm. Therefore, the pathologic T stage for this breast cancer patient is T3.",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and depth of invasion, and then apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition). I will use the extract_information tool to gather the necessary data and then apply the get_t_stage_rule tool to determine the T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size and extent of invasion were evaluated, and based on the provided information, the cancer was determined to be at a stage where it has grown to a certain size or has invaded nearby tissues, but has not yet spread to distant parts of the body or invaded major structures, which aligns with the characteristics of stage T2.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen: (. spec Type: SURGICAL P. RIGHT BREAST CANCER INVASIVE. DATE: 1. DOCTOR (s) : BITATERAL SIMPLE MASTECTOMY - SENTINEL NODE BX. A. LT BREAST MASTECTOMY. B. RT BREAST SENTINEL NODE #1. C. RT BREAST SENTINEL NODE #2. D. RT BREAST MASTECTOMY. RECEIVED IN FOUR PARTS. PART A: RECEIVED FRESH LABELED LEFT BREAST MASTECTOMY, STITCH AT 1200 IS A. SIMPLE MASTECTOMY SPECIMEN MEASURING 15 X 14.5 x 4 CM IN GREASTEST. DIMENSIONS. THE NIPPLE IS UNREMARKABLE WITHIN A 6.3 x 3.6 CM SKIN. ELLIPSE. THE SUPERFICIAL MARGIN IS MARKED BLUE WHILE THE DEEP ASPECT IS. MARKED WITH BLACK INK. SECTIONING REVEALS CENTRAL FIBROSIS WITH MULTIPLE. CYSTIC AREAS CONTAINING GREY MUCINOUS FLUID. THIS AREA IS MEASURES 10.5. x. 9 x 3 CM AND IS SURROUNDED BY GROSSLY UNREMARKABLE YELLOW FATTY TISSUE. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS: A1-NIPPLE; A2-CENTRAL. DEEP MARGIN; A3- UPPER OUTER QUADRANT; A5-6 UPPER INNER QUADRANT; A7-8. LOWER INNER QUADRANT AND A9-10-LOWER OUTER QUADRANT. PART B: RECEIVED FRESH LABELED SENTINEL NODE #1 HOT AND BLUE IS AN OVOID. FRAGMENT OF BLUE COLORED TISSUE AND SURROUNDING YELLOW FAT MEASURING 2 x 1. x 1 CM. SECTIONING REVEALS A GROSSLY UNREMARKABLE BLUE DYED NODE MEASURING. 1.7 CM IN GREATEST DIMENSION. A PORTION IS TAKEN PER PROTOCOL AND THE. REMAINDER IS SUBMITTED LABELED B. PART C: RECEIVED FRESH LABELED SENTINEL NODE #2 HOT IS AN OVOID PORTION OF. YELLOW FATTY TISSUE MEASURING 2 x 1 x 1 CM. SECTIONING REVEALS. UNREMARKABLE NODAL TISSUE SUBMITTED ENTIRELY LABELED C. PART D: RECEIVED FRESH LABELED. RIGHT BREAST MASTECTOMY,. STITCH AT 12 O'CLOCK IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 17 x 15 x. 5.0 CM. THE NIPPLE IS GROSSLY UNREMARKABLE WITHIN A 6 x 3 CM SKIN ELLIPSE. THE SUPERFICIAL ASPECT IS MARKED IN BLUE INK. THE DEEP MARGIN IS MARKED. IN BLACK INK. SECTIONING REVEALS A FIRM FIBROUS NODULE IN THE UPPER INNER. QUADRANT MEASURING 2.5 x 1.5 x 1.5 CM. THE LESION GROSSLY EXTENDS TO. WITHIN 0.8 CM OF THE MOST MEDIAL MARGIN AND IS 0.7 CM FROM BOTH THE. SUPERFICIAL AND DEEP MARGINS. THE CENTRAL PORTION OF THE BREAST CONSISTS. OF DENSE FIBROUS TISSUE WITH NUMEROUS CYSTIC AREAS AND THIS SURROUNDED BY. BLAND YELLOW FATTY TISSUE. THE CENTRAL AREA MEASURES 13 x 10.5 x 3.0 CM. (Costinsed). Specimen: atus: : Spec Type: SURGICAL P. ADDITIONALLY LOOSE WITHIN THE CONTAINER ARE TWO FRAGMENTS OF GROSSLY. UNREMARKABLE FATTY TISSUE TOGETHER MEASURING 7.5 x 5.7 x 2.0 CM. NO. SECTIONS ARE SUBMITTED. D1--NIPPLE AND ADJACENT SKIN (MIRROR IMAGE TO. RESEARCH), D2-3--FULL CROSS SECTION OF LESIONAL AREA, D4-5--FULL CROSS. SECTION TO LESIONAL AREA. NOTE D2 THROUGH D5 MIRROR IMAGE TO TISSUE. PROTOCOL, D5--SECTION - OF LESION AND MOST MEDIAL MARGIN, D7--TUMOR (MIRROR. IMAGE TO PROTOCOL), D8--UPPER INNER QUADRANT IMMEDIATELY ADJACENT TO. TUMOR; D9--UPPER OUTER QUADRANT 7 CM FROM TUMOR, D10--LOWER OUTER QUADRANT. 7 CM FROM TUMOR, D11--LOWER INNER QUADRANT 4 CM FROM TUMOR. PROCEDURES. 88307/4, IMMUNOPEROXIDAS/2, A BLK/10, BBX X6, CBX X6, D BLK/11. PART A LEFT BREAST, SIMPLE MASTECTOMY: DIFFUSE FIBROCYSTIC CHANGES WITH FCC. ADENOSIS AND FOCALLY MARKED NON-ATYPICAL INTRADUCTAL EPITHELIAL. HYPERPLASIA PRESENT. NO EVIDENCE OF MALIGNANCY. PART B RIGHT AXILLARY SENTINEL LYMPH NODE #1: REACTIVE LYMPH NODE WITH. NO EVIDENCE OF METASTATIC DISEASE, SUPPORTED BY NEGATIVE CYTOKERATIN. IMMUNOHISTOCHEMICAL STAINING. PART C RIGHT AXILLARY SENTINEL LYMPH NODE #2: ISOLATED TUMOR CELL. CLUSTER, 0.1 MM, IDENTIFIED IN A CAPSULAR LYMPHATIC SPACE. THE LESION IS. 1. VISIBLE ON ROUTINE H&E STAINING, CONFIRMED BY POSITIVE CYTOKERATIN. IMMUNOHISTOCHEMICAL STAINING. THE FOCUS DISAPPEARS ON DEEPER SECTIONING. INTO THE TISSUE BLOCK. PART D RIGHT SIMPLE MASTECTOMY: MODERATELY DIFFERENTIATED INFILTRATING. DUCTAL CARCINOMA, NUCLEAR GRADE III/III WITH A HIGH MITOTIC INDEX WITH. INVASIVE CARCINOMA SPANNING A MICROSCOPIC DISTANCE OF 2.6 CM. MINOR FOCI. OF MICROPAPILLARY-TYPE DUCTAL CARCINOMA IN SITU ARE PRESENT, BUT OVER 90%. OF THE TUMOR IS INVASIVE. THE TUMOR IS LOCATED IN THE UPPER INNER. QUADRANT OF THE BREAST (2 O'CLOCK POSITION) WITH A MICROSCOPIC TENDRIL OF. TUMOR EXTENDING TO THE SUPERFICIAL MARGIN (SLIDE D3) . THE MEDIAL MARGIN. IS FREE OF TUMOR BY A DISTANCE OF 5 MM AND THE DEEP MARGIN BY. APPROXIMATELY 1 CM. REPRESENTATIVE SECTIONS OF BREAST TISSUE AWAY FROM. THE PRIMARY TUMOR SITE SHOW PROLIFERATIVE FIBROCYSTIC CHANGES WITH AREAS. OF MARKED INTRADUCTAL EPITHELIAL HYPERPLASIA PRESENT, BUT NO ADDITIONAL. AREAS OF MALIGNANCY. Specimen: Spec Type: SURGICAL p. 1. (prelim.). (signature on file).\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the provided pathology report. The key information for determining the T stage is the size of the invasive carcinoma and whether it has extended to the chest wall or skin. The report mentions a \"MODERATELY DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA\" with \"INVASIVE CARCINOMA SPANNING A MICROSCOPIC DISTANCE OF 2.6 CM\" in the right breast. This measurement directly corresponds to the T stage criteria based on tumor size. According to the AJCC 7th edition, T1 is defined as a tumor 2 cm or less in greatest dimension, T2 is defined as a tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 is defined as a tumor more than 5 cm in greatest dimension, and T4 is defined as a tumor of any size with direct extension to the chest wall or skin. Since the invasive carcinoma spans 2.6 cm, which is more than 2 cm but not more than 5 cm, it falls into the T2 category. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the size of the tumor and the absence of extension to the chest wall or skin, the pathologic T stage for this breast cancer is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor measures 2.5 x 1.5 x 1.5 cm and spans a microscopic distance of 2.6 cm, which falls within the criteria for a T2 classification.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor: Account Number: THIS IS A CORRECTED REPORT. CORRECTED REPORT. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. PROCEDURE. EXCISION BIOPSY RIGHT BREAST LUMPECTOMY WITH SENTINEL LYMPH NODE BIOPSY (F.S.). TISSUES. A. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #1 FS. B. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #2 FS. C. LYMPH NODE (S) - ADDITIONAL NODE NON SENTINEL FS. D. BREAST EXCISION,NEEDLELOC,SIMPLE.MARGINS,ETC.-RIGHT - BREAST. LUMPECTOMY. WRI TISSUE. ADDENDUM. Immunostain for Cytokeratin was performed on specimens \"A\", \"B\", \"C\" and is negative. for metastatic adenocarcinoma. FS DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1, F.S. -. NEGATIVE LYMPH NODE (2 BLOCKS). B. RIGHT SENTINEL LYMPH NODE #2, F.S. -. NEGATIVE LYMPH NODE. C. NON-SENTINEL NODE, F.S. -. NEGATIVE LYMPH NODE. D. RIGHT BREAST (GROSS MARGINS) -. MARGINS ARE FREE (GROSS). (Reported to Surgeon: SURGICAL REPORT. Diagnosed by: FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1. ONE POSITIVE LYMPH NODE (1/1, MICROSCOPIC METASTATIC DUCTAL. CARCINOMA, 1 MM IN MAXIMAL DIMENSION. PLEASE SEE COMMENT). B. RIGHT SENTINEL LYMPH NODE #2 -. ONE NEGATIVE LYMPH NODE (0/1). C. NON-SENTINEL LYMPH NODE -. ONE NEGATIVE LYMPH NODE (0/1). D. RIGHT BREAST LUMPECTOMY. MODERATELY DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA. SCARFF-BLOOM-RICHARDSON GRADE II/III. THE TUMOR MEASURES 2.6 CM. IN MAXIMUM DIMENSION. ALL SURGICAL MARGINS ARE FREE OF THE LESION. THE CLOSEST SURGICAL. MARGINS ARE THE DEEP (POSTERIOR) SURGICAL MARGIN WHICH IS 1 MM. FROM. TUMOR (SLIDE 6) AND THE INFERIOR MARGIN, WHICH IS 4MM FROM THE INFERIOR. MARGIN (SLIDE 4). TUMOR STAGE: STAGE IIB, T2, Nimic, MX (GRADE 2). Diagnosed by: Revlewed and electronically sloned out by: COMMENT. Specimen \"A\" shows microscopic metastatic carcinoma which is only present in the permanent. section and not in the frozen section. This case is discussed with. on. COMMENT2. This case Is amended at the request of. to correct the tumor stage from T2, N1,. MX to T2, N1mic, MX. GROSS DESCRIPTION. The specimen is received in four separate containers labeled. esignated A, B,. C, D. A. The container Is received fresh unfixed labeled \"right sentinel lymph node #1 for frozen section\". The specimen consists of an ovoid nodule of tan-gray firm rubbery tissue which is 1.5: x 1 x 0.4. cm. and has attached fatty material. A single node is bisected and entirely submitted as two. frozen sections by Dr. The entire specimen including frozen sections are submitted. In three blocks. B. The container is received fresh unfixed labeled \"right sentinel lymph node #2 for frozen section\". The specimen consists of an ovold nodule of firm tan-gray soft rubbery tissue and attached fat. SURGICAL REPORT. and. measures. x 0.3 x 0.3 cm. The node is bisected and entirely submitted as a frozen section. by Dr. The entire specimen including frozen section is submitted In two blocks. C. The container is received fresh unfixed labeled additional node non-sentinel for frozen section\". The specimen consists of an ovoid nodule of pink-tan firm rubbery tissue with a scant amount of. attached fat 0.6 x 0.4 x 0,3 cm. in greatest dimension. The entire specimen is submitted as a. frozen section by Dr. The entire specimen is submitted in one block. D. The container is received fresh unfixed labeled \"right breast lump\" and consists of a 41 gm. ovoid. mass of apparent fatty tissue with an attached skín ellipse 5 5x 4.5 x 3.5 cm. in greatest overall. dimension. The attached skin ellipse is 4x 1 cm. in greatest overali dimension. Gross margins. are observed and appear free by Dr. There is a long suture indicating lateral margin. inked with purple dye, medial is inked red. There is a single short suture indicating superior. margin Inked with orange dye, inferior is inked black The skin is designated as anterior, posterior. is inked yellow. Sectioning reveals a firm tan-gray striated mass which is 2 2 cm. in greatest. overall dimension and grossly appears to be 0.4 cm. away from the inferior marg.n, 08 cm. away. from the superior margin, 03 cm. away from the posterior. 0.8 cm away from the medial margin. and 1 cm. away from the Inferior. The specimen is submitted in eleven blocks. Key Note Block Summary: 1-lateral, 2-medial, 3-superior, 4-inferior, 5-anterlor, 6-. posterior, 7 through 10-tumor, 11-skin. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS,. SPECIAL STAINS PERFORMED: Cytokeratin (AE1/AE3) (specimens A, B, c) (LQ). SURGICAL REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0YC.9BAD4BD4-A54B-4115-A00E-6AA88F344FE1",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extension. The T stage is classified as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the tumor measures 2.6 cm in maximum dimension. Since the tumor size is greater than 2 cm but less than or equal to 5 cm, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to extract relevant information from the pathology report, such as tumor size.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.6 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor. Account Numbe. PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT BREAST TOTAL MASTECTOMY WITH SENTINEL LYMPH ODE BIOPSY, F.S. TISSUES. A. LYMPH NODE (S) - LEFT SENTINEL LYMPH NODE #1 FS. B. LYMPH NODE (S) - LEFT SENTINEL LYMPH NODE #2 FS. C. BREAST MASTECTOMY (WMV) NODES - LEFT. WRI TISSUE. FS DIAGNOSIS. A. LEFT SENTINEL LYMPH NODE #1, F.S. -. NEGATIVE (0/1). B. LEFT SENTINEL LYMPH NODE #2, F.S. -. NEGATIVE (0/1). (Reported to surgeon: Diagnosed by: FINAL DIAGNOSIS. A. LEFT SENTINEL LYMPH NODE #1 -. ONE (1) BENIGN REACTIVE REGIONAL LYMPH NODE, NEGATIVE FOR. MALIGNANCY. B. LEFT SENTINEL LYMPH NODE #2 -. ONE (1) BENIGN REACTIVE REGIONAL LYMPH NODE, NEGATIVE FOR. MALIGNANCY. C. LEFT BREAST MASTECTOMY. MODERATELY DIFFERENTIATED INFILTRATING LOBULAR CARCINOMA, 6.6 CM., WITH. FOCI OF LOBULAR CARCINOMA IN-SITU INVOLVING TERMINAL. DUCTULES,. SCARFF-BLOOM-RICHARDSON BREAST CANCER HISTOLOGIC SCORE 6 (3+2+1). ALL DESIGNATED INKED SURGICAL MARGINS ARE FREE OF TUMOR. Patient Nam.. SURGICAL REPORT. Pathology Numbe. PATHOLOGIC TNM STAGE: T3 PNO(I+) MX, STAGE IIB, G2, INFILTRATING. LOBULAR CARCINOMA. PQRI CATEGORY II: 3260F. Diagnosed by. Reviewed and alectronically signed outby: COMMENT. The Immunohistochemical stains on the first sentinel lymph node (specimen A) reveals seven. positive cells with the Cytokeratin stain In the subcapsular space indicating incidental microscopic. micrometastases. The seven cells are in total measurements less than 0.1 mm. The second lymph node. (specimen B) is negative. No Individual positive cells seen. GROSS DESCRIPTION. The specimen is received in three separate containers labeled. lesignated A, B, C. A. The container Is received fresh unfixed labeled \"left sentinel lymph node #1 for frozen section\". The specimen consists of an ovoid mass of apparent fatty tissue which is 1 x 0.4x 0.3 cm. in. greatest overall dimension. Sectioning reveals a pink-tan firm nodule varying up to 0.4 cm. in. greatest dimension. Touch prep and frozen section are obtained by Dr. The entire. specimen including frozen section is submitted in two blocks. B. The container is received fresh unfixed labeled \"left sentinel lymph node #2 for frozen section\". and consists of an ovoid mass of apparent fatty tissue which is 0.4x 0.3x 0.3 cm. The specimen. is bisected revealing a thin rim of pink-tan firm tissue. Frozen section and touch prep are. obtained by. The entire specimen including frozen section is submitted in two. blocks. C. The container is received fresh unfixed labeled \"ieft breast - suture on upper outer quadrant\" and. consists of an 953 gm. apparent left breast which Is 23 x 20 x 5 cm. in greatest overall dimension. There is an attached suture indicating upper outer quadrant which is inked with yellow dye. The. lower outer quadrant Is inked with an orange dye. The upper inner quadrant is Inked with red. dye, and the lower inner is inked with green dye. Serial sectioning reveals a firm tan-gray tumor. mass which is 6.5 x 4.5 x 3 cm. in greatest overall dimension and grossly appears to be 2 cm. from the underlying resection line, 5.5 cm. from the lower outer quadrant, 7 cm. from the upper. inner, 8 cm. from the lower Inner and 8 cm. from the upper outer. The specimen Is submitted in. nine blocks. Key Note Block Summary: 1-nipple, 2 through 4-tumor, 5-deep resection line, 6-upper. inner, 7-upper outer, 8-lower inner, 9-lower outer. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: Pankeratin (specimens A &B) (CG). SURGICAL REPORT.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0YD.10DA3573-BD53-4579-AD90-E770CEF08498",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to look at the size of the tumor and its extent. The pathologic T stage is based on the largest dimension of the invasive component of the tumor. The T stages are defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. According to the provided pathology report, the tumor size is described as 6.6 cm. This directly corresponds to the definition of a T3 tumor, as it is greater than 5 cm. Therefore, based on the size of the tumor, the pathologic T stage for this breast cancer patient is T3.",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and other characteristics that influence T staging according to the AJCC Cancer Staging Manual (7th edition). Then, I will apply the appropriate T staging rule based on the extracted information.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor is more than 5 cm in greatest dimension.",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH SENTINEL LYMPH NODE BIOPSY, F.S., POSSIBLE AXILLARY DISSECTION, POSSIBLE. CED INSERTION. TISSUES. A. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #1 FS. B. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #2 FS. C. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #3 FS. D. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #4. E. AXILLARY - CONTENTS. F. BREAST EXCISION, NEEDLE LOC, SIMPLE, MARGINS,ETC. - RIGHT BREAST. LUMPECTOMY. G. MARGINS - ADDITIONAL LATERAL. ADDENDUM. ESTROGEN AND PROGESTERONE RECEPTOR RESULTS: ESTROGEN RECEPTORS -. NEGATIVE (0%) IN THE MALIGNANT CELLS. PROGESTERONE RECEPTORS -. NEGATIVE (0%) IN THE MALIGNANT CELLS. Comment: Immunohistochemical (IHC) stains for Estrogen Receptors (ER) and Progesterone. Receptors (PR) display an appropriate staining pattern on control tissue. Revlewed and electronically signed outby: FS DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1, F.S. -. ONE NEGATIVE LYMPH NODE (0/1). B. RIGHT SENTINEL LYMPH NODE #2, F.S. -. ONE NEGATIVE LYMPH NODE (0/1). SURGICAL REPORT. C. RIGHT SENTINEL LYMPH NODE, #3, F.S. -. ONE POSITIVE LYMPH NODE (1/1). F. RIGHT BREAST LUMP (GROSS MARGINS) -. 4.7 CM. TUMOR MASS AND FOCALLY INVOLVING LATERAL SURGICAL MARGIN. (REPORTED TO SURGEON: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. LYMPH NODE, REACTIVE. B. RIGHT SENTINEL LYMPH NODE #2 -. LYMPH NODE, REACTIVE. C. RIGHT SENTINEL LYMPH NODE, #3 -. METASTATIC POORLY DIFFERENTIATED DUCTAL ADENOCARCINOMA IN THE. LYMPH NODE. THE METASTATIC TUMOR INVOLVES APPROXIMATELY 40% THE SIZE OF THE. OF THE NODE AND BEST SEEN IN THE CRYOSTAT SECTIONS WITH NO EXTRA-. CAPSULAR EXTENSION. D. RIGHT SENTINEL LYMPH NODE #4 -. LYMPH NODE, ONE REACTIVE. E. RIGHT AXILLARY CONTENTS. LYMPH NODES, TOTAL OF FIFTEEN REACTIVE LYMPH NODES. F. RIGHT BREAST LUMP. BREAST TISSUE DISPLAYING POORLY DIFFERENTIATED DUCTAL ADENOCARCINOMA. OF THE BREAST, HIGH GRADE (2+3+3), 47 MM. IN GREATEST DIMENSION. THE NEAREST MARGIN IS THE LATERAL MARGIN APPROXIMATELY 1 MM. ALL OTHER MARGINS ARE FREE. ASSOCIATED FIBROADENOMA OF THE BREAST. G. ADDITIONAL LATERAL MARGIN -. FIBROADIPOSE AND BREAST TISSUE, NO PATHOLOGIC CHANGE. PTNM CLASSIFICAITON: T2 N1 MX, STAGE IIB, DUCTAL ADENOCARCINOMA OF BREAST,. G3. PQRI CATEGORY II: 3260F. Diagnosed by: COMMENT. Patient Nams. SURGICAL REPORT. Pathology Numbe. This case is discussed with Dr. by Dr. Breast cancer prognostic. profile will be performed and reported separately. GROSS DESCRIPTION. The specimen is received in seven separate containers labeled. signated A. through E. A. The container is received fresh unfixed labeled \"right sentinel lymph node #1 for frozen section\". and consists of an ovoid mass of apparent fatty material measuring 1.5x 1 x 0.6 cm. Sectioning. reveals a 0.5 cm. pink-tan firm nodule. Touch prep and frozen section are obtained by Dr. The entire specimen including frozen section is submitted In two blocks. B. The container is received fresh unfixed labeled \"right sentinel lymph node #2 for frozen section\". and consists of an irregular mass of apparent fat which is 1 x 0.6 x 0.4 cm in greatest overall. dimenslon. Sectioning reveals a 0.8 cm. purple-tan firm nodule. Touch prep and frozen section. are obtained by Dr. The entire specimen Including frozen section Is submitted in two. blocks. C. The container is received fresh unfixed labeled \"right sentinel lymph node #3 for frozen section\". and consists of an irregular mass of apparent fat which is 1 x 0.4 x 0.4 cm. in greatest overall. dimension. Sectioning reveais a pink-tan nodule 0.5 cm. in greatest dimension. Touch prep and. frozen section are obtained by Dr. The entire specimen including frozen section is. submitted in two blocks. D. The container is received fresh unfixed labeled \"right sentinel lymph node #4 for frozen section\". and consists of an irregular mass of apparent fat which is 0.6 x 0.4x 0.3 cm. The specimen is. deferred for permanent. The entire specimen is submitted in one block. E. The container is received fresh unfixed labeled \"right axillary contents\" and consists of an. irregular mass of fat which is 4.5 x 4 x 3 cm. in greatest overall dimension. Sectioning reveais. purple-tan nodules varying up to 2 cm. in greatest dimension. The specimen is submitted in four. blocks. F. The container is received fresh unfixed labeled \"right breast lump\" and consists of a 57 gm. ovoid. mass of apparent fatty and fibrous-encased tissue measuring 6,5 x 5 x 5 cm. in greatest overali. dimension. Sectioning reveals a tumor mass which is 6x 5 x 5 cm. in greatest overall dimension. There are two short sutures indicating superior margin inked with red dye, inferior is inked yellow. There Is a single short suture Indicating anterior margin Inked with orange dye, deep is inked with. black. There is a single long suture indicating lateral margin inked with blue dye, medial is inked. green. Gross margins are observed by Dr. The tumor mass grossly appears to be 0.6. away from the superior, 1 cm. away from the inferior, 1.5 cm. away from the anterior, 1 cm. away. from the deep and grossly appears to Involved the lateral or less than 0.1 cm. from the lateral; is. approximately 0.4 cm. away from the medial. The specimen is submitted in ten blocks. Key Note Block Summary: 1-superior, 2-inferior, -anterior, 4-deep, 5-lateral, 6-. medial, 7 through 10-random. G. The container Is received fresh unfixed labeled \"additional lateral margin\" and consists of a 7 gm. irregular mass of apparent fatty tissue which is 3 x 2.5 x 2 cm. in greatest overall dimension. There is an attached suture indicating new lateral margin inked with black dye. Serial sectioning. reveals apparent fatty tissue. The entire specimen is submitted as six blocks. Pathology Numbr. SURGICAL REPORT. Pathology Numbe. MICROSCOPIC EXAM. MICROSCOPIO EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: ER, PR, Her-2 (IHC) (specimen F-2) -. Pathology Numbe. SURGICAL REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to understand what each T stage represents in terms of tumor size and extent. The T stages are defined as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. Looking at the provided pathology report, the key information for determining the T stage is the size of the tumor. The report states that the tumor mass is '47 MM. IN GREATEST DIMENSION.' This measurement directly corresponds to the criteria for the T stages. Since 47 mm is equivalent to 4.7 cm, which is more than 2 cm but not more than 5 cm, the tumor falls into the T2 category. Additionally, there's no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 4.7 cm, which is greater than 2 cm but less than or equal to 5 cm, according to standard T-staging criteria.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Chief of Pathology. specimen. Status SOUT. spec Type: SURGICAL P. TREOPERATIVA. BREAST CANCER IN SITU/NIPPLE DISCHARGE/LT BREAST MACROMASTIA. OPERATION PERFORSED. DOCTOR (S) : PROCEDURE: SENTINEL NODE DEEP AXILLARY. TISSUE REGIOVED. A. LT BREAST TISSUE. B. RT SIMPLE MASTECTOMY. C. RT AXILLA SENTINEL NODE #1. PART A RECEIVED FRESH LABELED. LEFT BREAST TISSUE, IS. A LEFT BREAST TISSUE, IS A 643.5 GRAMS OF FIBROFATTY BREAST TISSUE AND. SKIN SUBMITTED IN 2 PIECES, ONE IS A PORTION OF SKIN WITH AREOLAR TYPE. TISSUE AT ONE END AND THE SECOND IS SKIN AND UNDERLYING FIBROFATTY TISSUE. REMOVED IN A BREAST REDUCTION PATTERN. SECTIONING REVEALS BLAND YELLOW. FATTY TISSUE WITH FINE FIBROUS BANDS AND NO AREAS OF MYELOFIBROSIS OR. MASS IS IDENTIFIED. REPRESENTATIVE TISSUE IS SUBMITTED AS FOLLOWS: A1--KKIN TISSUE SUPERIOR, A2--MEDIAL ARM, A3 THROUGH A5--LATERAL ARM FROM. SUPERIOR TO INFERIOR. PART B RECEIVED FRESH LABELED. RIGHT SIMPLE MASTECTOMY. STITCH 12 O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 21 x 21.5 x. 6.6 CM. THE NIPPLE IS UNREMARKABLE. WITHIN A 21.2 x 12.5 CM SKIN. ELLIPSE, A SUTURE DENOTES 12 O' CLOCK. THE SUPERFICIAL ASPECT IS MARKED. WITH BLUE INK, THE DEEP MARGIN WITH BLACK INK. A WELL-HEALED SCAR IS. NOTED ON THE LATERAL ASPECT OF THE BREAST SKIN MEASURING 5.0 CM IN. LENGTH. SECTIONING REVEALS BLAND YELLOW FATTY TISSUE WITH FINE FIBROUS. BANDS IN THE MIDPORTION. BLUE DYE IS NOTED. THERE IS AN° AREA-OF GRAY. FIBROSIS WITH TAN-BROWN DISCOLORATION SUGGESTIVE OF A PREVIOUS BIOPSY. SITE IN THE UPPER OUTER QUADRANTS. THERE IS A FIRM NODULE IN THE 9. O' CLOCK LATERAL ASPECT OF THE SPECIMEN WITH FOCAL BLUE DYE SUGGESTIVE OF. A LYMPH NODE. THIS IS 1.1 CM FROM THE DEEP MARGIN. SECTION IS SUBMITTED. IN B2 (MIRROR IMAGE TO PROTOCOL) THE AREA BETWEEN THIS BIOPSY SITE IS 5. CM FROM THE DEEP MARGIN. BIOPSY CLIPS ARE NOT OTHERWISE IDENTIFIED. WITHIN THE SPECIMEN. SECTIONS ARE SUBMITTED AS FOLLOWS: B1--NIPPLE AND. SKIN SCAR, 2--POSSIBLE LYMPH NODE AT 9 O' CLOCK AREA, B3-DEEP MARGIN TO. B2, B4--DEEP MARGIN TO PREVIOUS BIOPSY SITE, B5 THROUGH 012--ESTIONS OF. THIS PREVIOUS BIOPSY SITE WITH B7 AND B12 THE FARTHEST FROM EACH OTHER AT. 2 CM SPA, B13 - - NODULARITY IMMEDIATELY DEEP TO B12, UPPER OUTER QUADRANT,. B14--UPPER OUTER QUADRANT IMMEDIATELY ADJACENT TO B13, B15--LOWER OUTER. QUADRANT IMMEDIATELY INFERIOR TO B2, B16--RANDOM LOWER OUTER QUADRANT 6. CM FROM PREVIOUS BIOPSY SITE, 817--NODULARITY 6 O' CLOCK AREA 9 CM FROM. PREVIOUS BIOPSY SITE (MIRROR IMAGE TO PROTOCOL), B18 --LOWER INNER. ogy. 2. Specimen. spec Type: SURGICAL P. GROSS DESCRIPTION. QUADRANT, B19--PUPPER - INNER QUADRANT. SEPARATELY SUBMITTED WITHIN THE. CONTAINER IS A SMALL FRAGMENT OF YELLOW FATTY TISSUE MEASURING 3.5 x 3.0. x 1.2 CM IN GREATEST DIMENSION. THIS IS GROSSLY UNREMARKABLE AND. REPRESENTATIVE TISSUE IS SUBMITTED IN B20. PART C RECEIVED FRESH LABELED. RIGHT AXILLA FIRST. SENTINEL NODE HOT AND BLUE, IS YELLOW-TAN FATTY TISSUE MEASURING 3.4 x. 2.0 x 1.0 CM. SECTIONING REVEALS A GROSSLY UNREMARKABLE FAT-REPLACED. NODAL TISSUE SUBMITTED ENTIRELY LABELED c. PROCEDURES. PROCEDURES: 88305, 88307/2, IMMUNOPEROXIDAS, A BLK/5, B BLK/20, CBX X6. FINAL DIAGNOSIS. PART A LEFT BREAST, REDUCTION MAMMOPLASTY: 1. CONSISTENT WITH MACROMASTIA. 2. SCATTERED FOCI OF ATYPICAL LOBULAR HYPERPLASIA. PART B RIGHT BREAST, SIMPLE MASTECTOMY: 1. MODERATELY DIFFERENTIATED INTRADUCTAL AND INFILTRATING DUCT. CARCINOMA. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2, MODERATE. MITOTIC INDEX AND TUBULE FORMATION 3 FOR A TOTAL NOTTINGHAM SCORE OF. 7. DCIS OF THE CRIBRIFORM AND PAPILLARY TYPES, NUCLEAR GRADE 2 HAS. RARE FOCI OF INTRALUMINAL NECROSIS AND COMPRISES APPROXIMATELY 50% OF. THE TUMOR. 2. THE TUMOR IS MULTIFOCAL IN THE UPPER OUTER QUADRANT WITH THE LARGEST. INVASIVE FOCUS MEASURING 7 MM IN GREATEST DIMENSION. ADDITIONAL. INVASIVE FOCI ARE ALSO PRESENT THAT RANGE FROM 2 TO 3 MM IN GREATEST. DIMENSION. DCIS IS IDENTIFIED ON 15 OF 20 BLOCKS EXAMINED HAVING A. MAXIMUM CALCULATED DIMENSION OF 6 CM. 3. THE NIPPLE SKIN, RANDOM SECTIONS OF REMAINING QUADRANTS AND MARGINS. ARE FREE OF TUMOR. 4. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. 5. THE BIOPSY SITE. IS PRESENT. PART C RIGHT AXILLA, SENTINEL LYMPH NODE BIOPSY: METASTATIC BREAST. CARCINOMA IS IDENTIFIED IN THE SUBCAPSULAR SINUS/CORTEX IN A FOCUS. MEASURING 0.17 MM IN GREATEST MICROSCOPIC DIMENSION ON THE CYTOKERATIN. STAIN WHICH WERE NOT SEEN ON INITIAL H AND E EXAMINATION. RARE. Chief of Pathology. Specimen: Spec Type: SURGICAL P. FINAL DIAGNOSTS. ADDITIONAL ISOLATED TUMOR CELLS ARE ALSO PRESENT. (prelim.). (signature on file).\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report regarding the size and extent of the tumor.\\n1. **Tumor Size and Extent**: The report mentions that the largest invasive focus measures 7 mm in greatest dimension, and there are additional invasive foci ranging from 2 to 3 mm. However, it also notes that DCIS (ductal carcinoma in situ) is identified on 15 of 20 blocks examined, with a maximum calculated dimension of 6 cm. This indicates that while the invasive component is relatively small, the overall tumor size, including the DCIS component, is larger.\\n2. **Definition of T Stages**:\\n   - **T1**: Tumor >0.1 cm but = 2 cm in greatest dimension.\\n   - **T2**: Tumor >2 cm but = 5 cm in greatest dimension.\\n   - **T3**: Tumor >5 cm in greatest dimension.\\n   - **T4**: Tumor of any size with direct extension to the chest wall or skin.\\n3. **Determining T Stage**: Given that the largest invasive focus is 7 mm (which is less than 1 cm) but the overall tumor dimension, considering the DCIS component, is up to 6 cm, we need to consider how the AJCC staging manual addresses such cases. For the purpose of T staging, the size of the invasive tumor is what's critical, but the presence of extensive DCIS can influence the overall assessment of tumor extent.\\n4. **Conclusion**: Since the largest invasive component is 7 mm, which falls into the T1 category based on invasive size alone, but considering the extensive DCIS and the multifocal nature of the tumor, the staging might be influenced by the overall tumor extent. However, according to the AJCC 7th edition, the T stage is primarily based on the size of the invasive component. Therefore, based on the information provided, the pathologic T stage would be determined by the size of the invasive tumor, which is less than 2 cm.\\n",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, we need to analyze the pathology report provided by the user. We will first extract relevant information from the report, such as tumor size and depth of invasion. Then, we will compare the extracted values against the AJCC Cancer Staging Manual (7th edition) criteria to determine the appropriate T stage. Finally, we will use the produce_final_staging_response function to format our response into a JSON schema with 'reasoning' and 'stage' as keys.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 7 mm corresponds to a T1 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Chief of Pathology. Specimen: spec Type: SURGICAL P. OPERATION PERFORMED. DOCTOR (8) : TISSUE RENOVED. A. LT AXILLARY NODE DISSECTION. B. LT PARTIAL MASTECTOMY. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT AXILLARY NODE. DISSECTION, IS YELLOW-RED FATTY TISSUE MEASURING 15 x 12.5 x 4.0 CM. THIS IS EXAMINED FOR LYMPH NODES. THE NODAL TISSUE IS IDENTIFIED. PRIMARILY AT ONE END OF THE SPECIMEN, NITH 75% CONSISTING OF BLAND YELLOW. FATTY TISSUE. MULTIPLE LYMPH NODES ARE IDENTIFIED AND GROSSLY POSITIVE. SECTIONS ARE SUBMITTED AS FOLLOWS: A1 THROUGH A8 ---ONE SECTION EACH OF. GROSSLY POSITIVE LYMPH NODES WITH A RIBBON CLIP IDENTIFIED IN THE NODE. CORRESPONDING TO A2. NOTE THAT MIRROR IMAGE RESEARCH BLOCKS ARE TAKEN ON. EACH. A9 AND 10--ONE NODE EACH BISECTED, All--TWO NODES EACH BISECTED,. A12-- TWO NODES, A13--ONE NODE BISECTED, A14--ONE NODE BISECTED, A15--ONE. NODE BISECTED, A16 THROUGH A19--ONI GROSSLY FAT-REPLACED NODE TOTAL. PART B RECEIVED FRESH LABELED. LEFT PARTIAL MASTECTOMY. LONG STITCH LATERAL SHORT STITCH SUPERIOR, IS AN OVOID PORTION OF. YELLOW-PINK FATTY TISSUE MEASURING 11.5 x 7 x 4.7 CM IN GREATEST. DIMENSIONS. THE SPECIMEN IS ORIENTED BY TWO SUTURES. A LARGE PALPABLE. MASS IS PRESENT MEDIALLY. SECTIONING REVEALS THIS PALPABLE MASS TO HAVE. A FIRM PINK-TAN GRITTY CUT SURFACE MEASURING 4.0 x 2.8 x 3 CM IN GREATEST. DIMENSIONS. THIS LESION EXTENDS TO THE INFERIOR MARGIN AND IS 0.4 CM. FROM THE MARGIN GROSSLY. IT IS 0.6 CM FROM THE DEEP MARGIN, 0.8 CM FROM. THE SUPERFICIAL MARGIN AND GREATER THAN 1 CM FROM ALL OTHER MARGINS. SECTIONING THE LATERAL ASPECT OF THE SPECIMEN CONSISTS OF BLAND YELLOW. FATTY TISSUE. SECTIONS ARE SUBMITTED AS FOLLOWS: B1 --PBRPENDICULAR. MEDIAL MARGIN, B2--TUMOR (MIRROR IMAGE TO PROTOCOL) B3--LESION AND DEEP. MARGIN, 84--LESION AND DEEP INFERIOR MARGIN CLOSEST TO TUMOR,. B5 --INFERIOR SUPERFICIAL MARGIN WITH LESION, B6--LESION AND SUPERFICIAL. MARGIN (MIRROR IMAGE TO PROTOCOL), B7 - -SUPERFICIAL SUPERIOR MARGIN,. B8--SUPERIOR - DEEP MARGIN. NOTE THAT B2 THROUGH B8 CONSTITUTE ONE FULL. CROSS-SECTION OF THE LESION IN ITS GREATEST DIMENSION. B9 - -PERPENDICULAR. LATERAL MARGIN, B10--TISSUE FROM LATERAL ASPECT OF THE SPECIMEN,. B11 - -TUMOR AND SUPERFICIAL MARGIN (MIRROR IMAGE TO PROTOCOL) B12--TUMOR. (MIRROR IMAGE TO PROTOCOL). Chief of Pathology. Specimen: Spec Type: SURGICAL P. PATH PROCEDURES. PROCEDURES: 88307/2, A BLK/19, B BLK/12. FINAL DIAGNOSIS. PART A LEFT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST CARCINOMA. IS IDENTIFIED IN 14 OF 18 NODES EXAMINED AND EXTRANODAL EXTENSION IS. MULTIFOCALLY PRESENT. PART B LEFT BREAST, PARTIAL MASTECTOMY: 1. POORLY DIFFERENTIATED INTRADUCTAL AND INFILTRATING DUCT CARCINOMA,. NUCLEAR GRADE III, HIGH MITOTIC INDEX AND TUBULE FORMATION 2, FOR A. TOTAL NOTTINGHAM SCORE OF 8. DCIS OF THE SOLID TYPE COMPRISES. APPROXIMATELY 5% OF THE TUMOR. 2. THE GROSS TUMOR HAS A MAXIMUM DIMENSION OF 4 CM. 3. THE INVASIVE TUMOR IS IDENTIFIED 6 MM OR MORE FROM THE INKED MARGINS. OF EXCISION. 4. LYMPHOVASCULAR INVASION IS PRESENT. 5. BIOPSY CHANGES. ARE PRESENT. COBS. 1. , (prelim.). (signature on file). I.D.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is defined as follows: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, and T4 - Tumor of any size with direct extension to the chest wall or skin. The key information from the pathology report is the size of the tumor. According to the report, 'THE GROSS TUMOR HAS A MAXIMUM DIMENSION OF 4 CM.' This information directly corresponds to the criteria for determining the T stage. Since the tumor is greater than 2 cm but less than or equal to 5 cm, it falls into the T2 category. The presence of lymphovascular invasion and metastatic carcinoma in the lymph nodes, as well as the tumor's proximity to the margins, are important for overall staging but do not affect the T stage directly. The T stage is primarily concerned with the size and extent of the primary tumor.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report, such as tumor size and depth of invasion.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 4 cm, which falls into the T2 category according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Chief of. CPNSU. Specimen. Spec Type: SURGICAL p. OPERATION. DOCTOR (8) : PROCEDURE: PARTIAL MASTECTOMY/LUMPECTOMY-AXTLLARY NODE DISSECTION. TISSUE REMOVED. A. LT PARTIAL MASTECTOMY. B. LT AXILLARY NODE. C. LT BREAST INFERIOR AND SUPERFICIAL MARGIN. GROSS DESCRIUTION. PART A RECEIVED FRESH LABELED. LEFT PARTIAL MASTECTOMY LONG. EQUALS LATERAL SHORT EQUALS SUPERIOR, IS AN OVOID PORTION OF YELLOW-PINK. FATTY TISSUE MEASURING 7 x 6 x 3.5 CM. THE SPECIMEN IS ORIENTED BY TWO. SUTURES AND MARKED AS FOLLOWS LATERAL ORANGE, MEDIAL RED, SUPERIOR. GREEN, INFERIOR BLUE, SUPERFICIAL BLACK, DEEP YELLOW. A LARGE PALPABLE. MASS IS FELT WITHIN THE SPECIMEN INFERIOR AND MEDIALLY. SECTIONING. REVEALS A ROUNDED PINK-TAN MASS MEASURING 2.4 x 2.2 x 2.7 CM IN GREATEST. DIMENSIONS. THIS APPROACHES THE SUPERFICIAL, DEEP AND INFERIOR MARGINS,. GROSSLY EXTENDING TO WITHIN 0.2 CM OF EACH OF THESE. IT IS GREATER THAN. 1 CM FROM THE OTHER MARGINS. THE SPECIMEN CONSISTS OF PINK-TAN FIBROUS. TISSUE IN THE MEDIAL ASPECT OF THE SPECIMEN AND YELLOW FATTY TISSUE MORE. LATERALLY. A RIBBON CLIP IS IDENTIFIED WITHIN THIS LESION. SECTIONS ARE. SUBMITTED AS FOLLOWS: A1 --REPRESENTATIVE PERPENDICULAR MEDIAL MARGIN,. A2 - -REPRESENTATIVE - PERPENDICULAR LATERAL MARGIN, A3 - --TUMOR (MIRROR IMAGE. TO PROTOCOL), A4--TUMOR AND INFERIOR MARGIN (MIRROR IMAGE TO PROTOCOL). A5 - -LESION AND INFERIOR MARGIN, A6--TUMOR AND SUPERFICIAL MARGIN,. A7--TUMOR AND DEEP MARGIN. NOTE THAT A5 THROUGH A6 IS ONE FULL. CROSS-SECTION OF LESION, WITH A6 MIRROR IMAGE TO TISSUE TAKEN PER. PROTOCOL. A8 --TISSUE - AND SUPERFICIAL MARGIN CORRESPONDING TO THE TUMOR. IN A3 (MIRROR IMAGE TO PROTOCOL TISSUE), A9--TISSUE TO INCLUDE THE DEEP. AND SUPERIOR MARGINS CORRESPONDING TO THE CROSS-SECTION DEPICTED IN A5. THROUGH 7, A10--THE CORRESPONDING DEEP MARGIN TO THE TUMOR TAKEN IN A3,. All --THE LATERAL ASPECT OF THE TUMOR TO INCLUDE THE INFERIOR SUPERFICIAL. MARGIN. PART B RECEIVED FRESH LABELED. LEFT AXILLARY NODE. DISSECTION, IS A PORTION OF YELLOW-RED FATTY TISSUE MEASURING 10 x 7.6 x. 4.8 CM IN GREATEST DIMENSIONS. THIS IS EXAMINED FOR LYMPH NODES WHICH. ARE THEN SUBMITTED AS FOLLOWS: 1--GROSSLY UNREMARKABLE LYMPH NODE,. B2 - - SECTION OF GROSSLY POSITIVE LYMPH NODE, B3 --SECTION - OF GROSSLY. POSITIVE LYMPH NODE WITH COIL CLIP. NOTE: SPECIMENS B1 THROUGH 3 ARE. MIRROR IMAGES TO PROTOCOL SECTIONS. B4 AND ---ONE NODE TOTAL, B6--TWO. NODES EACH BISECTED, B7--TWO NODES EACH BISECTED, B8 - THREE - NODES EACH. BISECTED, B9 - THREE NODES, B10--ONE NODE BISECTED, B11--ONE NODE. BISECTED, B12 - ONE NODE BISECTED. AFTER A SHORT TIME OF ACETIC FORMALIN FIXATION, ADDITIONAL NODES ARE. Chief of Pathology. specimen: spec Type: SURGICAL p. GROSS DESCRIPTION. IDENTIFIED AND SUBMITTED AS FOLLOWS: B13--ONE NODE BISECTED, B14 - -FIVE -. NODES, B15--THREE NODES EACH BISECTED, B16--TWO NODES EACH BISECTED. PART C RECEIVED LABELED LEFT BREAST INFERIOR AND. SUPERFICIAL MARGIN STITCH AT NEW MARGIN, IS AN OVOID PORTION OF. YELLOW-PINK FATTY TISSUE MEASURING 6.4 x 5.4 x 1.1 CM. SUTURE DENOTES A. NEW MARGIN. THIS SIDE IS MARKED WITH BLUE INK WITH A PERIMETER OF BLACK. INK. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED LABELED C1 THROUGH. 10. PATH PROCEDURES. PROCEDURES: 88307/3, A BLK/11, B BLK/16, C BLK/10. FINAL DIAGHONTS. PART A LEFT PARTIAL MASTECTOMY: IN SITU AND POORLY DIFFERENTIATED. INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE III/III WITH A HIGH MITOTIC. INDEX. THE INVASIVE TUMOR IS 2.- 4 CM IN MAXIMUM MICROSCOPIC DIMENSION. A 0.9 CM FOCUS OF DUCT CARCINOMA IN SITU OF THE MICROPAPILLARY AND. COMEDOCARCINOMA TYPES IS PRESENT ADMIXED WITH AND ADJACENT TO THE. INVASIVE TUMOR. DUCT CARCINOMA IN SITU IS PRESENT 1 MM FROM THE. SUPERFICIAL MARGIN, WITH INVASIVE CARCINOMA 1.5 MM FROM THE SUPERFICIAL/. MARGIN. INVASIVE CARCINOMA IS ALSO PRESENT IN A MICROSCOPIC SATELLITE. NODULE 1 MM FROM THE DEEP MARGIN. THE INFERIOR MARGIN IS CLEAR BY A. DISTANCE OF 3 MM. THE SUPERIOR, MEDIAL, AND LATERAL MARGINS ARE ALL. CLEAR OF TUMOR BY DISTANCES EXCEEDING 1 CM. THERE IS A SMALL FOCUS OF. ATYPICAL DUCT HYPERPLASIA 3 MM FROM THE MEDIAL MARGIN. PART B LEFT AXILLARY LYMPH NODE DISSECTION: METASTATIC CARCINOMA. IDENTIFIED IN 5 OF 28 AXILLARY LYMPH NODES. PART C LEFT BREAST SUPERFICIAL AND INFERIOR MARGIN, REEXCISION: FRAGMENTS OF BENIGN FATTY BREAST TISSUE AND A MICROSCOPIC FOCUS OF. INFILTRATING DUCT CARCINOMA. THIS 1 MM FOCUS OF CARCINOMA HAS A. CAUTERIZED MARGIN AND IS SEPARATE FROM THE ADJACENT ADIPOSE TISSUE. THE. AREA IS NOT INKED, BUT ITS RELATIONSHIP TO THE MARGIN CANNOT BE. ACCURATELY DETERMINED BECAUSE IT IS NOT ATTACHED TO THE INKED MARGIN. PORTION OF THE SPECIMEN. THIS FOCUS OF TUMOR IS PRESENT IN 1 OF 10. TISSUE BLOCKS (BLOCK C10). CODE. 1. (prelim.).\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the invasive tumor and its extent. The key information from the pathology report includes: 1. The invasive tumor is 2.4 cm in maximum microscopic dimension. 2. The tumor approaches the superficial, deep, and inferior margins but is within 0.2 cm of these margins, and it is greater than 1 cm from the other margins. However, the critical factor for T staging is the size of the tumor and its extension to the chest wall or skin. Given the tumor size is 2.4 cm, which is less than 5 cm, and there is no mention of the tumor extending to the chest wall or skin, we can rule out T3 and T4 based on the size and extension criteria. Between T1 and T2, T1 is defined as a tumor less than or equal to 2 cm, and T2 is defined as a tumor more than 2 cm but not more than 5 cm. Since the tumor is 2.4 cm, it falls into the T2 category because it is more than 2 cm but less than 5 cm.",
    "BaselineChoice": "T2",
    "Monologue": "The pathology report mentions a tumor size of 2.4 cm, which suggests a T2 stage, but we need to check if there are any other factors that could change the staging, such as lymph node involvement or margin status.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The invasive tumor is 2.4 cm in maximum microscopic dimension, which falls within the criteria for a T2 classification.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Chief of Pathology. Specimen. Spec Type: SURGICAL P. DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s). PROCEDURE: MASTECTOMY PARTIAL/LOMPECTOMY/RXISTON BENTINEL NODE. FEMOVED. A. RT BREAST. B. RT SENTINEL NODE #1. C. RT NON SENTINEL NODE. D. RT SENTINEL NODE #2. E. RT BREAST ADDITIONAL POST INK NEW MARGIN. PART A RECEIVED LABELED. RIGHT BREAST 10 O'CLOCK LONG. EQUALS LATERAL SHORT EQUALS SUPERIOR, IS AN OVOID PORTION OF YELLOW FATTY. TISSUE MEASURING 9.5 x 6.3 x 4.0 CM. THE SPECIMEN IS ORIENTED BY TWO. SUTURES AND BLUE DYE IS NOTED WITHIN THE SPECIMEN. SUPERFICIALLY ON THE. LATERAL ONE-HALF, THERE IS A SKIN ELLIPSE MEASURING 4.2 x 0.8 CM. TWO. NEEDLE LOCALIZATION WIRES ENTER THE INFERIOR LATERAL ASPECT OF THE. SPECIMEN. SECTIONING REVEALS THE MAJORITY OF THE SPECIMEN TO CONSIST OF. BLAND YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. IN THE MIDPORTION OF. THE SPECIMEN, THERE IS A PINK-TAN GRITTY AREA. THIS IS IN THE MEDIAL. ONE-HALF, AND LATERAL TO THIS, THERE IS DENSE PINK-TAN FIBROUS TISSUE. THE FIRM AREA MEASURES 1.7 x 1.4 x 2.0 CM IN GREATEST DIMENSIONS. THERE. IS A SECOND FIRM AREA IMMEDIATELY INFERIOR TO THIS AREA WHICH BY. PALPATION MEASURES 0.7 CM IN GREATEST DIMENSION. THIS APPROACHES THE. INFERIOR MARGIN BY 0.3 CM. THE LARGER LESION IS 1 CM FROM THE CLOSEST. MARGIN, WHICH IS SUPERFICIAL AND DEEP. SECTIONS ARE SUBMITTED AS. FOLLOWS: Al--PERPENDICULAR MEDIAL MARGIN, A2 -PERPENDICULAR LATERAL. MARGIN, A3 --CENTRAL TUMOR (MIRROR IMAGE TO PROTOCOL) . A4 THROUGH. A8--TISSUE SURROUNDING A3 AS FOLLOWS: DEEP MARGIN, INFERIOR MARGIN TO. INCLUDE SEPARATE PALPABLE NODULE, --SUPERFICIAL INFERIOR ASPECT,. A7--SUPERFICIAL MARGIN, A8--SUPERIOR MARGIN. A9 AND 10--FULL. CROSS-SECTION OF LESION TO INCLUDE THE DEEP AND SUPERFICIAL MARGINS,. RESPECTIVELY; A11--LATERAL ASPECT OF LESION TO INCLUDE SUPERFICIAL MARGIN. (MIRROR IMAGE TO PROTOCOL). PART B RECEIVED FRESH LABELED. RIGHT SENTINEL NODE #1. HOT AND BLUE, ARE TWO PORTIONS OF YELLOW-PINK FATTY TISSUE MEASURING 1.7. x 1 x 0.5 CM AND 1.7 x 1.5 x 0.8 CM. IN THE SMALLER PORTION, THERE IS A. 0.6-CM GROSSLY UNREMARKABLE LYMPH NODE. THE LARGER PORTION CONSISTS OF. FATTY TISSUE WITH FOCAL BLUE DYE. BLUE DYE IS ALSO NOTED WITHIN THE. NODE. THE SPECIMEN IS SUBMITTED ENTIRELY LABELED B. - or. Phon. Specimen: Spec Type: SURGICAL P. GROSS. PART C RECEIVED FRESH LABELED. RIGHT NONSENTINEL LYMPH. NODE, IS AN OVOID PORTION OF PINK-TAN TISSUE MEASURING 1.8 x 1 x 1 CM. SECTIONING REVEALS IT TO BE A GROSSLY UNREMARKABLE LYMPH NODE. A PORTION. IS SUBMITTED PER PROTOCOL. THE REMAINDER IS SUBMITTED LABELED C. PART D RECEIVED FRESH LABELED. SENTINEL NODE #2 HOT, IS. AN IRREGULAR PORTION OF YELLOW-RED FATTY TISSUE MEASURING 2.5 x 1.5 x 1.0. CM. NO DISTINCT NODAL TISSUE IS IDENTIFIED. THE SPECIMEN IS ENTIRELY. SUBMITTED LABELED D. PART E RECEIVED LABELED. RIGHT BREAST ADDITIONAL. POSTERIOR INK AT NEW MARGIN, IS AN OVOID PORTION OF YELLOW FATTY TISSUE. MEASURING 6 x 4.8 x 0.8 CM. THE SIDE OF THE SPECIMEN WHICH DEMONSTRATES. THE INK IS MARKED WITH BLUE INK WITH A PERIMETER OF BLACK INK. THIS IS. SECTIONED AND SUBMITTED ENTIRELY LABELED E1 THROUGH 9. PATH PROCHDES. PROCEDURES: 88305, 88307/4, IMMUNOPEROXIDAS/2, A BLK/11, BBX X6, C BLK, DBX x6, E BLK/9. PARAL. PART A RIGHT BREAST, PARTIAL MASTECTOMY: 1. MODERATELY DIFFERENTIATED IN SITU AND INFILTRATING CARCINOMA WITH. MIXED DUCTAL AND LOBULAR DIFFERENTIATION, PREDOMINANTLY LOBULAR,. NUCLEAR GRADE I WITH LOW MITOTIC INDEX, WITH AN IN SITU COMPONENT. OF APPROXIMATELY 20% OF SOLID AND CRIBRIFORM TYPE. 2. TWO (2) TUMOR NODULES ARE PRESENT MEASURING 1.7 AND 0.5 CM IN. GREATEST DIMENSION. ALL MARGINS OF RESECTION ARE FREE OF NEOPLASM BY. A DISTANCE OF 5 MM OR GREATER. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. FIBROCYSTIC DISEASE. 5. BIOPSY SITE CHANGE WITH ORGANIZING FAT NECROSIS AND REACTIVE FIBROSIS. PART B RIGHT SENTINEL NODE #1, BIOPSY: LYMPH NODE (1) WITH A MINUTE. FOCUS OF ISOLATED TUMOR CELLS WHICH IS ONLY VISIBLE ON CYTOKERATIN STAIN. AND NOT ON THE ROUTINE STEP SECTIONS. THE FOCUS OF TUMOR CELLS MEASURES. APPROXIMATELY 0.05 MM IN GREATEST DIMENSION. PART C RIGHT NONSENTINEL LYMPH NODE, BIOPSY: LYMPH NODE (1) WITH FATTY. INFILTRATION, NEGATIVE FOR TUMOR. PART D RIGHT SENTINEL NODE #2, BIOPSY: ADIPOSE TISSUE CONTAINING A. Chief of Pathology. 11. Specimen: Spec Type: SURGICAL P. PINAL. MINUTE CRUSHED LYMPHOID AGGREGATE, NEGATIVE FOR TUMOR BY STEP SECTION AND. CYTOKERATIN STAIN. PART E RIGHT BREAST, ADDITIONAL POSTERIOR MARGIN: LIPOMATOUS BREAST. TISSUE WITH NO EVIDENCE OF RESIDUAL NEOPLASM. THE NEW INKED MARGIN IS. FREE OF NEOPLASM. FIBROCYSTIC CHANGE WITH DUCT HYPERPLASIA OF THE USUAL. TYPE WITH INTRADUCTAL PAPILLOMATOSIS, APOCRINE METAPLASIA AND CYST. FORMATION. CODR. 1. (prelim.). (signature on file).\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extension into surrounding tissues. The key information from the pathology report is as follows:\\Image shows the tumor size to be 1.7 cm in greatest dimension for the larger lesion, and there's a mention of a second firm area (tumor nodule) measuring 0.7 cm. However, for the purpose of T staging, the size of the largest tumor focus is what's critical.\\nThe report does not mention any direct extension of the tumor to the chest wall or skin, which would be necessary for a T3 or T4 classification, respectively. Specifically, T4 classification involves tumors of any size with direct extension to the chest wall or skin, including inflammatory breast cancer. Since there's no mention of such extension, T4 can be ruled out.\\nT3 tumors are those larger than 5 cm but without evidence of chest wall or skin involvement. Given the largest tumor dimension is 1.7 cm, this does not meet the criteria for T3.\\nBetween T1 and T2, T1 tumors are 2 cm or less in greatest dimension, and T2 tumors are more than 2 cm but not more than 5 cm. Given the largest tumor is 1.7 cm, it falls into the T1 category.\\nTherefore, based on the tumor size being 1.7 cm, which is less than 2 cm, the pathologic T stage is T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The largest tumor nodule measures 1.7 cm in greatest dimension, which falls within the T2 category according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        caie? of Pathology. Specimen: spec Type: SURGICAL P. PREOPRRAT. LEFT BREAST CANCER INVASIVE. OPERATION PERFORDED. DOCTOR (S) : PROCEDURE: MASTECTOMY MODIFTED RADICAL. RESOVER. A. LEFT MODIFIED RADICAL MASTECTOMY. B. LT DEEP MARGIN BENEATH TUMOR. GROSS. PART A RECEIVED LABELED. LEFT MODIFIED RADICAL. MASTECTOMY STITCH AT 12 O'CLOCK, IS A LEFT MODIFIED RADICAL MASTECTOMY. WITH A SKIN ELLIPSE MEASURING 20 x 8.5 CM WITH A GROSSLY UNREMARKABLE. NIPPLE. THE SPECIMEN ITSELF MEASURES 26.5 x 14 x 3.5 CM. THE AXILLARY. CONTENTS ARE DISSECTED OFF THE SPECIMEN AND THIS AREA IS MARKED WITH RED. INK DENOTING THAT THIS IS NOT A TRUE MARGIN. THE AXILLARY TAIL IS. EXAMINED FOR LYMPH NODES. IN THE LOWER AXILLARY TAIL THERE IS A 3. .7-CM. IN GREATEST DIMENSION GROSSLY POSITIVE LYMPH NODE. ADDITIONAL NODES ARE. ALSO IDENTIFIED. TWO ADDITIONAL GROSSLY POSITIVE NODES ARE SUBMITTED,. ONE SECTION EACH, IN A1 AND A2 WITH MIRROR IMAGES PER PROTOCOL. A3 IS A. GROSSLY UNREMARKABLE LYMPH NODE WITH MIRROR IMAGE IN PROTOCOL. A4--ONE. SECTION OF A GROSSLY POSITIVE LYMPH NODE WITH MIRROR IMAGE PROTOCOL,. A5--LARGEST - LYMPH NODE, A6--TWO NODES, EACH BISECTED, A7--TWO NODES, EACH. BISECTED, A8--NINE NODES. EIGHTEEN LYMPH NODES ARE IDENTIFIED IN ALL. THE SUPERFICIAL ASPECT OF THE BREAST IS THEN MARKED WITH BLUE INK, THE. DEEP WITH BLACK INK. LATERAL TO THE NIPPLE THERE IS A PINK-TAN FIRM. GRITTY MASS MEASURING 7 x 3 x 4.5 CM. THIS GROSSLY EXTENDS TO WITHIN 0.2. CM OF THE DEEP MARGIN. CENTRALLY IN THE BREAST THE TISSUE IS TAN AND. FIBROUS. THE PERIMETER OF THE SPECIMEN IS FATTY WITH FINE FIBROUS BANDS. SECTIONS OF THE BREAST ARE SUBMITTED AS FOLLOWS: A9--NIPPLE - AND SKIN. (MIRROR IMAGE TO PROTOCOL), A10--SECTION OF TUMOR TO INCLUDE DEEP MARGIN. (MIRROR IMAGE TO PROTOCOL), All THROUGH A16--A FULL CROSS SECTION FROM. SUPERIOR TO INFERIOR OF THE LESION TO INCLUDE THE DEEP MARGIN IN A11, 12,. 14, AND 16 WITH A13 AND A15 REPRESENTING THE SUPERFICIAL SECTIONS TO A12. AND A14, RESPECTIVELY, A17 --TUMOR AND DEEP MARGIN, A18--THE MOST LATERAL. ASPECT OF THE LESION, A19--THE MEDIAL ASPECT OF THE LESION (4.5 CM FROM. PREVIOUS SECTION), A20--LOWER OUTER QUADRANT, A21--UPPER OUTER QUADRANT,. A22--UPPER - INNER QUADRANT 5 CM FROM TUMOR, A23-LOWER INNER QUADRANT 5 CM. FROM TUMOR, A22 AND A23--MIRROR IMAGES TO PROTOCOL TISSUE. PART B RECEIVED LABELED. DEEP MARGIN BENEATH TUMOR. STITCH NEW MARGIN, IS AN IRREGULAR PORTION OF RED-TAN MUSCULAR TISSUE. WITH CAUTERY ARTIFACT ON THE SIDE WITH THE SUTURE DENOTING THE NEW. MARGIN. THIS MEASURES 2.7 x 2.5 x 0.4 CM IN GREATEST DIMENSIONS. THE. Chief of Pathology. Specimen: Spec Type: SURGICAL P. SIDE DESIGNATED AS THE NEW MARGIN IS MARKED WITH BLUE INK WITH A. PERIMETER OF BLACK INK. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED. LABELED R1 THROUGH 3. PATH PROCEDURES. PROCEDURES: 88307, 88309, A BLK/23, B BLK/3. PART A LEFT MODIFIED RADICAL MASTECTOMY: IN SITU AND POORLY. DIFFERENTIATED INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE 3 OF 3 WITH A. HIGH MITOTIC INDEX. GROSSLY THE TUMOR SPANNED A DISTANCE OF 70 MM. LYMPHATIC SPACE INVASION IS PRESENT. A HIGH-GRADE IN SITU COMPONENT OF. THE COMEDOCARCINOMA TYPE IS PRESENT. 70 TO 80% OF THE TUMOR IS. INVASIVE. INVASIVE CARCINOMA IS LOCATED IN THE LYMPHATIC SPACES AT THE. DEEP MARGIN AND WITHIN THE STROMA OF THE BREAST 1.1 MM FROM THE DEEP. MARGIN. TUMOR IS PRESENT IN A LYMPHATIC SPACE IN A SECTION FROM THE. LOWER OUTER QUADRANT OF THE BREAST AWAY FROM THE GROSSLY IDENTIFIABLE. PRIMARY LESION. METASTATIC CARCINOMA IS PRESENT IN 5 OF 18 AXILLARY. LYMPH NODES. PART B DEEP MARGIN BENEATH TUMOR, REEXCISION: SKELETAL MUSCLE WITH NO. TUMOR IDENTIFIED. 1. , M.D. (prelim.). (signature on file).\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0YJ.90F13DE2-7C8F-4FA2-B9BF-D68EEC37D514",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report. The key factors in determining the T stage include the size of the tumor and whether the tumor has spread to the chest wall or skin.\", \"Step 1: Determine the size of the tumor. The report mentions that 'GROSSLY THE TUMOR SPANNED A DISTANCE OF 70 MM.' This indicates the tumor is larger than 5 cm but does not exceed 10 cm, as tumors larger than 10 cm would be classified differently.\", \"Step 2: Check for involvement of the chest wall or skin. The report does not mention any direct involvement of the chest wall, but it does mention that the tumor extends to within 0.2 cm of the deep margin and that there is lymphatic space invasion present. However, for T4 classification, the tumor would need to have direct extension to the chest wall or skin, which is not indicated here.\", \"Based on these observations, we can rule out T1 (tumors 2 cm or less in greatest dimension) and T4 (tumors of any size with direct extension to the chest wall or skin). The tumor size (70 mm) places it in the T3 category according to the AJCC 7th edition staging manual, which includes tumors more than 5 cm but not more than 10 cm in greatest dimension without evidence of chest wall or skin involvement.\", ",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor measures more than 5 cm in greatest dimension and extends to within 0.2 cm of the deep margin, according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Chief of Pathology. Specimen: Req# 2. Spec Type: SURGICAL P. LEFT BREAST CANCER INVASIVE. OPERATION PERFORNED. DOCTOR (8) : PROCEDURE: STMPLE MASTRCTOMY/EX) EXCTSIONAL SENTINEL NODE. A. LT MASTECTOMY. B. RT MASTECTOMY. c. LT SENTINEL NODE #1. D. LT SENTINEL NODE #2. PART A RECEIVED LABELED. LEFT MASTECTOMY STITCH AT. 12 O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 15 x 15 x 3.5 CM IN. GREATEST DIMENSIONS. THE NIPPLE IS IN THE INFERIOR PORTION OF A SKIN. ELLIPSE MEASURING 9.7 x 5.5 CM IN GREATEST DIMENSIONS. A SUTURE DENOTES. 12 O'CLOCK. BLUE DYE IS NOTED IN THE SUPERIOR PORTION OF THE SPECIMEN. THE SUPERFICIAL MARGIN IS MARKED IN BLUE INK, THE DEEP MARGIN IN BLACK. INK. SECTIONING REVEALS THE CENTRAL ASPECT OF THE BREAST TO CONSIST OF. DENSE TAN FIBROUS TISSUE WITH FOCAL CYSTIC AREAS WITH BROWN MUCINOUS. MATERIAL. THIS IS SURROUNDED BY BLAND YELLOW FATTY TISSUE AT THE. PERIMETER. IN THE SUPERIOR 12 O'CLOCK AREA, THERE IS A DISTINCT PINK-TAN. GRITTY AREA WITHIN THIS FIBROUS TISSUE WHICH MEASURES 1.6 x 1.3 x 3.5 CM,. WHICH SPANS INTO THE 2 O'CLOCK AREA WHERE THERE IS FOCAL RED-TAN. DISCOLORATION SUGGESTIVE OF PREVIOUS BIOPSY. GROSSLY, THESE AREAS OF. FIRMNESS ARE CONTIGUOUS. THIS LESION IS 0.5 CM FROM THE DEEP MARGIN. A. WING CLIP IS IDENTIFIED IN THIS 12 O'CLOCK AREA. SECTIONS ARE SUBMITTED. AS FOLLOWS: A1--KKIN AND NIPPLE, A2 AND 3--12 O'CLOCK LESION WITH DEEP. MARGIN (MIRROR IMAGE TO PROTOCOL), A4--TISSUE SUPERFICIAL TO LESION TO. INCLUDE SUPERFICIAL MARGIN AND SKIN, A5-- O'CLOCK AREA (MIRROR TMAGE TO. PROTOCOL), A6--2 O'CLOCK AREA WITH DEEP MARGIN, A7--TISSUE SUPERFICIAL TO. A8, A8--UPPER OUTER QUADRANT TISSUE BETWEEN THE 12:00 AND 2:00 AREAS. (MIRROR IMAGE TO PROTOCOL), A9 --UPPER INNER QUADRANT 2 CM FROM THE 12. O' CLOCK LESION, A10--LOWER INNER QUADRANT 3.5 CM FROM THE 12 O'CLOCK. LESION, All--LOWER OUTER QUADRANT 3.5 CM FROM THE 12 O'CLOCK LESION. (NOTE: A9 THROUGH A10 ARE MIRROR IMAGES TO PROTOCOL SECTIONS). A12--TISSUE FROM CENTRAL BREAST, A13--ADDITIONAL TISSUE LOWER OUTER. QUADRANT. PART B RECEIVED LABELED. RIGHT MASTECTOMY STITCH AT. 12 O'CLOCK, IS A SIMPLE MASTECTOMY SPECIMEN WITH OVERALL DIMENSIONS OF 20. x 16.5 x 3.0 CM. THE NIPPLE IS UNREMARKABLE AND SITS WITHIN A 9 x 4.5 CM. SKIN ELLIPSE. A SUTURE DENOTES 12 0'CLOCK. THE SUPERFICIAL ASPECT IS. MARKED IN BLUE, THE DEEP MARGIN IN BLACK INK. SECTIONING REVEALS THE. Chief of Pathology. Specimen: Rea# : Spec Type: SURGICAL P. GROSS DESCRIPTION. CENTRAL ASPECT OF THE BREAST TO CONSIST OF DENSE PINK-TAN FIBROUS TISSUE. WITH FOCAL AREAS OF CYST FORMATION CONTAINING BROWN OILY MATERIAL. THIS. IS SURROUNDED BY A PERIMETER OF BLAND YELLOW FATTY TISSUE. SECTIONS ARE. SUBMITTED AS FOLLOWS: B1--NIPPLE, B2--CENTRAL DEEP MARGIN, B3 AND. 4 -UPPER INNER QUADRANT, B5 AND ---UPPER OUTER QUADRANT, B7 AND -LOWER. OUTER QUADRANT, B9 AND 10--LOWER INNER QUADRANT. NOTE THAT B1, B3, B5,. B7 AND B9 ARE MIRROR IMAGES TO PROTOCOL PIECES. PART C RECEIVED FRESH LABELED. LEFT SENTINEL NODE. #1, IS AN OVOID PORTION OF BLUE-STAINED TISSUE AND YELLOW FAT MEASURING. 2.1 x 1.7 x 1.0 CM. SECTIONING REVEALS A 1.0 CM IN DIAMETER GROSSLY. UNREMARKABLE LYMPH NODE. ONE-HALF IS SUBMITTED PER PROTOCOL; THE. REMAINDER IS SUBMITTED LABELED C. PART D RECEIVED FRESH LABELED. LEFT SENTINEL NODE. #2, IS AN OVOID PORTION OF YELLOW FATTY TISSUE MEASURING 2 x 1.2 x 0.5. CM. SECTIONING REVEALS A 0.6 CM IN DIAMETER GROSSLY UNREMARKABLE LYMPH. NODE. THE TISSUE IS SUBMITTED ENTIRELY LABELED D. PROCEDURES: 88307/4, IMMUNOPEROXIDAS/2, A BLK/13, B BLK/10, CBX X3, DBX X3. FIMAE. PART A LEFT BREAST, SIMPLE MASTECTOMY: 1. MULTICENTRIC IN SITU AND INVASIVE LOBULAR CARCINOMA OF BREAST,. NUCLEAR GRADE II WITH MODERATE MITOTIC INDEX, WITH TUMOR IDENTIFIED. IN THE PREVIOUSLY BIOPSIED SITES. AND ALSO IN RANDOM. SECTIONS FROM THE LOWER INNER QUADRANT, CENTRAL BREAST AND NIPPLE. SKIN. 2. THE TUMOR NODULES MEASURE IN SIZE FROM 2 MM TO 35 MM TGROSSLY) . THE. DEEP MARGIN IS FREE OF NEOPLASM. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. A SMALL INTRAMAMMARY LYMPH NODE (1) IS NEGATIVE FOR TUMOR (SLIDE A7). 5. FIBROCYSTIC DISEASE WITH DENSE FIBROSIS AND FIBROADENOMA. PART B RIGHT BREAST, SIMPLE MASTECTOMY: PROLIFERATIVE FIBROCYSTIC. DISEASE WITH DENSE FIBROSIS, SCLEROSING ADENOSIS, APOCRINE METAPLASIA,. CYST FORMATION AND RADIAL SCAR FORMATION. MICROCALCIFICATIONS ARE. PRESENT. ATYPIA OR MALIGNANCY IS NOT IDENTIFIED. PART C LEFT SENTINEL NODE #1, BIOPSY: LYMPH NODE (1), NEGATIVE FOR. Chief of Fathology. Specimen: Spec Type: SURGICAL P. FINAS. TUMOR BY STEP SECTION AND CYTOKERATIN STAIN. A FOCUS OF PERINODAL. FIBROSIS IS PRESENT WHICH MAY REPRESENT A PREVIOUS BIOPSY SITE. PART D LEFT SENTINEL NODE #2, BIOPSY: LYMPH NODE (1), NEGATIVE FOR. TUMOR BY STEP SECTION AND CITOKERATIN STAIN. (prelim. ). (signature on file).\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report regarding the size of the tumor and its extension. The AJCC staging manual defines the T stages as follows: T1 - Tumor ≤ 20 mm; T2 - Tumor > 20 mm but ≤ 50 mm; T3 - Tumor > 50 mm; T4 - Tumor of any size with direct extension to the chest wall or skin (excluding the nipple and areola).",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor measures 1.6 x 1.3 x 3.5 cm, which is more than 2 cm but not more than 5 cm in greatest dimension, according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Chief of Pathology. Specimen: Spec Type: SURGICAL p. LEFT BREAST CANCER INVASIVE. OPERATION PERFORMED. DATE: €. DOCTOR (s) : PROCKDURE: STMPLE MASTRCTOMY/SENTINEL NODE Bx. A. LT BREAST 7:00 SUPERFICIAL MARGIN. B. LT BREAST MASTECTOMY. C. LT SENTINEL NODE #1. D. LT SENTINEL NODE #2. E. LT BREAST ADDITIONAL TISSUE 12:00. F. RT SENTINEL NODE #1. G. RT SENTINEL NODE #2. H. RT BREAST TISSUE. PART A RECEIVED LABELED. LEFT BREAST 7 O'CLOCK SUPERFICIAL. MARGIN INK MARKS NEW MARGIN, IS AN OVOID FLAT PORTION OF YELLOW FATTY. TISSUE MEASURING 6 x 4 x 0.9 CM IN GREATEST DIMENSIONS. INK IS FOUND ON. ONE SIDE OF THE SPECIMEN. THIS IS RE-INKED WITH BLUE INK WITH A. PERIMETER OF BLACK INK. THIS IS SECTIONED AND SUBMITTED ENTIRELY LABELED. A1 THROUGH 6. PART B RECEIVED LABELED. LEFT BREAST STITCH AT 12 O'CLOCK,. IS A SIMPLE MASTECTOMY SPECIMEN MEASURING 16 x 16 x 5.2 CM. THE NIPPLE. IS UNREMARKABLE WITHIN A 9.5 x 4.8 CM SKIN ELLIPSE. BLUE DYE IS NOTED IN. THE MID-SUPERIOR PORTION OF THE SPECIMEN. A SUTURE DENOTES 12 O'CLOCK. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP MARGIN WITH. BLACK INK. SECTIONING REVEALS THE CENTRAL 80% OF THE SPECIMEN TO CONSIST. OF FIRM PINK-TAN TISSUE WITH SOME CYSTIC AREAS. THERE IS ILL-DEFINED. INDURATION WITHIN THIS FIBROUS TISSUE AS WELL AS FOCAL NODULARITY. THE. MOST INDURATED TISSUE MEASURES 9.0 CM FROM SUPERIOR TO INFERIOR, 9.0 CM. FROM MEDIAL TO LATERAL AND UP TO 3.8 CM FROM SUPERFICIAL TO DEEP. THIS. IS IN THE CENTRAL PORTION OF THE BREAST. GROSSLY, THIS INVOLVES THE. CENTRAL FOUR QUADRANTS OF THE SPECIMEN. THE CENTRAL LESIONAL AREA IS. GREATER THAN 1 CM FROM THE SUPERIOR, INFERIOR, MEDIAL AND LATERAL MARGINS. GROSSLY. SECTIONING THE CENTRAL FIBROUS TISSUE REVEALS A MOTTLED PINK TO. GRAY-WHITE APPEARANCE. SECTIONS ARE SUBMITTED AS FOLLOWS: B1--NIPPLE,. B2 - -UPPER OUTER QUADRANT, --UPPER INNER QUADRANT, B4 -LOWER INNER. QUADRANT, B5--LOWER OUTER QUADRANT. NOTE: B1 THROUGH B5 ARE MIRROR. IMAGE TO PROTOCOL SECTIONS. B6--UPPER OUTER QUADRANT AND DEEP MARGIN,. B7 -EXTREME INFERIOR LESION WITH SUPERFICIAL MARGIN (7 O'CLOCK AREA),. B8 - -EXTREME SUPERIOR LESION WITH 5 CM OF INTERVENING TISSUE BETWEEN THIS. AND B7, B9 - EXTREME MEDIAL ASPECT OF THE LESION, B10--EXTREME LATERAL. Chief of Fathology. Specimen. Spec Type: SURGICAL P. GROSS DESCRIPTION. ASPECT OF THE LESION 9 CM FROM B9, B11 --SUBAREOLAR - - AREA, 812--UPPER OUTER. QUADRANT, 813--UPPER INNER QUADRANT, B14--LOWER INNER QUADRANT,. B15 --LOWER OUTER QUADRANT, B16--QUESTION BIOPSY SITE CENTRAL BREAST,. B17--QUESTION FIBROCYSTIC DISEASE UPPER INNER QUADRANT. PART C RECEIVED LABELED. LEFT SENTINEL NODE #1 HOT AND. BLUE, IS YELLOW-RED FATTY TISSUE MEASURING 2.7 x 2.1 x 1.2 CM. FOCAL. BLUE DYE IS NOTED. SECTIONING REVEALS THIS TO BE A LARGELY FAT-REPLACED. LYMPH NODE WITH FOCAL BLUE DISCOLORATION. IN THE ADJACENT TISSUE, THREE. ADDITIONAL LYMPH NODES ARE IDENTIFIED MEASURING 0.5 TO 0.7 CM IN GREATEST. DIMENSION. THE LARGEST GROSSLY FAT-REPLACED NODE IS SUBMITTED AS C1. THE. REMAINING THREE NODES ARE SUBMITTED AS C2. PART D RECEIVED LABELED. LEFT SENTINEL NODE #2 HOT AND. BLUE, IS YELLOW FATTY TISSUE MEASURING 3 x 2.7 x 1.0 CM. SECTIONING. REVEALS A 1.4 CM IN GREATEST DIAMETER GROSSLY UNREMARKABLE LYMPH NODE,. SUBMITTED LABELED D. PART E RECEIVED LABELED. LEFT BREAST ADDITIONAL 12 O'CLOCK. MARGIN INK AT NEW MARGIN, IS AN IRREGULAR PORTION OF YELLOW-RED FATTY. TISSUE MEASURING 11.5 x 5.3 x 1.0 CM. INK IS FOUND ON ONE SIDE OF THE. SPECIMEN. THIS IS FURTHER MARKED WITH BLUE INK WITH A PERIMETER OF BLACK. INK. REPRESENTATIVE TISSUE IS SUBMITTED LABELED E1 THROUGH 10. APPROXIMATELY 70% OF THE SPECIMEN IS SUBMITTED. PART F RECEIVED LABELED. RIGHT SENTINEL NODE #1 HOT AND. BLUE, IS AN OVOID PORTION OF YELLOW-BLUE TISSUE MEASURING 1.1 X 0.5 x 0.5. CM. SECTIONING REVEALS THIS TO BE UNREMARKABLE NODAL TISSUE, SUBMITTED. LABELED F. PART G RECEIVED LABELED. RIGHT SENTINEL NODE 2 BLUE AND. HOT, IS YELLOW-RED FATTY TISSUE WITH BLUE DYE MEASURING 0.8 x 0.5 x 0.4. CM. THIS IS BISECTED REVEALING UNREMARKABLE NODAL TISSUE. THIS IS. SUBMITTED LABELED G. PART H RECEIVED LABELED. IS A SIMPLE MASTECTOMY SPECIMEN. MEASURING 20.5 x 18 x 4.5 CM. THE NIPPLE IS UNREMARKABLE WITHIN A 9.3 x. 6.2 CM SKIN ELLIPSE. FOCAL BLUE DISCOLORATION IS NOTED IN THE 12 O'CLOCK. AREA WHERE THERE IS AN ORIENTING SUTURE. THE SUPERFICIAL ASPECT IS. MARKED WITH BLUE INK, THE DEEP WITH BLACK INK. SECTIONING REVEALS THE. CENTRAL 85% OF THE SPECIMEN TO CONSIST OF PINK-TAN, FIRM FIBROUS TISSUE. WITH MULTIPLE CYSTIC SPACES CONTAINING CLOUDY BROWN FLUID. NO DISTINCT. MASSES ARE IDENTIFIED. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS: H1--NIPPLE, H2 - -CENTRAL DEEP MARGIN, H3 AND --UPPER INNER QUADRANT, H5. AND 6--UPPER OUTER QUADRANT, H7 AND 8 -LOWER OUTER QUADRANT, H9 AND. 10--LOWER INNER QUADRANT. NOTE THAT H4 IS THE EXTREME MEDIAL MARGIN. Chief of Pathology. Specimen: Spec Type: SURGICAL P. PROCEDURES : 88307/8, IMMUNOPEROXIDAS/4, A BLK/6, B BLK/17, CBX x6/2, DBX X6, E BLK/10,. FBX X6, GBX X6, H BLK/10. FINAL DIACNOSTS. PART A LEFT BREAST, REEXCISION OF SUPERFICIAL 7 O' CLOCK MARGIN: FATTY. BREAST TISSUE WITH NO EVIDENCE OF TUMOR AND CLEAR MARGIN. PART B LEFT BREAST, SIMPLE MASTECTOMY: 1. DIFFUSELY MULTIFOCAL AND MULTICENTRIC INTRALOBULAR AND INFILTRATING. LOBULAR CARCINOMA, NUCLEAR GRADE II, LOW MITOTIC INDEX AND TUBULE. FORMATION 3, WITH TOTAL NOTTINGHAM SCORE OF 6. 2. THE INVASIVE TUMOR IS SEEN IN SECTIONS FROM EACH OF THE FOUR. QUADRANTS ON 14 OF 17 BLOCKS EXAMINED, HAVING A MAXIMUM GROSS. DIMENSION OF 9 CM. 3. THE TUMOR IS GREATER THAN 1 CM FROM THE MARGINS OF EXCISION. 4. LYMPHOVASCULAR INVASION IS IDENTIFIED. PART C LEFT AXILLA, SENTINEL LYMPH NODE: METASTATIC BREAST CARCINOMA IS. IDENTIFIED ON H&E STEP SECTIONS AND CYTOKERATIN STAIN IN 3 LYMPH NODES,. THE LARGEST FOCUS OF WHICH MEASURES 5 MM. PART D LEFT AXILLA, SENTINEL LYMPH NODE BIOPSY #2: METASTATIC CARCINOMA. CONSISTENT WITH BREAST PRIMARY IS MULTIFOCALLY IDENTIFIED IN THE LYMPHOID. SINUSES ON H&E STEP SECTIONS AND CYTOKERATIN STAIN IN 1 LYMPH NODE. PART E LEFT BREAST, REEXCISION OF 12 O'CLOCK MARGIN: FATTY BREAST. TISSUE WITH NO EVIDENCE OF TUMOR AND CLEAR MARGIN. PARTS F AND G RIGHT AXILLA, SENTINEL LYMPH NODE BIOPSIES 1 AND 2: NO -. EVIDENCE OF METASTATIC TUMOR ON H&E STEP SECTIONS OR CYTOKERATIN STAIN IN. 2 LYMPH NODES EXAMINED. PART H RIGHT BREAST, SIMPLE MASTECTOMY: FIBROCYSTIC CHANGES INCLUDING. COLUMNAR CELL HYPERPLASIA WITH FOCAL AREA OF MILD EPITHELIAL ATYPIA,. APOCRINE METAPLASIA, MILD TO MODERATE USUAL DUCT HYPERPLASIA, DENSE. FIBROUS STROMA AND MICROCYST FORMATION. Chisf of Pathology. Specimen: Spec Type: SURGICAL P. CODE. 1. ) (prelim.). (signature on file).\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor as described in the pathology report. The key information for staging is the maximum dimension of the invasive tumor and whether it has invaded the chest wall or skin. Here’s the step-by-step reasoning:",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage, I need to extract information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "The tumor size is 9.0 cm and greater than 1 cm from the margins of excision, with depth of invasion not explicitly stated.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor. Account Number: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT BREAST LUMPECTOMY, LEFT AXILLARY SENTINEL MAPPING, F.S. TISSUES. A. BREAST EXCISION, NEEDLE LOC, SIMPLE, MARGINS, ETC. - LEFT BREAST LUMP. B. MARGINS - ADDITIONAL ANTERIOR MARGIN. C. MARGINS - ADDITIONAL SUPERIOR MARGIN. D. LYMPH NODE (S) - SENTINEL LYMPH NODE #1 FS. E. LYMPH NODE (S) - SENTINEL LYMPH NODE #2 FS. F. LYMPH NODE (S) - SENTINEL LYMPH NODE #3 FS. G. LYMPH NODE (S) - SENTINEL LYMPH NODE #4 FS. H. LYMPH NODE (S) - ADDITIONAL NON-SENTINEL NODE FS. FS DIAGNOSIS. A. LEFT BREAST LUMP \"GROSS MARGINS\". BREAST TISSUE WITH TUMOR (2.4 X 2.2 2.2 CM.) EXTENDING WITHIN 0.2 CM. OF NEAREST SUPERIOR SURGICAL MARGIN AND 0.3 CM. OF ANTERIOR SURGICAL. MARGIN. ALL DESIGNATED SURGICAL MARGINS ARE FREE OF TUMOR (GROSS). D. SENTINEL LYMPH NODE #1, F.S.-. LYMPH NODE, NEGATIVE FOR MALIGNANCY,. E. SENTINEL LYMPH NODE #2, F.S. -. LYMPH NODE, NEGATIVE FOR MALIGNANCY. F. SENTINEL LYMPH NODE #3, F.S.-. LYMPH NODE, NEGATIVE FOR MALIGNANCY. G. SENTINEL LYMPH NODE #4, F.S. LYMPH NODE, NEGATIVE FOR MALIGNANCY. H. SENTINEL LYMPH NODE #5, F.S. -. LYMPH NODE, NEGATIVE FOR MALIGNANCY. (Reported to surgeon: SURGICAL REPORT. Pathology Numb. Diagnosed by: FINAL DIAGNOSIS. A. LEFT BREAST LUMP -. INFILTRATIVE DUCT CARCINOMA (2.4 CM.). BLOOM-RICHARDSON GRADING: GRADE III OF III (MINIMAL TUBULE FORMATIONS, HIGH NUCLEAR GRADE. AND HIGH MITOTIC INDEX). DCIS: NONE IDENTIFIED. TUMORAL NECROSIS/CALCIFICATION: NECROSIS ONLY. LOBULAR CANCERIZATION: PRESENT, FOCAL. SURGICAL MARGINS: UNINVOLVED, SUPERIOR MARGIN IS THE CLOSEST AND IS 0.2 CM. FROM. THE TUMOR. B. ADDITIONAL ANTERIOR MARGIN -. BENIGN BREAST TISSUE, THE NEW REVISED ANTERIOR MARGIN IS 0.9 CM. (0.3. 0.6 CM.). C. ADDITIONAL SUPERIOR MARGIN -. BENIGN BREAST TISSUE, THE NEW REVISED SUPERIOR MARGIN IS 0.8 CM. (0.2 + 0.6 CM.). D. SENTINEL LYMPH NODE #1 -. ONE BENIGN REACTIVE LYMPH NODE (0/1). E. SENTINEL LYMPH NODE #2-. ONE BENIGN REACTIVE LYMPH NODE (0/1). F. SENTINEL LYMPH NODE #3. ONE BENIGN REACTIVE LYMPH NODE (0/1). G. SENTINEL LYMPH NODE #4. ONE BENIGN REACTIVE LYMPH NODE (0/1). H. ADDITIONAL NON-SENTINEL LYMPH NODE-. ONE BENION REACTIVE LYMPH NODE. PTNM CLASSIFICATION: T2, NO, MX, STAGE IIA. Diagnosedby: COMMENT. The ER, PR, and Her-2/neu have been performed on previous surgical. This case is. discussed with Dr. by Dr. COMMENT2. SURGICAL REPORT. Patmology Number: Lymph nodes in parts D, E, F, G and H are negative for malignancy by Cytokeratin (AE1/AE3). staining. GROSS DESCRIPTION. The specimen is received in eight separate containers labeled. hated A. through H. A. The container is received fresh unfixed labeled \"left breast lump for gross margin\". The specimen. consists of a 20 gm. ovoid mass of apparent fatty and fibrous encased tissue which is 4.1 X 3.3 x. 2.5 cm. in greatest overall dimension. There is a single short suture indicating anterior margin. inked with yellow dye, posterior/deep margin is inked black. There are two short sutures. Indicating superior margin Inked with orange dye, inferlor is Inked red. There is a single long. suture indicating lateral margin inked with blue dye, medial is inked green. Sectioning reveals. a. well-circumcised tumor mass which is 2.4x 2.2x 2.2 cm. in greatest overall dimension and. consists of a pink-tan firm with scattered cystic spaces filled with amber-colored fluld. The tumor. mass grossly appears to be 0.3 cm. from the anterior, 0.5 cm. from the posterior/deep, 0.2 cm. from the superior, o 4 cm. from the inferior, 0.6 cm. from the lateral, 0.6 cm. from the medial. The. specimen is submitted In ten blocks. Key Note Block Summary: 1-anterior, 2-posterlor/deep, 3-superior, 1-inferior, 5-. medial, 6-lateral, 7 through 10-remaining. B. The container is received fresh unfixed labeled \"additional anterior margin - suture on new. anterior margin\". The specimen consists of a 2 gm. ovoid mass of apparent fatty tissue which is. 3.5 x 2) 0.6 cm. In greatest overall dimension. There is an attached suture indicating new. anterior margin Inked orange. Serial sectioning reveals fatty tissue and a scant amount of pink-. tan firm tissue. The entire specimen is submitted in two blocks. C. The container is received fresh unfixed labeled \"additional superior margin - suture on new. superior margin\". The specimen consists of a 3 gm. ovoid mass of apparent fatty tissue which. is. 2.5 x 2.5 x 0.6 cm. in greatest overall dimension. The attached suture indicates new superior. margin inked with yellow dye. Serial sectioning reveals fatty tissue. The entire specimen is. submitted in two blocks. The container is received fresh unfixed labeled \"sentinel lymph node #1 for frozen section\". The. specimen consists of an ovoid nodule of tan-gray firm rubbery tissue with attached fatty material. measuring 0.6 x 0.6x 0.4 cm. Touch prep and frozen section are obtained by Dr. The entire specimen Including frozen section is submitted In two blocks. E. The container is received fresh unfixed labeled \"sentinel lymph node #2 for frozen section\". The. specimen consists of an ovoid nodule of tan-gray firm rubbery tissue with attached fatty material. 0.3 x 0.3 x 0.2 cm. Touch prep and frozen section are obtained by Dr. The. specimen is bisected and the entire specimen including frozen section is submitted in two blocks. F. The container is received fresh unfixed labeled \"sentinel lymph node #3\". The specimen consists. of an ovold nodule of tan-gray firm rubbery tissue with attached fatty material 0.3 x 0.3 x 0,3 cm. Frozen section and touch prep are obtained by Dr. The specimen is bisected and. the entire specimen including frozen section is submitted in two blocks. G. The container is received fresh unfixed labeled \"sentinel lymph node #4 for frozen section\". The. specimen consists of an ovold nodule of tan-gray firm rubbery tissue with fatty material 0.6x 0.3 x. 0.3 cm. Frozen section and touch prep are obtained by Dr. (. The specimen is. bisected. The entire specimen including frozen section is submitted in two blocks. SURGICAL REPORT. Number: H. The container is received fresh unfixed labeled \"additional non-sentinel node for frozen section\". The specimen consists of an ovoid nodule of tan-gray firm rubbery tissue with attached fatty. material 0.3 x 0.2 x 0.2 cm. Frozen section and touch prep are obtained by Dr. The. specimen is bisected. The entire specimen including frozen section is submitted in two blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: Cytokeratin (AE1/AE3) (specimens D, E, F, a, H). SURGICAL REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size of the tumor and its extent. The pathologic T stage is based on the size of the invasive tumor as measured after fixation and processing. The AJCC 7th edition provides the following definitions for T stages in breast cancer: T1 - Tumor ≤ 2 cm, T2 - Tumor > 2 cm but ≤ 5 cm, T3 - Tumor > 5 cm, T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided pathology report, the tumor size is described as 2.4 x 2.2 x 2.2 cm. Since the tumor is more than 2 cm but less than or equal to 5 cm, it falls into the T2 category. There is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "Analyze pathology report, extract tumor size, and apply T-staging rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 2.4 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition)",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number: Doctor: Account Number: PRE-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. LEFT BREAST CANCER. PROCEDURE. LEFT MODIFIED RADICAL MASTECTOMY. TISSUES. A. BREAST MASTECTOMY (WANO) NODES - LEFT BREAST & AXILLARY CONTENTS. B. MARGINS - ADDITIONAL INFERIOR SKIN LEFT BREAST. WRI TISSUE. FINAL DIAGNOSIS. A. LEFT BREAST AND AXILLARY CONTENTS, 1619 GMS. -. INFILTRATIVE DUCT CARCINOMA (CONFLUENT REGION MEASURES 13.6 CM.). SCARFF-BLOOM-RICHARDSON GRADING: GRADE 3 OF 3 (ABSENT TUBULAR FORMATIONS, HIGH NUCLEAR GRADE. AND MODERATE MITOTIC INDEX). DCIS: NONE IDENTIFIED. ANGIOLYMPHATIC INVASION: PRESENT, MULTIFOCAL. TUMORAL CALCIFICATION/NECROSIS: PRESENT. SURGICAL MARGINS: UNINVOLVED. NON-NEOPLASTIC BREAST -. FIBROADENOMA 0.3 CM. FIVE POSITIVE LYMPH NODES WITH EXTRACAPSULAR EXTENSION (6/5). THE LARGEST NODE MEASURES 1.6 CM. AND THE TUMOR INVOLVES THREE-FOURTHS. OF THE NODE. OVERLYING NIPPLE, AREOLA AND SKIN: FOCAL EXTENSION OF THE TUMOR INTO EPIDERMIS WITHOUT ULCERATION. B. ADDITIONAL INFERIOR SKIN LEFT BREAST -. POSITIVE FOR INFILTRATIVE DUCT CARCINOMA, THE TUMOR INVOLVES THE DERMIS. WITHOUT EXTENSION TO EPIDERMIS. (SATELLITE SKIN NODULE). THE INKED MARGINS ARE FREE. PTNM CLASSIFICATION: SURGICAL REPORT. T4B, N2a, MX, STAGE GROUPING IIIB. Diagnosed by: and. COMMENT. The multiple sections from the tumor reveal a poorly differentiated infiltrative duct carcinoma with. widespread angiolymphatic invasion. The satellite nodule grossly observed appears to be a direct. extension from the primary tumor with peripheral tumefaction. The overlying epidermis is involved by the. tumor but does not exhibit ulceration. The Bloom-Richardson grading was upgraded to 3 based on. complete evaluation of the entire tumor mass. The ER, PR, and Her-2/neu have been performed on the previous surgical. This case Is discussed with. on. GROSS DESCRIPTION. The specimen is received in two separate containers labelec. esignated A and B. A. The container is received fresh unfixed labeled \"left breast and axillary contents - suture on. upper outer quadrant\". The specimen consists of a 1,519 gm. apparent left breast which is 30 x. 20 x 7.5 cm. in greatest overall dimension. There is an attached suture indicating upper outer. quadrant inked with orange dye, lower outer quadrant is inked yellow, upper inner quadrant is. inked with green dye, lower inner quadrant is inked with red dye. The deep margin is inked black. Sectioning reveals a tumor mass directly beneath the nipple which is 13.5x 7 x 4 cm. in greatest. overall dimension and is 1.5 cm. from the deep margin, 2 cm. from the upper outer margin, 2.5. cm. from the lower outer margin, 2 cm. from the upper inner margin, and 4 cm. from the lower. inner margin. There is a satellite nodule which is 0.6 cm. in greatest dimension and is 1.5 cm. from the main tumor mass and has a distance of 0.6 cm. from the upper inner margin. Sectioning. through the remaining breast stroma reveals fatty and fibrous-encased tissue. Sectioning through. the attached axillary fat reveals rare tan-gray nodules varying up to 1 cm. in greatest dimension. The specimen is submitted in twelve blocks. Key Note Block Summary: 1-nipple with underlying tumor, 2 through 4-tumor mass, 5-. satellite nodule and upper inner quadrant, 6-lower inner quadrant, 7-lower outer quadrant, 8-. upper outer quadrant, 9-deep, 10 through 12-rare nodules. B. The container is received fixed labeled \"additional inferior skin left breast\". The specimen. consists of a skin ellipse which is 7 x 1x 1 cm. in greatest overall dimension. The skin. has been previously marked with purple-blue dye. The specimen is serially sectioned. revealing no apparent gross abnormalities. The entire specimen is submitted in two. blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.\n        ",
    "Answer": 3,
    "Filename": "TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report. The T stage is based on the size of the tumor and whether it has spread to the chest wall or skin. Here's the step-by-step analysis:\\n1. **Tumor Size**: The report mentions that the confluence region of the tumor measures 13.6 cm. This size is crucial for determining the T stage.\\n2. **Tumor Extension**: The report also mentions that there is focal extension of the tumor into the epidermis without ulceration and involvement of the dermis in the additional inferior skin, indicating skin involvement.\\nBased on the AJCC Cancer Staging Manual (7th edition), the T stages are defined as follows:\\n- **T1**: Tumor ≤ 20 mm.\\n- **T2**: Tumor > 20 mm but ≤ 50 mm.\\n- **T3**: Tumor > 50 mm.\\n- **T4**: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules).\\nGiven the tumor's size (13.6 cm, which is > 50 mm) and its extension into the skin (focal extension into the epidermis and involvement of the dermis), we need to consider both the size and the extension for staging.\\nHowever, the key factor here is the skin involvement, which automatically classifies the tumor as T4 according to the AJCC staging manual, regardless of its size. The presence of a satellite nodule in the skin further supports this classification.\\nTherefore, based on the information provided in the pathology report, the pathologic T stage for this breast cancer patient is **T4**.",
    "BaselineChoice": "T4",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor's size and its extension into the skin without ulceration, as well as the presence of a satellite skin nodule.",
    "Choice": "T4"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen # : (Age: Race: Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 B: LEFT AXILLARY TISSUE. C: LEFT MASTECTOMY D: NEW INFERIOR MARGIN. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE #1, BIOPSY: - ONE OF TWO LYMPH NODES WITH ISOLATED TUMOR CELLS (ITC) DETECTED BY. CYTOKERATIN IMMUNOHISTOCHEMICAL STAINING, refer to part C. B. SOFT TISSUE, LEFT AXILLA, EXCISION: BENIGN FIBROADIPOSE AND VASCULAR CONNECTIVE TISSUE WITH NERVE. - NO EVIDENCE OF LYMPH NODES. - NEGATIVE FOR MALIGNANCY. C. /. I, MASTECTOMY: i TYPE: INVASIVE LOBULAR CARCINOMA. AISTOLOGIC GRADE: GRADE 2, MODERATELY DIFFERENTIATED. - NOTTINGHAM SCORE: 6 (Tubules= 3, Nuclei 2, Mitoses= 1). TI\". IZE (GREATEST DIMENSION) : GREATER THAN 5.0 CM, see comment. ITE (QUADRANT) : OUTER UPPER AND MID. \"YPE: INVASIVE LOBULAR CARCINOMA. OLC IC GRADE: GRADE 1, WELL DIFFERENTIATED. NOTTINGHAM SCORE: 5 (Tubules= 3, Nuclei 1, Mitoses= 1). - TUMOR SIZE (GREATEST DIMENSION) : 0.3 CM, measured microscopically. - TUMOR SITE (QUADRANT) : INNER UPPER. - TUMOR FOCALITY: MULTIFOCAL. - TUMOR NECROSIS: NOT IDENTIFIED. - MICROCALCIFICATIONS: PRESENT; ASSOCIATED WITH INVASIVE AND IN SITU. TUMOR AND ALSO NON-NEOPLASTIC TISSUE. - LYMPH-VASCULAR INVASION: PRESENT, slide C6. - MARGINS: NEGATIVE FOR MALIGNANCY. - DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN = 0.5 CM, DEEP. - IN SITU COMPONENT: LOBULAR CARCINOMA IN SITU (LCIS). - DISTANCE OF LCIS FROM NEAREST MARGIN = LESS THAN 0.1 CM, DEEP. - LYMPH NODES: ONE OF TWO NODES WITH ISOLATED TUMOR CELLS. - NUMBER OF SENTINEL LYMPH NODES EXAMINED: 2. - NUMBER OF LYMPH NODES WITH MACROMETASTASES: o. - NUMBER OF LYMPH NODES WITH MICROMETASTASES: o. - NUMBER OF LYMPH NODES WITH ISOLATED TUMOR CELLS: 1. - EXTRANODAL EXTENSION: NOT IDENTIFIED. Specimen #: FINAL DIAGNOSIS (continued) : - NIPPLE/ SKIN INVOLVEMENT: NOT IDENTIFIED. ANCILLARY STUDIES (performed on core biopsy. - ESTROGEN RECEPTORS: POSITIVE. - PROGESTERONE RECEPTORS: POSITIVE. - HER 2 NEU by IHC: NEGATIVE. - ADDITIONAL PATHOLOGIC CHANGES: - PRIOR BIOPSY SITE CAVITY/ CHANGES. PATHOLOGIC STAGE: pT3 (m) NO (i+) (sn), (AJCC 7th Edition). D. SOFT TISSUE, NEW INFERIOR MARGIN, EXCISION: - FIBROADIPOSE CONNECTIVE TISSUE AND SCATTERED ATROPHIC BREAST. PARENCHYMA; NEGATIVE FOR MALIGNANCY. Comments: Macroscopically, two masses were noted within the outer upper and outer. mid regions, separated by approximately 1.5 cm. However, sampling of the. intervening tissue confirms the presence of invasive lobular carcinoma. The masses have a similar histologic appearance of invasive lobular. carcinoma, grade 2. Therefore, the upper outer/mid tumors are best. classified as a single mass and staged as pT3. A smaller separate tumor. is noted within the inner upper quadrant. The prior core biopsy. ) and ancillary studies are reviewed. This case received prospective peer review. CLINICAL DIAGNOSIS AND HISTORY: ear-old female with left breast cancer. PRE-OPERATIVE DIAGNOSIS: Breast cancer. POST-OPERATIVE DIAGNOSIS: None provided. Specimen #: GROSS DESCRIPTION: A: Received fresh, labelled with the patient's name. and designated, \"Sentinel Node #1\" consists of 2.0 x 2.0 x 0.6 cm. irregular portion of red-yellow soft tissue. Sectioning reveals a single. 1.3 x 0.5 x 0.4 cm pink-tan lymph node. The lymph node is bisected and. entirely submitted in 2 cassettes. B: Received in formalin, labeled with the patient's name. and designated, \"Left Axillary Tissue\" consists of two irregular. shaped fragments of yellow lobular adipose tissue measuring 2.3 and 1.3 cm. in greatest dimension. Sectioning reveals six possible lymph nodes. measuring up to 0.2 cm in greatest dimension each. The specimen is. entirely submitted in three cassettes as follows: B1- -. five. possible. lymph. nodes; B2- one possible lymph node, bisected; B3- remaining adipose. tissue. C: Receivo fresh, labelled with the patient's name. and de. lated, \"Left Mastectomy (Long-Lateral; Short-Superior)\" consists. of. so gram mastectomy specimen oriented with a short stitch superior. and ung st. lateral. The specimen measures 25.0 cm medial to lateral;. 21.0 cm r. to inferior; and 4.0 cm anterior to posterior. The. light¹. ed superficial skin ellipse measures 24.0 x 14.2 cm and. cm centrally located, everted nipple. No discharge is. The deep margin is inked black. Serial sections reveal a 4.0. x 4. x 3.0 cr poorly defined mass in the mid-outer breast (mass #1) . On. section. t. cut surface is firm, pink-white and shows a 0.3 cm. bloc. opsy cavity. The mass comes to within 0.5 cm of the deep. per/outer quadrant and lower/outer quadrant fibrous tissue. mass is markedly dense and nodular. Located in the. u. =1,. quan ant, adjacent to the superior-medial portion of mass #1,. is a secu fairly well defined mass measuring 0.9 x 0.8 x 0.5 cm. This. mass is located 2.0 cm from the deep margin. The second mass is located. approximately 1.5 cm from the first mass. The remainder of the specimen. is. composed of lobulated, yellow-tan adipose tissue admixed with a moderate. amount of otherwise unremarkable fibrous tissue. Located along the. lateral edge of the specimen (at the junction of the deep and superficial. margins) there is a single 0.4 cm ill-defined induration. This lateral. margin is inked blue. No lymph nodes are identified. Representative. sections are submitted as follows: C1 - skin; C2- upper/outer quadrant. mass; C3- upper/outer quadrant deep margin (to C2) ; C4- outer mid (OM). mass with cavity and deep margin; C5- deep margin, OM; C6- outer mid mass. C7-C9- additional outer mid mass; C10-C11- - induration along margin; C12-. upper/inner quadrant; C13- lower/inner quadrant; C14-lower/outer quadrant;. C15-upper/outer quadrant; C16- nipple; C17- sections of firm areas between. first and second mass. Matched sections of C1,C2,C4,C6-C9 and C12-C15 are submitted in OCT and. Specimen #: GROSS DESCRIPTION (continued) : Paraffin per CBCP protocol. D: Received in formalin, labeled with the patient's name. d designated, \"New Inferior Margin\" consists of an unoriented. The specimen is inked. Serial sectioning reveals a yellow lobular cut. fragment. of yellow lobular adipose tissue measuring 14.0 x 6.5 x 3.0 cm. surface with no well defined lesions or nodules grossly identified and. scattered areas of dense fibrous tissue. Representative sections are. submitted in seguential order in six cassettes representing various. fibrous areas. Time in formalin: >80 hours.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report regarding the size and extent of the tumor. The T stage is based on the size of the tumor and whether it has spread to the chest wall or skin. Here's the step-by-step analysis:\\n1. **Tumor Size**: The report mentions two masses. The larger one is described as being greater than 5.0 cm in greatest dimension, which directly influences the T staging. The smaller, separate tumor is 0.3 cm, but its size does not affect the overall T staging since the larger tumor's size is the determining factor.\\n2. **Tumor Location and Spread**: There's no mention of the tumor spreading to the chest wall or involving the skin, which would be indicative of a T4 classification. The report does mention lymphovascular invasion and the presence of isolated tumor cells in a lymph node, but these findings affect the N stage rather than the T stage.\\n3. **AJCC 7th Edition Guidelines**: According to the AJCC 7th edition, a tumor is classified as T1 if it is 2 cm or less in greatest dimension, T2 if it is more than 2 cm but not more than 5 cm, T3 if it is more than 5 cm, and T4 if it is of any size with direct extension to the chest wall or skin.\\nGiven that the largest tumor is greater than 5.0 cm and there's no mention of chest wall or skin involvement, the pathologic T stage is determined solely by the size of the tumor.",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, compare numerical values, and apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition). I will first extract the tumor size and other relevant details from the report.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is greater than 5 cm, which corresponds to a T3 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Number: PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. PROCEDURE. MODIFIEO RADICAL RIGHT MASTECTOMY, SENTINEL LYMPH NODE BIOPSY, F.S.; POSSIBLE AXILLARY DISSECTION. TISSUES. A. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #1FS. B. LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #2FS. C LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #3FS. D LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #4FS. E LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #5FS. F LYMPH NODE (S) - RIGHT SENTINEL LYMPH NODE #6FS. G BREAST MASTECTOMY (WAVO) NODES - RIGHT BREAST AND AXILLARY CONTENTS. FS DIAGNOSIS. A. LYMPH NODE #1, F.S. -. DEFERRED FOR PERMANENT. B. LYMPH NODE #2, F.S. -. DEFERRED FOR PERMANENT. C. LYMPH NODE #3, F.S. -. DEFERRED FOR PERMANENT. D. LYMPH NODE #4, F.S. -. POSITIVE FOR METASTATIC MALIGNANCY (1/1). E. LYMPH NODE #5, F.S. -. DEFERRED FOR PERMANENT. F. LYMPH NODE #6, F.S.. DEFERRED FOR PERMANENT. (REPORTED TO SURGEON: Diagnosed by. FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. SURGICAL REPORT. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. B. RIGHT SENTINEL LYMPH NODE #2 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. c. RIGHT SENTINEL LYMPH NODE #3 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. D. RIGHT SENTINEL LYMPH NODE #4 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. E. RIGHT SENTINEL LYMPH NODE #5 -. LYMPH NODE, NEGATIVE FOR MALIGNANCY. F. RJOHT SENTINEL LYMPH NODE #6 -. LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. G. RIGHT BREAST AND AXILLARY CONTENTS. POORLY DIFFERENTIATED INVASIVE DUCTAL CARCINOMA, 75 MM IN GREATEST. DIMENSION, EXTENDINO WITHIN 26 MM. OF THE NEAREST DEEP INKED SURGIGAL. MARGIN. ALL DESIGNATED INKED SURGICAL MARGINS ARE FREE OF TUMOR. SCARFF-BLOOM-RICHARDSON BREAST CANCER HISTOLOGIC SCORE OF 9. (3+3+3). EXTENSIVE ANGIOLYMPHATIC INVASION IS PRESENT. SCLEROSING ADENOSIS, FIBROSIS, DUCT ECTASIA, AND APOCRINE METAPLASIA,. REMAINING BREAST TISSUE DISPLAYS FIBROCYSTIC CHANGE INCLUDING. INCIDENTAL FIBROADENOMA, 10 MM. IN GREATEST DIMENSION. STIPPLED MICROCALCIFICATIONS AND MONCKEBERG'S MEDIAL CALCIFICATIONS ARE. PRESENT IN THE NON-NEOPLASTIC TISSUE. THIRTEEN REACTIVE REGIONAL AXILLARY LYMPH NODES, NEGATIVE FOR. MALIGNANCY. PATHOLOGIC TNM STAGE: T3 N2a M not applicable, STAGE IIIA, G3, INVASIVE DUCTAL. CARCINOMA. PORI CATEGORY II: 3260F. Diagnosed by. Reviewed a d electronicaliv signed nut by: COMMENT. This case is discussed with Dr. on. SURGICAL REPORT. Patient Nam. Key Note Block Summary. 1-nipple, 2 through 7-tumor, 8-deep resection line, 9-. superior/lateral/red, 10-inferior/lateral/black, 11-superior/medial/green, 12-. inferior/medial/orange, 13, 14 and 15-random, 16, 17 and 18-apparent nodes. MICROSCOPIC EXAM. MICROSCOPIO EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SYNOPTIC REPORT: Specimen. Total breast (including nipple and skin). Procedure. Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph nodes, Axillary dissection. Specimen Integrity: Single Intact specimen (margins can be evaluated). Specimen Size: greatest dimension - 27 cm.; additional dimensions 20 x 5.5 cm. Specimen Laterality. Right. Tumor Site: Mid superior lateral. Tumor Size. Greatest dimension of largest focus of invasion over 0.1 cm.: 7.5cm;. Additional dimensions: 5x 3 cm. Tumor Focality: Single focus of Invasive carcinoma. Skin: Invasive carcinoma does not invade into the dermis or epidermis. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma In-situ: No DCIS is present. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise. specified). Glandular: Score 3: <10% of tumor area forming giandular/tubular structures. Nuclear P(eomorphism: Score 3: Vesicular nuclel, often with prominent nucleoli, exhibiting marked. variation in size and shape, occasionally with very large and bizarre forms. Mitotic Count. Score 3. Overall Grade. Grade 3: scores of 8 or 9. Margins: uninvolved by invasive carcinoma: Distance from closest margin: 25 mm (deep). Distance from superior margin: 35 mm. Distance from inferior margin: 80 mm. Distance from posterior margin: 25 mm. Distance from medial margin: 80 mm. Distance from lateral margin: 35 mm. Treatment Effect: In the breast - No known presurgical therapy. In the lymph nodes - No known presurgical therapy. Lymph-Vascular Invasion: Present. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 6. Total number of lymph nodes examined: 19. Number of lymph nodes with macrometastases: 5. Size of largest metastatic deposit: 15 mm. Extranodal Extension: Present. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin, one level. H&E, multiple levels. Immunohistochernistry. Pathologic Stage: SURGICAL REPORT. I. COMMENT2. Immunohistochernical (IHC) stain for pankeratin (AE1/AE3) is negative for micrometastáses in. the uninvolved regional lymph nodes (specimens E and G). GROSS DESCRIPTION. The specimen IS received in seven separate containers labeled. designated A. through G. A. The container is received fresh unfixed labeled \"right sentinel lymph node #1 for frozen section\". and consists of an ovoid nodule of apparent fat which is 0.3 x 03x 0.2 cm. Sectioning reveals a. 0.3 cm. tan-gray nodule. Frozen section is deferred by Dr. The entire specimen is. submitted in one block. B. The container is received fresh unfixed labeled \"right sentinel lymph node #2 for frozen section\". and consists of an irregular mass of apparent fat which Is 0.8 x 0.6 x 0.4 cm. in greatest overal. dimension. Sectioning reveais a 0.6 cm. tan-gray nodule. Frozen section is deferred by Dr. The entire specimen is submitted in one block. C. The container is received fresh unfixed labeled \"right sentinel lymph node #3 for frozen section\". and consists of an ovoid mass of apparent fat which is x 1 x 0.6 cm. in greatest dimension. Sectioning reveals a 0.3 cm. tan-gray area. Frozen section is deferred by Dr. D. The container Is received fresh unfixed labeled \"right sentinel lymph node #4 for frozen section\". and consists of an ovoid mass of tan-gray firm rubbery tissue which is 1.5x 1 x 1 cm ingreatest. overall dimension. Touch prep and frozen section are obtained by Dr. The entire. specimen including frozen section is submitted in two blocks. E. The container is received fresh unfixed labeled \"right sentinel lymph node #5 for frozen section\". and consists of an irregular mass of apparent fat which is 1 x 0.4x 03 cm. in greatest overall. dimension. Sectioning reveais a 0.3 cm. tan-gray area. Frozen section is deferred by Dr. The entire specimen is submitted in one block. F. The container is received fresh unfixed labeled \"right sentinel lymph node #6 for frozen section\". and consists of an irregular mass of apparent fat which is 0.6 x 0.4x 0.4 cm. Sectioning reveals. 0.3 cm. tan-gray area. Frozen section is deferred by Dr. The entire spedimen is. submitted in one block. G. The container is received fresh unfixed labeled right breast - suture on superior/lateral aspect\". and consists of a 1,242 gm. apparent right breast which is 27 x 20 x 5.5 cm. in greatest overali. dimension and has an apparent axillary tall. There is an attached suture indicating. superior/lateral aspect inked with red dye, lower lateral is inked black, upper medial is inked. green, lower medial is inked orange. The underlying deep is inked with yellow. There is a. eccentrically placed nipple which is slightly inverted. Sectioning through the breast stroma. reveals a gray-white irregular-bordered tumor mass which grossly appears to be 7.5 x 5x 3 cm. In greatest overall dimension and grossly appears to be located in the mid superior/lateral region. The tumor mass is 2.5 cm. from the underlying/yellow margin, 3.5 cm. from the. superior/lateral/red margin, 8 cm. from the inferior/lateral/black margin, 8 cm. from the. superior/medial/green margin and 7 cm. from the inferior/medial/orange margin. Sectioning. through the attached axiliary fat reveals pink-tan nodules varying up to 1.5 cm in greatest. dimension. The specimen is submitted in eighteen blocks. SURGICAL REPORT. Primary Tumor: pT3. Regional Lymph Nodes: pN2a. Distant Metasstasis: Not applicable. Ancillary Studies. ER. Performed on another specimen - -. Immunoreactive tumor cells present - Quantiation 90%. PR. Performed on another specimen -. No immunoreactive tumor cells present. Immunoperoxidate Suties. Performed on another specimen - S-1500-10. Negative (score 0). Microcalcifications: Present in non-neoplastic tissue. Clinical History. Palpable mass. SPECIAL STAINS PERFORMED: pankeratin (blocks E, G16 through G18). SURGICAL REPORT.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to consider the size and extent of the primary tumor. The T stage is classified as follows: T1 (tumor ≤ 20 mm), T2 (tumor > 20 mm but ≤ 50 mm), T3 (tumor > 50 mm), and T4 (tumor of any size with direct extension to the chest wall or skin). The provided pathology report states that the greatest dimension of the largest focus of invasion is 7.5 cm. Since 7.5 cm is greater than 50 mm, the tumor size alone would place it in the T3 category. Additionally, the report mentions that the invasive carcinoma does not invade into the dermis or epidermis, which suggests there is no skin involvement that would classify it as T4. Therefore, based on the tumor size and the absence of direct extension to the chest wall or skin, the pathologic T stage for this breast cancer patient is T3.",
    "BaselineChoice": "T3",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report provided by the user, such as tumor size and extent of invasion. Then, I will compare these details against the criteria for each T stage to identify the appropriate stage. Finally, I will use the extracted information and the comparison results to produce a final response that includes my reasoning and the predicted T stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 7.5 cm corresponds to a T3 stage according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T3"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sexc F. Date Collected: I. Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREASTS CANCER. PROCEDURE. RIGHT SENTINEL LYMPH NODE BIOPSY. TISSUES. A. LYMPH NODE (S) - SENT NODE #1 \"FS. B. LYMPH NODE (S) - SENT NODE #2 FS. C. BREAST EXCISION,NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST MASS. D. AXILLARY - AXILLARY CONTENTS. E. MARGINS - ADDITIONAL RIGHT BREAST TISSUE. F. MARGINS - ADDITIONAL LATERAL MAGINS. WRI TISSUE -. FS DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE#1, F.S. -. ONE POSITIVE LYMPH NODE (1/M). B. FS NOT PERFORMED PER DR. DEFER. C. RIGHT BREAST MASS, F.S. -. TUMOR MASS 4.7 CM. AND INVOLVING SUPERIOR, INFERIOR,. MEDIAL, ANTERIOR SURGICAL MARGINS. TUMOR IS ALSO VERY CLOSE TO POSTERIOR AND LATERAL SURGICAL MARGINS. (WITH SMALL INDURATED NODULES). E. ADDITIONAL RIGHT BREAST TISSUE (GROSS MARGINS ONLY) -. LATERAL SURGICAL MARGIN IS POSITIVE FOR MALIGNANCY. THE REMAINING SURGICAL MARGINS ARE FREE OF TUMOR. F. ADDITIONAL LATERAL MARGIN (GROSS MARGINS ONLY) -. SURGICAL MARGIN is FREE OF LESION. SURGICAL REPORT. nology Number. (Time Reported to Surgeon: FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. POSITIVE FOR MULTIPLE FOCI OF METASTATIC BREAST. CANCER. B. RIGHT SENTINEL LYMPH NODE #2 -. POSITIVE FOR METASTASIS, SUBCAPSULAR SINUS DEPOSITS,. MEASURING LESS THAN 0.2 MM. IN AGGREGATE (1/1). c. RIGHT BREAST MASS -. POSITIVE FOR INFILTRATING CARCINOMA MEASURING 4.7 CM. IN GREATEST. DIMENSION WITH FOCAL EXTENSION TO THE SUPERIOR, INFERIOR AND MEDIAL. MARGINS WITH EXTENSION TO WITHIN 1/2 MM. OF THE ANTERIOR AND LATERAL. MARGINS RESECTION. D. AXILLARY CONTENTS -. POSITIVE FOR METASTASIS IN FOUR OF TWENTY TWO LYMPH NODES, TWO OF FOUR. DISPLAY SUBCAPSULAR METASTASIS MEASURING MORE THAN 2 MM. IN GREATEST. DIMENSION, ONE OF FOUR DISPLAYS MICROMETASTASIS IN SUBCAPSULAR SINUS. MEASURING LESS THAN 2 MM. AND REMAINING ONE OF FOUR DISPLAYS ISOLATED. POSITIVE CELLS IN SUBCAPSULAR SINUSES (4/22). E. ADDITIONAL RIGHT BREAST TISSUE-. POSITIVE FOR ADDITIONAL CARCINOMA WITH FOCAL EXTENSION TO THE LATERAL,. ANTERIOR, SUPERIOR AND INFERIOR SURGICAL MARGINS OF RESECTION. F. ADDITIONAL LATERAL MARGINS. POSITIVE FOR FOCAL EXTENSION TO THE NEW LATERAL. SURGICAL MARGIN OF RESECTION. PTNM CLASSIFICATION: T2 N2a, MX, STAGE IIIA. Comment: This case is discussed with Dr. The Cytokeratin (AE1/AE3) performed on specimen \"B and 0\" support the diagnosis. given. E-cadherin stain on specimen \"C\" confirms the infiltrative duct carcinoma. (. Signature on file. GROSS DESCRIPTION. SURGICAL REPORT. nology Number. The specimen is received in six separate containers labeled. designated A, B, C, D, E. and F. A. The container is received fresh unfixed labeled \"right sentinel lymph node #1. for frozen section\". The specimen consist of an ovoid mass of pink-tan, firm,. rubbery tissue with attached fat measuring 1.5x 1x 1 cm in greatest overall. dimension. Touch prep and frozen section are obtained by Dr. The entire. specimen, including frozen section, submitted in two blocks. B. The container is received fresh unfixed labeled \"right sentinel lymph node #2. for frozen section\". The specimen consists of an ovoid mass of tan-gray, firm,. rubbery tissue with attached fat measuring 0.9 x 0.8 x 0.4 cm in greatest overall. dimension. A touch prep is obtained by Dr. A frozen section Is not. performed per Dr. Entire specimen one block. C. The container is received fresh unfixed labeled \"gross margins right breast. mass\". The specimen consists of an 18 gram ovoid mass of apparent fatty and fiber incased. ovoid mass which is 5.5 x 3 x 2 cm in greatest overali dimension. There is an Inserted Indicator. wire. There is an attached single suture indicating anterior margin inked with a blue dye. Posterior is inked with a black. There are two short sutures indicating superior margin inked with. a red dye. Inferior is inked with a yellow. There is a long suture indicating lateral margin Inked. with an orange. Medial is Inked with a green. Gross margins are observed by Dr. He. states tumor mass is 4.7 cm and involving superior, inferior, medial, anterior, surgical margins. Tumor mass is very close to the posterior and lateral surgical margin, with small indurated. nodules. The specimen is submitted in twelve blocks. Key note block summary: 1- superior, 2 - Inferior, 3 - anterior, 4 - posterior, 5 -. lateral, 6 - medial. All of those are perpendicular. 7 through 12 - remaining. D. The container is received fresh unfixed labeled \"exiliary contents\". The specimen. consists of an irregular mass of apparent fatty tissue measuring 10 x 8: x 3 cm in. greatest overali dimension. Serial sectioning reveais firm, purple-tan nodules. varying up to 0.9 cm in greatest dimension. The entire specimen is submitted in. five blocks. E. The container is received fresh unfixed for gross margins which are obtained by. Dr. labeled \"additional right breast tissue\". There is a single short suture indicating anterior. margin inked with an orange dye. Deep margin is inked with a black dye. There are two short. sutures indicating superior margin inked with a red dye. Inferior is inked with a yellow. There is a. single long suture indicating lateral margin inked with a green dye. Medial is inked with a blue. Sectioning reveais firm nodules varying up to 4 cm in greatest dimension. Lateral/green margin is. grossly positive. These nodules are chiefly located in the anterior lateral area and approximately. 0.2 cm from the anterior margin. The specimen is submitted in nine blocks. Key note block summary: 1 - lateral, 2 - medial, 3 - anterior, 4 - deep, 5 - superior, 6 - inferior,. 7 through 9 - random. F. The container is received fresh unfixed labeled \"additional lateral margins -. suture on new lateral margin which is inked with a green dye. Gross margins are. observed by Dr. Sectioning reveais firm paipable nodules varying up to. 0,3 cm in greatest dimension. They appear to be 0.4 cm from the new lateral. margin. The specimen is submitted as four sections in four blocks. SURGICAL REPORT. mology Number: MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: E-Cadherin (specimen C); Cytokeratin. (AE1/AE3) (specimens B and D). SURGICAL REPORT.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report regarding the size of the tumor and its extension. The T stage is classified as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided report, the tumor mass is described as measuring 4.7 cm in greatest dimension. This measurement directly corresponds to the criteria for T2, as it is more than 2 cm but not more than 5 cm. Furthermore, while the report mentions involvement and closeness to various surgical margins, it does not describe direct extension to the chest wall or skin, which would be required for a T4 classification. Thus, based on the size of the tumor, the pathologic T stage for this breast cancer patient is T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and involvement of margins. Then, I will apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition) to determine the correct T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size of 4.7 cm corresponds to a T2 stage according to the AJCC Cancer Staging Manual (7th edition), despite its involvement of multiple surgical margins.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Path- site : breast, central portion (50.1. Chief of. specimen: spec Type: SURGICAL P. RT BR CA - INVASIVE. DOCTOR(s) $. PROCEDURE: A.RT BR TISSUE. B.RT AX SENTINEL NODE #1. C.RT AX SENTINEL NODE #2. D.RT AX SENTINEL NODE #3. PART A RECEIVED LABELED. RIGHT BREAST, IS A SIMPLE. MASTECTOMY SPECIMEN MEASURING 28 x 27 x 5.7 CM. THE NIPPLE IS. UNREMARKABLE. THE SURROUNDING SKIN ELLIPSE MEASURES 25.5 x 16.3 CM. FOCAL BLUE DYE IS NOTED IN THE CENTRAL PORTION OF THE SKIN WHICH IS UPPER. OUTER QUADRANT TO THE NIPPLE. A SUTURE DENOTES 12 O' CLOCK. ADDITIONALLY. WITHIN THE CONTAINER IS A V-SHAPED PORTION OF SKIN WITH UNDERLYING FATTY. TISSUE MEASURING 9.5 x 10 X 1.6 CM IN GREATEST DIMENSIONS. THIS IS NOT. OTHERWISE ORIENTED. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE. DEEP WITH BLACK INK. SECTIONING REVEALS BLAND YELLOW FATTY TISSUE NITH. FINE FIBROUS BANDS AND A STELLATE PINK-GRAY FIBROUS LESION IN THE 9. O' CLOCK AREA MEASURING 2.2 x 1.7 x 3.0 CM FROM MEDIAL TO LATERAL. THIS. IS ALSO IN THE CENTRAL PORTION OF THE BREAST. IT IS 2 CM FROM THE DEEP. MARGIN AND 2 CM FROM THE SKIN AND THEREBY GREATER THAN 3 CM FROM ALL. OTHER MARGINS. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE (MIRROR. IMAGE TO PROTOCOL), A2--DEEP MARGIN TO LESION, A3 AND 4--FULL. CROSS-SECTION OF LESION, A5--LESION, A6 AND 7--FULL CROSS-SECTION OF. LESION. NOTE THAT A5 THROUGH A7 ARE MIRROR IMAGE TO PROTOCOL SECTIONS. AND NOTE THAT A7 IS IN AREA OF WING CLIP. A8--UPPER INNER QUADRANT,. A9 -UPPER OUTER QUADRANT, A10--LOWER OUTER QUADRANT, .1--LOWER INNER. QUADRANT. NOTE: A8 THROUGH All ARE MIRROR IMAGES TO PROTOCOL SECTIONS. SECTIONING THE SEPARATELY SUBMITTED PORTION OF TISSUE REVEALS IT TO BE. GROSSLY UNREMARKABLE, AND A REPRESENTATIVE SECTION AT THE POINT OF THE. V. IS SUBMITTED LABELED A12. PART B RECEIVED LABELED. RIGHT AXILLA SENTINEL NODE #1,. IS A 3 x 1.8 x 1.2 CM PORTION OF YELLOW FATTY TISSUE WITHIN WHICH IS A. 1.5 CM CENTRALLY FAT-REPLACED GROSSLY UNREMARKABLE LYMPH NODE. THIS IS. BISECTED AND SUBMITTED LABELED B. PART C RECEIVED LABELED. RIGHT AXILLA SENTINEL NODE #2,. IS A 3.7 x 2 x 1.3 CM IRREGULAR FRAGMENT OF YELLOW-RED FATTY TISSUE. SECTIONING REVEALS A GROSSLY FAT-REPLACED GROSSLY UNREMARKABLE LYMPH. Chief of Pathology. thone. Tax. (Contizued). Specimen. Spec Type: SURGICAL P. NODE, SUBMITTED LABELED C1 THROUGH 3. PART D RECEIVED LABELED. RIGHT AXILLA SENTINEL NODE #3,. IS AN OVOID PORTION OF YELLON FATTY TISSUE MEASURING 3 x 1.7 x 0.5 CM. SECTIONING REVEALS GROSSLY FAT-REPLACED NODAL TISSUE. THE SPECIMEN IS. ENTIRELY SUBMITTED LABELED D. PROCEDURES: 88307/4, IMMUNOPEROXIDAS/3. A BLK/12, BBX X6, CBX x6/3, DBX X6. PART A RIGHT SIMPLE MASTECTOMY: POORLY DIFFERENTIATED INFILTRATING DUCT. CARCINOMA, NUCLEAR GRADE II/III WITH A MODERATE MITOTIC INDEX. THE TOMOR. IS 22 MM IN MAXIMUM MICROSCOPIC DIMENSION. AREAS OF POSSIBLE LYMPHATIC. SPACE INVASION ARE PRESENT, BUT THIS MAY ONLY BE RETRACTION ARTIFACT. ALL MARGINS ARK FREE OF TUNOR BY DISTANCES OF AT LEAST 20 MM. PARTS B, c, AND D RIGHT AXILLARY SENTINEL LYMPH NODES NUMBERS 1-3,. BIOPSIES: LYMPH NODES WITH NO EVIDENCE OF MSTASTATIC DISEASE, SUPPORTED. BY NEGATIVE CITOKERATIN IMMUNOHISTOCHEMICAL STAINING. 1. (prelim.). (signature on file).\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the size and extent of the primary tumor. The T stage is based on the largest dimension of the invasive tumor. The key information from the pathology report is the size of the tumor, which is described as 2.2 x 1.7 x 3.0 cm, with the largest dimension being 3.0 cm, but later it's mentioned that 'THE TUMOR IS 22 MM IN MAXIMUM MICROSCOPIC DIMENSION.' This indicates the largest dimension of the tumor is actually 2.2 cm. According to the AJCC Cancer Staging Manual (7th edition), T1 is defined as a tumor that is 2 cm or less in greatest dimension. Since the tumor in this case is 2.2 cm, which is slightly over 2 cm, we need to consider T2. T2 is defined as a tumor more than 2 cm but not more than 5 cm in greatest dimension. Given that the tumor size falls within this range, the pathologic T stage for this breast cancer patient would be T2.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and depth of invasion, and then apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition).",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        SURGICAL REPORT. Sex. F. Date Collected: I. Date Received: M.R. Number. Doctor: Account Numbe. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH SENTINEL LYMPH NODE BIOPSY, F.S.: POSSIBLE AXILLARY DISSECTION. TISSUES. A. BREAST EXCISION,NEEDLE LOC, SIMPLE,MARGINS,ETC - RIGHT BREAST LUMP. B. SENTINEL LYMPH NODE (S) - #1 \"FS. FS DIAGNOSIS. RIGHT BREAST LUMP (GROSS MARGINS) -. MARGINS GROSSLY NEGATIVE FOR MALIGNANCY. a. RIGHT SENTINEL LYMPH NODE #1, F.S. -. SENTINEL NODE #1, NEGATIVE FOR MALIGNANCY. (REPORTED TO SURGEON: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT BREAST LUMP -. POORLY DIFFERENTIATED INFILTRATINO DUCTAL CARCINOMA WITH CENTRAL. THE TUMOR MEASURES IN MAXIMUM DIMENSION. II//II). NECROSIS (SCARFF-BLOOM-RICHARDSON GRADE. 3 CM. LYMPHOVASCULAR INVASION IDENTIFIED INSIDE THE TUMOR. ALL SURGICAL MAROINS ARE FREE OF THE TUMOR. B. RIGHT SENTINEL LYMPH NODE #1 . ONE POSITIVE LYMPH NODE (1/1). PTNM CLASSIFICATION: STAGE IIB, T2 N1 MX. PQRI CATEGORY II: 3260F. Diagnosed by: Revlewed and electronically signed out by: SURGICAL REPORT. COMMENT. Specimen \"B\" shows metastatic carcinoma which is shown in the permanent section and not In. the frozen section. This case is discussed with Dr. GROSS DESCRIPTION. The specimen is received in two separate containers labeled. designated A. and B. A. The container Is received fresh unfixed labeled \"right breast lump\" and consists of a 33 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 5.5 x 4.5 x 2 om. In greatest overall. dimension. There are two sutures indicating superior margin inked with yellow dye, inferior Is. inked green. There Is a single short suture indicating lateral margin inked with orange dye,. medial is inked black. There is a single short suture indicating anterior margin Inked with blue. dye, posterior Is Inked red. Sectioning reveais a tumor which is 3x 2.5) 1 cm. in greatest overall. dimension and grossly appears to be 0.4 cm. from the superior/yellow, 0.9 cm. from the. inferior/green, 0.4 cm. from the medial/black, 0.3 cm. from the lateral/orange, 0.5 cm. from the. anterior/blue, 0.6 cm. from the posterior/red. The specimen is submitted In twelve blocks. Key Note Block Summary: 1-superior, 2-inferlor, 3-medial, 4-lateral, 5-anterior, 6-. posterior, 7 through - tumor, 10 through 12-random. B. The container Is received fresh unfixed labeled \"right sentinel lymph node #1 for frozen section\". and consists of an ovoid mass of apparent fat which is 1.5x x 0.6 cm. in greatest overail. dimension. Sectioning reveais a 1 cm. pink-tan firm nodule. Touch prep and frozen section are. obtained by Dr. The entire specimen including frozen section is submitted in two. blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. Patient Narr. SURGICAL REPORT.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to identify the size of the tumor. The pathologic T stage is classified as follows: T1 - Tumor 2 cm or less in greatest dimension, T2 - Tumor more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report, such as tumor size and whether the tumor has invaded the chest wall or skin. Then, I can apply the T-staging rules to determine the appropriate stage (T1, T2, T3, or T4). Finally, I will produce a final response with my reasoning and the predicted T stage.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        chief of Pathology. Specimen: Reg# 2. Spec Type: SURGICAL P. BREAST CANCER INVASIVE. DOCTOR (§) : PROCEDURE: A. RT BREAST DEEP MARGIN. B. LT BREAST. c. RT PREAST AND AXILLARY NODES. RECRIVED. RTS. LABELED. RIGHT DEEP MARGIN INK MARKS NEW. .RREGULAR PORTION OF YELLOW FATTY AND BRONN MUSCULAR TISSUE. ME. LNG 4.8 x 2.2 x 0.6 CM IN GREATEST DIMENSIONS. ONE SIDE OF THE. SPECIMEN IS RECEIVED MARKED WITH BLUE INK. THIS SIDE IS FURTHER MARKED. NTTU PITE INV. TH A PERIMETER OF RED INK. THE SPECIMEN IS SECTIONED AND. 3D LABELED A1 THROUGH A3. PA. ABELED. LEFT BREAST IS A SIMPLE. MAS1. EN MEASURING 24.5 x 21 x 3.8 CM. A SUTURE DENOTES 12. O'CLO. THE NI PLE IS FLAT WITHIN A 23.7 x 15.3 CM SKIN ELLIPSE. IN. THE 9 O'CLOCK AREA OF THE BREAST THERE IS A 0.5 CM IN DIAMETER. FLONER-SHAPED RED-BROWN SKIN LESION. THE SUPERFICIAL ASPECT IS MARKED. NITH BLUE INK, THE DEEP WITH BLACK INK. SECTIONING REVEALS THE SPECIMEN. TO CONSIST OF BLAND YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THERE. ARE NODULAR FIRM AREAS NOTED CENTRALLY THAT DO NOT FORM DISCRETE MASSES. SECTIONS ARE SUBMITTED AS FOLLOWS: 31--NIPPLE AND DESCRIBED SKIN LESION,. B2 - CENTRAL DEEP MARGIN, B3 AND B4 --UPPER OUTER QUADRANT, B5 AND. 86--UPPER INNER QUADRANT, B7 AND B8--LOWER INNER QUADRANT, B9 AND. B10--LOWER - OUTER QUADRANT, B11--TISSUE CENTRAL. NOTE THAT B1, B3, B5,. B7, B9, AND B11 ARE MIRROR IMAGE TISSUE TAKEN PER PROTOCOL. ADDITIONAL SECTIONS FROM THE LOWER INNER QUADRANT ARE SUBMITTED LABELED. B12 THROUGH B14, A SECTION FROM THE SUBAREOLAR AREA IN B15, AND. ADDITIONAL TISSUE FROM THE UPPER OUTER QUADRANT B16 AND 17. PART c RECEIVED LABELED. RIGHT BREAST AND AXILLARY LYMPH. NODE IS A RIGHT MODIFIED RADICAL MASTECTOMY SPECIMEN WITH FRAGMENTS OF. LOOSE TISSUE WHICH ALSO DEMONSTRATE PALPABLE LYMPH NODES. THE OVERALL. DIMENSIONS ARE 30 x 22 x 4.3 CM. THE NIPPLE IS FLATTENED. IMMEDIATELY. Chief of Pathology. Tax. Specimen: spec Type: SURGICAL P. LATERAL TO THE NIPPLE IS A PALPABLE MASS. THE SKIN ELLIPSE MEASURES 22.6. x 14. 0 CM. A SMALL RAISED PIGMENTED LESION IS FOUND IN THE LOWER OUTER. QUADRANT ADJACENT TO THE SKIN RESECTION MARGIN MEASURING 0.4 CM IN. DIAMETER. THE SUPERFICIAL ASPECT IS MARKED IN BLUE INK, THE DEEP. ASPECT WITH BLACK INK. WHERE THE AXILLARY TAIL IS REMOVED, IT IS MARKED. IN RED AND DOES NOT REPRESENT TRUE MARGIN. THE AXILLARY TAIL IS EXAMINED. FOR LYMPH NODES. IN THE LOW AXILLARY TAIL, THERE IS A 2.8 CM CENTRALLY. 7AT-REPLACED LYMPH NODE WITH A COIL CLIP. ONE HALF IS SUBMITTED PER. PROTOCOL. THE REMAINDER IS SUBMITTED AS C1. A SECOND LOW NODE IS. GROSSLY POSITIVE 1.6 CM IN GREATEST DIMENSION. ONE HALF IS SUBMITTED AS. C2 WITH THE REMAINDER SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE THEN. SUBMITTED AS FOLLOWS: C3--ONE HALF GROSSLY UNREMARKABLE LYMPH NODE. (MIRROR IMAGE TO PROTOCOL), C4--TWO NODES EACH BISECTED, C5--ONE NODE. BISECTED, C6--ONE NODE BISECTED, C7--ONE NODE BISECTED, C8--TWO NODES. EACH BISECTED, C9--FOUR NODES, C10--TWO NODES EACH BISECTED, C11 AND. C12--ONE NODE TOTAL. SECTIONING REVEALED THE BREAST TO CONSIST OF BLAND. YELLOW FATTY TISSUE WITH FINE FIBROUS BANDS. THE PALPABLE MASS IS. ILL-DEFINED WITH PINK-TAN TISSUE INTERSPERSED IN THE YELLOW-FATTY TISSUE. THIS EXTENDS FROM THE SUBAREOLAR AREA IN THE LONER OUTER QUADRANT. MEASURING 6 CM FROM MEDIAL TO LATERAL BY PALPATION 6.5 CM FROM SUPERIOR. TO INFERIOR AND 4 CM FROM SUPERFICIAL TO DEEP IN AN ILL-DEFINED MANNER. GROSSLY THIS EXTENDS TO WITHIN 0.5 CM OF THE DEEP MARGIN. SECTIONS ARE. SUBMITTED AS FOLLOWS: C13--NIPPLE (MIRROR IMAGE TO PROTOCOL), C14 AND. C15--LESION AND CLOSEST GROSS DEEP MARGIN, C16--THE MOST LATERAL ASPECT. OF THE LESION (MIRROR IMAGE TO PROTOCOL), C17--THE MOST CENTRAL AND. MEDIAL PORTION OF THE LESION (MIRROR IMAGE TO PROTOCOL) NOTE THAT C16. AND C17 ARE 6 CM APART, C18--TUMOR (MIRROR IMAGE TO PROTOCOL), C19--THE. MOST INFERIOR ASPECT OF THE LESION WITH INFERIOR SUPERFICIAL MARGIN,. C20--THE SUPERIOR PORTION OF THE LESION OR ADJACENT TO MARGIN CENTRAL. SPECIMEN, C21--UPPER OUTER QUADRANT, C22--LOWER INNER QUADRANT,. C23--UPPER INNER QUADRANT, C24 AND C25--ADDITIONAL SECTIONS OF CENTRAL. TUMOR (MIRROR IMAGE TO PROTOCOL) . PROCEDURES: 88307/2, 88309, A BLK/3, B BLK/17, C BLK/25, ER PR KI67 HER2. PART A RIGHT BREAST DEEP MARGIN REEXCISION: FIBROADIPOSE TISSUE AND. SKELETAL MOSCLE WITH NO EVIDENCE OF MALIGNANCY. THE NEW INKED MARGIN IS. FREE OF NEOPLASM. PART B LEFT BREAST, SIMPLE MASTECTOMY: 1. INFILTRATING LOBULAR CARCINOMA, NUCLEAR GRADE I WITH LOW MITOTIC. INDEX, IDENTIFIED IN THE LOWER INNER QUADRANT WITH AN ESTIMATED TUMOR. DIMENSION OF 21 MM (SLIDES B7, B8, B12-14). Chief of yathology. Speciment. status: Spec Type: SURGICAL P. 2. THE NIPPLE AND DEEP MARGIN ARE FREE OF NEOPLASM. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. PROLIFERATIVE FIBROCYSTIC DISEASE WITH A FOCUS OF LOBULAR CARCINOMA. IN SITU IDENTIFIED IN THE UPPER OUTER QUADRANT ALONG WITH SCLEROSING. ADENOSIS, DUCT HYPERPLASIA OF THE OSUAL TYPE, APOCRINE METAPLASIA AND. CYST FORMATION. PART C RIGHT BREAST, MODIFIED RADICAL MASTECTOMY: 1. LARGE MODERATELY DIFFERENTIATED INTRADUCTAL AND INFIL/TRATING DUCT. CARCINOMA, NUCLEAR GRADE II WITH LOW MITOTIC INDEX NITH FOCI OF. MUCINOUS DIFFERENTIATION SPANNING A DISTANCE OF 65 MM. 2. THE DEEP MARGIN IS FREE OF NEOPLASM. DUCTAL CARCINOMA IN SITU. INVOLVES THE NIPPLE. 3. LYMPHATIC INVASION IS PRESENT. 4. METASTATIC CARCINOMA TO 1 OF 15 AXILLARY LYMPH MODES. ONE LYMPH NODE. DEMONSTRATES PREVIOUS BIOPSY SITE CHANGE BUT NO RESIDUAL NEOPLASM. 5. HEMANGIOMA, SKIN OF BREAST. RECEPTOR AND PROGNOSTIC FACTOR DETERMINATION WILL BE PERFORMED ON BLOCK. B7. -. ESTROGEN RECEPTOR: POSITIVE. Nuclei Stained: 100%. Intensity: 3. Reference Range Negative <1%. Positive >= 1t. PROGESTERONE RECEPTOR: NEGATIVE. Nuclei stained: o. Intensity: 1. Reference Range: Negative <1%. Positive >= 1%. Her-2/neu: NEGATIVE. Score: 1+. Reference Range: Negative 0 - 1+. Equivocal 2+. Chief of Fatholegy. specimen: Spec Type: SURGICAL P. Positive 3+. Ki-67: LOW. Nuclei Stained: 3. Intensity: Reference Range: Low <10%. Borderline 10-20%. High >20%. See full scanned report for details. 1. 1. SENT TO: 2. REQUESTED BYs. 3. DATE SEST: 4. KETHOD or. 5. NO. or BLOCKS: 7. KATERIAL (#) TO BE RETURNED: 14. SPECINEE SENT (x/m) $ 1. (prelim.). (signature on file). 0.\n        ",
    "Answer": 2,
    "Filename": "TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to identify the size of the tumor and whether it has invaded nearby tissues or structures. The T stages are defined as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, T4 - Tumor of any size with direct extension to the chest wall or skin. Based on the provided pathology report, the key information is found in Part C of the report, which describes the right breast, modified radical mastectomy specimen. It mentions a 'LARGE MODERATELY DIFFERENTIATED INTRADUCTAL AND INFIL/ TRATING DUCT CARCINOMA, NUCLEAR GRADE II WITH LOW MITOTIC INDEX WITH FOCI OF MUCINOUS DIFFERENTIATION SPANNING A DISTANCE OF 65 MM.' This indicates the tumor spans 6.5 cm from superior to inferior, which is the dimension that should be considered for staging. Since the tumor is more than 5 cm in its greatest dimension, it falls into the T3 category. ",
    "BaselineChoice": "T3",
    "Monologue": "I need to extract the tumor size from the pathology report to determine the T stage.",
    "ToolsQueued": "['extract_information', 'produce_final_staging_response']",
    "Rationale": "Tumor size in the left breast is 21 mm and in the right breast is 65 mm, corresponding to T1 and T3 respectively according to the AJCC Cancer Staging Manual (7th edition).",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        of '. specimen: spec Type: SURGICAL P. D. RIGHT BREAST CANCER - INVASIVE. DOCTOR ($): PROCKDURE: MODIFIND BADICAL. A. RIGHT MODIFIED RADICAL MASTECTOMY. B. MEDIAL SKIN RIGHT BREAST. PART A IS RECEIVED LABELED. RIGHT MODIFIED RADICAL. MASTECTOMY STITCH MARKS 12 O'CLOCK, IS A RIGHT MODIFIED RADICAL. MASTECTOMY SPECIMEN MEASURING 26 x 18.5 x 5.5 CM IN GREATEST DIMENSIONS. THE NIPPLE IS UNREMARKABLE AND IS WITHIN A 19 x 11.7 CM SKIN ELLIPSE. IN. THE 5 TO 6 O'CLOCK AREA AT THE INFERIOR MARGIN THERE IS A 3 CM IN. DIAMETER CYSTIC STRUCTURE. THE SKIN HAS A BROWN DISCOLORED PLAQUE-LIKE. AREA AT 12 O'CLOCK. THERE IS A PALPABLE FIBROUS MASS IN THE BREAST TISSUE. BENEATH THE SUTURE SPANNING A DISTANCE OF 6 x 5 x 3.5 CM. THE SUPERFICIAL. ASPECT IS MARKED WITH BLUE INK, THE DEEP MARGIN WITH BLACK. THE AXILLARY. TAIL IS REMOVED FROM THE SPECIMEN AND WHERE IT IS REMOVED IT IS MARKED. WITH RED INK AND DOES NOT REPRESENT TRUE MARGIN. THERE IS ONE GROSSLY. POSITIVE LYMPH NODE IN THE MIDPORTION OF THE AXILLARY TAIL. THE HIGHEST. NODE GROSSLY IS NEGATIVE. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--ONE-HALF OF A GROSSLY POSITIVE LYMPH NODE (REMAINDER. SUBMITTED PER PROTOCOL), 13--GROSSLY HIGHEST LYMPH NODE, A4--ONE LYMPH. NODE BISECTED, A5--ONE LYMPH NODE BISECTED, A6--ONE LYMPH NODE. A7--TUMOR. AND DEEP MARGIN, A8 AND A9--TUMOR AND SKIN ADDING TO A8 AN AREA OF COIL. CLIP, A10--TUMOR AT INFERIOR ASPECT ADJACENT TO FIBROUS TISSUE,. All--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER INNER QUADRANT,. 12--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER OUTER QUADRANT,. A13--ADDITIONAL UPPER OUTER QUADRANT, A14--LOWER OUTER QUADRANT 4.5 CM. FROM GROSS TUMOR, A15--LOWER INNER QUADRANT 3 CM FROM GROSS TUMOR,. A16--CYSTIC STRUCTURE IN 5 O'CLOCK AREA. THE AXILLARY TAIL IS THEN. FURTHER EXAMINED FOR LYMPH NODES, WHICH ARE SUBMITTED AS FOLLOWS : A17--ONE NODE BISECTED, A18--ONE BONE BISECTED, A19--ONE NODE BISECTED,. A20--ONE NODE BISECTED. ASSOCIATED WITH THE PLAQUE-LIKE AREA OF THE SKIN. IS AN UNDERLYING FIRM PINK-GRAY MASS MEASURING 3.5 x 3.3 x 3.1 CM IN. GREATEST DIMENSIONS. GROSSLY THIS EXTENDS TO WITHIN 0.8 CM OF THE DEEP. MARGIN. THE CENTRAL PORTION OF THE BREAST ALSO DEMONSTRATES DENSE. GRAY-TAN FIBROUS TISSUE WITH MULTIPLE CYSTS. ADDITIONAL SECTIONS ARE SUBMITTED AS FOLLONS FOLLONING INITIAL REVIEW OF. SLIDES: A21 AND A22--SKIN MARGIN, 23--SUPERFICIAL MARGIN. Chief of Pathology. Fhone (. (Contiaued). Speciment. Regti. spec Type: SURGICAL P. PART B IS RECEIVED. MEDIAL SKIN RIGHT BREAST. IT CONSISTS. OF AN UNORIENTED, SOMEWHAT TRIANGULAR PORTION OF SKIN WITH UNDERLYING. SUBCUTANEOUS TISSUE, APPROXIMATELY 2 x 1 x 1 CM. THE RESECTION IS INKED. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED IN CASSETTES B1 AND B2. PROCEDURES: 88305, 88309, A BLK/23, B BLK/2. PART A RIGHT MODIFIED RADICAL MASTECTOMY: IN SITU AND INFILTRATING. DUCTAL CARCINOMA. THE INFILTRATING TUMOR IS MODERATELY DIFFERENTIATED,. NUCLEAR GRADE III/III WITH A MODERATE MITOTIC INDEX. THE SUPERFICIAL. ASPECT OF THE TUMOR EXTENDS INTO THE DERMIS. THE DEEP MARGIN IS FREE OF. TUMOR BY A DISTANCE OF 10 MM FOR A SUPERFICIAL TO DEEP SIZE OF 35 MM. OVER 90% OF THE TUMOR IS INVASIVE. AREAS OF PROBABLE BREAST LYMPHATIC. SPACE INVASION ARK PRESENT BUT DERMAL LYMPHATIC SPACE INVASION IS NOT. IDENTIFIED. BREAST TISSUE AWAY FROM THE PRIMARY TUMOR MASS SHONS. PROLIFERATIVE FIBROCYSTIC DISEASE. SKIN MARGINS CLOSEST TO THE TUMOR ARE. NEGATIVE. METASTATIC CARCINOMA IS PRESENT IN 4 OF 9 LYMPH NODES. PART B MEDIAL SKIN OF RIGHT BREAST, RESECTION: SKIN AND SUBCUTANEOUS FAT. WITH NO EVIDENCE OF MALIGNANCY. 1. (prelim.). (signature on file).\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A",
    "BaselineRationale": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the information provided in the pathology report. The T stage is based on the size of the tumor and whether it has spread to the skin or chest wall. Here's the step-by-step analysis:\\n1. **Tumor Size**: The report mentions a palpable fibrous mass in the breast tissue with dimensions of 6 x 5 x 3.5 cm. However, for T staging, we consider the size of the invasive component. The report states that the superficial to deep size of the tumor is 35 mm, which is approximately 3.5 cm.\\n2. **Skin Involvement**: The report notes that the superficial aspect of the tumor extends into the dermis, indicating skin involvement. However, it specifies that dermal lymphatic space invasion is not identified, suggesting that while the tumor reaches the skin, it does not extensively invade the dermal lymphatics.\\n3. **Chest Wall Involvement**: There is no mention of the tumor invading the chest wall.\\nBased on these observations, we can apply the AJCC Cancer Staging Manual (7th edition) criteria for T staging:\\n- T1: Tumor ≤ 20 mm in greatest dimension.\\n- T2: Tumor > 20 mm but ≤ 50 mm in greatest dimension.\\n- T3: Tumor > 50 mm in greatest dimension.\\n- T4: Tumor of any size with direct extension to the chest wall or skin (ulceration or skin nodules).\\nGiven that the tumor size is approximately 3.5 cm (35 mm), which falls into the T2 category based on size alone, and considering the skin involvement without chest wall involvement or extensive dermal lymphatic invasion, the tumor is classified based on its size since the skin involvement described does not meet the criteria for T4 (which typically involves more extensive skin involvement like ulceration, skin nodules, or direct invasion into the chest wall).\\nTherefore, the pathologic T stage for this breast cancer patient is T2, based on the tumor size being greater than 20 mm but less than or equal to 50 mm.",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage, I need to extract relevant information from the pathology report and apply the AJCC Cancer Staging Manual (7th edition) rules.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is between 2 cm and 5 cm in greatest dimension.",
    "Choice": "T2"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        Specimen #: ge: if Race: Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE BIOPSY, LEFT. B: LEFT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. SENTINEL LYMPH NODE, DESIGNATED LEFT BREAST, BIOPSY: -LYMPH NODES EXAMINED 2. - -LYMPH NODES POSITIVE FOR METASTASIS: o. (EXAMINATION OF MULTIPLE SECTIONS STAINED WITH HEMATOXIN AND EOSIN. AND BY IMMUNOHISTOCHEMISTRY FOR CYTOKERATIN). B. LEFT BREAST, LUMPECTOMY: -TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. -NOTTINGHAM GRADE: 2 (MODERATELY DIFFERENTIATED). -NOTTINGHAM SCORE: 7 (Tubules- 3, Nuclei= 3, Mitoses= 1, mitotic count. 4 per 10 HPF at 40x power). -TUMOR SIZE (GREATEST DIMENSION) : GREATEST DIMENSION 1.5 CM. (MEASURED GROSSLY). TUMOR NECROSIS: ABSENT. -MICROCALCIFICATIONS: PRESENT IN DUCTAL CARCINOMA IN-SITU, INVASIVE. CARCINOMA, AND BENIGN DUCTS. -VENOUS/LYMPHATIC INVASION: ABSENT. -MARGINS : NOT INVOLVED (BUT CLOSE: -DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN: 0.95 MM FROM SUPERIOR MARGIN (B2). -DISTANCE OF INTRADUCTAL CARCINOMA FROM NEAREST MARGIN: 1.1 MM FROM SUPERIOR MARGIN (B1). - INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU WITH FOCAL NECROSIS, GRADE 2. COMPRISES LESS THAN 20% OF THE TUMOR. LOBULAR CARCINOMA IN SITU. -ESTROGEN RECEPTORS: POSITIVE. (REPORTED ON EARLIER CORE BIOPSY. -PROGESTERONE RECEPTORS: POSITIVE. (REPORTED ON EARLIER CORE BIOPSY. -HER 2 NEU by IHC: NEGATIVE (1+). (REPORTED ON EARLIER CORE BIOPSY. - PATHOLOGIC STAGE: pT1cNO (i-) MX. Specimen #: FINAL DIAGNOSIS (continued) : - -ADDITIONAL PATHOLOGIC CHANGES: ADENOSIS. CHANGES CONSISTENT WITH PRIOR BIOPSY. CLINICAL DIAGNOSIS AND HISTORY: left breast cancer. GROSS DESCRIPTION: A. Received fresh labeled with the patient's name. designated \"SENTINEL LYMPH NODE BIOPSY LEFT BREAST\" consists of a 4.0 x. 3.0 x 1.0 cm irregular portion of soft tissue. Sectioning reveals two grey. yellow fatty lymph nodes each measuring 1.5 x 1.0 x 0.3 cm in overall. dimension. The specimen is entirely submitted as follows : A1-A2: lymph node #1. A3-A4: lymph node #2. A5-A6: remaining adipose tissue. 6CFNS. B. Received fresh with accompanying radiograph and embedded localization. wire labeled with the patient' S name. designated \"LEFT. BREAST LUMPECTOMY\" consists of an irregular portion of tan yellow soft. tissue oriented with short stitch superior and long lateral. The specimen. measures 9.5 cm medial to lateral, 6.5 cm superior to inferior, 2.5 cm. anterior to posterior. The superior margin is focally disrupted. The. specimen is inked as follows: superior blue, inferior green, medial red,. lateral yellow, anterior orange, posterior black. Serial sections reveal a. fairly well defined pink grey gritty mass measuring 1.5 x 1.2 x 1.0 cm in. overall dimension. The mass comes to within 0.2 cm of the anterior margin. and is located 1.0 cm from superior margin. The remainder of the cut. surface is composed of markedly dense pink grey fibrous tissue with. lobulated yellow tan adipose tissue. No additional lesions are identified. Sections are submitted as follows : B1-B2: - mass. B3: anterior margin. B4: normal appearing fibrous tissue. specimen #: GROSS DESCRIPTION (continued) : B5-B6: medial and posterior margin. B7-B8 : superior margin. B9-B10: inferior margin. B11-B12: lateral margin. 12CFSS.\n        ",
    "Answer": 0,
    "Filename": "TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to focus on the tumor size, as this is the primary factor in determining the T stage for breast cancer. The T stages are defined as follows: T1 - Tumor is 2 cm or less in greatest dimension, T2 - Tumor is more than 2 cm but not more than 5 cm in greatest dimension, T3 - Tumor is more than 5 cm in greatest dimension, and T4 - Tumor of any size with direct extension to the chest wall or skin. According to the pathology report provided, the tumor size (greatest dimension) is 1.5 cm, which falls into the category of T1. Additionally, there is no mention of the tumor extending to the chest wall or skin, which would be required for a T4 classification. Therefore, based on the tumor size, the pathologic T stage for this breast cancer patient is T1.",
    "BaselineChoice": "T1",
    "Monologue": "To determine the pathologic T stage for breast cancer according to the AJCC Cancer Staging Manual (7th edition), I need to extract relevant information from the pathology report and apply the T-staging rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size and extent of invasion were evaluated, and based on the provided information, the cancer was determined to be at an early stage with minimal invasion.",
    "Choice": "T1"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        FOI. Specimen #: 'Age: pare: AMENDED. SPECIMEN: A: LEFT BREAST MASTECTOMY B: RIGHT BREAST. FINAL DIAGNOSIS: A. BREAST, LEFT MASTECTOMY: - MODERATELY DIFFERENTIATED INFILTRATING LOBULAR CARCINOMA WITH. LOBULAR CARCINOMA IN SITU, EXTENDING INTO THE MILK DUCTS AND SKIN OF. THE NIPPLE AND INVOLVING THE UPPER OUTER QUADRENT, AND EXTENDING. WITHIN 1MM OF (BUT NOT INVOLVING) THE DEEP SURGICAL MARGIN. ATYPICAL LOBULAR HYPERPLASIA INVOLVING THE LOWER INNER QUADRANT AND. LOWER OUTER QUADRANT. B. BREAST, RIGHT) MASTECTOMY: - LOBULAR CARCINOMA IN SITU (1MM) WITH EXTENSIVE LOBULAR HYPERPLASIA. - ATYPICAL LOBULAR HYPERPLASIA. - FIBROCYSTIC CHANGES INCLUDING CYSTS, FIBROSIS, AND APOCRINE. METAPLASIA. COMMENT #1: ESTROGEN RECEPTORS : NEGATIVE. PROGESTERONE RECEPTORS: POSITIVE (80-90% OF NUCLEAR SUTAINING). COMMENT #2: HER2/NEU (FISH METHODOLOGY) : NOT AMPLIFIED (1.1). CLINICAL DIAGNOSIS AND HISTORY: -year-old with left infiltrating lobular carcinoma by biopsy. Scheduled. for bilateral mastectomy and left sentinel node biopsy. PRE-OPERATIVE DIAGNOSIS: Left breast carcinoma. TC. Specimen #: GROSS DESCRIPTION: A. LEFT BREAST MASTECTOMY received fresh is a 243.0 gram simple mastectomy. specimen, 15.5 x 15.0 x 3.3 cm, with overlying ellipse of nipple bearing. skin, 4.8 x 3.3 cm. The skin and nipple are unremarkable. The specimen is. oriented with sutures (long=lateral, short=superior) and inked as follows : Blue-superior superficial, green-inferior superficial, and. black-posterior. Sectioning reveals a 3.2 x 3.0 x 2.0 cm tumor centrally. extending into the upper inner quadrant. The tumor has poorly defined. stellate borders and a firm, tan, gritty cut surface. It is located 0.3 cm. from the inked posterior margin. The remaining tissue is predominantly. fibrous with a few admixed fluid filled cysts. Sections of skin, tumor,. and grossly unremarkable fibrous tissue harvested for the CBCP protocol;. matching paraffin sections are as follows: A1: Skin, medial tip. A2: Tumor, lateral portion. A3: Fibrous, 1.0 cm inferior to tumor. A4: Fibrous, 2.0 cm inferior to tumor. A5: Fibrous, 5.0 cm inferior to tumor. Sections through the nipple are placed in cassette labeled A6. There is no. surgical scar visible. There is a detached fragment of skin measuring 3.4. x 2.1 x 1.6 cm. A representative section from this tissue fragment is. placed in cassette A7. Representative sections of tumor are placed in. cassettes A8 through A10. Other representative sections are as follows: All: Upper inner quadrant. A12 Lower inner quadrant. A13: Lower outer quadrant. A14: Upper outer quadrant. 14CFSS. B. RIGHT BREAST received fresh is a 336.0 gram simple mastectomy specimen,. 18. x 12.5 x 2.5 cm. The specimen is oriented with sutures (long-lateral,. short-superior) and inked as follows Blue-superior superficial,. green-inferior superficial, black-posterior. The specimen is serially. sectioned revealing predominantly fibrous tissue with scattered admixed. cysts measuring up to 1.2 cm in diameter. No disctete masses are. identified. One section of each, skin and fibrous tissue (lower outer. quadrant) are harvested for the CBCP protocol; mirror images for Histology. are in cassettes B1 and B2 respectively. There is no visible scar in the. overlying nipple/areola. Sections from the areola are placed in cassette. B3. Representative sections from the 1.2 cm cyst from the central superior. quadrant (centrally between the upper inner and upper outer quadrant) are. placed in cassette B4. Representative sections are placed as follows. Specimen # : GROSS DESCRIPTION (continued) : B5-B6: Upper outer quadrant. B7-B8: Lower outer quadrant. B9-B10: Lower inner quadrant. B11-B12: Upper inner quadrant. 12CFSS.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to analyze the provided pathology report. The key information for determining the T stage is the size of the tumor and its extent, including whether it has invaded the chest wall or skin. Here's the step-by-step analysis:\\n1. **Identify the tumor size**: The report mentions a tumor size of 3.2 x 3.0 x 2.0 cm, which is crucial for determining the T stage. According to the AJCC 7th edition, T1 tumors are 2 cm or less in greatest dimension, T2 tumors are more than 2 cm but not more than 5 cm, T3 tumors are more than 5 cm, and T4 tumors are any size with direct extension to the chest wall or skin.\\n2. **Assess skin and chest wall involvement**: The report mentions that the tumor extends into the skin of the nipple but does not indicate invasion of the chest wall. The involvement of the skin, particularly if it's limited to the nipple, needs careful consideration in the context of the AJCC staging manual.\\n3. **Apply AJCC criteria**: Given the tumor size (3.2 cm) and the involvement of the skin of the nipple, we need to determine if this qualifies as T4 due to skin involvement. However, the AJCC criteria specify that T4 includes tumors of any size with direct extension to the chest wall or to the skin (not including the nipple or areola), or with edema (including peau d'orange) or ulceration of the skin of the breast, or with satellite nodules or metastases confined to the same breast.\\n4. **Determine the T stage**: Based on the size (3.2 cm, which is more than 2 cm but not more than 5 cm) and the specific details about skin involvement limited to the nipple, the tumor does not meet the criteria for T4 based on the skin involvement as described. Therefore, the tumor is classified based on its size.\\n",
    "BaselineChoice": "T2",
    "Monologue": "To determine the pathologic T stage for breast cancer, I need to extract relevant information from the pathology report, such as tumor size and extent of invasion. Then, I'll apply the T-staging rules according to the AJCC Cancer Staging Manual (7th edition) to determine the appropriate T stage (T1, T2, T3, or T4). I will use the 'extract_information' tool to gather the necessary data and the 'get_t_stage_rule' tool to apply the T-staging rules.",
    "ToolsQueued": "['extract_information', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor extends into the skin of the nipple, indicating skin involvement.",
    "Choice": "T4"
  },
  {
    "Question": "\n        Based on the following pathology report for a breast cancer patient, determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer, according to the AJCC Cancer Staging Manual (7th edition). \n        Choose from T1, T2, T3, T4.\n\n        This report contains corrections, additions or deletions. Any previous versions are stored internally and are available if necessary. Specimen: Spec Type: SURGICAL P. Suba Dr: LEFT BREAST CANCER INVASIVE. DOCTOR (S) 3. PROCEDURE: SENTINEL NODR BX/SIMPLE MASTECTOMY. A. LT SENTINEL NODE #1 - FS. B. LEFT BREAST. C. LEFT AXILLARY NODES. D. ADDITIONAL ANTERIOR MARGIN OF THE INFERIOR PORTION OF LEFT BREAST. A. METASTATIC CARCINOMA. PART A IS RECEIVED DESIGNATED. SENTINEL LYMPH. NODE #1. IT IS RECEIVED IN THE FRESH STATE FOR FROZEN. SECTION AND CONSISTS OF A FRAGMENT OF YELLOWISH-PINK FIBROADIPOSE TISSUE. WITH 2 PALPABLE NODULES, THE SPECIMEN HAVING OVERALL DIMENSIONS 4.3 x. 2.7 x 1.5 CM WITH THE LARGEST NODULE MEASURING 2 x 2 x 1 CM AND THE. SMALLER 1.5 x 1.2 x 0.3 CM. SECTIONING THE LARGER NODULE SHOWS MULTIPLE. GRAY-WHITE NODULES WITHIN A TANNISH-PINK PARENCHYMA MEASURING UP TO 0.6. x 0.4 x 0.4 CM. THE SMALLER NODULE ON SECTIONING REVEALS A. TANNISH-PURPLE PARENCHYMA WITH A 0.8 x 0.5 x 0.5-CM GRAYISH-TAN NODULE. THE SECTIONS SUBMITTED FOR FROZEN SECTION ARE SUBMITTED FOR PERMANENTS. LABELED. SECTIONS OF UNFROZEN TISSUE ARE SUBMITTED WITH A. REPRESENTATIVE SECTION FROM THE LARGEST NODULE AND THE REMAINING SMALLER. NODULE ENTIRELY. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS FSA. SECTION FROM LARGER AND SMALLER NODULES IN 1 CASSETTE: A1-CROSS. SECTION OF LARGEST NODULE, A2 -SMALLER NODULE ENTIRELY, SECTION. PART B RECEIVED LABELED. LEFT BREAST, IS A. SIMPLE MASTECTOMY SPECIMEN MEASURING 23.5 x 22 x 8.0 CM. THE NIPPLE. IS. UNREMARKABLE WITHIN A 13.5 x 9-CM SKIN ELLIPSE. A SUTURE DENOTES 12. THE SUPERFICIAL ASPECT IS MARKED WITH BLUE INK, THE DEEP WITH. Specimen: tatus: Spec Type: SURGICAL P. BLACK. SECTIONING REVEALS YELLOW FATTY TISSUE INTERSPERSED WITH. PINK-TAN GRANULAR FIBROUS TISSUE WHICH IS PRESENT DIFFUSELY THROUGHOUT. THE BREAST. IN THE 6 AND 7 CLOCK AREA, THERE IS A FIRM PINK-TAN LESION. WHICH HAS A CENTRAL CYLDNDRICAL-SHAPEI METAL CLIP. THIS FIRM AREA. MEASURES 4 x 2.5 X 3 CM IN GREATEST DIMENSIONS. IT GROSSLY EXTENDS TO. WITHIN 0.8 CM OF THE DEEP MARGIN AND 0.3 CM OF THE SUPERFICIAL MARGIN. SUPERIOR AND CENTRAL WITHIN THE BREAST, THERE IS A 4.5 x 2-CM AREA OF. FATTY TISSUE WITHOUT FIBROUS BANDS NHICH GROSSLY SEEMS DELINEATED FROM. THE SURROUNDING PARENCHYMAL TISSUE (B2) SECTIONS ARE SUBMITTED AS. FOLLOWS: B1--NIPPLE, 12--CENTRAL FATTY TISSUE, B3--TUMOR AND. SUPERFICIAL MARGIN, B4 THROUGH 7--FULL CROSS-SECTION OF THE LESION TO. INCLUDE THE DEEP AND SUPERFICIAL MARGIN, B8--FIBROUS TISSUE IMMEDIATELY. LATERAL TO THE LESION, 19--TISSUE IMMEDIATELY MEDIAL TO LESION IN LOWER. INNER QUADRANT, B10--UPPER INNER QUADRANT 14 CM FROM LESION, B11--TISSUE. AT 9 O' CLOCK 9 CM FROM LESION, B12--LOWER OUTER QUADRANT 4 CM FROM. LESION, B13--3 O'CLOCK 13 CM FROM LESION, B14--UPPER OUTER QUADRANT 15. CM FROM LESION, 15--ADDITIONAL SECTION OF TUMOR AND SUPERFICIAL MARGIN. SECTIONS OF TUMOR AND BREAST TISSUE ARE SUBMITTED PER PROTOCOL. AFTER X-RAYING THE SPECIMEN, A CLIP IS IDENTIFIED IN THE 6 O' CLOCK AREA. AT THE EDGE OF THE SKIN ELLIPSE. THIS IS 3 CM ANTERIOR AND LATERAL TO. THE PREVIOUSLY DESCRIBED LESION. THIS AREA CONSISTS OF A RED-BROWN CLOT. SURROUNDED BY INDURATED YELLOW-TAN FATTY TISSUE MEASURING 1.7 x 1.0 x 1.5. CM. THIS IS 0.5 CM FROM THE INFERIOR SUPERFICIAL MARGIN AND 3.5 CM FROM. THE DEEP MARGIN. SECTIONS FROM THIS AREA ARE SUBMITTED IN B16 THROUGH. B19. B20--DEEP MARGIN TO LESION B21 -TISSUE TAKEN BETWEEN THIS LESION. AND THE LARGER TUMOR MASS. TISSUE IS ALSO TAKEN FROM THE SECOND AREA PER. PROTOCOL. PART C RECEIVED LABELED. LEFT AXILLARY NODE,. IS YELLOW-RED FATTY TISSUE MEASURING 7.5 x 6 x 1.7 CM. THIS IS EXAMINED. FOR LYMPH NODES. ALSO LOOSE WITHIN THE CONTAINER IS A 1-CM OVOID. RED-TAN STRUCTURE. THIS IS CONSISTENT WITH A GROSSLY UNREMARKABLE LYMPH. NODE. IT IS SECTIONED AND SUBMITTED LABELED C1 WITH A PORTION SUBMITTED. PER PROTOCOL. THREE LARGER NODES ARE IMMEDIATELY IDENTIFIABLE WITHIN. THE FATTY TISSUE. THESE ARE SECTIONED WITH ONE-HALF OF EACH SUBMITTED. WITHIN C2 THROUGH C4, RESPECTIVELY, WITH C3 GROSSLY POSITIVE. SECTIONS. OF THESK NODES ARE ALSO SUBMITTED PER PROTOCOL. ADDITIONAL NODES ARE. SUBMITTED AS FOLLOWS: --FOUR NODES. PART D RECEIVED LABELED. ADDITIONAL ANTERIOR. MARGIN OF THE INFERIOR PORTION OF LEFT BREAST STITCH MARKS 12 O'CLOCK,. IS AN ELLIPTICAL PORTION OF BROWN PIGMENTED SKIN MEASURING 16 x 2.7 x. 0.9 CM. ALONG THE MIDPORTION OF ONE EDGE IS A SUTURE DENOTING 12. D'CLOCK. THIS EDGE IS MARKED WITH BLUE INK. THE 3 O'CLOCK SIDE OF THE. SPECIMEN IS THEN MARKED BLACK AND THE 9 O'CLOCK RED. THE 3 O' CLOCK. ELLIPTICAL END IS AMPUTATED AND BISECTED LONGITUDINALLY AND SUBMITTED AS. Specimen: Spec Type: SURGICAL P. D1. THE 9 O'CLOCK ELLIPTICAL END IS AMPUTATED AND BISECTED. LONGITUDINALLY AND SUBMITTED LABELED D2. BY PALPATION, THERE IS SOME. NODULARITY IN THE CENTRAL PORTION OF THE SPECIMEN AND CROSS-SECTIONS ARE. SUBMITTED IN D3 AND 4. ADDITIONAL SECTIONS FROM THE 3 O' 'CLOCK SIDE ARE. SUBMITTED IN D5 AND ADDITIONAL SECTIONS FROM THE 9 D'CLOCK SIDE ARE. SUBMITTED IN D6. PROCEDURES: PATH FS , A BLK/2, B BLK/15, C BLK/5, D BLK/6, FS-A. PART A LEFT AXILLA, SENTINEL LYMPH NODE #1: METASTATIC BREAST CARCINOMA. IS PRESENT IN ONE OF TWO LYMPH NODES EXAMINED. EXTRANODAL EXTENSION IS. NOT IDENTIFIED. PART B LEFT BREAST, SIMPLE MASTECTOMY. 1. INTRADUCTAL AND INFILTRATING DUCT CARCINOMA. INVASIVE COMPONENT. IS POORLY DIFFERENTIATED SHOWING NUCLEAR GRADE 3/3, MODERATE MITOTIC. INDEX AND TUBULE FORMATION 3 WITH TOTAL NOTTINGHAM SCORE OF 8. HIGH GRADE DCIS OF THE CRIBRIFORM AND SOLID TYPES HAVING AREAS. OF COMEDONECROSIS IS IDENTIFIED SURROUNDING AND WITHIN THE TUMOR. WITH EXTENSION INTO TERMINAL LOBULES COMPRISING APPROKIMATELY 20% OF. THE TUMOR. 2. THE INVASIVE COMPONENT HAS A MAXIMUM GROSS DIMENSION OF 4 CM AND IS. FOCALLY IDENTIFIED APPROXIMATELY 2 MM FROM THE NEAREST INKED. SUPERFICIAL MARGIN (B15). 3. RANDOM SECTIONS OF THE REMAINING QUADRANTS AND NIPPLE SKIN ARE FREE. OF TUMOR. SEE COMMENT. 4. LYMPHOVASCULAR INVASION IS IDENTIFIED. 5. THE BIOPSY SITE. IS PRESENT. 6. DIFFUSE LACTATIONAL CHANGES. PART C LEFT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST CARCINOMA. IS IDENTIFIED IN 1 OF 6 LYMPH NODES EXAMINED. EXTRANODAL EXTENSION IS. NOT SEEN. Specimen: Spec Type: SURGICAL P. PART D LEFT BREAST, ADDITIONAL ANTERIOR MARGIN OF THE INFERIOR PORTION,. EXCISION: SKIN AND SUBCUTANEOUS TISSUE WITH NO EVIDENCE OF RESIDUAL. TUMOR AND CLEAR MARGIN. THE SECOND BIOPSY SITE WAS NOT IDENTIFIED ON INITIAL GROSS EXAMINATION. THE SPECIMEN NILL BE X-RAYED TO FIND THE BIOPSY CLIP AND ADDITIONAL. SECTIONS WILL BE SUBMITTED. ADDITIONAL SECTIONS SURROUNDING THE SECOND BIOPSY SITE SHOW DCIS, SOME OF. WHICH EXTENDS INTO TERMINAL LOBULES, RARE MICROSCOPIC FOCI OF. INFILTRATING DUCT CARCINOMA, AND LYMIPHOVASCULAR INVASION. 1.\n        ",
    "Answer": 1,
    "Filename": "TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10",
    "BaselineRationale": "To determine the pathologic T stage (T1, T2, T3, or T4) for breast cancer according to the AJCC Cancer Staging Manual (7th edition), we need to identify the size of the invasive component of the tumor and whether it has extended to the chest wall or skin. The key information from the pathology report is as follows:\\n1. The invasive component of the tumor has a maximum gross dimension of 4 cm.\\n2. The tumor is focally identified approximately 2 mm from the nearest inked superficial margin, indicating close proximity to but not involvement of the skin.\\n3. There is no mention of the tumor extending to the chest wall.\\nBased on the AJCC Cancer Staging Manual (7th edition), the T stage is determined as follows:\\n- T1: Tumor ≤ 2 cm in greatest dimension.\\n- T2: Tumor > 2 cm but ≤ 5 cm in greatest dimension.\\n- T3: Tumor > 5 cm in greatest dimension.\\n- T4: Tumor of any size with direct extension to the chest wall or skin.\\nGiven that the invasive component of the tumor is 4 cm in its greatest dimension and does not extend to the chest wall or skin (though it is close to the skin margin), the pathologic T stage would be T2.",
    "BaselineChoice": "T2",
    "Monologue": "Plan: Extract tumor size, check if it matches T1, T2, T3, or T4 criteria, and apply the appropriate rule to determine the T stage.",
    "ToolsQueued": "['extract_information', 'compare_numerical_values', 'get_t_stage_rule', 'produce_final_staging_response']",
    "Rationale": "The tumor size is more than 2 cm but not more than 5 cm in greatest dimension.",
    "Choice": "T2"
  }
]